Sentence,class,file
J Bone Miner Metab 2006; 24:1-6;  PMID:16369890; http://dx.doi.org/10.1007/s00774- 005-0637-0 24.,Non-OADS,/arxiv_data1/oa_pdf/ef/6e/de-5-34.PMC3897596.pdf
Prev Med 2012; 55:146-50; PMID:22634425; http://dx.doi.org/10.1016/j.ypmed.2012.05.011 26.,OADS,/arxiv_data1/oa_pdf/ef/6e/de-5-34.PMC3897596.pdf
Cancer Causes Control 2010; 21:1701-9;  PMID:20552265; http://dx.doi.org/10.1007/s10552- 010-9599-1 27.,Non-OADS,/arxiv_data1/oa_pdf/ef/6e/de-5-34.PMC3897596.pdf
The seasonality of  pandemic and non-pandemic influenzas: the roles  of solar radiation and vitamin D. Int J Infect Dis  2010; 14:e1099-105; PMID:21036090; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ef/6e/de-5-34.PMC3897596.pdf
"review Dermato- endocrinology 5:1, 38–50; January/February/March 2013; © 2013 Landes Bioscience 38  D ermato- e ndocrinology  volume 5  i ssue 1review *Correspondence to: Jörg Reichrath; Email: joerg.reichrath@uks.eu Submitted: 12/05/12; Accepted: 02/28/13http://dx.doi.org/10.4161/derm.24156Solar U v  (Uv) -B-radiation exerts both beneficial and adverse  effects on human health.",Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Ann N Y Acad Sci  1985; 453:1-13; PMID:3000262; http://dx.doi.org/10.1111/j.1749-6632.1985.tb11793.x 2.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Prog Biophys Mol Biol 2006; 92:9-16; PMID:16603232; http://dx.doi.org/10.1016/j.pbiomolbio.2006.02.010 3.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
N Engl J Med  2007; 357:266-81; PMID:17634462; http://dx.doi.org/10.1056/NEJMra070553 4.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Exp Dermatol 2004; 13(Suppl 4):11-5; PMID:15507106; http://dx.doi.org/10.1111/j.1600-0625.2004.00257.x 5.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Anticancer Agents Med Chem 2013; 13:83-97; PMID:23094924; http://dx.doi.org/10.2174/187152013804487272.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
http://dx.doi.org/10.1016/j.jaad.2012.05.044.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
http://dx.doi.org/10.1016/j.jaad.2012.07.022.9.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
J Am Acad Dermatol 1997; 36:19-28; PMID:8996256; http://dx.doi.org/10.1016/S0190-9622(97)70320-7 11.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Prog Biophys Mol Biol 2009; 99:104-13; PMID:19268496; http://dx.doi.org/10.1016/j.pbiomolbio.2009.02.003 12.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Adv Exp Med Biol 2008; 624:16-30; PMID:18348444; http://dx.doi.org/10.1007/978-0-387-77574-6_2 13.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Adv Exp Med Biol 2008; 624:162-78; PMID:18348455; http://dx.doi.org/10.1007/978-0-387-77574-6_13 14.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
J Photochem Photobiol B 2001; 63:8-18; PMID:11684447; http://dx.doi.org/10.1016/S1011-1344(01)00198-115.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Cancer Causes Control 2011; 22:885-97; PMID:21472378; http://dx.doi.org/10.1007/s10552-011-9762-3 16.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Int J Cancer 1998; 76:628-34; PMID:9610717; http://dx.doi.org/10.1002/(SICI)1097-0215(19980529)76:5<628::AID-IJC3>3.0.CO;2-S 17.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Lancet 1994; 344:1510-1; PMID:7968149; http://dx.doi.org/10.1016/S0140-6736(94)90330-1 19.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Cancer Causes Control 2010; 21:387-91; PMID:19921445; http://dx.doi.org/10.1007/s10552-009-9470-4 20.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
PLoS One 2012; 7:e35211; PMID:22493740; http://dx.doi.org/10.1371/journal.pone.0035211,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
J Cutan Pathol 2004; 31:224-31; PMID:14984574; http://dx.doi.org/10.1111/j.0303-6987.2003.00183.x 36.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Carcinogenesis 2007; 28:390-7; PMID:16950800; http://dx.doi.org/10.1093/carcin/bgl156 39.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Cancer Lett 2003; 189:175-81; PMID:12490310; http://dx.doi.org/10.1016/S0304-3835(02)00516-5 40.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Carcinogenesis 2009; 30:1170-80; PMID:19403841; http://dx.doi.org/10.1093/carcin/bgp103 41.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Onkologie 2001; 24:128-33; PMID:11441291; http://dx.doi.org/10.1159/000050299 29.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Mol Cancer Ther 2011; 10:2179-88; PMID:21878656; http://dx.doi.org/10.1158/1535-7163.MCT-11-0422 31.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
2012 Sep 28. pii: S0960-0760(12)00190-2. http://dx.doi.org/10.1016/j.jsbmb.2012.09.024.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Am J Pathol 1999; 155:583-9; PMID:10433950; http://dx.doi.org/10.1016/S0002-9440(10)65153-X 33.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Lab Invest 2004; 84:693-702; PMID:15077124; http://dx.doi.org/10.1038/labinvest.3700096 34.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Recent Results Cancer Res 2003; 164:259-69; PMID:12899528; http://dx.doi.org/10.1007/978-3-642-55580-0_1921.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
J Invest Dermatol 2010; 130:1438-43; PMID:20043012; http://dx.doi.org/10.1038/jid.2009.402 22.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
"Ann Epidemiol 1992; 2:231-9; PMID:1342273; http://dx.doi.org/10.1016/1047-2797(92)90055-U 23.  v an Dam RM, Huang Z, Giovannucci E, Rimm EB,  Hunter DJ, Colditz GA, et al.",OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Arch Dermatol 2011; 147:1379-84; PMID:21844426; http://dx.doi.org/10.1001/archdermatol.2011.231 25.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
J Invest Dermatol 2010; 130:1438-43; PMID:20043012; http://dx.doi.org/10.1038/jid.2009.402 26.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Cancer Causes Control 2004; 15:219; PMID:15088627; http://dx.doi.org/10.1023/B:CACO.0000019571.83095.97 27.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Arch Dermatol 2010; 146:1105-10; PMID:20956641; http://dx.doi.org/10.1001/archdermatol.2010.247Table 2.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Biochem Biophys Res Commun  1971; 43:893-8; PMID:4935292; http://dx.doi.org/10.1016/0006-291X(71)90701-7 71.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
J Phys Chem B 2007; 111:7409-14; PMID:17523621; http://dx.doi.org/10.1021/jp070167f 72.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
J Steroid Biochem Mol Biol 2010; 121:164-8; PMID:20399269; http://dx.doi.org/10.1016/j.jsbmb.2010.03.082 73.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
J Invest Dermatol 2007; 127:707-15; PMID:17170736; http://dx.doi.org/10.1038/sj.jid.5700597 74.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Carcinogenesis 1997; 18:2379-84; PMID:9450485; http://dx.doi.org/10.1093/car-cin/18.12.2379 75.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Semin Perinatol 1997; 21:351-66; PMID:9352609; http://dx.doi.org/10.1016/S0146-0005(97)80002-X 77.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Mutat Res 1999; 424:37-49; PMID:10064848; http://dx.doi.org/10.1016/S0027-5107(99)00006-8 78.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Physiol Rev 2007; 87:315-424; PMID:17237348; http://dx.doi.org/10.1152/physrev.00029.2006 80.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Science 1991; 254:1001-3; PMID:1948068; http://dx.doi.org/10.1126/science.1948068 81.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Photochem Photobiol 1995; 62:218-30; PMID:7480131; http://dx.doi.org/10.1111/j.1751-1097.1995.tb05262.x 82.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
J Investig Dermatol Symp Proc 1999; 4:6-10; PMID:10537000; http://dx.doi.org/10.1038/sj.jidsp.5640173 57.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
J Biol Chem 2000; 275:11678-85; PMID:10766787; http://dx.doi.org/10.1074/jbc.275.16.11678 58.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
J Immunol Methods 2003; 280:125-33; PMID:12972193; http://dx.doi.org/10.1016/S0022-1759(03)00269-2 59.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Mutat Res 2004; 556:135-42; PMID:15491641; http://dx.doi.org/10.1016/j.mrfmmm.2004.07.011 60.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
J Photochem Photobiol B 2001; 63:88-102; PMID:11684456; http://dx.doi.org/10.1016/S1011-1344(01)00206-8 62.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
EXS 2006; 96:131-57; PMID:16383017; http://dx.doi.org/10.1007/3-7643-7378-4_6 63.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Nucleic Acids Res 2003; 31:2786-94; PMID:12771205; http://dx.doi.org/10.1093/nar/gkg402 65.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Photochem Photobiol 2004; 79:145-51; PMID:15068027; http://dx.doi.org/10.1562/0031-8655(2004)079<0145:UCPDDN>2.0.CO;2 66.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Oncogene 1999; 18:4247-53; PMID:10435637; http://dx.doi.org/10.1038/sj.onc.1202789 67.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Nat Genet 2000; 25:144-6; PMID:10835626; http://dx.doi.org/10.1038/75985 43.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Ann N Y Acad Sci 1985; 453:73-9; PMID:3865598; http://dx.doi.org/10.1111/j.1749-6632.1985.tb11799.x 46.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
FASEB J 2008; 22:2379-92; PMID:18326785; http://dx.doi.org/10.1096/fj.07-105437 49.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
J Exp Med 1989; 170:1117-31; PMID:2529340; http://dx.doi.org/10.1084/jem.170.4.1117 50.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Br J Pharmacol 1995; 114:1257-65; PMID:7620717; http://dx.doi.org/10.1111/j.1476-5381.1995.tb13341.x 52.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
J Invest Dermatol 1998; 110:1-7; PMID:9424078; http://dx.doi.org/10.1046/j.1523-1747.1998.00084.x 53.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Nitric Oxide 2004; 10:179-93; PMID:15275864; http://dx.doi.org/10.1016/j.niox.2004.04.005 54.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
J Invest Dermatol 2009; 129:834-42; PMID:18818674; http://dx.doi.org/10.1038/jid.2008.296,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Science 1998; 281:1674-7; PMID:9733514; http://dx.doi.org/10.1126/science.281.5383.1674 116.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Mol Cell Biol 2004; 24:8884-94; PMID:15456863; http://dx.doi.org/10.1128/MCB.24.20.8884-8894.2004 118.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Mutat Res 2005; 571:185-205; PMID:15748647; http://dx.doi.org/10.1016/j.mrfm-mm.2004.06.059 120.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
J Invest Dermatol 2010; 130:1914-21; PMID:20336084; http://dx.doi.org/10.1038/jid.2010.59 121.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
J Exp Med 1983; 158:84-98; PMID:6223114; http://dx.doi.org/10.1084/jem.158.1.84 122.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
J Exp Med 1996; 183:1491-500; PMID:8666907; http://dx.doi.org/10.1084/jem.183.4.1491 124.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Cell Immunol 1987; 109:206-21; PMID:2958141; http://dx.doi.org/10.1016/0008-8749(87)90305-4 125.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Photochem Photobiol 1995; 62:176-83; PMID:7638263; http://dx.doi.org/10.1111/j.1751-1097.1995.tb05255.x 126.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Cell 1992; 71:1081-91; PMID:1473146; http://dx.doi.org/10.1016/S0092-8674(05)80058-3 127.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
J Invest Dermatol 2009; 129:2694-701; PMID:19516263; http://dx.doi.org/10.1038/jid.2009.128 129.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
J Invest Dermatol 2010; 130:1209-12; PMID:20393477; http://dx.doi.org/10.1038/jid.2009.374100.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Environ Mol Mutagen 2001; 38:180-90; PMID:11746753; http://dx.doi.org/10.1002/em.1070 101.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Carcinogenesis 2001; 22:987-98; PMID:11408341; http://dx.doi.org/10.1093/carcin/22.7.987 102.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Carcinogenesis 2004; 25:11-9; PMID:14555612; http://dx.doi.org/10.1093/carcin/bgg186 103.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Nature 2007; 447:941-50; PMID:17581577; http://dx.doi.org/10.1038/nature05978 104.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
DNA Repair (Amst) 2008; 7:1542-50; PMID:18585103; http://dx.doi.org/10.1016/j.dnarep.2008.05.011 105.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
J Biol Chem 2003; 278:37536-44; PMID:12860987; http://dx.doi.org/10.1074/jbc.M305135200 108.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
J Biol Chem 2000; 275:11492-7; PMID:10753968; http://dx.doi.org/10.1074/jbc.275.15.11492 109.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Mutat Res 2001; 488:211-31; PMID:11397650; http://dx.doi.org/10.1016/S1383-5742(01)00057-6 111.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Carcinogenesis 1997; 18:245-9; PMID:9054614; http://dx.doi.org/10.1093/carcin/18.2.245 113.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Nature 1992; 356:215-21; PMID:1552940; http://dx.doi.org/10.1038/356215a0 114.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Genes Dev 1997; 11:3471-81; PMID:9407038; http://dx.doi.org/10.1101/gad.11.24.347185.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Biochemistry 2004; 43:8169-77; PMID:15209513; http://dx.doi.org/10.1021/bi049761v 86.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Biochem Biophys Res Commun 2004; 316:123-8; PMID:15003520; http://dx.doi.org/10.1016/j.bbrc.2004.02.022 87.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Am J Pathol 2000; 157:1975-81; PMID:11106570; http://dx.doi.org/10.1016/S0002-9440(10)64836-5 88.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Toxicol Appl Pharmacol 2004; 195:298-308; PMID:15020192; http://dx.doi.org/10.1016/j.taap.2003.08.019 89.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
J Cell Biochem 2003; 89:663-73; PMID:12858333; http://dx.doi.org/10.1002/jcb.10540 90.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Arch Dermatol Res 2004; 295:527-34; PMID:15042383; http://dx.doi.org/10.1007/s00403-004-0451-x 91.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
J Cell Biochem 2004; 93:951-67; PMID:15389877; http://dx.doi.org/10.1002/jcb.20227 92.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
J Photochem Photobiol B 2005; 78:141-8; PMID:15664501; http://dx.doi.org/10.1016/j.jphotobiol.2004.09.010 93.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
J Invest Dermatol 1990; 95:55-9; PMID:2366001; http://dx.doi.org/10.1111/1523-1747.ep12873312 95.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Expert Rev Mol Med 2002; 4:1-22; PMID:14585163; http://dx.doi.org/10.1017/S146239940200532X 97.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
EMBO J 2002; 21:4719-29; PMID:12198174; http://dx.doi.org/10.1093/emboj/cdf456 98.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Nature 1968; 218:652-6; PMID:5655953; http://dx.doi.org/10.1038/218652a0 99.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Prog Biophys Mol Biol 2006; 92:86-91; PMID:16620921; http://dx.doi.org/10.1016/j.pbio-molbio.2006.02.002 135.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
J Dermatol Sci 2010; 59:192-7; PMID:20691571; http://dx.doi.org/10.1016/j.jdermsci.2010.07.005132.,OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
J Invest Dermatol 2005; 125:840-6; PMID:16185286; http://dx.doi.org/10.1111/j.0022-202X.2005.23894.x 133.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
Photochem Photobiol Sci 2004; 3:736-40; PMID:15295628; http://dx.doi.org/10.1039/b313199h 131.,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
J Invest Dermatol 1999; 112:939-44; PMID:10383742; http://dx.doi.org/10.1046/j.1523-1747.1999.00610.x,Non-OADS,/arxiv_data1/oa_pdf/78/5c/de-5-38.PMC3897597.pdf
"Curiously some of the earli - est phytoplankton including Emiliania huxleyi (which is a coc - colithophore, i.e., has a calcium carbonate exoskeleton) which has existed unchanged in the Sargasso Sea (Atlantic Ocean) for more than 500 million years when exposed to sunlight not only  *Correspondence to: Michael F. Holick; Email: mfholick@bu.edu Submitted: 03/15/13; Accepted: 03/28/13http://dx.doi.org/10.4161/derm.24476vi tamin D is the sunshine vitamin that has been produced on  this earth for more than 500 million years.",Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Clin Invest 1993; 91:2552-5; PMID:8390483; http://dx.doi.org/10.1172/JCI116492.20.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
N Engl J Med  2007; 357:266-81; PMID:17634462; http://dx.doi.org/10.1056/NEJMra070553.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
N Engl J Med  2010; 362:239-52; PMID:20089974; http://dx.doi.org/10.1056/NEJMra0903074.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Clin Endocrinol Metab 2011; 96:1911-30; PMID:21646368; http://dx.doi.org/10.1210/jc.2011-0385.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Endocrinology  1994; 135:655-61; PMID:8033813; http://dx.doi.org/10.1210/en.135.2.655.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Biol Chem 1999; 274:4174-9; PMID:9933613; http://dx.doi.org/10.1074/jbc.274.7.4174.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Biol Chem 1995;  270:8706-11; PMID:7721775; http://dx.doi.org/10.1074/jbc.270.15.8706.Clinical Translational Institute Grant  UL-1-RR-25711.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Cell  Biochem 2003; 88:296-307; PMID:12520530; http://dx.doi.org/10.1002/jcb.10338.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Food Chem 2012; 135:396-401; PMID:22868105; http://dx.doi.org/10.1016/j.foodchem.2012.04.132.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Bone Miner Res 2007; 22(Suppl 2):V28-33; PMID:18290718; http://dx.doi.org/10.1359/jbmr.07s211.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Clin Invest 2006; 116:2062-72; PMID:16886050; http://dx.doi.org/10.1172/JCI29449.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Nature 1939; 143:121; http://dx.doi.org/10.1038/143121a0.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Dtsch Med Wochenschr 1919; 45:712-3; http://dx.doi.org/10.1055/s-0028-1137830.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Am Med Assoc 1921; 77:39; http://dx.doi.org/10.1001/jama.1921.02630270037013.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Curr Opin Endocrinol Diabetes Obes 2002; 9:87-98; http://dx.doi.org/10.1097/00060793-200202000-00011.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Am J Public Health 2007; 97:1746-54; PMID:17761571; http://dx.doi.org/10.2105/AJPH.2006.091736.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Zoo Biol 2004; 23:33-43; http://dx.doi.org/10.1002/zoo.10104.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Clin Endocrinol Metab 1987; 64:1165-8; PMID:3033008; http://dx.doi.org/10.1210/jcem-64-6-1165.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Arch Dermatol 1988; 124:1802-4; PMID:3190255; http://dx.doi.org/10.1001/arch-derm.1988.01670120018003.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Hum Evol 2000; 39:57-106; PMID:10896812; http://dx.doi.org/10.1006/jhev.2000.0403.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Lancet 1982; 1:74-6;  PMID:6119494; http://dx.doi.org/10.1016/S0140-6736(82)90214-8.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch Biochem Biophys 2007; 460:213-7; PMID:17254541; http://dx.doi.org/10.1016/j.abb.2006.12.017.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Am Acad Dermatol 2007; 57:588-93; PMID:17637484; http://dx.doi.org/10.1016/j.jaad.2007.03.004.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Br J Nutr 2012; 108:1557-61; PMID:22264449; http://dx.doi.org/10.1017/S0007114511007161.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Clin Endocrinol Metab 2009; 94:940-5; PMID:19106272; http://dx.doi.org/10.1210/jc.2008-1217.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Science 2007; 318:1453-5; PMID:17962522; http://dx.doi.org/10.1126/sci-ence.1147417.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Clin Invest  1985; 76:1536-8; PMID:2997282; http://dx.doi.org/10.1172/JCI112134.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Lancet 1989; 2:1104-5; PMID:2572832; http://dx.doi.org/10.1016/S0140-6736(89)91124-0.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Photodermatol Photoimmunol Photomed 2001; 17:168-71; PMID:11499538; http://dx.doi.org/10.1034/j.1600-0781.2001.170405.x.37.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Cancer Prev Res (Phila) 2011; 4:1485-94; PMID:21733837; http://dx.doi.org/10.1158/1940-6207.CAPR-11-0165.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Clim Change 1994; 28:375-94; http://dx.doi.org/10.1007/BF01104080.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Clin Endocrinol Metab 1988; 67:373-8; PMID:2839537; http://dx.doi.org/10.1210/jcem-67-2-373.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Steroid Biochem Mol Biol 2005; 97:111-20; PMID:16154354; http://dx.doi.org/10.1016/j.jsbmb.2005.06.003.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Bone Miner Res 1995; 10:545-9; PMID:7610924; http://dx.doi.org/10.1002/jbmr.5650100406.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
JPEN J Parenter Enteral Nutr 2012; 36(Suppl):9S-19S; PMID:22179524; http://dx.doi.org/10.1177/0148607111430189.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Science 1981; 211:590-3; PMID:6256855; http://dx.doi.org/10.1126/science.6256855.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Experientia 1973; 29:1181-93; PMID:4758912; http://dx.doi.org/10.1007/BF01935064.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Recueil des T ravaux Chimiques des Pays-Bas 1977; 96:113-7; http://dx.doi.org/10.1002/recl.19770960406.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Recueil des T ravaux Chimiques des Pays-Bas 1977; 96:104-12; http://dx.doi.org/10.1002/recl.19770960405.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Tetrahedron Lett 1961; 2:565-72; http://dx.doi.org/10.1016/S0040-4039(01)91648-X.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Int J Epidemiol 1980; 9:227-31; PMID:7440046; http://dx.doi.org/10.1093/ije/9.3.227.71.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Am Acad Dermatol 2003; 48:909-18; PMID:12789184; http://dx.doi.org/10.1067/mjd.2003.272.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Am Acad Dermatol 2002; 47:930-7; PMID:12451381; http://dx.doi.org/10.1067/mjd.2002.127254.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Nutrients 2013; 5:111-48; PMID:23306192; http://dx.doi.org/10.3390/nu5010111.61.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Br J Nutr 2001; 86(Suppl 1):S97-103; PMID:11520426; http://dx.doi.org/10.1079/BJN2001345.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
"H olick M. Vitamin D and health: Evolution, bio- logic functions, and recommended dietary intakes for vitamin D. Clinical Review in Bone and Mineral Metabolism 2009; 7:2-19; http://dx.doi.org/10.1007/s12018-009-9026-x.",Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Prog Biophys Mol Biol 2006; 92:39-48; PMID:16600341; http://dx.doi.org/10.1016/j.pbiomolbio.2006.02.001.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Clin Endocrinol Metab 2001; 86:1212-21; PMID:11238511; http://dx.doi.org/10.1210/jc.86.3.1212.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Invest Dermatol 1996; 106:673-8; PMID:8618003; http://dx.doi.org/10.1111/1523-1747.ep12345496.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
URL:http://www.nobelprize.org/nobel_prizes/medicine/laureates/1903/.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Accessed: 2012-09-08 (Archived by WebCite ® at  http://www.webcitation.org/6AWpWACU0).,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Am Acad Dermatol 2003; 49:1096-106; PMID:14639391; http://dx.doi.org/10.1016/S0190-9622(03)00021-5.Figure 49.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Lancet 1989; 2:1176-8; PMID:2572900; http://dx.doi.org/10.1016/S0140-6736(89)91789-3.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Lancet 1985; 1:307-9; PMID:2857364; http://dx.doi.org/10.1016/S0140-6736(85)91082-7.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Am J Public Health 2006; 96:252-61; PMID:16380576; http://dx.doi.org/10.2105/AJPH.2004.045260.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
N Engl J Med 2011; 364:1385-7; PMID:21428761; http://dx.doi.org/10.1056/NEJMp1102022.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Natl Cancer Inst 2002; 94:1301-11; PMID:12208895; http://dx.doi.org/10.1093/jnci/94.17.1301.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Nutr Cancer 2005; 51:32-6; PMID:15749627; http://dx.doi.org/10.1207/s15327914nc5101_5.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Am J Clin Nutr 2011; 94:1471-8; PMID:22030222; http://dx.doi.org/10.3945/ajcn.111.017715.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Am J Clin Nutr 2011; 94:1144-9; PMID:21880848; http://dx.doi.org/10.3945/ajcn.111.015032.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Am J Prev Med 2007; 32:210-6; PMID:17296473; http://dx.doi.org/10.1016/j.amepre.2006.11.004.88.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Lancet 2001; 358:641-2; PMID:11530156; http://dx.doi.org/10.1016/S0140-6736(01)05788-9.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Natl Cancer Inst 2005; 97:1466-74; PMID:16204696; http://dx.doi.org/10.1093/jnci/dji293.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Cancer Epidemiol Biomarkers Prev 2007; 16:422-9; PMID:17372236; http://dx.doi.org/10.1158/1055-9965.EPI-06-0865.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Photochem Photobiol 1997; 66:260-4; PMID:9277146; http://dx.doi.org/10.1111/j.1751-1097.1997.tb08652.x.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Lancet 1983; 1:545-8; PMID:6131254; http://dx.doi.org/10.1016/S0140-6736(83)92808-8.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Invest Dermatol 2001; 117:1193-9; PMID:11710932; http://dx.doi.org/10.1046/j.0022-202x.2001.01503.x.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Nitric Oxide 2004; 10:179-93; PMID:15275864; http://dx.doi.org/10.1016/j.niox.2004.04.005.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Clin Oncol 2010; 28:4191-8; PMID:20713849; http://dx.doi.org/10.1200/JCO.2010.28.6674.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Natl Cancer Inst 2007; 99:1594-602; PMID:17971526; http://dx.doi.org/10.1093/jnci/djm204.78.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Lancet 1989; 2:1176-8; PMID:2572900; http://dx.doi.org/10.1016/S0140-6736(89)91789-3.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Cancer 2002; 94:1867-75; PMID:11920550; http://dx.doi.org/10.1002/cncr.10427.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Int J Epidemiol 1994; 23:1133-6; PMID:7721513; http://dx.doi.org/10.1093/ije/23.6.1133.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Prev Med 1990; 19:614-22; PMID:2263572; http://dx.doi.org/10.1016/0091-7435(90)90058-R. 82.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Health Phys 2004; 87:532-8; PMID:15551791; http://dx.doi.org/10.1097/01.HP .0000137179.03423.0b.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Cancer 1992; 70:2861-9; PMID:1451068; http://dx.doi.org/10.1002/1097-0142(19921215)70:12<2861::AID-CNCR2820701224>3.0.CO;2-G. 84.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
BMC Cancer 2006; 6:264; PMID:17096841; http://dx.doi.org/10.1186/1471-2407-6-264.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Natl Cancer Inst 2006; 98:451-9; PMID:16595781; http://dx.doi.org/10.1093/jnci/djj101.Figure 51.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Am J Epidemiol 2012; 175:236-44; PMID:22193171; http://dx.doi.org/10.1093/aje/kwr295.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Ann Intern Med 2011; 155:827-38; PMID:22184690; http://dx.doi.org/10.7326/0003-4819-155-12-201112200-00005.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Am Acad Dermatol 2002; 46:926-30; PMID:12063493; http://dx.doi.org/10.1067/mjd.2002.121354.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Lancet 1997; 349:1801-4; PMID:9269215; http://dx.doi.org/10.1016/S0140-6736(96)12098-5.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J T rop Pediatr 2004; 50:364-8; PMID:15537725; http://dx.doi.org/10.1093/tropej/50.6.364.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Lancet 1947; 1:764; PMID:20342341; http://dx.doi.org/10.1016/S0140-6736(47)91513-4.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Hyg (Lond) 1981; 86:35-47; PMID:7462597; http://dx.doi.org/10.1017/S0022172400068728.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Epidemic influenza and vitamin D. Epidemiol Infect 2006; 134:1129-40; PMID:16959053; http://dx.doi.org/10.1017/S0950268806007175.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
PLoS One 2010; 5:e11088; PMID:20559424; http://dx.doi.org/10.1371/journal.pone.0011088.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Am J Clin Nutr 2010; 91:1255-60; PMID:20219962; http://dx.doi.org/10.3945/ajcn.2009.29094.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Nutr Rev 2012; 70:548-52; PMID:22946854; http://dx.doi.org/10.1111/j.1753-4887.2012.00517.x.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Exp Med 1963; 117:27-42; PMID:14022146; http://dx.doi.org/10.1084/jem.117.1.27.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Nature 2000; 406:782-7; PMID:10963608; http://dx.doi.org/10.1038/35021228.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Science 2006; 311:1770-3; PMID:16497887; http://dx.doi.org/10.1126/science.1123933.Figure 52.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Expert Rev Gastroenterol Hepatol 2012; 6:445-7; PMID:22928897; http://dx.doi.org/10.1586/egh.12.31.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Ann Neurol 2004; 55:65-71; PMID:14705113; http://dx.doi.org/10.1002/ana.10788.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
JAMA 2006; 296:2832-8; PMID:17179460; http://dx.doi.org/10.1001/jama.296.23.2832.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Neurology 2004; 62:60-5; PMID:14718698; http://dx.doi.org/10.1212/01.WNL.0000101723.79681.38.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Diabetologia 2008; 51:1391-8; PMID:18548227; http://dx.doi.org/10.1007/s00125-008-1061-5.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Lancet 2001; 358:1500-3; PMID:11705562; http://dx.doi.org/10.1016/S0140-6736(01)06580-1.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Gastroenterology 2012; 142:482-9; PMID:22155183; http://dx.doi.org/10.1053/j.gas-tro.2011.11.040.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Environ Health Perspect 2010; 118:957-61; PMID:20338859; http://dx.doi.org/10.1289/ehp.0901861.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Arthritis Rheum 2004; 50:72-7; PMID:14730601; http://dx.doi.org/10.1002/art.11434.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Arthritis Rheum 2006; 54:3719-20; PMID:17075887; http://dx.doi.org/10.1002/art.22191.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Endocr Rev 2008; 29:726-76; PMID:18694980; http://dx.doi.org/10.1210/er.2008-0004.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Bone Miner Res 2006; 21:37-47; PMID:16355272; http://dx.doi.org/10.1359/JBMR.050908.132.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Am J Med 2001; 111:452-6; PMID:11690570; http://dx.doi.org/10.1016/S0002-9343(01)00899-3.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Periodontol 2009; 80:1433-9; PMID:19722793; http://dx.doi.org/10.1902/jop.2009.090077.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Autoimmun Rev 2012; 12:127-36; PMID:22776787; http://dx.doi.org/10.1016/j.aut-rev.2012.07.007.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Toxicology 2002; 181-182:71-8; PMID:12505287; http://dx.doi.org/10.1016/S0300-483X(02)00257-3.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Diabetologia 2008; 51:1391-8; PMID:18548227; http://dx.doi.org/10.1007/s00125-008-1061-5.126.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Immunol 2009; 182:4289-95; PMID:19299728; http://dx.doi.org/10.4049/jimmunol.0803736.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Allergy Clin Immunol 2008; 122:261-6; PMID:18439663; http://dx.doi.org/10.1016/j.jaci.2008.03.027.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Infect Immun 2008; 76:3837-43; PMID:18505808; http://dx.doi.org/10.1128/IAI.00353-08.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Steroid Biochem Mol Biol 2010; 121:221-7; PMID:20302932; http://dx.doi.org/10.1016/j.jsbmb.2010.03.037.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Biochem Pharmacol 2001; 61:365-71; PMID:11172742; http://dx.doi.org/10.1016/S0006-2952(00)00564-5.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Mol Med (Berl) 2010; 88:441-50; PMID:20119827; http://dx.doi.org/10.1007/s00109-010-0590-9.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Nat Clin Pract Rheumatol 2008; 4:404-12; PMID:18594491; http://dx.doi.org/10.1038/ncprheum0855.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Hypertension 1997; 30:150-6; PMID:9260973; http://dx.doi.org/10.1161/01.HYP .30.2.150.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Lancet 1998; 352:709-10; PMID:9728997; http://dx.doi.org/10.1016/S0140-6736(05)60827-6.Figure 55.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Clin Endocrinol (Oxf) 2011; 75:575-84; PMID:21682758; http://dx.doi.org/10.1111/j.1365-2265.2011.04147.x.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Prev Med 2010; 51:228-33; PMID:20600257; http://dx.doi.org/10.1016/j.ypmed.2010.06.013.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Am J Cardiol 2012; 109:359-63; PMID:22071212; http://dx.doi.org/10.1016/j.amjcard.2011.09.020.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Circulation 2008; 117:503-11; PMID:18180395; http://dx.doi.org/10.1161/CIRCULATIONAHA.107.706127.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Nat Rev Endocrinol 2011; 7:73-5; PMID:21263437; http://dx.doi.org/10.1038/nrendo.2010.234.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Clin Endocrinol Metab 2010; 95:4584-91; PMID:20660028; http://dx.doi.org/10.1210/jc.2010-0606.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Pediatrics 2009; 124:e371-9; PMID:19661053; http://dx.doi.org/10.1542/peds.2009-0213.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
JAMA 1999; 282:1539-46; PMID:10546693; http://dx.doi.org/10.1001/jama.282.16.1539.162.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Schizophr Res 2004; 67:237-45; PMID:14984883; http://dx.doi.org/10.1016/j.schres.2003.08.005.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Arch Gen Psychiatry 2004; 61:774-80; PMID:15289276; http://dx.doi.org/10.1001/archpsyc.61.8.774.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Arch Gen Psychiatry 1990; 47:869-74; PMID:2393346; http://dx.doi.org/10.1001/archpsyc.1990.01810210077012.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Arch Gen Psychiatry 1988; 45:189-92; PMID:3337616; http://dx.doi.org/10.1001/arch-psyc.1988.01800260109013.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Arch Gen Psychiatry 2008; 65:508-12; PMID:18458202; http://dx.doi.org/10.1001/archpsyc.65.5.508.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Intern Med 2008; 264:599-609; PMID:18793245; http://dx.doi.org/10.1111/j.1365-2796.2008.02008.x.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Epilepsy Behav 2012; 24:131-3; PMID:22503468; http://dx.doi.org/10.1016/j.yebeh.2012.03.011.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Am J Geriatr Psychiatry 2006; 14:1032-40; PMID:17138809; http://dx.doi.org/10.1097/01.JGP .0000240986.74642.7c.186.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Steroid Biochem Mol Biol 2004; 89-90:387-92; PMID:15225806; http://dx.doi.org/10.1016/j.jsbmb.2004.03.004.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Circulation 2009; 120:687-98; PMID:19667238; http://dx.doi.org/10.1161/CIRCULATIONAHA.109.856070.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Diabetes Care 2012; 35:1158-64; PMID:22399697; http://dx.doi.org/10.2337/dc11-1714.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Schizophr Bull 2009; 35:582-95; PMID:19357239; http://dx.doi.org/10.1093/schbul/sbp023.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Br  J Psychiatry 1987; 150:598-608; PMID:3307980; http://dx.doi.org/10.1192/bjp.150.5.598.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Br J Psychiatry 1991; 158:764-9; PMID:1873629; http://dx.doi.org/10.1192/bjp.158.6.764.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Schizophr Res 1997; 28:1-38; PMID:9428062; http://dx.doi.org/10.1016/S0920-9964(97)00092-3.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
T ranscult Psychiatry 1998; 35:39-74; http://dx.doi.org/10.1177/136346159803500102.171.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Heart 2012; 98:609-14; PMID:22373722; http://dx.doi.org/10.1136/heartjnl-2011-301356.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Obesity (Silver Spring) 2012; 20:1444-8; PMID:22262154; http://dx.doi.org/10.1038/oby.2011.404.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Am J Cardiol 2010; 106:963-8; PMID:20854958; http://dx.doi.org/10.1016/j.amjcard.2010.05.027.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Clin Endocrinol Metab 2007; 92:2017-29; PMID:17389701; http://dx.doi.org/10.1210/jc.2007-0298.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Diabetes Care 2006; 29:650-6; PMID:16505521; http://dx.doi.org/10.2337/diacare.29.03.06.dc05-1961.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Diabetes Care 2004; 27:2813-8; PMID:15562190; http://dx.doi.org/10.2337/diacare.27.12.2813.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Stroke 2008; 39:2611-3; PMID:18635847; http://dx.doi.org/10.1161/STROKEAHA.107.513655.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Maturitas 2010; 65:225-36; PMID:20031348; http://dx.doi.org/10.1016/j.maturitas.2009.12.013.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Diabetologia 2012; 55:1668-78; PMID:22426800; http://dx.doi.org/10.1007/s00125-012-2529-x.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Apoptosis 2006; 11:151-9; PMID:16502254; http://dx.doi.org/10.1007/s10495-006-3558-z.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Br J Nutr 2010; 103:549-55; PMID:19781131; http://dx.doi.org/10.1017/S0007114509992017.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Steroid Biochem Mol Biol 2003; 84:223-30; PMID:12711007; http://dx.doi.org/10.1016/S0960-0760(03)00032-3.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Eur Heart J 2012; 33:2980-90; PMID:22267242; http://dx.doi.org/10.1093/eurheartj/ehr459.Figure 58.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Am J Clin Nutr 2010; 91:1621-6; PMID:20427729; http://dx.doi.org/10.3945/ajcn.2009.27972.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Vitamin D2 is as effective as vitamin D 3 in maintaining circulating concentrations  of 25-hydroxyvitamin D. J Clin Endocrinol Metab 2008; 93:677-81; PMID:18089691; http://dx.doi.org/10.1210/jc.2007-2308.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Clin Endocrinol Metab 2009; 94:3314-21; PMID:19567516; http://dx.doi.org/10.1210/jc.2009-0018.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Clin Endocrinol Metab 2008; 93:2716-21; PMID:18413426; http://dx.doi.org/10.1210/jc.2007-2790.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Calcif Tissue Int 2004; 74:150-6; PMID:14648011; http://dx.doi.org/10.1007/s00223-003-0083-8.209.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Neurology 2010; 74:18-26; PMID:19940273; http://dx.doi.org/10.1212/WNL.0b013e3181beecb7.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Br J Psychiatry 2013; 202:100-7; PMID:23377209; http://dx.doi.org/10.1192/bjp.bp.111.106666.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Clin Endocrinol Metab 2011; 96:53-8; PMID:21118827; http://dx.doi.org/10.1210/jc.2010-2704.203.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Arch Intern Med 2010; 170:1135-41; PMID:20625021; http://dx.doi.org/10.1001/archinternmed.2010.173.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Chem Neuroanat 2005; 29:21-30; PMID:15589699; http://dx.doi.org/10.1016/j.jchemneu.2004.08.006.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Nature 1981; 294:765-7; PMID:7033797; http://dx.doi.org/10.1038/294765a0.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Med  Hypotheses 1998; 51:267-8; PMID:9792205; http://dx.doi.org/10.1016/S0306-9877(98)90085-8.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Dtsch Med Wochenschr 1919; 45:712-3; http://dx.doi.org/10.1055/s-0028-1137830.219.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Clin Endocrinol Metab 2004; 89:5387-91; PMID:15531486; http://dx.doi.org/10.1210/jc.2004-0360.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Am Acad Dermatol 1991; 25:751-60; PMID:1802896; http://dx.doi.org/10.1016/S0190-9622(08)80964-4.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Am Diet Assoc 2004; 104:980-3; PMID:15175600; http://dx.doi.org/10.1016/j.jada.2004.03.028.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Comp Biochem Physiol B 1993; 105:553-65; PMID:8365111; http://dx.doi.org/10.1016/0305-0491(93)90088-M. 247.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Pediatr 2008; 122:1142-52; http://dx.doi.org/10.1542/peds.2008-1862.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Pediatr 1994; 125:487-90; PMID:8071764; http://dx.doi.org/10.1016/S0022-3476(05)83303-7.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Clin Endocrinol Metab 2006; 91:405-12; PMID:16278262; http://dx.doi.org/10.1210/jc.2005-1436.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Lancet 1998; 351:805-6; PMID:9519960; http://dx.doi.org/10.1016/S0140-6736(05)78933-9.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Arch Intern Med 2009; 169:1806-8; PMID:19858440; http://dx.doi.org/10.1001/archin-ternmed.2009.361.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Ann Epidemiol 2009; 19:73-8; PMID:18329892; http://dx.doi.org/10.1016/j.annepidem.2007.12.001.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
N Engl J Med 2001; 345:66-7; PMID:11439958; http://dx.doi.org/10.1056/NEJM200107053450115.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Ann Intern Med 1997; 127:203-6; PMID:9245225; http://dx.doi.org/10.7326/0003-4819-127-3-199708010-00004.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Clin Endocrinol Metab 1989; 68:882-7; PMID:2541158; http://dx.doi.org/10.1210/jcem-68-5-882.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Bone  Miner Res 2007; 22(Suppl 2):V64-8; PMID:18290725; http://dx.doi.org/10.1359/jbmr.07s221.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Clin Pediatr (Phila) 2013; 52:82-5; PMID:22492833; http://dx.doi.org/10.1177/0009922812439245.235.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Int J Cancer 1995; 60:489-94; PMID:7829262; http://dx.doi.org/10.1002/ijc.2910600411.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Invest Dermatol 2003; 120:1087-93; PMID:12787139; http://dx.doi.org/10.1046/j.1523-1747.2003.12246.x.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Plast Reconstr Surg 1968; 41:560-3; PMID:5654897; http://dx.doi.org/10.1097/00006534-196806000-00008.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Clin J Am Soc Nephrol 2008; 3:1548-54; PMID:18550652; http://dx.doi.org/10.2215/CJN.01350308.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Int J Cancer 1998; 78:587-93; PMID:9808527; http://dx.doi.org/10.1002/(SICI)1097-0215(19981123)78:5<587::AID-IJC10>3.0.CO;2-E.227.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Acta Paediatr 2005; 94:547-52; PMID:16188742; http://dx.doi.org/10.1080/08035250410025276.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Photodermatol Photoimmunol Photomed 2007; 23:179-85; PMID:17803596; http://dx.doi.org/10.1111/j.1600-0781.2007.00302.x.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Photodermatol Photoimmunol Photomed 2012; 28:307-11; PMID:23126292; http://dx.doi.org/10.1111/phpp.12000.,OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Gastroenterology 2001; 121:1485-8; PMID:11729127; http://dx.doi.org/10.1053/gast.2001.29686.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Eur J Cancer 1998; 34(Suppl 3):S3-6; PMID:9849401; http://dx.doi.org/10.1016/S0959-8049(98)00003-3.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Clin Endocrinol (Oxf) 2012; 77:26-35; PMID:22168576; http://dx.doi.org/10.1111/j.1365-2265.2011.04320.x.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Clin Exp Dermatol 2009; 34:621-38; PMID:19236422; http://dx.doi.org/10.1111/j.1365-2230.2008.03002.x.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Lancet 2008; 371:1777-82; PMID:18502302; http://dx.doi.org/10.1016/S0140-6736(08)60765-5.264.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Curr Opin Clin Nutr Metab Care 2012; 15:567-79; PMID:23075936; http://dx.doi.org/10.1097/MCO.0b013e3283594978.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Clin Endocrinol Metab 2012; 97:1153-8; PMID:22442274; http://dx.doi.org/10.1210/jc.2011-2601.259.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
J Bone Miner Res 2011; 26:2341-57; PMID:21706518; http://dx.doi.org/10.1002/jbmr.463.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
Evolution and function of vitamin  D. Recent Results Cancer Res 2003; 164:3-28; PMID:12899511; http://dx.doi.org/10.1007/978-3-642-55580-0_1.,Non-OADS,/arxiv_data1/oa_pdf/b7/47/de-5-51.PMC3897598.pdf
"19,20 We have now established that P450scc can  hydroxylate vitamin D3 in a sequential manner at positions C17,  C20, C22 and C23 to produce 20-hydroxyvitamin D3 (20(OH) D3), 20,23(OH)2D3, 20,22(OH)2D3 and 17,20,23(OH)3D3  as the main products, with additional production of 17(OH) *Correspondence to: Andrzej Slominski; Email: aslominski@uthsc.edu Submitted: 12/04/12; Revised: 02/04/13; Accepted: 02/09/13http://dx.doi.org/10.4161/derm.23938Novel metabolic pathways initiated by the enzymatic action of  CYP11A1 on 7DHC (7-dehydrocholesterol), ergosterol, vitamins D 3 and D2 were characterized with help of chemical synthesis,  Uv  and mass spectrometry and NM r  analyses.",Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
Drug Discov Today Dis Mech 2008; 5:137-44; PMID:19492070; http://dx.doi.org/10.1016/j.ddmec.2008.04.004.,OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
Endocr Rev 2000; 21:457-87; PMID:11041445; http://dx.doi.org/10.1210/er.21.5.457.,Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
Eur J Biochem 2004; 271:4178-88; PMID:15511223; http://dx.doi.org/10.1111/j.1432-1033.2004.04356.x.5.,OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
PLoS One 2009; 4:e4309; PMID:19190754; http://dx.doi.org/10.1371/journal.pone.0004309.,Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
Int J Biochem Cell Biol 2012; 44:2003-18; PMID:22877869; http://dx.doi.org/10.1016/j.biocel.2012.07.027.,OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
Drug Metab Dispos 2012; 40:436-44; PMID:22106170; http://dx.doi.org/10.1124/dmd.111.042515.8.,Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
Chem Biol 2005; 12:931-9; PMID:16125105; http://dx.doi.org/10.1016/j.chem - biol.2005.06.010.,OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
FEBS J 2005; 272:4080-90; PMID:16098191; http://dx.doi.org/10.1111/j.1742-4658.2005.04819.x.,OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
J Steroid Biochem Mol Biol 2008; 112:213-9; PMID:19000766; http://dx.doi.org/10.1016/j.jsbmb.2008.10.005.,OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
Steroids 2010; 76:193-203; PMID:21070794; http://dx.doi.org/10.1016/j.steroids.2010.10.009.,OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
J Cell  Biochem 2003; 88:296-307; PMID:12520530; http://dx.doi.org/10.1002/jcb.10338.,OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
Exp  Dermatol 2011; 20:7-13; PMID:21197695; http://dx.doi.org/10.1111/j.1600-0625.2010.01202.x.,Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
FEBS Lett 1985; 182:107-10; PMID:3972117; http://dx.doi.org/10.1016/0014-5793(85)81164-9.,OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
Endocrinology 1961; 68:411-6; PMID:13746869; http://dx.doi.org/10.1210/endo-68-3-411.,Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
J Steroid Biochem Mol Biol 2002; 82:401-11; PMID:12589948; http://dx.doi.org/10.1016/S0960-0760(02)00224-8.,OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
J Steroid Biochem 1987; 26:137-43; PMID:3821102; http://dx.doi.org/10.1016/0022-4731(87)90042-2.,Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
J Endocrinol 1966; 34:447-56; PMID:5933098; http://dx.doi.org/10.1677/joe.0.0340447.,Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
J Endocrinol 1985; 107:415-9; PMID:4067494; http://dx.doi.org/10.1677/joe.0.1070415.,Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
Lipids 2012; 47:1-12; PMID:21874273; http://dx.doi.org/10.1007/s11745-011-3605-6.,Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
J Clin Endocrinol Metab 1999; 84:1157-9; PMID:10084612; http://dx.doi.org/10.1210/jc.84.3.1157.,Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
J Invest Dermatol 2002; 118:310-5; PMID:11841549; http://dx.doi.org/10.1046/j.0022-202x.2001.01648.x.,Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
Prenat Diagn 2001; 21:207-12; PMID:11260610; http://dx.doi.org/10.1002/1097-0223(200103)21:3<207::AID-PD27>3.0.CO;2-I.,OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
J Invest Dermatol 2011; 131:1167-9; PMID:21228816; http://dx.doi.org/10.1038/jid.2010.425.,Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
PLoS One 2010; 5:e9907; PMID:20360850; http://dx.doi.org/10.1371/journal.pone.0009907.,OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
Steroids 2010; 75:926-35; PMID:20542050; http://dx.doi.org/10.1016/j.steroids.2010.05.021.,OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
Br J Cancer 2011; 105:1874-84; PMID:22095230; http://dx.doi.org/10.1038/bjc.2011.458.,Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
PLoS One 2009; 4:e5988; PMID:19543524; http://dx.doi.org/10.1371/journal.pone.0005988.,Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
J Invest Dermatol 2008; 128:2271-80; PMID:18368131; http://dx.doi.org/10.1038/jid.2008.62.,Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
Steroids 2004; 69:51-60; PMID:14715377; http://dx.doi.org/10.1016/j.ste-roids.2003.09.013.,OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
J Steroid Biochem Mol Biol 2002; 82:225-32; PMID:12477489; http://dx.doi.org/10.1016/S0960-0760(02)00155-3.,OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
Steroids 2010; 75:230-9; PMID:20025893; http://dx.doi.org/10.1016/j.steroids.2009.12.004.,OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
Steroids 2009; 74:218-28; PMID:19028513; http://dx.doi.org/10.1016/j.steroids.2008.10.017.,OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
Photochem Photobiol Sci 2008; 7:1570-6; PMID:19037511; http://dx.doi.org/10.1039/b809005j.11.,Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
FEBS J 2008; 275:2585-96; PMID:18410379; http://dx.doi.org/10.1111/j.1742-4658.2008.06406.x.,OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
Drug Metab Dispos 2011; 39:1577-88; PMID:21677063; http://dx.doi.org/10.1124/dmd.111.040071.,Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
FASEB J 2012; 26:3901-15; PMID:22683847; http://dx.doi.org/10.1096/fj.12-208975.,OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
J Steroid Biochem Mol Biol 2012; 129:163-71; PMID:22210453; http://dx.doi.org/10.1016/j.jsbmb.2011.11.012.,OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
Drug Metab Dispos 2010; 38:1553-9; PMID:20554701; http://dx.doi.org/10.1124/dmd.110.034389.,Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
J Steroid Biochem Mol Biol 2010; 119:171-9; PMID:20193763; http://dx.doi.org/10.1016/j.jsbmb.2010.02.022.,OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
FEBS J 2006; 273:2891-901; PMID:16817851; http://dx.doi.org/10.1111/j.1742-4658.2006.05302.x.,OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
Drug Metab Dispos 2009; 37:761-7; PMID:19116262; http://dx.doi.org/10.1124/dmd.108.025619.,Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
Placenta 2005; 26:273-81; PMID:15823613; http://dx.doi.org/10.1016/j.placenta.2004.06.012.,OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
Endocr Rev 2011; 32:81-151; PMID:21051590; http://dx.doi.org/10.1210/er.2010-0013.,Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
Biochem Pharmacol 2012; 84:1696-704; PMID:23041230; http://dx.doi.org/10.1016/j.bcp.2012.09.032.,Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
Am J Physiol Cell Physiol 2011; 300:C526-41; PMID:21160030; http://dx.doi.org/10.1152/ajpcell.00203.2010.,Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
J Pineal Res 2003; 34:75-8; PMID:12485375; http://dx.doi.org/10.1034/j.1600-079X.2003.02111.x.,Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
Curr Top Med Chem 2002; 2:181-97; PMID:11899100; http://dx.doi.org/10.2174/1568026023394443.,Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
T rends Endocrinol Metab 2008; 19:17-24; PMID:18155917; http://dx.doi.org/10.1016/j.tem.2007.10.007.,OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
Mol Cell Endocrinol 2012; 351:152-66; PMID:22245784; http://dx.doi.org/10.1016/j.mce.2012.01.004.,OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
Exp Dermatol 2008; 17:713-30; PMID:18643846; http://dx.doi.org/10.1111/j.1600-0625.2008.00767.x.,Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
FASEB J 2006; 20:1564-6; PMID:16793870; http://dx.doi.org/10.1096/fj.05-5227fje.,OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
FASEB J 2005; 19:176-94; PMID:15677341; http://dx.doi.org/10.1096/fj.04-2079rev.,OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
J Steroid Biochem 1982; 17:615-9; PMID:6294414; http://dx.doi.org/10.1016/0022-4731(82)90562-3.,Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
Expert Rev Anticancer Ther 2012; 12:585-99; PMID:22594894; http://dx.doi.org/10.1586/era.12.40.,Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
Steroids 2011; 76:193-203; PMID:21070794; http://dx.doi.org/10.1016/j.steroids.2010.10.009.,OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
Mol Cell Endocrinol 2012; 361:143-52; PMID:22546549; http://dx.doi.org/10.1016/j.mce.2012.04.001.,OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
J Clin Endocrinol Metab 2013; 98:E298-303; PMID:23295467; http://dx.doi.org/10.1210/jc.2012-3074.,Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
Free Radic Biol Med 1991; 11:47-61; PMID:1937129; http://dx.doi.org/10.1016/0891-5849(91)90187-8.,Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
FEBS Lett 1993; 326:285-8; PMID:8325381; http://dx.doi.org/10.1016/0014-5793(93)81809-E.53.,OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
Physiol Rev 2004; 84:1155-228; PMID:15383650; http://dx.doi.org/10.1152/phys-rev.00044.2003.,Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
J Clin Endocrinol Metab 1996; 81:2746-9; PMID:8675607; http://dx.doi.org/10.1210/jc.81.7.2746.,Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
Mol Cell Endocrinol 2007; 265-266:143-9; PMID:17197073; http://dx.doi.org/10.1016/j.mce.2006.12.012.,OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
J Med Chem 2012; 55:3573-7; PMID:22404326; http://dx.doi.org/10.1021/jm201478e.,Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
J Org Chem 2005; 70:9849-56; PMID:16292815; http://dx.doi.org/10.1021/jo051556d.,OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
Steroids 2009; 74:218-28; PMID:19028513; http://dx.doi.org/10.1016/j.steroids.2008.10.017.,OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
J Clin Endocrinol Metab 1989; 68:882-7; PMID:2541158; http://dx.doi.org/10.1210/jcem-68-5-882.,Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
PLoS One 2009; 4:e4309; PMID:19190754; http://dx.doi.org/10.1371/journal.pone.0004309.,Non-OADS,/arxiv_data1/oa_pdf/cd/79/de-5-7.PMC3897599.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 1 Korean J Urol 2014;55:1http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.1 .1&domain=pdf&date_stamp=2014-1-17www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.1.1 Editorial Taking a Great Leap Forward on a Blue Horse This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativeco mmons.org/licenses/by-nc/3.",Non-OADS,/arxiv_data1/oa_pdf/75/68/kju-55-1.PMC3897623.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 17 Korean J Urol 2014;55:17-22http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.1 .17&domain=pdf&date_stamp=2014-1-17www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.1.17 Original Article - Urological Oncology Risk Factors for Postoperative Hemorrhage After Partial  Nephrectomy Saebin Jung, Gyeong Eun Min, Benjamin I. Chung1, Seung Hyun Jeon Department of Urology, Kyung Hee University School of Medicine, Seoul, Korea, 1Department of Urology, Stanford University School of  Medicine, Stanford, CA, USA Purpose:  To evaluate the frequency and clinical  characteristics of postoperative hemor- rhage as a complication of partial nephrectomy.",Non-OADS,/arxiv_data1/oa_pdf/3d/68/kju-55-17.PMC3897624.pdf
"Keywords:  Nephrectomy; Postoperative hemorrhage; Renal cell carcinom This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 3 February, 2013 accepted 8 October, 2013 Corresponding Author: Seung Hyun JeonDepartment of Urology, Kyung  Hee University Medical Center,  23 Kyungheedae-ro, Dongdaemun-gu, Seoul 130-872,  Korea TEL: +82-2-958-8537FAX: +82-2-959-6048 E-mail: juro@khu.ac.kr INTRODUCTION Renal cell carcinoma is a relatively prevalent urologic ma- lignancy, involving over 50,000 new cases in the United States alone each year [1].",Non-OADS,/arxiv_data1/oa_pdf/3d/68/kju-55-17.PMC3897624.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 2 Korean J Urol 2014;55:2-8http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.1 .2&domain=pdf&date_stamp=2014-1-17www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.1.2 Review Article Laparoendoscopic Management of Midureteral Strictures Christos Komninos1,2, Kyo Chul Koo1, Koon Ho Rha1 1Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea, 2Department of Urology, General  Hospital of Nikaia ‘St.",Non-OADS,/arxiv_data1/oa_pdf/4a/51/kju-55-2.PMC3897625.pdf
"Keywords:  Laparoscopy; Reconstructive surgical procedures; Robotics; Ureter This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 30 December, 2013 accepted 8 January, 2014 Corresponding Author: Koon Ho Rha Department of Urology,  Urological Science Institute, Yonsei University College of  Medicine, 50 Yonsei-ro,  Seodaemun-gu, Seoul 120-752, Korea TEL: +82-2-2228-2310 FAX: +82-2-312-2538E-mail: khrha@yuhs.ac INTRODUCTION Ureteral stricture is a commo n cause of luminal narrowing  of the ureter, which results in upper urinary tract ob-struction and renal damage if left untreated [1].",Non-OADS,/arxiv_data1/oa_pdf/4a/51/kju-55-2.PMC3897625.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 23 Korean J Urol 2014;55:23-28http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.1 .23&domain=pdf&date_stamp=2014-1-17www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.1.23 Original Article - Urological Oncology Interfraction Prostate Movement in Bone Alignment After Rectal  Enema for Radiotherapy Young Eun Seo, Tae Hyo Kim, Ki Soo Lee, Won Yeol Cho, Hyung-Sik Lee1, Won-Joo Hur1,  Youngmin Choi1 Departments of Urology and 1Radiation Oncology, Dong-A University College of Medicine, Busan, Korea Purpose:  To assess the effect of a rectal enema on interfraction prostate movement in  bone alignment (BA) for prostate radiotherapy  (RT), we analyzed the spatial difference  in prostates in a bone-matched setup.Materials and Methods:  We performed BA retrospectively with data from prostate can- cer patients who underwent image-guided RT (IGRT).",Non-OADS,/arxiv_data1/oa_pdf/2c/d3/kju-55-23.PMC3897626.pdf
"Keywords:  Displacement; Enema; Image guided  radiotherapy; Prostate neoplasms This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 12 July, 2013 accepted 28 August, 2013 Corresponding Author: Youngmin ChoiDepartment of Radiation  Oncology, Dong-A University  Hospital, 26 Daesingongwon-ro, Seo-gu, Busan 602-715, Korea TEL: +82-51-240-5380 FAX: +82-51-254-5889E-mail: cymin00@dau.ac.kr INTRODUCTION The prostate is in front of th e rectum and is separated by  just a fascia.",Non-OADS,/arxiv_data1/oa_pdf/2c/d3/kju-55-23.PMC3897626.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 29 Korean J Urol 2014;55:29-35http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.1 .29&domain=pdf&date_stamp=2014-1-17www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.1.29 Original Article - Laparoscopy/Robotics Hand-Assisted Retroperitoneoscopic Nephroureterectomy With  Bladder Cuffing After Preperitoneal and Retroperitoneal Perivesical Ballooning Chang Hee Kim, Kwang Taek Kim, Khae Hawn Kim, Sang Jin Yoon Department of Urology, Gachon University Gil Medical Center, Incheon, Korea Purpose:  We aimed to describe th e surgical technique of ha nd-assisted retroperitoneo- scopic nephroureterectomy (HARNU) with bl adder cuffing after preperitoneal and ret- roperitoneal perivesical ballooning.",Non-OADS,/arxiv_data1/oa_pdf/d2/de/kju-55-29.PMC3897627.pdf
"Keywords:  Endoscopy; Hand-assisted laparosco py; Nephrectomy; Tr ansitional cell  carcinoma; Ureteral neoplasms  This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 13 September, 2013 accepted 16 October, 2013 Corresponding Author: Sang Jin Yoon Department of Urology, Gachon  University Gil Medical Center,  Gachon University of Medicine  and Science, 21 Namdong-daero  774beon-gil, Namdong-gu,  Incheon 405-760, Korea TEL: +82-32-460-3334 FAX: +82-32-460-8340 E-mail: uysjr@hanmail.net INTRODUCTION Currently, nephroureterectomy with bladder cuff excision  is the standard treatment regimen for patients with upper  urinary tract urothelial carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/d2/de/kju-55-29.PMC3897627.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 36 Korean J Urol 2014;55:36-40http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.1 .36&domain=pdf&date_stamp=2014-1-17www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.1.36 Original Article - Urolithiasis The Effect of Terpene Combination on Ureter Calculus Expulsion  After Extracorporeal Shock Wave Lithotripsy  Dai Hee Kim, Hyeok Jun Goh, Ho Won Lee, Kyu Shik Kim, Yong Tae Kim, Hong Sang Moon,  Seung Wook Lee, Sung Yul Park Department of Urology, Hanyang University College of Medicine, Seoul, Korea Purpose:  Terpene combination (Rowatinex) is know n to help with the expulsion of uri- nary stones.",Non-OADS,/arxiv_data1/oa_pdf/5d/df/kju-55-36.PMC3897628.pdf
"Keywords:  Lithotripsy; Terpene co mbination; Urolithiasis  This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 31 May, 2013 accepted 2 October, 2013 Corresponding Author: Sung Yul Park Department of Urology, Hanyang University College of Medicine,  222 Wangsimni-ro,  Seongdong-gu, Seoul 133-791,  Korea TEL: +82-2-2290-8596 FAX: +82-2-2299-2186E-mail: syparkuro@hanyang.ac.kr INTRODUCTION Urinary stones are a common illness and account for about  12% of patient visits in urolo gy outpatient departments [1].",Non-OADS,/arxiv_data1/oa_pdf/5d/df/kju-55-36.PMC3897628.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 41 Korean J Urol 2014;55:41-46http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.1 .41&domain=pdf&date_stamp=2014-1-17www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.1.41 Original Article - Lasers in Urology An Analytical Comparison of Short-term Effectiveness and Safety  Between Thulium:YAG Laser Vaporesection of the Prostate and Bipolar Transurethral Resection of the Prostate in Patients With Benign Prostatic Hyperplasia Joon Woo Kim, Yeon Joo Kim, Yoon Hyung Lee, Joon Beom Kwon, Sung Ryong Cho, Jae Soo Kim Department of Urology, Daegu Fatima Hospital, Daegu, Korea Purpose:  In recent years, laser surgery has been widely used to treat benign prostatic  hyperplasia (BPH).",Non-OADS,/arxiv_data1/oa_pdf/6d/54/kju-55-41.PMC3897629.pdf
"Keywords:  Prostatic hyperplasia; Thulium; Transurethral resection of the prostate This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 4 June, 2013 accepted 2 October, 2013 Corresponding Author: Jae Soo Kim Department of Urology, Daegu Fatima Hospital, 99 Ayang-ro,  Dong-gu, Daegu 701-724, Korea TEL: +82-53-940-7152FAX: +82-53-954-7417 E-mail: mdkjs99@hanmail.net INTRODUCTION Benign prostatic hyperplasia (BPH) is one of the most com- mon causes of urinary obstruct ion, which occurs in 50% to  60% of men aged 60 years or older [1].",Non-OADS,/arxiv_data1/oa_pdf/6d/54/kju-55-41.PMC3897629.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 47 Korean J Urol 2014;55:47-51http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.1 .47&domain=pdf&date_stamp=2014-1-17www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.1.47 Original Article - Voiding Dysfunction Changes in Bladder Wall Thickness and Detrusor Wall Thickness  After Surgical Treatment of Benign Prostatic Enlargement in Patients With Lower Urinary Tract Symptoms: A Preliminary Report Hakmin Lee, Minsoo Choo, Myong Kim, Sung Yong Cho, Seung Bae Lee, Hyeon Jeong,  Hwancheoul Son Department of Urology, SMG-SNU Boramae Medical Center, Seoul, Korea  Purpose:  The purpose of the present study was to evaluate the perioperative changes  in bladder wall thickness and detrusor  wall thickness after transurethral  prostatectomy.",Non-OADS,/arxiv_data1/oa_pdf/1a/3b/kju-55-47.PMC3897630.pdf
"Keywords:  Lower urinary tract symptoms; Prostate; Urinary bladder  This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 28 June, 2013 accepted 24 September, 2013 Corresponding Author: Hwancheoul Son Department of Urology,  SMG-SNU Boramae Medical  Center, 20 Boramae-ro 5-gil,  Dongjak-gu, Seoul 156-707,  Korea TEL: +82-2-870-2391 FAX: +82-2-870-3863 E-mail: volley@snu.ac.kr INTRODUCTION Benign prostatic hyperplasia (BPH) and lower urinary  tract symptoms (LUTS) have  become very common among  middle-aged men in Korea.",Non-OADS,/arxiv_data1/oa_pdf/1a/3b/kju-55-47.PMC3897630.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 52 Korean J Urol 2014;55:52-56http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.1 .52&domain=pdf&date_stamp=2014-1-17www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.1.52 Original Article - Voiding Dysfunction Clinical Effects of Discontinuing 5-Alpha Reductase Inhibitor in  Patients With Benign Prostatic Hyperplasia Won Kim, Jae Hung Jung, Tae Wook Kang, Jae Mann Song, Hyun Chul Chung Department of Urology, Yonsei University Wonju College of Medicine, Wonju, Korea Purpose:  To assess changes in lower urinary tr act symptoms (LUTS) , prostate volume,  and serum prostate-specific antigen (PSA) af ter discontinuation of 5-alpha reductase  inhibitor (5ARI) combination therapy in patients with benign prostatic hyperplasia  (BPH).",Non-OADS,/arxiv_data1/oa_pdf/40/a4/kju-55-52.PMC3897631.pdf
"Keywords:  5-Alpha reductase inhibitors; Prostate specific antigen; Prostatic hyperplasia This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 27 June, 2013 accepted 2 October, 2013 Corresponding Author: Hyun Chul Chung Department of Urology, Yonsei  University Wonju College of  Medicine, 20 Ilsan-ro, Wonju  220-701, Korea TEL: +82-33-741-0654 FAX: +82-33-741-1930 E-mail: chc7174@yonsei.ac.kr INTRODUCTION Benign prostatic hyperplasia (BPH) is a progressive and  androgen-dependent disease that causes lower urinary  tract symptoms (LUTS) [1].",Non-OADS,/arxiv_data1/oa_pdf/40/a4/kju-55-52.PMC3897631.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 57 Korean J Urol 2014;55:57-63http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.1 .57&domain=pdf&date_stamp=2014-1-17www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.1.57 Original Article - Sexual Dysfunction Urologists’ Perceptions and Practice Patterns in Peyronie’s Disease:  A Korean Nationwide Survey Including Patient Satisfaction Young Hwii Ko, Ki Hak Moon, Sung Won Lee1, Sae Woong Kim2, Dae Yul Yang3, Du Geon Moon4,  Woo Sik Chung5, Kyung Jin Oh6, Jae Seog Hyun7, Ji Kan Ryu8, Hyun Jun Park9, Kwangsung Park6 Department of Urology, Yeungnam University College of Medicine, Daegu, 1Department of Urology, Samsung Medical Center,  Sungkyunkwan University School of Medicine, Seoul, 2Department of Urology, The Catholic Univer sity of Korea College of Medicine, Seoul,  3Department of Urology, Hallym Univer sity College of Medicine, Chuncheon, 4Department of Urology, Korea University College of Medicine,  Seoul, 5Department of Urology, Ewha Womans University School of Medicine, Seoul, 6Department of Urology, Chonnam National  University Medical School, Gwangju, 7Department of Urology, Gyeongsang National  University School of Medicine, Jinju, 8Department  of Urology, Inha University School of Medicine, Incheon, 9Department of Urology, Busan National University School of Medicine, Yangsan,  Korea Purpose:  A nationwide survey was conducted of Korean urolog ists to illustrate physi- cians’ perceptions and real practical pa tterns regarding Peyronie disease (PD).",Non-OADS,/arxiv_data1/oa_pdf/00/61/kju-55-57.PMC3897632.pdf
"Keywords:  Data collection; Peni le induration; Perception This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 23 July, 2013 accepted 23 September, 2013 Corresponding Author: Kwangsung Park Department of Urology, Chonnam National University  Medical School, 160 Baekseo-ro,  Dong-gu, Gwangju 501-746, Korea TEL: +82-62-220-6701 FAX: +82-62-227-1643E-mail: uropark@gmail.com INTRODUCTION Peyronie disease (PD) is a connective tissue disorder that  is characterized by localized fibrotic plaques in the tunica albuginea, most commonly on the dorsal surface of the pe-nis, that result in penile bend ing and often pain [1].",Non-OADS,/arxiv_data1/oa_pdf/00/61/kju-55-57.PMC3897632.pdf
SUPPLEMENTARY MATERIALS Supplementary questionnaire can be found via http://kjur-ology.org/src/sm/kju-55-57-s001.pdf.,Non-OADS,/arxiv_data1/oa_pdf/00/61/kju-55-57.PMC3897632.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 64 Korean J Urol 2014;55:64-68http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.1 .64&domain=pdf&date_stamp=2014-1-17www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.1.64 Original Article - Pediatric Urology Which Patients Are at Higher Risk for Residual Valves After  Posterior Urethral Valve Ablation?",Non-OADS,/arxiv_data1/oa_pdf/50/20/kju-55-64.PMC3897633.pdf
"Keywords:  Posterior urethral valves; Preoperati ve findings; Residual valve; Valve  ablation This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 25 July, 2013 accepted 8 October, 2013 Corresponding Author: Mohamadreza Farsiani Department of Urology,  Shahid-Faghihi Hospital, Shiraz  University of Medical Sciences, KarimkhanZand St., Shiraz, Iran TEL: +987112331006 FAX: +987112330724E-mail: mohamadreza_far30@ yahoo.com INTRODUCTION Posterior urethral valve (PUV) is the most common cause  of congenital bladder outlet obstruction in boys and causes renal failure in 25% to 30% of cases before adolescence.",Non-OADS,/arxiv_data1/oa_pdf/50/20/kju-55-64.PMC3897633.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 69 Korean J Urol 2014;55:69-73http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.1 .69&domain=pdf&date_stamp=2014-1-17www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.1.69 Original Article - Pediatric Urology Reasons for Delayed Orchiopexies in a Korean Tertiary Care  Hospital Hyunsoo Ahn, Hahn Ey Lee, Kwanjin Park, Hwang Choi1 Department of Urology, Seoul National University, Seoul, 1Armed Forces Capital Hospital, Seongnam, Korea Purpose:  Since the 1990s, it has been well known that orchiopexies should be performed  by no later than 2 years of age.",Non-OADS,/arxiv_data1/oa_pdf/22/dd/kju-55-69.PMC3897634.pdf
"Keywords:  Cryptorchidism; Orchiope xy; Tertiary care centers This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 4 June, 2013 accepted 24 September, 2013 Corresponding Author: Kwanjin Park Department of Urology, Seoul  National University Hospital, Seoul National University, 101  Daehak-ro, Jongno-gu, Seoul  110-744, KoreaTEL: +82-2-2072-0695 FAX: +82-2-742-4665 E-mail: urodori@yahoo.co.kr INTRODUCTION  Cryptorchidism is the most common genital anomaly iden- tified in males at birth with a prevalence of about 1% at 1  year of age [1,2].",Non-OADS,/arxiv_data1/oa_pdf/22/dd/kju-55-69.PMC3897634.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 74 Korean J Urol 2014;55:74-76http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.1 .74&domain=pdf&date_stamp=2014-1-17www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.1.74 Case Report Intolerance to Sunitinib Treatment in Hemodialysis Patients With  Metastatic Renal Cell Carcinoma  Ibrahim Yildiz, Fatma Sen, Leyla Kilic, Rumeysa Ciftci, Mert Basaran Department of Medical Oncology, Institute of Oncology, Istanbul University, Istanbul, Turkey Sunitinib is a multiple tyrosine kinase recept or inhibitor that is approved for the treat- ment of metastatic renal cell carcinoma (RCC).",Non-OADS,/arxiv_data1/oa_pdf/e5/fb/kju-55-74.PMC3897635.pdf
"Keywords:  Renal cell carcinoma; Renal dialysis; Sunitinib This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 1 February, 2012 accepted 30 March, 2012 Corresponding Author: Ibrahim Yildiz Division of Medical Oncology,  Institute of Oncology, Istanbul University, Istanbul, Turkey TEL: +90-505-7465178 FAX: +90-212-5348078E-mail: dr_ibrahim2000@yahoo.",Non-OADS,/arxiv_data1/oa_pdf/e5/fb/kju-55-74.PMC3897635.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 77 Korean J Urol 2014;55:77-79http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.1 .77&domain=pdf&date_stamp=2014-1-17www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.1.77 Case Report Ureteral Substitution Using Appendix for a Ureteral Defect Caused  by a Retroperitoneal Rhabdomyosarcoma in a Child  Byung Il Yoon, Chan Gyu Hong, Seol Kim, U-Syn Ha, Jae Hee Chung1, Sae Woong Kim,  Yong-Hyun Cho, Dong Wan Sohn Departments of Urology and 1Surgery, The Catholic University of Korea College of Medicine, Seoul, Korea A 7-year-old boy was diagnosed with a recurrent embryonal rhabdomyosarcoma in the  retroperitoneum.",Non-OADS,/arxiv_data1/oa_pdf/89/14/kju-55-77.PMC3897636.pdf
"Keywords:  Appendix; Substitution; Ureter This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 2 April, 2012 accepted 15 May, 2012 Corresponding Author: Dong Wan Sohn Department of Urology, Yeouido St. Mary’s Hospital, The Catholic  University of Korea College of  Medicine, 10 63(yuksam)-ro, Yeongdeungpo-gu, Seoul 150-713,  Korea TEL: +82-2-3779-1038FAX: +82-2-761-1626 E-mail: uroking@naver.com INTRODUCTION  Although various approaches to  the treatment of ureteral  defects have been introduced , renal autotransplantation  or ureteral substitution using intestine may be the only mo-dality of treatment in the case  of an extensive ureteral  defect.",Non-OADS,/arxiv_data1/oa_pdf/89/14/kju-55-77.PMC3897636.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 9 Korean J Urol 2014;55:9-16http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.1 .9&domain=pdf&date_stamp=2014-1-17www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.1.9 Review Article Hypogonadism in Human Immunodeficiency Virus-Positive Men Jane Ashby, David Goldmeier1, Hossein Sadeghi-Nejad2 Berkshire Healthcare NHS Foundation Trust, Slough, UK, 1Imperial College Healthcare NHS Trust, St Mary 's Hospital, London, UK,  2Division of Urology, Department of Surgery, UMDNJ New Jersey Medical School, Newark, NJ, USA In recent years, the life expectancy for th ose living with human immunodeficiency virus  (HIV) with access to combined antiretrov iral therapy (cART) has increased.",Non-OADS,/arxiv_data1/oa_pdf/99/98/kju-55-9.PMC3897637.pdf
"Keywords:  Androgens; HIV; Hypogonadism; Testosterone This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 17 September, 2013 accepted 13 December, 2013 Corresponding Author: Jane Ashby Garden Clinic, Upton Hospital,  Albert St., Slough SL1 2BJ, UKTEL: +441753635606 FAX: +441753536938 E-mail: janeashby99@hotmail.com INTRODUCTION In recent years, the rate of growth of the human im- munodeficiency virus (HIV) epidemic has slowed with a re- duction in the annua l number of new HIV infections and  a dramatic reduction in HIV-associated mortality [1-3].",Non-OADS,/arxiv_data1/oa_pdf/99/98/kju-55-9.PMC3897637.pdf
"Schizophrenia involves symptoms  such as hallucination and delusions (a positive symptom), desire  to withdraw and not talk to people (negative symptoms), and Involvement of Genetic and Environmental Factors  in the Onset of Depression Toshitaka Nabeshima1,2* and Hyoung-Chun Kim3 1Department of Regional Pharmaceutical Care and Sciences, Graduate School of Pharmaceutical Sciences, Meijo University,  2NPO, Japanese Drug Organization of Appropriate Use and Research, Nagoya 468-8503, Japan, 3Neuropsychopharmacology  & Toxicology Program, College of Pharmacy, Kangwon National University, Chuncheon 200-701, Koreahttp://dx.doi.org/10.5607/en.2013.22.4.235 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/8a/cc/en-22-235.PMC3897684.pdf
"Key words:  depression, genetic factors, environmental factors, epigenetics, glucocorticoide Copyright © Experimental Neurobiology 2013. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8a/cc/en-22-235.PMC3897684.pdf
236 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.235Toshitaka Nabeshima and Hyoung-Chun Kim cognitive impairment.,OADS,/arxiv_data1/oa_pdf/8a/cc/en-22-235.PMC3897684.pdf
237 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.235Potential Factors in Depression Onset underlie the therapeutic efficacy of antidepressant treatment:  Decreased BDNF levels are associated with both human  depression and a range of rodent models of the disorder.,Non-OADS,/arxiv_data1/oa_pdf/8a/cc/en-22-235.PMC3897684.pdf
"238 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.235Toshitaka Nabeshima and Hyoung-Chun Kim patients with depression and using animal models of depression  have implicated ATP-binding cassette sub-family B member 1  (ABCB1) [30], histone deacetylase (HDAC6) [31], a promoter  region related to serotonin transporter gene transcription (5- TT LPR) [32, 33], neuritin [34], and disrupted in schizophrenia 1  (DISC1) [35] as candidate genes.",Non-OADS,/arxiv_data1/oa_pdf/8a/cc/en-22-235.PMC3897684.pdf
"239 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.235Potential Factors in Depression Onset Disrupted-in-Schizophrenia 1 (DISC1) defects In a family in Scotland, five generations include multiple patients  with psychiatric disorders, including schizophrenia and mood  disorders.",Non-OADS,/arxiv_data1/oa_pdf/8a/cc/en-22-235.PMC3897684.pdf
"240 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.235Toshitaka Nabeshima and Hyoung-Chun Kim information into RNA on the basis of genetic information in DNA,  and the creation of a protein on the basis of the RNA information.",OADS,/arxiv_data1/oa_pdf/8a/cc/en-22-235.PMC3897684.pdf
"241 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.235Potential Factors in Depression Onset suggested by hypermethylation of the same gene as an early event  in tumorigenesis, as well as by tumor type-specific methylation  landscape [50].",Non-OADS,/arxiv_data1/oa_pdf/8a/cc/en-22-235.PMC3897684.pdf
Available from: http://www.47news.jp/CN/201107/ CN2011070701000777.html.,Non-OADS,/arxiv_data1/oa_pdf/8a/cc/en-22-235.PMC3897684.pdf
Available from: http://www.47news.jp/CN/201009/ CN2010090701000179.html.,Non-OADS,/arxiv_data1/oa_pdf/8a/cc/en-22-235.PMC3897684.pdf
242 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.235Toshitaka Nabeshima and Hyoung-Chun Kim structurally related compounds.,OADS,/arxiv_data1/oa_pdf/8a/cc/en-22-235.PMC3897684.pdf
243 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.235Potential Factors in Depression Onset 38.,Non-OADS,/arxiv_data1/oa_pdf/8a/cc/en-22-235.PMC3897684.pdf
"Interestingly, accumulating data for recent years have suggested  that Dyrk1A is involved in the regulation of cytoskeletal proteins  such as tubulin, actin, and microtubule-associated protein New Perspectives of Dyrk1A Role in Neurogenesis  and Neuropathologic Features of Down Syndrome Joongkyu Park1,2 and Kwang Chul Chung1* 1Department of Systems Biology, College of Life Science and Biotechnology, Y onsei University, Seoul 120-749, Korea,  2Program in Cellular Neuroscience, Neurodegeneration and Repair (CNNR), Department of Cellular and Molecular  Physiology, Y ale University School of Medicine, New Haven, CT 06510, USAhttp://dx.doi.org/10.5607/en.2013.22.4.244 Exp Neurobiol.",OADS,/arxiv_data1/oa_pdf/bf/82/en-22-244.PMC3897685.pdf
"Key words:  down syndrome, Dyrk1A, neuritogenesis, synaptogenesis, cytoskeletal proteins Copyright © Experimental Neurobiology 2013. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/82/en-22-244.PMC3897685.pdf
245 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.244Dyrk1A and Alteration of Neurogenesis in Down Syndrome tau and the alteration in neurogenesis of DS.,OADS,/arxiv_data1/oa_pdf/bf/82/en-22-244.PMC3897685.pdf
246 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.244Joongkyu Park and Kwang Chul Chung serine 202 and 404 residues [33].,OADS,/arxiv_data1/oa_pdf/bf/82/en-22-244.PMC3897685.pdf
"247 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.244Dyrk1A and Alteration of Neurogenesis in Down Syndrome Driscoll DJ, Cantu ES, T ranebjaerg L, Mikkelsen M, W atkins  PC, Antonarakis SE (1989) Molecular genetic approach  to the characterization of the “Down syndrome region” of  chromosome 21.",OADS,/arxiv_data1/oa_pdf/bf/82/en-22-244.PMC3897685.pdf
248 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.244Joongkyu Park and Kwang Chul Chung syndrome patients.,Non-OADS,/arxiv_data1/oa_pdf/bf/82/en-22-244.PMC3897685.pdf
"LRRK2 as a Potential Genetic Modifier of  Synucleinopathies: Interlacing the Two Major  Genetic Factors of Parkinson’s Disease Cheol Hwan Hyun2#, Chae Y oung Y oon2#, He-Jin Lee2,3 and Seung-Jae Lee1,2* 1Department of Biomedical Science and Technology, 2Institute of Biomedical Science and Technology,  3Department of Anatomy, School of Medicine, Konkuk University, Seoul 143-701, Koreahttp://dx.doi.org/10.5607/en.2013.22.4.249 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/77/14/en-22-249.PMC3897686.pdf
"Key words:  Parkinson ’ s disease, LRRK2, alpha-synuclein, synucleinopathy, transmission, neurodegeneration Copyright © Experimental Neurobiology 2013. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/77/14/en-22-249.PMC3897686.pdf
"250 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.249Cheol Whan Hyun, et al.",Non-OADS,/arxiv_data1/oa_pdf/77/14/en-22-249.PMC3897686.pdf
251 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.249LRRK2 and Alpha-Synuclein the unconventional exocytosis [49].,Non-OADS,/arxiv_data1/oa_pdf/77/14/en-22-249.PMC3897686.pdf
"252 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.249Cheol Whan Hyun, et al.",Non-OADS,/arxiv_data1/oa_pdf/77/14/en-22-249.PMC3897686.pdf
253 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.249LRRK2 and Alpha-Synuclein investigations into these hypothetical mechanisms are likely to  provide answers as to whether these two genes indeed interplay in  generating synucleinopathy and potential targets for therapy for  Lewy body diseases.,Non-OADS,/arxiv_data1/oa_pdf/77/14/en-22-249.PMC3897686.pdf
"254 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.249Cheol Whan Hyun, et al.",Non-OADS,/arxiv_data1/oa_pdf/77/14/en-22-249.PMC3897686.pdf
255 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.249LRRK2 and Alpha-Synuclein bodies from Parkinson’s disease and dementia with lewy  bodies.,Non-OADS,/arxiv_data1/oa_pdf/77/14/en-22-249.PMC3897686.pdf
"256 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.249Cheol Whan Hyun, et al.",OADS,/arxiv_data1/oa_pdf/77/14/en-22-249.PMC3897686.pdf
257 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.249LRRK2 and Alpha-Synuclein 71.,OADS,/arxiv_data1/oa_pdf/77/14/en-22-249.PMC3897686.pdf
"Finally, this leads to neurological abnormalities, such as decrease Curcumin Can Prevent the Changes in Cerebellar  Structure and Function Induced by Sodium  Metabisulfite in Rat Ali Noorafshan1,2, Ali Rashidiani-Rashidabadi2, Saied Karbalay-Doust1,2*,  Aghdas Poostpasand2, Mohammad-Amin Abdollahifar2 and Reza Asadi-Golshan2 1Histomorphometry and Stereology Research Centre, Shiraz University of Medical Sciences,  2Anatomy Department, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Fars 71348-45794, Iranhttp://dx.doi.org/10.5607/en.2013.22.4.258 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/ec/e8/en-22-258.PMC3897687.pdf
"Key words:  cerebellum, sulfite, curcumin, rat, histology Copyright © Experimental Neurobiology 2013. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ec/e8/en-22-258.PMC3897687.pdf
"260 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.258Ali Noorafshan, et al.",OADS,/arxiv_data1/oa_pdf/ec/e8/en-22-258.PMC3897687.pdf
"262 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.258Ali Noorafshan, et al.",OADS,/arxiv_data1/oa_pdf/ec/e8/en-22-258.PMC3897687.pdf
"264 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.258Ali Noorafshan, et al.",OADS,/arxiv_data1/oa_pdf/ec/e8/en-22-258.PMC3897687.pdf
"266 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.258Ali Noorafshan, et al.",OADS,/arxiv_data1/oa_pdf/ec/e8/en-22-258.PMC3897687.pdf
"Additionally, Agm protected against neuronal damage The Effect of Agmatine on Expression of IL-1β and  TLX Which Promotes Neuronal Differentiation in  Lipopolysaccharide-Treated Neural Progenitors Juhyun Song1, Bokara Kiran Kumar1, Somang Kang1,2,  Kyung Ah Park1, Won Taek Lee1 and Jong Eun Lee1,2* 1Department of Anatomy, 2BK21 Plus Project for Medical Sciences,  Y onsei University College of Medicine, Seoul 120-752, Koreahttp://dx.doi.org/10.5607/en.2013.22.4.268 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/77/42/en-22-268.PMC3897688.pdf
"Key words:  agmatine, neural progenitor cell (NPC), differentiation, lipopolysaccharide, IL-1β, TLX Copyright © Experimental Neurobiology 2013. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/77/42/en-22-268.PMC3897688.pdf
269 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.268Effect of Agmatine on Differentiation of NPCs caused by glucocorticoids and glutamate toxicity in primary  hippocampal neuron cultures and cell lines [12-15].,OADS,/arxiv_data1/oa_pdf/77/42/en-22-268.PMC3897688.pdf
"270 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.268Juhyun Song, et al.",OADS,/arxiv_data1/oa_pdf/77/42/en-22-268.PMC3897688.pdf
271 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.268Effect of Agmatine on Differentiation of NPCs [34].,OADS,/arxiv_data1/oa_pdf/77/42/en-22-268.PMC3897688.pdf
"272 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.268Juhyun Song, et al.",OADS,/arxiv_data1/oa_pdf/77/42/en-22-268.PMC3897688.pdf
273 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.268Effect of Agmatine on Differentiation of NPCs and its deletion leads to non-proliferative NSCs [48].,Non-OADS,/arxiv_data1/oa_pdf/77/42/en-22-268.PMC3897688.pdf
"274 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.268Juhyun Song, et al.",OADS,/arxiv_data1/oa_pdf/77/42/en-22-268.PMC3897688.pdf
275 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.268Effect of Agmatine on Differentiation of NPCs Natl Acad Sci U S A 105:751-756.,OADS,/arxiv_data1/oa_pdf/77/42/en-22-268.PMC3897688.pdf
"276 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.268Juhyun Song, et al.",OADS,/arxiv_data1/oa_pdf/77/42/en-22-268.PMC3897688.pdf
"M6B has been reported  to be expressed in neurons and oligodendrocytes [11], but its Distribution of the Immunoreactivity for  Glycoprotein M6B in the Neurogenic Niche and  Reactive Glia in the Injury Penumbra Following  Traumatic Brain Injury in Mice Kyung Mee Choi1, Joo Y eon Kim1 and Y ounghwa Kim2* 1Department of Anatomy, Korea University College of Medicine, Seoul 136-705, 2Department of Emergency Medical  Technology, College of Nursing and Public Health, Kyungil University, Gyeongsan 721-701, Koreahttp://dx.doi.org/10.5607/en.2013.22.4.277 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/6e/fc/en-22-277.PMC3897689.pdf
"Key words:  astrocytes, injury, M6B, nestin, neurogenesis, stem cells Copyright © Experimental Neurobiology 2013. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/fc/en-22-277.PMC3897689.pdf
"278 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.277Kyung Mee Choi, et al.",OADS,/arxiv_data1/oa_pdf/6e/fc/en-22-277.PMC3897689.pdf
"279 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.277Expression and Regulation of Glycoprotein M6B in the Mouse Astrocytes Expression of GPM6B in neural stem cells Because neural stem cells (NSCs) in the SVZ are known to express  GFAP , we examined whether M6B-IR was found in NSCs both  in vivo  and in vitro  (Figs.",OADS,/arxiv_data1/oa_pdf/6e/fc/en-22-277.PMC3897689.pdf
"280 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.277Kyung Mee Choi, et al.",OADS,/arxiv_data1/oa_pdf/6e/fc/en-22-277.PMC3897689.pdf
"281 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.277Expression and Regulation of Glycoprotein M6B in the Mouse Astrocytes Considering that NSCs also express GFAP , expression of M6B- IR in both astrocytes and NSCs also indicate the molecular  similarity of these two cell populations.",OADS,/arxiv_data1/oa_pdf/6e/fc/en-22-277.PMC3897689.pdf
"282 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.277Kyung Mee Choi, et al.",OADS,/arxiv_data1/oa_pdf/6e/fc/en-22-277.PMC3897689.pdf
"Mitochondrial Dysfunction of Immortalized Human  Adipose Tissue-Derived Mesenchymal Stromal Cells  from Patients with Parkinson’s Disease   Hyo Eun Moon1,2,3, Seung Hee Y oon5, Y ong Suk Hur6, Hyung Woo Park1,2,3,  Ji Y oung Ha5, Kyung-Hee Kim5, Jung Hee Shim5, Seung Hyun Y oo6, Jin H. Son5,  Seung Leal Paek1,2,3,8, In Keyoung Kim1, Jae Ha Hwang1, Dong Gyu Kim1,  Han-Joon Kim4, Beom Seok Jeon4, Sung Sup Park7 and Sun Ha Paek1,2,3* 1Department of Neurosurgery, 2Cancer Research Institute, 3Ischemic/Hypoxic Disease Institute, Seoul National University  College of Medicine, 4Department of Neurology, Seoul National University College of Medicine, Seoul 110-744, 5Department  of Brain & Cognitive Sciences, College of Pharmacy, Brain Disease Research Institute, Ewha Woman’s University, Seoul  120-750, 6Department of Biochemistry, Inha University School of Medicine, Incheon 402-751, 7Department of Laboratory  Medicine, Seoul National University Hospital, Seoul 110-744, Korea, 8Department of Neurosurgery, Mayo Clinic, USA http://dx.doi.org/10.5607/en.2013.22.4.283 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/c3/6f/en-22-283.PMC3897690.pdf
"Key words:  h TERT , hAD-MSC, immortalization, Parkinson ’ s disease, diagnosis Copyright © Experimental Neurobiology 2013. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c3/6f/en-22-283.PMC3897690.pdf
"284 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.283Hyo Eun Moon, et al.",OADS,/arxiv_data1/oa_pdf/c3/6f/en-22-283.PMC3897690.pdf
285 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.283hAD-MSCs and Mitochondrial Dysfunction which were a 26-year-old female and a 36-year-old female.,OADS,/arxiv_data1/oa_pdf/c3/6f/en-22-283.PMC3897690.pdf
"286 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.283Hyo Eun Moon, et al.",OADS,/arxiv_data1/oa_pdf/c3/6f/en-22-283.PMC3897690.pdf
"W estern blot analysis was performed with the National  Institutes of Health image processing and analyzing program  (ImageJ, v1.38; http://rsb.info.nih.gov/ij/).",OADS,/arxiv_data1/oa_pdf/c3/6f/en-22-283.PMC3897690.pdf
"287 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.283hAD-MSCs and Mitochondrial Dysfunction scanning microscope (Carl Zeiss LSM 510META, Carl Zeiss, Jena,  Germany).",OADS,/arxiv_data1/oa_pdf/c3/6f/en-22-283.PMC3897690.pdf
"288 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.283Hyo Eun Moon, et al.",OADS,/arxiv_data1/oa_pdf/c3/6f/en-22-283.PMC3897690.pdf
289 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.283hAD-MSCs and Mitochondrial Dysfunction are expressed as the means±standard deviation (SEM).,OADS,/arxiv_data1/oa_pdf/c3/6f/en-22-283.PMC3897690.pdf
"290 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.283Hyo Eun Moon, et al.",OADS,/arxiv_data1/oa_pdf/c3/6f/en-22-283.PMC3897690.pdf
"291 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.283hAD-MSCs and Mitochondrial Dysfunction weeks, homogeneous populations of hAD-MSCs were established  from non-PD , PD, Parkin  with the culture system.",OADS,/arxiv_data1/oa_pdf/c3/6f/en-22-283.PMC3897690.pdf
"292 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.283Hyo Eun Moon, et al.",OADS,/arxiv_data1/oa_pdf/c3/6f/en-22-283.PMC3897690.pdf
293 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.283hAD-MSCs and Mitochondrial Dysfunction staining was done to examine mitochondria expression (Fig.,OADS,/arxiv_data1/oa_pdf/c3/6f/en-22-283.PMC3897690.pdf
"294 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.283Hyo Eun Moon, et al.",OADS,/arxiv_data1/oa_pdf/c3/6f/en-22-283.PMC3897690.pdf
295 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.283hAD-MSCs and Mitochondrial Dysfunction structurally impaired mitochondria.,Non-OADS,/arxiv_data1/oa_pdf/c3/6f/en-22-283.PMC3897690.pdf
"296 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.283Hyo Eun Moon, et al.",OADS,/arxiv_data1/oa_pdf/c3/6f/en-22-283.PMC3897690.pdf
297 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.283hAD-MSCs and Mitochondrial Dysfunction elucidated whether the chromosomal rearrangement is the cause  of the immortalization accompanied by the strong telomerase  activity or is a result of the immortalization process [34].,OADS,/arxiv_data1/oa_pdf/c3/6f/en-22-283.PMC3897690.pdf
"298 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.283Hyo Eun Moon, et al.",OADS,/arxiv_data1/oa_pdf/c3/6f/en-22-283.PMC3897690.pdf
299 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.283hAD-MSCs and Mitochondrial Dysfunction Redox Signal 1:5-27.,Non-OADS,/arxiv_data1/oa_pdf/c3/6f/en-22-283.PMC3897690.pdf
"300 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.283Hyo Eun Moon, et al.",OADS,/arxiv_data1/oa_pdf/c3/6f/en-22-283.PMC3897690.pdf
"Other studies  have reported that the administration of HMGB1 monoclonal  antibody suppresses infarct formation in the postischemic brain HMGB1-Binding Heptamer Confers Anti- Inflammatory Effects in Primary Microglia Culture  Il-Doo Kim and Ja-Kyeong Lee * Department of Anatomy, Inha University School of Medicine, Incheon 400-712, Koreahttp://dx.doi.org/10.5607/en.2013.22.4.301 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/9f/7f/en-22-301.PMC3897691.pdf
"Key words:  HMGB1, HBHP , inflammation, microglia Copyright © Experimental Neurobiology 2013. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9f/7f/en-22-301.PMC3897691.pdf
302 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.301Il-Doo Kim and Ja-Kyeong Lee [13] and protects the blood-brain barrier [14].,Non-OADS,/arxiv_data1/oa_pdf/9f/7f/en-22-301.PMC3897691.pdf
"303 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.301Anti-Inflammatory Effects of HBHP in Microglia Activation Biotin pull-down Assay  To analyze the binding of HBHP to HMGB1, a pull-down  assay was performed using a 20 µl of streptavidin agarose beads  (50% slurry) (Pierce, Rockford, IL, USA).",OADS,/arxiv_data1/oa_pdf/9f/7f/en-22-301.PMC3897691.pdf
"304 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.301Il-Doo Kim and Ja-Kyeong Lee T o obtain LPS-free LCM, culture media were replaced with fresh  medium after 18 hrs of LPS treatment and LCM was collected  at 12 or 24 hrs later.",Non-OADS,/arxiv_data1/oa_pdf/9f/7f/en-22-301.PMC3897691.pdf
305 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.301Anti-Inflammatory Effects of HBHP in Microglia Activation was clearly inhibited dose dependently by HMGB1 A box but not  by HMGB1 B box (Fig.,Non-OADS,/arxiv_data1/oa_pdf/9f/7f/en-22-301.PMC3897691.pdf
306 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.301Il-Doo Kim and Ja-Kyeong Lee with various exogenous or endogenous molecules.,OADS,/arxiv_data1/oa_pdf/9f/7f/en-22-301.PMC3897691.pdf
307 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.301Anti-Inflammatory Effects of HBHP in Microglia Activation 10.,Non-OADS,/arxiv_data1/oa_pdf/9f/7f/en-22-301.PMC3897691.pdf
"Accordingly,  it has been reported that selective ablation of reactive astrocytes  exacerbates traumatic neuronal damage and that transplantation Absence of Delayed Neuronal Death in ATP- Injected Brain: Possible Roles of Astrogliosis Hey-Kyeong Jeong1,2, Ilo Jou1,2,3 and Eun-Hye Joe1,2,3,4* 1Department of Pharmacology, 2Neuroscience Graduate Program in Department of Biomedical Sciences,  3Chronic Inflammatory Disease Research Center, 4Brain Disease Research Center,  Ajou University School of Medicine, Suwon 443-721, Korea http://dx.doi.org/10.5607/en.2013.22.4.308 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/40/fd/en-22-308.PMC3897692.pdf
"Key words:  brain injury, astrogliosis, delayed neuronal death Copyright © Experimental Neurobiology 2013. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/40/fd/en-22-308.PMC3897692.pdf
"309 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.308Neuroprotective Roles of Astrogliois of astrocytes diminishes brain damage [18, 19].",Non-OADS,/arxiv_data1/oa_pdf/40/fd/en-22-308.PMC3897692.pdf
"310 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.308Hey-Kyeong Jeong, et al.",OADS,/arxiv_data1/oa_pdf/40/fd/en-22-308.PMC3897692.pdf
"311 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.308Neuroprotective Roles of Astrogliois within 3 h after ATP-injection, and further neuronal death did not  occur [1].",Non-OADS,/arxiv_data1/oa_pdf/40/fd/en-22-308.PMC3897692.pdf
"312 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.308Hey-Kyeong Jeong, et al.",OADS,/arxiv_data1/oa_pdf/40/fd/en-22-308.PMC3897692.pdf
"313 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.308Neuroprotective Roles of Astrogliois microglia the damaged sites, which prevents propagation of  the disrupted microenvironmental effect on the surrounding  tissues [1].",Non-OADS,/arxiv_data1/oa_pdf/40/fd/en-22-308.PMC3897692.pdf
"314 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.308Hey-Kyeong Jeong, et al.",OADS,/arxiv_data1/oa_pdf/40/fd/en-22-308.PMC3897692.pdf
"Consistent with  this, histochemically reactive zinc [detected by N-(6-methoxy-8- quinolyl)-p-carboxybenzoylsulphonamide (TFL-Zn)] was also  detected in CAA in Tg2576 mice, and noticeable reduction of  CAA was observed in Zn T3-depleted Tg2576 mice ( APP+/ZnT3-/-) Zinc-Triggered Induction of Tissue Plasminogen  Activator and Plasminogen in   Endothelial Cells and Pericytes Mun-Kyung Cho, Eun-Sun Sun and Y ang-Hee Kim * Department of Molecular Biology, Sejong University, Seoul 143-747, Koreahttp://dx.doi.org/10.5607/en.2013.22.4.315 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/6c/82/en-22-315.PMC3897693.pdf
"Key words:  zinc, amyloid-β (Aβ), tissue plasminogen activator (tPA), plasminogen (PLG), cerebral amyloid angiopathy (CAA) Copyright © Experimental Neurobiology 2013. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6c/82/en-22-315.PMC3897693.pdf
"316 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.315Mun-Kyung Cho, et al.",OADS,/arxiv_data1/oa_pdf/6c/82/en-22-315.PMC3897693.pdf
317 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.315Induction of tPA/PLG by Zinc sonicated with a water ultrasound sonicator for 10 min at RT .,Non-OADS,/arxiv_data1/oa_pdf/6c/82/en-22-315.PMC3897693.pdf
"318 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.315Mun-Kyung Cho, et al.",OADS,/arxiv_data1/oa_pdf/6c/82/en-22-315.PMC3897693.pdf
319 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.315Induction of tPA/PLG by Zinc or pericyte cultures.,Non-OADS,/arxiv_data1/oa_pdf/6c/82/en-22-315.PMC3897693.pdf
"320 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.315Mun-Kyung Cho, et al.",OADS,/arxiv_data1/oa_pdf/6c/82/en-22-315.PMC3897693.pdf
321 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.315Induction of tPA/PLG by Zinc 23.,Non-OADS,/arxiv_data1/oa_pdf/6c/82/en-22-315.PMC3897693.pdf
"Developmental Role of Anoctamin-1/TMEM16A  in Ca2+-Dependent Volume Change in Supporting  Cells of the Mouse Cochlea Eunyoung Yi2, Jaekwang Lee1 and C. Justin Lee1,3* 1WCI Center for Functional Connectomics, Korea Institute of Science and Technology, Seoul 136-791, 2College of Pharmacy and Natural Medicine Research Institute, Mokpo National University, Muan 534-729, 3KU-KIST Graduate School of Converging Science & Techonology, Korea University, Seoul 136-790, Koreahttp://dx.doi.org/10.5607/en.2013.22.4.322 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/44/82/en-22-322.PMC3897694.pdf
"Key words:  Anoctamin-1 (Ano1)/TMEM16A, cochlea, greater epithelial ridge, cell volume change, Ca2+-activated chloride channel,  supporting cell Copyright © Experimental Neurobiology 2013. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/44/82/en-22-322.PMC3897694.pdf
"323 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.322Functional Expression of ANO1 in Cochlea Most types of cells in the GER and LER of the mouse cochlea  undergo dramatic functional, neural, and morphologic changes  during the initial 2 postnatal weeks.",Non-OADS,/arxiv_data1/oa_pdf/44/82/en-22-322.PMC3897694.pdf
"324 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.322Eunyoung Yi, et al.",OADS,/arxiv_data1/oa_pdf/44/82/en-22-322.PMC3897694.pdf
325 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.322Functional Expression of ANO1 in Cochlea were thought to be IHCs.,OADS,/arxiv_data1/oa_pdf/44/82/en-22-322.PMC3897694.pdf
"326 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.322Eunyoung Yi, et al.",Non-OADS,/arxiv_data1/oa_pdf/44/82/en-22-322.PMC3897694.pdf
"327 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.322Functional Expression of ANO1 in Cochlea spontaneous electrical activity in GI tract and oviduct [27, 28],  is also expressed in GER supporting cell in neonatal cochlea  before hearing onset.",Non-OADS,/arxiv_data1/oa_pdf/44/82/en-22-322.PMC3897694.pdf
"328 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.322Eunyoung Yi, et al.",OADS,/arxiv_data1/oa_pdf/44/82/en-22-322.PMC3897694.pdf
329 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.322Functional Expression of ANO1 in Cochlea the mouse oviduct are dependent upon a calcium activated  chloride conductance encoded by Tmem16a.,Non-OADS,/arxiv_data1/oa_pdf/44/82/en-22-322.PMC3897694.pdf
"According to the national  survey conducted in South Korea in 2009 [3], 74.4% of married Reliability and Validity of the Korean Version of  the Lifespan Sibling Relationship Scale Hyeonseok S Jeong1, Eu Jin Jeong2, Si Y oung Yu2, Y ounghyun C Lyoo3,  Jooyeon J Im1, Sujin Bae4 and Jieun E Kim2* 1Interdisciplinary Program in Neuroscience, Seoul National University College of Natural Sciences, Seoul 151-747,  2Department of Brain & Cognitive Sciences, Ewha Womans University, Seoul 120-750,  3Department of Public Administration, Y onsei University, Seoul 120-749, Korea,  4Department of Psychiatry, Utah University School of Medicine, Salt Lake City 84112, USAhttp://dx.doi.org/10.5607/en.2013.22.4.330 Exp Neurobiol.",OADS,/arxiv_data1/oa_pdf/de/31/en-22-330.PMC3897695.pdf
"Key words:  sibling relationships, validity, reliability, lifespan sibling relationship scale, psychometrics Copyright © Experimental Neurobiology 2013. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/de/31/en-22-330.PMC3897695.pdf
331 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.330Lifespan Sibling Relationship Scale women had two or more children.,Non-OADS,/arxiv_data1/oa_pdf/de/31/en-22-330.PMC3897695.pdf
"332 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.330Hyeonseok S Jeong, et al.",OADS,/arxiv_data1/oa_pdf/de/31/en-22-330.PMC3897695.pdf
"333 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.330Lifespan Sibling Relationship Scale were all statistically significant, coefficient r ranging from 0.68 to  0.79.",OADS,/arxiv_data1/oa_pdf/de/31/en-22-330.PMC3897695.pdf
"334 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.330Hyeonseok S Jeong, et al.",OADS,/arxiv_data1/oa_pdf/de/31/en-22-330.PMC3897695.pdf
"335 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.330Lifespan Sibling Relationship Scale languages, which partly reflects the lack of research that examines  the role of sibling relationship.",Non-OADS,/arxiv_data1/oa_pdf/de/31/en-22-330.PMC3897695.pdf
"336 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.330Hyeonseok S Jeong, et al.",OADS,/arxiv_data1/oa_pdf/de/31/en-22-330.PMC3897695.pdf
"Upon admission, her serum sodium  was 120 mmol/L, which was corrected to 134 mmol/L after 3 Anti-LGI1 Limbic Encephalitis Presented with  Atypical Manifestations Jung-Ju Lee1, Soon-Tae Lee2, Keun-Hwa Jung2, Kon Chu2 and Sang Kun Lee2* 1Department of Neurology, Eulji General Hospital, Eulji University College of Medicine, Seoul 139-872,  2Department of Neurology, Comprehensive Epilepsy Center, Biomedical Research Institute,  Seoul National University Hospital, Seoul 110-744, Koreahttp://dx.doi.org/10.5607/en.2013.22.4.337 Exp Neurobiol.",OADS,/arxiv_data1/oa_pdf/d5/3f/en-22-337.PMC3897696.pdf
"Key words:  limbic encephalitis, chest pain, seizure, immune Copyright © Experimental Neurobiology 2013. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/3f/en-22-337.PMC3897696.pdf
"338 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.337Jung-Ju Lee, et al.",OADS,/arxiv_data1/oa_pdf/d5/3f/en-22-337.PMC3897696.pdf
339 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.337Anti-LGI1 Limbic Encephalitis Presented with Atypical Manifestations it was related to the autoimmune activities.,Non-OADS,/arxiv_data1/oa_pdf/d5/3f/en-22-337.PMC3897696.pdf
"340 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.4.337Jung-Ju Lee, et al.",OADS,/arxiv_data1/oa_pdf/d5/3f/en-22-337.PMC3897696.pdf
"107Review http://dx.doi.org/10.9758/cpn.2013.11.3.107 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2013;11(3):107-117 Copyrightⓒ 2013, Korean College of Neuropsychopharmacology                       Received:  November 8, 2013 / Revised:  November 22, 2013 Accepted:  November 25, 2013 Address for correspondence: Stephen M. Lawrie, MD Department of Psychiatry, Royal Edinburgh Hospital, University of  Edinburgh, Edinburgh EH10 5HF, United KingdomTel: +44-131-537-6220, Fax: +44-131-537-6802E-mail: S.Lawrie@ed.ac.uk  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.The Neuroimmunology of Schizophrenia Annya M. Smyth, Stephen M. Lawrie Department of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh, United Kingdom Schizophrenia (SCZ) is a polygenic, multi-factorial disorder an d a definitive understanding of its pathophysiology has been la ck- ing since it was first described more than a century ago.",Non-OADS,/arxiv_data1/oa_pdf/c7/9b/cpn-11-107.PMC3897758.pdf
"118Review http://dx.doi.org/10.9758/cpn.2013.11.3.118 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2013;11(3):118-125 Copyrightⓒ 2013, Korean College of Neuropsychopharmacology                       Received:  November 18, 2013/ Revised:  December 3, 2013 Accepted:  December 4, 2013 Address for correspondence: Ganesan Venkatasubramanian,  MD, PhD Department of Psychiatry, National Institute of Mental Health A nd  Neurosciences (NIMHANS), Bangalore 560029, IndiaTel: +91-80-26995256, LAB: +91-80-26995366, Fax: +91-80-26564830E-mail: venkat.nimhans@yahoo.com  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Transcranial Direct Current Stimulation in Schizophrenia Sri Mahavir Agarwal, Venkataram Shivakumar, Anushree Bose, Adit i Subramaniam, Hema Nawani,  Harleen Chhabra, Sunil V. Kalmady, Janardhanan C. Narayanaswamy , Ganesan Venkatasubramanian  The Schizophrenia Clinic, Department of Psychiatry and Translat ional Psychiatry Laboratory, Neurobiology Research Centre, Nati onal  Institute of Mental Health and Neurosciences, Bangalore, India Transcranial direct current stimulation (tDCS) is an upcoming t reatment modality for patients with schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/c2/81/cpn-11-118.PMC3897759.pdf
"126Original Article http://dx.doi.org/10.9758/cpn.2013.11.3.126 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2013;11(3):126-131 Copyrightⓒ 2013, Korean College of Neuropsychopharmacology                       Received:  November 26, 2012/ Revised:  February 27, 2013 Accepted:  March 7, 2013 Address for correspondence: Young-Chul Jung, MD, PhD Department of Psychiatry, Severance Mental Health Hospital,Yons ei  University College of Medicine, 696-6 Tanbeol-dong, Gwangju 464-100, KoreaTel: +82-31-760-9501, Fax: +82-31-760-9501E-mail: eugenejung@yuhs.ac  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Effects of Color Temperature and Brightness on Electroencephalogram Alpha  Activity in a Polychromatic Light-emitting Diode Jin Young Park1,2, Ra-Yeon Ha1,2, Vin Ryu3, Eosu Kim1,2, Young-Chul Jung1,2 1Department of Psychiatry, 2Institute of Behavioral Science in Medicine, Yonsei University College of Medicine, Seoul, 3Department of  Psychiatry, Konyang University College of Medicine, Daejeon, Ko rea Objective: It has been reported that working and learning efficiency might  be increased through artificially controlling the color  temperature and brightness of light.",Non-OADS,/arxiv_data1/oa_pdf/3d/4d/cpn-11-126.PMC3897760.pdf
"132Original Article http://dx.doi.org/10.9758/cpn.2013.11.3.132 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2013;11(3):132-136 Copyrightⓒ 2013, Korean College of Neuropsychopharmacology                       Received:  January 23, 2013/ Revised:  May 11, 2013 Accepted:  May 13, 2013 Address for correspondence: Naohisa Tsujino, MD, PhD  Department of Psychiatry, Toho U niversity School of Medicine,  6-11-1, Omori-Nishi, Ota-ku, Tokyo 143-8541, Japan Tel: +81-3-3762-4151, Fax: +81-3-5471-5774 E-mail: ntsujino@med.toho-u.ac.jp  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Long-term Efficacy and Tolerability of  Perospirone for Young Help-seeking  People at Clinical High Risk: a Preliminary Open Trial Naohisa Tsujino1, Takahiro Nemoto1, Keiko Morita1, Naoyuki Katagiri1, Shinya Ito2, Masafumi Mizuno1 Departments of 1Neuropsychiatry and 2Social Medicine, Toho University School of Medicine, Tokyo, Jap an Objective: Interest in the “at-risk mental state ” (ARMS) for psychosis has increased because early intervention is expected  to delay or prevent the onset of schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/2f/49/cpn-11-132.PMC3897761.pdf
"137Original Article http://dx.doi.org/10.9758/cpn.2013.11.3.137 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2013;11(3):137-143 Copyrightⓒ 2013, Korean College of Neuropsychopharmacology                       Received:  April 4, 2013/ Revised:  May 27, 2013 Accepted:  June 10, 2013 Address for correspondence: Seung-Hwan Lee, PhD Department of Psychiatry, Inje University Ilsan Paik Hospital, 170  Juhwa-ro, Ilsanseo-gu, Goyang 411-706, KoreaTel: +82-31-910-7260, Fax: +82-31-910-7268E-mail: lshpss@paik.ac.kr  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Comparative Study of Heart Rate Variability in Patients with Schizophrenia,  Bipolar Disorder, Post-traumatic Stress Disorder, or Major Depressive Disorder Eunok Moon1, Seung-Hwan Lee1,2, Do-Hyung Kim2, Boram Hwang2 1Clinical Emotion and Cognition Research Laboratory, 2Department of Psychiatry, Inje University Ilsan Paik Hospital, Goyang, Korea Objective: Heart rate variability (HRV) changes as a function of psychiatr ic illness.",Non-OADS,/arxiv_data1/oa_pdf/ad/13/cpn-11-137.PMC3897762.pdf
"144Original Article http://dx.doi.org/10.9758/cpn.2013.11.3.144 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2013;11(3):144-151 Copyrightⓒ 2013, Korean College of Neuropsychopharmacology                       Received:  June 4, 2013/ Revised:  July 24, 2013 Accepted:  August 1, 2013 Address for correspondence: Md.",Non-OADS,/arxiv_data1/oa_pdf/43/ce/cpn-11-144.PMC3897763.pdf
"152Original Article http://dx.doi.org/10.9758/cpn.2013.11.3.152 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2013;11(3):152-157 Copyrightⓒ 2013, Korean College of Neuropsychopharmacology                       Received:  July 15, 2013/ Revised:  July 28, 2013 Accepted:  August 2, 2013 Address for correspondence: Chul-Eung Kim, MD, PhD Department and Research Instutitute of Psychiatry, Inha Univers ity  College of Medicine, 7-206, Sinheung-dong 3-ga, Jung-gu, Incheon 400-711, KoreaTel: +82-32-890-3475, Fax: +82-32-890-3558E-mail: kce320@inha.ac.kr  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.The Influence of Previous Antipsychotic Polypharmacy Versus Monotherapy on  the Effectiveness of Antipsychotic after Switching to Paliperidone Extended- release Hee-Won Lee1, Kyoung-Sae Na2, Seung-Ho Jung1, Min-Hee Kang1, Jeong Seop Lee1, Jae-Nam Bae1, Hee-Yun  Kim1, Chul-Eung Kim1 1Department of Psychiatry, Inha University Hospital, Incheon, 2Department of Psychiatry, Soonch unhyang Universi ty Bucheon Hosp ital,  Bucheon, Korea Objective: Although antipsychotic polypharmacy is widely used in the pharm acotherapy of schizophrenia, its effectiveness is  controversial.",Non-OADS,/arxiv_data1/oa_pdf/39/56/cpn-11-152.PMC3897764.pdf
"158Original Article http://dx.doi.org/10.9758/cpn.2013.11.3.158 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2013;11(3):158-164 Copyrightⓒ 2013, Korean College of Neuropsychopharmacology                       Received:  September 25, 2013/ Revised:  November 4, 2013 Accepted:  November 7, 2013 Address for correspondence: Yong-Wha Lee, MD, PhD Department of Laboratory Medicine and Genetics, Soonchunhyang  University Bucheon Hospital, Soonchunhyang University College o f  Medicine, 170 Jomaru-ro, Wonmi-gu, Bucheon 420-767, KoreaTel: +82-32-621-5943, Fax: +82-32-621-5944E-mail: lywmd@schmc.ac.kr  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Simultaneous Screening of 177 Drugs of Abuse in Urine Using  Ultra-performance Liquid Chromatogra phy with Tandem Mass Spectrometry  in Drug-intoxicated Patients  Yong-Wha Lee Department of Laboratory Medicine and Genetics, Soonchunhyang U niversity Bucheon Hospital, Soonchunhyang University College of   Medicine, Bucheon, Korea Objective: The demand for rapid and broad clinical toxicology screening me thods to identify drugs of abuse and medicinal  drugs is increasing steadily.",Non-OADS,/arxiv_data1/oa_pdf/cc/72/cpn-11-158.PMC3897765.pdf
"165Case Report http://dx.doi.org/10.9758/cpn.2013.11.3.165 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2013;11(3):165-167 Copyrightⓒ 2013, Korean College of Neuropsychopharmacology                       Received:  March 14, 2013/ Revised:  May 11, 2013 Accepted:  May 16, 2013 Address for correspondence: Daeho Kim, MD, PhD Department of Psychiatry, Hanyang University Guri Hospital, 153   Gyeonchunro, Guri 471-701, KoreaTel: +82-31-560-2274, Fax: +82-31-554-2599E-mail: dkim9289@hanyang.ac.kr  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Blonanserin-induced Mood Alteration in  Schizophrenia and Schizoaffective  Disorder: Two Cases Aran Min, Daeho Kim Department of Psychiatry, Hanyang University Medical Center, Ha nyang University School of Medicine, Seoul, Korea We report two outpatients, one with schizophrenia and one with schizoaffective disorder, who developed manic or hypomanic  episodes following the initiation of blonanserin during the cou rse of treatment.",Non-OADS,/arxiv_data1/oa_pdf/31/65/cpn-11-165.PMC3897766.pdf
"168Case Report http://dx.doi.org/10.9758/cpn.2013.11.3.168 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2013;11(3):168-169 Copyrightⓒ 2013, Korean College of Neuropsychopharmacology                       Received:  October 2, 2013/ Revised:  October 31, 2013 Accepted:  November 7, 2013 Address for correspondence: Sang-Yeol Lee, MD, PhD Department of Psychiatry, Wonkwang University School of  Medicine, 895 Muwang-ro, Iksan 570-711, KoreaTel: +82-63-859-1044, Fax: +82-63-857-1043E-mail: psysangyeol@hanmail.net  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Successful Early Clozapine Trial in the Treatment of First-episode  Schizophrenia: A Case Report Yeon-Jin Kim, Seung-Ho No, Sang-Yeol Lee Department of Psychiatry, Wonkwang University School of Medicin e, Iksan, Korea Clozapine remains the treatment of choice in refractory schizop hrenia despite its various requirement to prescribe, such as ma n- datory blood monitoring program and various metabolic complicat ion.",Non-OADS,/arxiv_data1/oa_pdf/b9/11/cpn-11-168.PMC3897767.pdf
"4, 2012G&I    Genomics & InformaticspISSN 1598-866X  eISSN 2234-0742 Genomics Inform  2013;11(4):163 http://dx.doi.org/10.5808/GI.2013.11.4.163 EDITORIAL *Corresponding author:  Tel: +82-2-820-0457, Fax: +82-2-824-4383, E-mail: sskimb@ssu.ac.kr Copyright © 2013 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Editor’s Introduction to This Issue Sangsoo Kim* School of Systems Biomedical Science, Soongsil University, Seoul 156-743, Korea Earlier issues in this year have focused on the theme of  epigenomics.",Non-OADS,/arxiv_data1/oa_pdf/1b/60/gni-11-163.PMC3897841.pdf
"G&I    Genomics & InformaticspISSN 1598-866X eISSN 2234-0742 Genomics Inform  2013;11(4):164-173 http://dx.doi.org/10.5808/GI.2013.11.4.164 REVIEW ARTICLE Received October 20, 2013; Revised November 12, 2013; Accepted November 19, 2013 *Corresponding author:  Tel: +82-31-219-1886, Fax: +82-31-219-1615, E-mail: jsjlee@ajou.ac.kr Copyright © 2013 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Interplay between Epigenetics and Genetics in Cancer Jae Duk Choi, Jong-Soo Lee* Department of Life Science, College of Natural Sciences, Ajou University, Suwon 443-749, Korea  Genomic instability, which occurs through both genetic mechanis ms (underlying inheritable phe notypic variations caused by  DNA sequence-dependent alterations, such as mutation, deleti on, insertion, inversion, translocation, and chromosomal  aneuploidy) and epigenomic ab errations (underlying inheritable phenotypic  variations caused by DNA sequence-inde- pendent alterations caused by a change of chromatin structu re, such as DNA methylation and histone modifications), is  known to promote tumorigenesis and tumor progression.",Non-OADS,/arxiv_data1/oa_pdf/af/e7/gni-11-164.PMC3897842.pdf
"G&I  Genomics & InformaticspISSN 1598-866X eISSN 2234-0742 Genomics Inform  2013;11(4):174-179 http://dx.doi.org/10.5808/GI.2013.11.4.174 REVIEW ARTICLE Received November 5, 2013; Revised November 12, 2013; Accepted November 15, 2013 *Corresponding author:  Tel: +82-2-2072-0832, Fax: +82-2-764-2199, E-mail: sehoon.lee119@gmail.com Copyright © 2013 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Application of Cancer Genomics to Solve Unmet  Clinical Needs Se-Hoon Lee1,2*, Sung Hoon Sim1, Ji-Yeon Kim1, SooJin Cha2, Ahnah Song2 1Department of Internal Medicine, Seoul National University Hospital,  Seoul National University College of Medicine, Seoul 110-799, Korea,  2Cancer Research Institute, Seoul National University College of Medicine, Seoul 110-799, Korea The large amount of data on cancer genome research has contribu ted to our understanding of cancer biology.",Non-OADS,/arxiv_data1/oa_pdf/ba/75/gni-11-174.PMC3897843.pdf
Available from: http://genome.wustl.edu/articles/detail/  doctor-survives-cancer-he-studies/.,Non-OADS,/arxiv_data1/oa_pdf/ba/75/gni-11-174.PMC3897843.pdf
"G&I   Genomics & InformaticspISSN 1598-866X eISSN 2234-0742 Genomics Inform  2013;11(4):180-185 http://dx.doi.org/10.5808/GI.2013.11.4.180 REVIEW ARTICLE Received October 23, 2013; Revised November 20, 2013; Accepted November 21, 2013 *Corresponding author:  Tel: +1-713-834-6154, Fax: +1-713-563-4235, E-mail: jlee@mdanderson.org Copyright © 2013 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Genomic Profiling of Liver Cancer Ju-Seog Lee* Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA Development of liver cancers is driven largely by genomic alte rations that deregulate signaling pathways, influencing growth  and survival of cancer cells.",Non-OADS,/arxiv_data1/oa_pdf/65/48/gni-11-180.PMC3897844.pdf
"G&I   Genomics & InformaticspISSN 1598-866X eISSN 2234-0742 Genomics Inform  2013;11(4):186-190 http://dx.doi.org/10.5808/GI.2013.11.4.186 REVIEW ARTICLE Received October 18, 2013; Revised November 18, 2013; Accepted November 20, 2013 *Corresponding author:  Tel: +82-2-2258-7343, Fax: +82-2-537-0572, E-mail: yejun@catholic.ac.kr Copyright © 2013 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Perspectives on Clinical Informatics:  Integrating Large-Scale Clinical, Genomic, and  Health Information for Clinical Care In Young Choi1, Tae-Min Kim2, Myung Shin Kim3, Seong K. Mun1,4, Yeun-Jun Chung5* 1Department of Medical Informatics, The Catholic University of Korea College of Medicine, Seoul 137-701, Korea,  2Department of Medical Informatics, MRC, IRCGP , The Catholic University of Korea College of Medicine, Seoul 137-701, Korea,  3Departments of Clinical Laboratory, The Catholic University of Korea College of Medicine, Seoul 137-701, Korea,  4Open Source Electronic Health Record Agent (OSEHRA), Arlington Innovation Center, Virginia T ech, Arlington, VA 22203, USA 5Department of Microbiology, Department of Medical Informatics, Integrated Research Center for  Genome Polymorphism (IRCGP), MRC, The Catholic University of Korea College of Medicine, Seoul 137-701, Korea The advances in electronic medical records (EMRs) and bioinformatics (BI) represent two significant trends in healthcare.",Non-OADS,/arxiv_data1/oa_pdf/2d/7c/gni-11-186.PMC3897845.pdf
"For example, the NSF BIGDATA program solicitation (http://www.nsf.gov), which is partially funded  by the National Institutes of Health (NIH), includes large-  scale data collection and analysis.",Non-OADS,/arxiv_data1/oa_pdf/2d/7c/gni-11-186.PMC3897845.pdf
"INBIOMEDvision (http://www.inbiomedvision.eu) is a  two-year initiative funded by the European Commission 7th Framework Program of Information and Communication  Technologies (ICT), with the aim of bridging the com- munities of bioinformatics and medical informatics.",Non-OADS,/arxiv_data1/oa_pdf/2d/7c/gni-11-186.PMC3897845.pdf
There is a great need for the  EMR community to adopt more open source software  methodologies that would allow rapid global collaboration (http://www.osehra.org).,Non-OADS,/arxiv_data1/oa_pdf/2d/7c/gni-11-186.PMC3897845.pdf
Available from: http://emerge.mc.,Non-OADS,/arxiv_data1/oa_pdf/2d/7c/gni-11-186.PMC3897845.pdf
"G&I   Genomics & InformaticspISSN 1598-866X eISSN 2234-0742 Genomics Inform  2013;11(4):191-199 http://dx.doi.org/10.5808/GI.2013.11.4.191 REVIEW ARTICLE Received October 18, 2013; Revised November 18, 2013; Accepted November 21, 2013 *Corresponding author:  Tel: +1-732-445-1027, Fax: +1-732-445-1147, E-mail: xing@biology.rutgers.edu  Copyright © 2013 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).A Primer for Disease Gene Prioritization Using  Next-Generation Sequencing Data Shuoguo Wang1,2, Jinchuan Xing1,2* 1Department of Genetics, The State University of New Jersey, Piscataway, NJ 08854, USA,  2Human Genetics Institute of New Jersey, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA High-throughput next-generation sequencing  (NGS) technology produces a tremendous amount of raw sequence data.",Non-OADS,/arxiv_data1/oa_pdf/05/84/gni-11-191.PMC3897846.pdf
FASTQC (http://www.bioinformatics.,Non-OADS,/arxiv_data1/oa_pdf/05/84/gni-11-191.PMC3897846.pdf
FASTX-Toolkit (http://hannonlab.cshl.,Non-OADS,/arxiv_data1/oa_pdf/05/84/gni-11-191.PMC3897846.pdf
Cutadapt (https://github.com/marcelm/cutadapt)  can be used for trimming short reads to remove potential  adapter contamination.,Non-OADS,/arxiv_data1/oa_pdf/05/84/gni-11-191.PMC3897846.pdf
"Mapping Once high-quality sequence data are obtained, a number  of bioinformatics programs, including Mosaik [7], MAQ  (http://maq.sourceforge.net/), mrFAST [8], BWA [9],  Bowtie2 [10], SOAP2 [11], and Subread [12], can be used to perform short-read sequence alignment to the reference  genome.",OADS,/arxiv_data1/oa_pdf/05/84/gni-11-191.PMC3897846.pdf
"Additionally, BWA has been utilized in  multiple large-scale projects and well-defined workflows,  including the Genome Analysis Toolkit (GATK) by Broad Institute [15], the 1000 Genome Project [16], the NHLBI  GO Exome Sequencing Project (ESP) (http://evs.gs.",OADS,/arxiv_data1/oa_pdf/05/84/gni-11-191.PMC3897846.pdf
"Various commercial companies, such as Seven Bridges  Genomics (https://www.sbgenomics.com/) and Geospiza  GeneSifter (http://www.geospiza.com/), also utilize BWA in their standard workflows.",Non-OADS,/arxiv_data1/oa_pdf/05/84/gni-11-191.PMC3897846.pdf
"Some BAM processing programs, such as Picard  (http://picard.sourceforge.net/) and Samtools [18], can identify these artificially duplicated sequences and remove  them.",OADS,/arxiv_data1/oa_pdf/05/84/gni-11-191.PMC3897846.pdf
"Some of  the commonly used software programs are SAMtools [18], freebayes (http://github.com/ekg/freebayes), SNPtools  [20], GATK UnifiedGenotyper, and GATK HaplotypeCaller.",OADS,/arxiv_data1/oa_pdf/05/84/gni-11-191.PMC3897846.pdf
"SAM, sequence alignment/map;  BAM, binary format; SNP, single nucleotid e polymorphism; VCF, variant call format.of Genes and Genomes (KEGG) (http://www.kegg.jp/);  BioCyc (http://www.biocyc.org/), provided by SRI inter- national; PANTHER [45]; Reactome [46]; and DAVID [47].",OADS,/arxiv_data1/oa_pdf/05/84/gni-11-191.PMC3897846.pdf
"Optionally, commercial systems, such as Ingenuity Pathway  Analysis (http://www.ingenuity.com/ products/ipa), Path- way Studio (http://www.elsevier.com/online-tools/pathway- studio), and GeneGo (http://portal.",Non-OADS,/arxiv_data1/oa_pdf/05/84/gni-11-191.PMC3897846.pdf
Ingenuity Variant Analysis (http://www.inge- nuity.com/products/variant-analysis) is also backed up with Ingenuity Knowledge Base and can consider the  upstream and downstream genes of a variant in a pathway  and evaluate the potential role of a gene by incorporating the related genes.,OADS,/arxiv_data1/oa_pdf/05/84/gni-11-191.PMC3897846.pdf
"There are a number of  such pipelines that are well defined and easy to use, such as the GATK pipeline, gkno system (http://gkno.me/), Galaxy  [48-50], and VAAST [30, 31].",Non-OADS,/arxiv_data1/oa_pdf/05/84/gni-11-191.PMC3897846.pdf
"Develop  cloud-based computing resources, such as the 1000 Genome Project (http://aws.amazon.com/1000geno- mes/), to create a more efficient way of managing,  processing, and sharing data.",Non-OADS,/arxiv_data1/oa_pdf/05/84/gni-11-191.PMC3897846.pdf
http://dx.doi.org/10.1093/bib/bbs086.,Non-OADS,/arxiv_data1/oa_pdf/05/84/gni-11-191.PMC3897846.pdf
"G&I    Genomics & InformaticspISSN 1598-866X eISSN 2234-0742 Genomics Inform  2013;11(4):200-210 http://dx.doi.org/10.5808/GI.2013.11.4.200 REVIEW ARTICLE Received October 15, 2013; Revised November 20, 2013; Accepted November 21, 2013 *Corresponding author:  Tel: +1-214-648-4003, Fax: +1-214-648-1663, E-mail: TaeHyun.Hwang@UTSouthwestern.edu Copyright © 2013 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Review of Biological Network Data and  Its Applications  Donghyeon Yu, MinSoo Kim, Guanghua Xiao, Tae Hyun Hwang* Department of Clinical Sciences, Quantitative Biomedical Research Center,  University of T exas Southwestern Medical Center, Dallas, TX 75390, USA Studying biological networks, such as protein-protein intera ctions, is key to understanding complex biological activities.",OADS,/arxiv_data1/oa_pdf/be/18/gni-11-200.PMC3897847.pdf
"4, 2013 Database Type Species URL Reference DroID Protein interaction Drosophila http://www.droidb.org [10] MIPS Protein interaction/functional catalog Mammal http://mips.helmholtz-muenchen.de [11] HPRD Protein interaction Human http://www.hprd.org [12] BioGRID (GRID) Protein interaction No restriction http://thebiogrid.org [13, 14] DIP Protein interaction No restriction http://dip.doe-mbi.ucla.edu/dip [15] STRING Protein interaction No restriction http://string-db.org [16] MINT Protein interaction No restriction http://mint.bio.uniroma2.it/mint [17] IntAct Protein interaction No restriction http://www.ebi.ac.uk/intact [18] Reactome Pathway/protein Interaction No restriction http://www.reactome.org [3] TRED Transcriptional regulatory Human/mouse/rat http://rulai.cshl.edu/cgi-bin/TRED/tred.",Non-OADS,/arxiv_data1/oa_pdf/be/18/gni-11-200.PMC3897847.pdf
cgi?process=home [19] RegulonDB Transcriptional regulatory Escherichia coli  K-12 http://regulondb.ccg.unam.mx/ [20]Table 1.,Non-OADS,/arxiv_data1/oa_pdf/be/18/gni-11-200.PMC3897847.pdf
"Public network resources Method Approach Implementation URL SPACE Gaussian graphical model C, R http://cran.r-project.org/web/packages/space Graphical Lasso Gaussian graphical model Fortran, R http://cran.r-project.o rg/web/packages/glasso CLIME Gaussian graphical model R http://cran.r-project.org/web/packages/clime GeneNet Gaussian graphical model R http:// cran.r-project.org/w eb/packages/GeneNet B-Course Bayesian network Java http://b-course.cs.helsinki.fi BNT Bayesian network Matlab http://code.google.com/p/bnt/ Werhli et al.",Non-OADS,/arxiv_data1/oa_pdf/be/18/gni-11-200.PMC3897847.pdf
"’s BN Bayesian network Matlab http://www.bioss.ac.uk/people/adriano/comparison/ comparison.html#software WGCNA Correlation C, R http://cran.r-project.org/web/packages/WGCNA Relevance network Information theory Java http://www.newatlantictech.com/products.html ARACNE Information theory C++, Java http://wiki.c2b2.columbia.edu/califanolab/index.php/ Software/ARACNE CLR Information theory C, Matlab http://m3d.mssm.edu/network_inference.html GTRNetwork Information theory Matlab ht tp://www.biomedcentral.com/1471-2105/12/233 NARROMI Information theory Matlab http://csb.shu.edu.cn/narromi.htmTable 2.",Non-OADS,/arxiv_data1/oa_pdf/be/18/gni-11-200.PMC3897847.pdf
"G&I   Genomics & InformaticspISSN 1598-866X eISSN 2234-0742 Genomics Inform  2013;11(4):211-217 http://dx.doi.org/10.5808/GI.2013.11.4.211 REVIEW ARTICLE Received October 15, 2013; Revised November 7, 2013; Accepted November 13, 2013 *Corresponding author:  Tel: +82-43-719-6526, Fax: +82-43-719-6530, E-mail: bhkang11@korea.kr Copyright © 2013 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Current Status, Challenges, Policies, and Bioethics of  Biobanks Byunghak Kang1*, Jaesun Park1, Sangyun Cho1, Meehee Lee1, Namhee Kim1,  Haesook Min1, Sooyoun Lee1, Ok Park2, Bokghee Han3 1Division of Biobank for Health Sciences, Korea National Institute of Health, Cheongwon 363-951, Korea,  2Division of Vaccine Preventable Diseases, Korea Centers for Disease Control and Prevention, Cheongwon 363-951, Korea,  3Center for Genome Science, Korea National Institute of Health, Cheongwon 363-951, Korea Many biobanks were established as bio repositories for biomedical research, and a number of biobanks were founded in the  1990s.",Non-OADS,/arxiv_data1/oa_pdf/b0/98/gni-11-211.PMC3897848.pdf
A new report by Visiongain (http://www.visiongain.,Non-OADS,/arxiv_data1/oa_pdf/b0/98/gni-11-211.PMC3897848.pdf
Available from: http://biospecimens.cancer.gov/best- practices/2011-NCIBestPractices.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b0/98/gni-11-211.PMC3897848.pdf
"G&I   Genomics & InformaticspISSN 1598-866X eISSN 2234-0742 Genomics Inform  2013;11(4):218-223 http://dx.doi.org/10.5808/GI.2013.11.4.218 REVIEW ARTICLE Received October 19, 2013; Revised November 3, 2013; Accepted November 11, 2013 *Corresponding author 1: Tel: +82-2-2258-7212, Fax: +82-2-537-0572, E-mail: lyra@catholic.ac.kr **Corresponding author 2:  Tel: +82-2-2258-7343, Fax: +82-2-537-0572, E-mail: yejun@catholic.ac.kr Copyright © 2013 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Introduction to International Ethical Standards Related  to Genetics and Genomics Seon-Hee Yim1*, Yeun-Jun Chung2** 1Department of Medical Education, Integrated Research Center for Genome Polymorphism, The Catholic University of Korea  College of Medicine, Seoul 137-701, Korea, 2Department of Microbiology, Integrated Research Center for Genome Polymorphism,  MRC, The Catholic University of Korea College of Medicine, Seoul 137-701, Korea The rapid advances in genetic knowledg e and technology raise various, sometimes unprecedented, ethical dilemmas in the  scientific community as well as the public  realm.",Non-OADS,/arxiv_data1/oa_pdf/89/a4/gni-11-218.PMC3897849.pdf
Available from: http://conventions.coe.,Non-OADS,/arxiv_data1/oa_pdf/89/a4/gni-11-218.PMC3897849.pdf
Available from: http://www.unesco.org/new/en/social-and-  human-sciences/themes/bioethics/human-genome- and-hu-man-rights.,Non-OADS,/arxiv_data1/oa_pdf/89/a4/gni-11-218.PMC3897849.pdf
Available from:  http://www.unesco.org/new/en/social-and-human-scien- ces/themes/bioethics/human-genetic-data/.,Non-OADS,/arxiv_data1/oa_pdf/89/a4/gni-11-218.PMC3897849.pdf
"4, 2013 http://www.unesco.org/new/en/social-and-human-scien- ces/themes/bioethics/bioethics-and-human-rights.",Non-OADS,/arxiv_data1/oa_pdf/89/a4/gni-11-218.PMC3897849.pdf
"G&I    Genomics & InformaticspISSN 1598-866X eISSN 2234-0742 Genomics Inform  2013;11(4):224-229 http://dx.doi.org/10.5808/GI.2013.11.4.224 REVIEW ARTICLE Received November 4, 2013; Revised November 21, 2013; Accepted November 22, 2013 *Corresponding author:  Tel: +82-2-710-9414, Fax: +82-2-2077-7322, E-mail: parkjh@sookmyung.ac.kr Copyright © 2013 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Receptor for Advanced Glycation Endproducts (RAGE),  Its Ligands, and Soluble RAGE: Potential Biomarkers  for Diagnosis and Therapeutic Targets for Human  Renal Diseases Eun Ji Lee, Jong Hoon Park* Department of Biological Science, Sookmyung Women’s University, Seoul 140-742, Korea Receptor for advanced glycation endproducts (RAGE) is a multi-li gand receptor that is able to bind several different ligands,  including advanced glycation endproduct s, high-mobility group protein (B)1 (H MGB1), S-100 calcium-binding protein,  amyloid- β-protein, Mac-1, and phosphatidylserine.",OADS,/arxiv_data1/oa_pdf/36/11/gni-11-224.PMC3897850.pdf
"G&I   Genomics & InformaticspISSN 1598-866X eISSN 2234-0742 Genomics Inform  2013;11(4):230-238 http://dx.doi.org/10.5808/GI.2013.11.4.230 REVIEW ARTICLE Received October 18, 2013; Revised November 20, 2013; Accepted November 21, 2013 *Corresponding author:  Tel: +1-905-688-5550, Fax: +1-905-688-1855, E-mail: pliang@brocku.ca Copyright © 2013 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Study of Modern Human Evolution via Comparative  Analysis with the Neanderthal Genome Musaddeque Ahmed, Ping Liang* Department of Biological Sciences, Brock University, St. Catharines, ON L2S 3A1, Canada Many other human species appeared in evolution in the last 6 million years that have not been able to survive to modern  times and are broadly known as archaic hum ans, as opposed to the extant modern humans.",Non-OADS,/arxiv_data1/oa_pdf/a5/cf/gni-11-230.PMC3897851.pdf
"The early success of such attempts eventually led to the  establishment of the Neanderthal Genome Project in 2005,  which first announced the complete genome sequence of Neanderthals in 2010 [27] and recently released a cleaner  and higher-coverage version (http://www.eva.mpg.de/nean dertal/).",Non-OADS,/arxiv_data1/oa_pdf/a5/cf/gni-11-230.PMC3897851.pdf
"G&I    Genomics & InformaticspISSN 1598-866X eISSN 2234-0742 Genomics Inform  2013;11(4):239-244 http://dx.doi.org/10.5808/GI.2013.11.4.239 ORIGINAL ARTICLE Received October 29, 2013; Revised November 20, 2013; Accepted November 21, 2013 *Corresponding author:  Tel: +82-2-710-9415, Fax: +82-2-2077-7322, E-mail: yoonsj@sookmyung.ac.kr Copyright © 2013 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Somatic Mutaome Profile in Human Cancer Tissues Nayoung Kim, Yourae Hong, Doyoung Kwon, Sukjoon Yoon* Department of Biological Sciences, Center for Advanced Bioinformatics and Systems Medicine,  Sookmyung Women’s University, Seoul 140-742, Korea Somatic mutation is a major cause of cancer progression and va ried responses of tumors against anticancer agents.",Non-OADS,/arxiv_data1/oa_pdf/5d/aa/gni-11-239.PMC3897852.pdf
QCanvas can be down- loaded freely from the website http://compbio.sook- myung.ac.kr/~qcanvas.,OADS,/arxiv_data1/oa_pdf/5d/aa/gni-11-239.PMC3897852.pdf
"G&I    Genomics & InformaticspISSN 1598-866X eISSN 2234-0742 Genomics Inform  2013;11(4):245-253 http://dx.doi.org/10.5808/GI.2013.11.4.245 ORIGINAL ARTICLE Received September 3, 2013; Revised November 16, 2013; Accepted November 18, 2013 *Corresponding author: Tel: +82-2-970-1320, Fax: +82-2-970-2402, E-mail: gobrian@kcch.re.kr Copyright © 2013 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Characterization of H460R, a Radioresistant Human  Lung Cancer Cell Line, and Involvement of Syntrophin  Beta 2 (SNTB2) in Radioresistance Chang-Nim Im1, Byeong Mo Kim1, Eun-Yi Moon2, Da-Won Hong1,  Joung Whan Park1, Sung Hee Hong1* 1Division of Radiation Cancer Research, Korea Institute of Radiological and Medical Sciences, Seoul 139-706, Korea,  2Department of Bioscience and Biotechnolog y, Sejong University, Seoul 143-747, Korea A radioresistant cell line was established by fractionated ionizi ng radiation (IR) and assessed  by a clonogenic assay, flow  cytometry, and Western blot analysis, as well as zymography and a wound healing assay.",Non-OADS,/arxiv_data1/oa_pdf/ea/08/gni-11-245.PMC3897853.pdf
"G&I  Genomics & InformaticspISSN 1598-866X eISSN 2234-0742 Genomics Inform  2013;11(4):254-262 http://dx.doi.org/10.5808/GI.2013.11.4.254 ORIGINAL ARTICLE Received October 17, 2013; Revised November 8, 2013; Accepted November 12, 2013 *Corresponding author:  Tel: +82-2-2228-1739, Fax: +82-2-313-1894, E-mail: jihyni@yuhs.ac Copyright © 2013 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Genetic Variations of ABCC2  Gene Associated with  Adverse Drug Reactions to Valproic Acid in Korean  Epileptic Patients Ji Hyun Yi1, Yang-Je Cho2, Won-Joo Kim2, Min Goo Lee1, Ji Hyun Lee1* 1Department of Pharmacology and Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine,  Seoul 120-752, Korea, 2Department of Neurology, Yonsei University College of Medicine, Seoul 120-752, Korea The multidrug resistance protein 2 ( MRP2 , ABCC2 ) gene may determine individual suscep tibility to adverse drug reactions  (ADRs) in the central nervous system (CNS) by  limiting brain access of an tiepileptic drugs, especially valproic acid (VPA).",OADS,/arxiv_data1/oa_pdf/05/82/gni-11-254.PMC3897854.pdf
"G&I    Genomics & InformaticspISSN 1598-866X eISSN 2234-0742 Genomics Inform  2013;11(4):263-271 http://dx.doi.org/10.5808/GI.2013.11.4.263 ORIGINAL ARTICLE Received July 17, 2013; Revised September 9, 2013; Accepted October 29, 2013 *Corresponding author:  Tel: +82-2-920-7211, Fax: +82-2-920-2078, E-mail: mlee@sungshin.ac.kr Copyright © 2013 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).TT Mutant Homozygote of Kruppel-like Factor 5   Is a Key Factor for Increasing Basal Metabolic  Rate and Resting Metabolic Rate in  Korean Elementary School Children  Jung Ran Choi1, In-Su Kwon2,3, Dae Young Kwon4, Myung-Sunny Kim4, Myoungsook Lee1,3*  1Research Institute of Obesity Science, Sungshin Women’s University, Seoul 142-137, Korea,  2Laboratory Exercise Biochemistry, Korea National Sport University, Seoul 138-763, Korea,  3Department of Food and Nutrition, Sungshin Women’s University, Seoul 142-137, Korea,  4Nutrition and Metabolism Research Group, Korea Food Research Institute, Seongnam 463-746, Korea We investigated the contribution of genetic variations of KLF5 to basal metabolic rate (BMR) and resting metabolic rate  (RMR) and the inhibition of obesity in Korean children.",Non-OADS,/arxiv_data1/oa_pdf/01/db/gni-11-263.PMC3897855.pdf
Analysis of the KLF5 SNP  The polymorphisms for the KLF5  (rs3782933) gene were  analyzed (http://www.ncbi.nlm.gov/).,OADS,/arxiv_data1/oa_pdf/01/db/gni-11-263.PMC3897855.pdf
All the primers for PCR amplification and DNA  sequencing were designed using the Primer3 software (http://Frodo.wi.mit.edu/cgi-bin/primer3/primer3); the se- quences are available upon request.,OADS,/arxiv_data1/oa_pdf/01/db/gni-11-263.PMC3897855.pdf
"G&I    Genomics & InformaticspISSN 1598-866X  eISSN 2234-0742 Genomics Inform  2013;11(4):272-276 http://dx.doi.org/10.5808/GI.2013.11.4.272 ORIGINAL ARTICLE Received October 3, 2013; Revised November 15, 2013; Accepted November 16, 2013 *Corresponding author:  Tel: +82-41-550-3451, Fax: +82-41-550-3450, E-mail: ahnty@dankook.ac.kr †Present address: Department of Periodontology and Oral Biology, College of Dentistry, University of Florida, Gainesville, FL 32 610, USA Copyright © 2013 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Phylogeny of Flavobacteria Group Isolated from  Freshwater Using Multilocus Sequencing Analysis Seyoung Mun1, Jungnam Lee1†, Siwon Lee2, Kyudong Han1, Tae-Young Ahn3* 1Department of Nanobiomedical Science & BK21 PLUS NBM Global Research Center for Regenerative Medicine,  Dankook University, Cheonan 330-714, Korea, 2Plant Quarantine Technology Center, Animal and  Plant Quarantine Agency, Suwon 443-440, Korea, 3Department of Microbiology, Dankook University, Cheonan 330-714, Korea Sequence analysis of the 16S rRNA gene has been widely used  for the classification of microorganisms.",Non-OADS,/arxiv_data1/oa_pdf/57/c2/gni-11-272.PMC3897856.pdf
"DNA sequences analysis For each of the seven genes, we aligned the DNA  sequences obtained from the seven Flavobacterium  isolates  using the software BioEdit, version 7.0 (http://www.mbio.",OADS,/arxiv_data1/oa_pdf/57/c2/gni-11-272.PMC3897856.pdf
"After that, the housekeep- ing gene sequences of the 14 added reference strains were collected using BLAST (http://blast.ncbi.nlm.nih.gov/) and  aligned in the same way.",OADS,/arxiv_data1/oa_pdf/57/c2/gni-11-272.PMC3897856.pdf
"In addition, we  compared the genetic similarity of the six housekeeping  genes and the 16S rRNA gene between the genus of Flavobacterium  using the pair distance of ClustalW  (weighted), which was supported by DNASTAR’s MegAlign  program in Lasergene, version 5.0 (http://www.dnastar.",OADS,/arxiv_data1/oa_pdf/57/c2/gni-11-272.PMC3897856.pdf
Supplementary material Supplementary data including one table can be found with  this article online at http://www.genominfo.org/src/sm/gni-  11-272-s001.pdf.,Non-OADS,/arxiv_data1/oa_pdf/57/c2/gni-11-272.PMC3897856.pdf
"G&I    Genomics & InformaticspISSN 1598-866X eISSN 2234-0742 Genomics Inform  2013;11(4):277-281 http://dx.doi.org/10.5808/GI.2013.11.4.277 ORIGINAL ARTICLE Received October 25, 2013; Revised November 20, 2013; Accepted November 21, 2013 *Corresponding author 1: Tel: +82-2-3480-3730, Fax: +82-2-3480-3606, E-mail: light@spo.go.kr **Corresponding author 2:  Tel: +82-42-879-8116, Fax: +82-42-879-8119, E-mail: kimsy@kribb.re.kr †Jong-Lyul Park and Seong-Min Park contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/50/1b/gni-11-277.PMC3897857.pdf
"Copyright © 2013 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Forensic Body Fluid Identification by Analysis of  Multiple RNA Markers Using NanoString Technology Jong-Lyul Park1,2†, Seong-Min Park1,2†, Jeong-Hwan Kim1, Han-Chul Lee3, Seung-Hwan Lee3,  Kwang-Man Woo3*, Seon-Young Kim1,2** 1Medical Genomics Research Center, KRIBB, Daejeon 305-806, Korea, 2Department of Functional Genomics, University of Science  of Technology, Daejeon 305-350, Korea, 3DNA orensic Division, Supreme Prosecutor’s Office, Seoul 137-730, Korea RNA analysis has become a reliable method of body fluid identification for forensic use.",Non-OADS,/arxiv_data1/oa_pdf/50/1b/gni-11-277.PMC3897857.pdf
Supplementary materials Supplementary data including one figure can be found  with this article online at http://www.genominfo.org/src/  sm/gni-11-277-s001.pdf.,Non-OADS,/arxiv_data1/oa_pdf/50/1b/gni-11-277.PMC3897857.pdf
"G&I    Genomics & InformaticspISSN 1598-866X eISSN 2234-0742 Genomics Inform  2013;11(4):282-288 http://dx.doi.org/10.5808/GI.2013.11.4.282 ORIGINAL ARTICLE Received October 29, 2013; Revised November 12, 2013; Accepted November 14, 2013 *Corresponding author:  Tel: +82-51-893-3569, Fax: +82-51-797-8569, E-mail: o@biophilos.org Copyright © 2013 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/76/20/gni-11-282.PMC3897858.pdf
Available from: http://pubchem.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/76/20/gni-11-282.PMC3897858.pdf
"G&I    Genomics & InformaticspISSN 1598-866X  eISSN 2234-0742 Genomics Inform  2013;11(4):289-291 http://dx.doi.org/10.5808/GI.2013.11.4.289 APPLICATION NOTE Received September 23, 2013; Revised November 18, 2013; Accepted November 19, 2013 *Corresponding author:  Tel: +91-7152-284679, Fax: +91-7152-284038, E-mail: satishangral@gmail.com Copyright © 2013 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).hpvPDB: An Online Proteome Reserve for Human  Papillomavirus Satish Kumar1*, Lingaraja Jena1, Sangeeta Daf2, Kanchan Mohod1,  Peyush Goyal3, Ashok K. Varma4 1Bioinformatics Centre and Biochemistry, Mahatma Gandhi Institute of Medical Sciences, Sevagram 442-102, India,  2Datta Meghe Institute of Medical Sciences (Deemed University), Nagpur 440-022, India, 3Department of Biotechnology,  Ministry of Science and Technology, New Delhi 110-003, India, 4Advanced Centre for Treatment,  Research and Education in Cancer, Khargar 410-210, India Human papillomavirus (HPV) infection is the leading cause of cancer mortality among women worldwide.",Non-OADS,/arxiv_data1/oa_pdf/a0/4a/gni-11-289.PMC3897859.pdf
"Keywords:  comparative modeling, DNA probes, genome, HPV, neoplasms, proteome Availability: This online reserve is made publicly availa ble at http://www.bicjbtdrc-mgims.in/hpvPDB/.",OADS,/arxiv_data1/oa_pdf/a0/4a/gni-11-289.PMC3897859.pdf
"The stereoche- mistry of each protein was evaluated through PROCHECK [7] analysis, available at the RCSB validation server (http://  deposit.rcsb.org/validate/), and validated using ProSA-web  [8] (http://prosa.services.came.sbg.ac.at/prosa.php).",OADS,/arxiv_data1/oa_pdf/a0/4a/gni-11-289.PMC3897859.pdf
A genome map of  each strain obtained by Geneious 5.4.4 software (available  from http://www.geneious.com/) is also integrated in this page.,OADS,/arxiv_data1/oa_pdf/a0/4a/gni-11-289.PMC3897859.pdf
"), protein structure (predicted 3D structure by homology modeling viewed by  Jmol (available from http://www.jmol.org/) [10] with the  JAVA platform, Ramachandran plot obtained by PROCHECK and Z-score and Energy plot obtained by ProSA-Web.",OADS,/arxiv_data1/oa_pdf/a0/4a/gni-11-289.PMC3897859.pdf
Available from:  http://www.jmol.org/.,Non-OADS,/arxiv_data1/oa_pdf/a0/4a/gni-11-289.PMC3897859.pdf
Ultrafast pulse measurement device http://www.fastlite.com/en/cat465017- 460522 -Wizzler.html (Accessed 22nd Sept 2013).,Non-OADS,/arxiv_data1/oa_pdf/15/48/srep03818.PMC3897952.pdf
"Frequency-resolved optical gating (FROG), http://www.swampoptics.com/ products _grenoverview.htm (Accessed 22nd Sept 2013).",OADS,/arxiv_data1/oa_pdf/15/48/srep03818.PMC3897952.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3818 | DOI: 10.1038/srep03818 5",Non-OADS,/arxiv_data1/oa_pdf/15/48/srep03818.PMC3897952.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/0b/bb/srep03813.PMC3897953.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3813 | DOI: 10.1038/srep03813 7",Non-OADS,/arxiv_data1/oa_pdf/0b/bb/srep03813.PMC3897953.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3806 | DOI: 10.1038/srep03806 5",Non-OADS,/arxiv_data1/oa_pdf/ae/39/srep03806.PMC3897954.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3819 | DOI: 10.1038/srep03819 10",Non-OADS,/arxiv_data1/oa_pdf/7f/3a/srep03819.PMC3897956.pdf
"We identified 343 germline duplications, including 6 novel duplications that do not overlap with more than 50% of the genome locus of previouslyreported CNV regions in the Database of Genomic Variants (DGV, http://projects.tcag.ca/variation/) 17.",OADS,/arxiv_data1/oa_pdf/d5/1e/srep03807.PMC3897957.pdf
"2Somatic deletions that reciprocally overlap with more than 50% of the genome locus of previously reported CNV regions in the Database of Genomic Varia nts (DGV, http://projects.tcag.ca/variation/, July 23, 2013 version) are represented with ‘‘Yes’’ in the DGV column.",Non-OADS,/arxiv_data1/oa_pdf/d5/1e/srep03807.PMC3897957.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d5/1e/srep03807.PMC3897957.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3807 | DOI: 10.1038/srep03807 9",Non-OADS,/arxiv_data1/oa_pdf/d5/1e/srep03807.PMC3897957.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/04/6a/srep03804.PMC3897958.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3804 | DOI: 10.1038/srep03804 7",Non-OADS,/arxiv_data1/oa_pdf/04/6a/srep03804.PMC3897958.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3820 | DOI: 10.1038/srep03820 5",Non-OADS,/arxiv_data1/oa_pdf/09/3b/srep03820.PMC3898040.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3812 | DOI: 10.1038/srep03812 6",Non-OADS,/arxiv_data1/oa_pdf/37/96/srep03812.PMC3898045.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/55/65/srep03808.PMC3898047.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3808 | DOI: 10.1038/srep03808 4",Non-OADS,/arxiv_data1/oa_pdf/55/65/srep03808.PMC3898047.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/82/2d/srep03803.PMC3898048.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3803 | DOI: 10.1038/srep03803 11",Non-OADS,/arxiv_data1/oa_pdf/82/2d/srep03803.PMC3898048.pdf
"All MS/MS spectra were analyzed by Sequest against the curated version of B. bacteriovorus protein sequence database (3583 entries, UniProt (http://www.uniprot.",OADS,/arxiv_data1/oa_pdf/ad/a8/srep03811.PMC3898049.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ad/a8/srep03811.PMC3898049.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3811 | DOI: 10.1038/srep03811 8",Non-OADS,/arxiv_data1/oa_pdf/ad/a8/srep03811.PMC3898049.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3817 | DOI: 10.1038/srep03817 7",Non-OADS,/arxiv_data1/oa_pdf/eb/3e/srep03817.PMC3898052.pdf
Published by Elsevier B.V. http://dx.doi.org/10.1016/j.bbadis.2013.07.019 Contents lists available at ScienceDirect Biochimica et Biophysica Acta journal homepage: www.elsevier.com/locate/bbadis Open  access  under  CC BY-NC-SA  license.,Non-OADS,/arxiv_data1/oa_pdf/33/cc/main.PMC3898073.pdf
The aminopeptidase activity assay was performed as described ( http://www.sigmaaldrich.com/ img/assets/18160/Aminopeptidase.pdf ) with the following revisions: the reaction cocktail used a 2 mM L-leucine- p-nitroanilide solution; 150μg of lysate was added to the reaction; the lysates were inhibited with 10 μM puromycin; the reaction was prepared in 1 ml and then 200μl was immediately transferred to a 96-well plate in triplicate; the assay was carried out at RT.,Non-OADS,/arxiv_data1/oa_pdf/33/cc/main.PMC3898073.pdf
"and Harvard University, Charlestown, MA 02129, USA 3Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, UK 4Eidgeno ¨ssische Technische Hochschule, Deutsch English Department of Chemistry and Applied Biosciences, 8093 Zurich, Switzerland 5Department of Genetics, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA 6Division of Genetics, Brigham and Women’s Hospital, 77 Avenue Louis Pasteur, Boston, MA 02115, USA 7Howard Hughes Medical Institute, 4000 Jones Bridge Road, Chevy Chase, MD 20815, USA 8MRC/UCL Centre for Medical Molecular Virology, Division of Infection & Immunity, University College London, Gower Street, London W1CE 6BT, UK 9These authors contributed equally to this work 10Present address: Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Albert Sherman Center, 368 Plantation Street, 8 1001, Worcester, MA 01655, USA *Correspondence: abraham.brass@umassmed.edu http://dx.doi.org/10.1016/j.celrep.2013.10.033 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/aa/86/main.PMC3898084.pdf
SUPPLEMENTAL INFORMATION Supplemental information includes Supplemental Experimental Procedures and ﬁve ﬁgures and can be found with this article online at http://dx.doi.org/ 10.1016/j.celrep.2013.10.033 .,Non-OADS,/arxiv_data1/oa_pdf/aa/86/main.PMC3898084.pdf
"Published onlineSeptember 25, 2013. http://dx.doi.org/10.1016/j.jmb.2013.09.024 .",OADS,/arxiv_data1/oa_pdf/aa/86/main.PMC3898084.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)PPAR gpathway and ERBB2-positive cancer stem cells X Wang et al 5521 &2013 Macmillan Publishers Limited Oncogene (2013) 5512 – 5521",Non-OADS,/arxiv_data1/oa_pdf/ff/c0/onc2013217a.PMC3898098.pdf
"This study is aprospective cohort representative of the British populationthat has measured birth weight, subsequent anthropometricmarkers of growth and weight gain, blood pressure duringclinical investigation http://www.kidney-international.org &2013 International Society of Nephrology Correspondence: Richard J. Silverwood, Department of Non-Communicable Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, Keppel Street, London,WC1E 7HT, UK.",Non-OADS,/arxiv_data1/oa_pdf/0a/b8/ki2013223a.PMC3898099.pdf
Linear regression models for a 1 kg increase in birth weight by overweight status at age 36 in the multiple imputation analysis(n=4584).Supplementary material is linked to the online version of the paper at http://www.nature.com/ki REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/0a/b8/ki2013223a.PMC3898099.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on European Journal of Clinical Nutrition website (http://www.nature.com/ejcn)Gastroesophageal reﬂux and gastrostomy E Toporowska-Kowalska et al 1174 European Journal of Clinical Nutrition (2013) 1169 – 1174 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/39/0b/ejcn2013164a.PMC3898100.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)PDK-1 in PKB-dependent embryonic stem cell self-renewal LS Ling et al 5408 Oncogene (2013) 5397 – 5408 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/bb/02/onc201344a.PMC3898101.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/S Ryser et al.",Non-OADS,/arxiv_data1/oa_pdf/46/a6/jid2013300a.PMC3898102.pdf
"Kidney International (2013) 84,1214– 1225; doi:10.1038/ki.2013.200; published online 5 June 2013KEYWORDS: delayed graft function; diagnosis; kidney transplantation; outcomes; renal transplantation Renal transplantation provides clear benefits for patients with end-stage kidney disease,1,2and significant cost savings compared with dialysis.3,4In 2010, 16,151 renal transplants were performed in the United States (http://optn.transplant.hrsa.gov), and 2687 in the United Kingdom (http://www.uktransplant.org.uk).",Non-OADS,/arxiv_data1/oa_pdf/15/e4/ki2013200a.PMC3898105.pdf
"14clinical investigation http://www.kidney-international.org &2013 International Society of Nephrology Correspondence: Rosamonde E. Banks, Clinical and Biomedical Proteomics Group, Cancer Research UK Centre, Leeds Institute of Molecular Medicine, St. James’s University Hospital, Beckett Street, Leeds LS9 7TF, UK.E-mail: r.banks@leeds.ac.uk Received 30 September 2012; revised 14 March 2013; accepted 21 March 2013; published online 5 June 2013 1214 Kidney International (2013) 84, 1214– 1225",Non-OADS,/arxiv_data1/oa_pdf/15/e4/ki2013200a.PMC3898105.pdf
Supplementary material is linked to the online version of the paper at http://www.nature.com/ki REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/15/e4/ki2013200a.PMC3898105.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)Mer contributes to leukemogenesis in AML AB Lee-Sherick et al 5368 Oncogene (2013) 5359 – 5368 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/0c/4d/onc201340a.PMC3898106.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)Anti-angiogenic roles of CTLD-speciﬁc antibodies in vitro M-K Ki et al 5457 &2013 Macmillan Publishers Limited Oncogene (2013) 5449 – 5457",Non-OADS,/arxiv_data1/oa_pdf/ea/4a/onc2013156a.PMC3898107.pdf
"This analyses MMR gene promoter methylation atMLH1 ,MSH2 ,MLH3 ,MSH6 ,PMS2 ,MGMT and MLH3 (Genomic locations of the probes can be found at http://www.mlp a.com).",Non-OADS,/arxiv_data1/oa_pdf/b3/e3/onc2012584a.PMC3898108.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)Early colonic neoplasia displays genomic instability AD Beggs et al 5337 &2013 Macmillan Publishers Limited Oncogene (2013) 5333 – 5337",Non-OADS,/arxiv_data1/oa_pdf/b3/e3/onc2012584a.PMC3898108.pdf
"SAM (http://www-stat.stanford.edu/ Btibs/SAM/) was used to determine the association of miRNAs with MCV status, tumor metastasis, and disease-speciﬁc survival.",OADS,/arxiv_data1/oa_pdf/6e/da/jid2013355a.PMC3898110.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/HX i e et al.",Non-OADS,/arxiv_data1/oa_pdf/6e/da/jid2013355a.PMC3898110.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on European Journal of Clinical Nutrition website (http://www.nature.com/ejcn)y = 11.31x2 - 20.321x + 11.84 R2 = 0.944 00.511.522.533.544.55 0.9 1 1.1 1.2 1.3Tvol(ml) Figure 6.",Non-OADS,/arxiv_data1/oa_pdf/dc/58/ejcn2013173a.PMC3898111.pdf
"Human B7-H4 contains a putative NLS motif and is a cytoplasmic- nuclear shuttling protein To identify a potential NLS motif in the B7-H4 protein sequence, the coding region of human B7-H4 was analyzed using the predictNLS program (http://cubic.bioc.columbia.edu/predictNLS).",OADS,/arxiv_data1/oa_pdf/3b/bd/onc2012600a.PMC3898118.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)Functional implication of intranuclear B7-H4 L Zhang et al 5358 Oncogene (2013) 5347 – 5358 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/3b/bd/onc2012600a.PMC3898118.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)The primary cilium acts as a suppressor of cartilage tumors LH o et al 5396 Oncogene (2013) 5388 – 5396 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/9a/5d/onc2012588a.PMC3898120.pdf
Available at: http://investor.theravance.com/releasedetail.cfm?ReleaseID=801611 .,Non-OADS,/arxiv_data1/oa_pdf/2e/70/12325_2013_Article_75.PMC3898122.pdf
Available athttp://investor.theravance.com/releasedetail.cfm?ReleaseID=789930 .,Non-OADS,/arxiv_data1/oa_pdf/2e/70/12325_2013_Article_75.PMC3898122.pdf
Available at http://www.almirall.com/ webcorp2/cda/comunicacion_detalle_noticia.jsp?id=2593 .,Non-OADS,/arxiv_data1/oa_pdf/2e/70/12325_2013_Article_75.PMC3898122.pdf
"National Comprehensive Cancer Network (NCCN) Clinical practice guidelines in oncology: breastcancer, Version 2.2011. http://www.nccn.org/ patients/guidelines/breast/index.html (accessed October 7, 2013).",Non-OADS,/arxiv_data1/oa_pdf/89/85/12325_2013_Article_60.PMC3898123.pdf
"Common Terminology Criteria for Adverse Events (CTCAE), version 3.0 published August 9, 2006. http://ctep.cancer.gov/ protocolDevelopment/electronic_applications/ docs/ctcaev3.pdf (accessed October 7, 2013).",Non-OADS,/arxiv_data1/oa_pdf/89/85/12325_2013_Article_60.PMC3898123.pdf
http://www.pharma.,Non-OADS,/arxiv_data1/oa_pdf/89/85/12325_2013_Article_60.PMC3898123.pdf
"Amgen Europe B.V., Breda, The Netherlands, 29 August 2013. http://www.ema.",Non-OADS,/arxiv_data1/oa_pdf/0f/7d/12325_2013_Article_63.PMC3898130.pdf
"Roche Registration Ltd., Welwyn Garden City, UK, 19 June 2012. http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/000739/WC500033672.pdf .",Non-OADS,/arxiv_data1/oa_pdf/0f/7d/12325_2013_Article_63.PMC3898130.pdf
"According to the reports of the General Veterinary Inspectorate (RRW-6 2007 –2011, http://www.wetgiw.gov.pl/index.php?",Non-OADS,/arxiv_data1/oa_pdf/98/ce/436_2013_Article_3625.PMC3898139.pdf
"World Rabbit Sci 15:23 –28 Duszynski DW, Upton SJ, Couch L (1999) The coccidia of the world http://biology.unm.edu/biology/coccidia/lagomorph.html Foronda PR, Figueruelo EO, Ortega AR, Abreu NA, Casanowa JC (2005) Parasites (viruses, coccidia and helminths) of the wild rabbit (Oryctolagus cuniculus ) introduced to Canary Islands from Iberian Peninsula.",Non-OADS,/arxiv_data1/oa_pdf/98/ce/436_2013_Article_3625.PMC3898139.pdf
"http://eur-lex.eur opa.eu/LexUriServ/ LexUriServ.do?uri=OJ:L:2004:226:0083:0127:EN:PDF Rinaldi L, Russo T, Schioppi M, Pennacchio S, Cringoli G (2007) Passalurus ambiguus : new insights into copromicroscopic diag- nosis and circadian rhythm of egg excretion.",Non-OADS,/arxiv_data1/oa_pdf/98/ce/436_2013_Article_3625.PMC3898139.pdf
Accessed June 2010 athttp://www.idf.org 21.,Non-OADS,/arxiv_data1/oa_pdf/13/30/592_2011_Article_357.PMC3898142.pdf
Accessed June 2011 at http://www.biomedcentral.com/1471-2296/11/37 29.,Non-OADS,/arxiv_data1/oa_pdf/13/30/592_2011_Article_357.PMC3898142.pdf
Accessed June 2010 at http://www.idf.org 39.,Non-OADS,/arxiv_data1/oa_pdf/13/30/592_2011_Article_357.PMC3898142.pdf
http://www.aemmedi.it .,Non-OADS,/arxiv_data1/oa_pdf/13/30/592_2011_Article_357.PMC3898142.pdf
"http://www.astrazeneca- us.com/pi/caprelsa.pdf (Accessed Sep 10, 2013).",Non-OADS,/arxiv_data1/oa_pdf/d2/3a/12325_2013_Article_69.PMC3898148.pdf
"http://www.ema.europa.eu/docs/en_ GB/document_library/EPAR_-_Product_Information/ human/002315/WC500123555.pdf (Accessed Sep 10, 2013).",Non-OADS,/arxiv_data1/oa_pdf/d2/3a/12325_2013_Article_69.PMC3898148.pdf
"http://ctep.cancer.gov/protocolDevelopment/ electronic_applications/ctc.htm#ctc_40 (Accessed Nov 22, 2012).",Non-OADS,/arxiv_data1/oa_pdf/d2/3a/12325_2013_Article_69.PMC3898148.pdf
"http://www.crediblemeds.org/everyone/composite- list-all-qtdrugs (Accessed Sep 10, 2013).",OADS,/arxiv_data1/oa_pdf/d2/3a/12325_2013_Article_69.PMC3898148.pdf
"Aloxi (palonosetron) Summary of ProductCharacteristics, Helsinn Birex Pharmaceuticals Ltd. http://www.ema.europa.eu/docs/en_GB/document_ library/EPAR_-_Product_Information/human/000563/WC500024259.pdf (Accessed Sep 10, 2013).",OADS,/arxiv_data1/oa_pdf/d2/3a/12325_2013_Article_69.PMC3898148.pdf
http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/d2/3a/12325_2013_Article_69.PMC3898148.pdf
"http://www.fda.gov/ohrms/dockets/ac/03/ brieﬁng/3928B1_01_Merck%20Backgrounder.pdf(Accessed Sep 10, 2013).",Non-OADS,/arxiv_data1/oa_pdf/d2/3a/12325_2013_Article_69.PMC3898148.pdf
"http://dx.doi.org/10.1016/j.curtheres.2013.04.001☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per- mits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",OADS,/arxiv_data1/oa_pdf/96/93/main.PMC3898180.pdf
Cancer Facts and Figures 2012. http://www.cancer.,Non-OADS,/arxiv_data1/oa_pdf/96/93/main.PMC3898180.pdf
2012. http://nccam.nih.gov/health/yohimbe .,Non-OADS,/arxiv_data1/oa_pdf/96/93/main.PMC3898180.pdf
"http://dx.doi.org/10.1016/j.curtheres.2013.06.003☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permits non- commercial use, distribution, and reproduction in any medium, provided theoriginal author and source are credited.",OADS,/arxiv_data1/oa_pdf/07/32/main.PMC3898182.pdf
"http://dx.doi.org/10.1016/j.curtheres.2013.09.002☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permits non- commercial use, distribution, and reproduction in any medium, provided theoriginal author and source are credited.",OADS,/arxiv_data1/oa_pdf/7c/1d/main.PMC3898187.pdf
"http://dx.doi.org/10.1016/j.curtheres.2013.08.001☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per- mits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",OADS,/arxiv_data1/oa_pdf/60/e5/main.PMC3898188.pdf
"http://dx.doi.org/10.1016/j.curtheres.2013.09.003☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per- mits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/ea/51/main.PMC3898189.pdf
"http://dx.doi.org/10.1016/j.curtheres.2013.10.002☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per- mits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/7b/cd/main.PMC3898190.pdf
"http://dx.doi.org/10.1016/j.curtheres.2013.04.003☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per- mits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/a1/e8/main.PMC3898191.pdf
http://www.dlt.ri.gov/lmi/laus/us/usadj.,Non-OADS,/arxiv_data1/oa_pdf/a1/e8/main.PMC3898191.pdf
http://www.ssa.gov/oact/cola/AWI.html .,Non-OADS,/arxiv_data1/oa_pdf/a1/e8/main.PMC3898191.pdf
"http://dx.doi.org/10.1016/j.curtheres.2013.06.002☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per- mits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/13/4a/main.PMC3898192.pdf
"http://dx.doi.org/10.1016/j.curtheres.2013.09.004☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per- mits non-commercial use, distribution, and reproduction in any medium, providedthe original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/bd/08/main.PMC3898193.pdf
"http://dx.doi.org/10.1016/j.curtheres.2013.10.001☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per- mits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",OADS,/arxiv_data1/oa_pdf/3d/4b/main.PMC3898194.pdf
"http://dx.doi.org/10.1016/j.curtheres.2013.09.001☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per- mits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",OADS,/arxiv_data1/oa_pdf/a4/33/main.PMC3898195.pdf
March 2005. http://www.cncro.com/fgwjDetail_28.html .,Non-OADS,/arxiv_data1/oa_pdf/a4/33/main.PMC3898195.pdf
Guidance for industry: statistical approaches to establishing bioequivalence.January 2001. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070244.pdf .,Non-OADS,/arxiv_data1/oa_pdf/a4/33/main.PMC3898195.pdf
"http://dx.doi.org/10.1016/j.curtheres.2013.06.004☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per- mits non-commercial use, distribution, and reproduction in any medium, providedthe original author and source are credited.",OADS,/arxiv_data1/oa_pdf/0b/4f/main.PMC3898196.pdf
http://www.diabetes.org/ diabetes-basics/diabetes-statistics .,Non-OADS,/arxiv_data1/oa_pdf/0b/4f/main.PMC3898196.pdf
http://www.diabetesatlas.,Non-OADS,/arxiv_data1/oa_pdf/0b/4f/main.PMC3898196.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/bc/87/srep03823.PMC3898202.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3823 | DOI: 10.1038/srep03823 6",Non-OADS,/arxiv_data1/oa_pdf/bc/87/srep03823.PMC3898202.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e8/d5/srep03805.PMC3898204.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3805 | DOI: 10.1038/srep03805 6",Non-OADS,/arxiv_data1/oa_pdf/e8/d5/srep03805.PMC3898204.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3816 | DOI: 10.1038/srep03816 7",Non-OADS,/arxiv_data1/oa_pdf/99/c9/srep03816.PMC3898205.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/2a/78/srep03810.PMC3898208.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3810 | DOI: 10.1038/srep03810 9",Non-OADS,/arxiv_data1/oa_pdf/2a/78/srep03810.PMC3898208.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)CDK4/6 inhibition by PD-0332991 in PCa CES Comstock et al 5491 &2013 Macmillan Publishers Limited Oncogene (2013) 5481 – 5491",Non-OADS,/arxiv_data1/oa_pdf/9c/0d/onc201383a.PMC3898261.pdf
"http://dx.doi.org/10.1016/j.celrep.2013.11.032 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative WorksLicense, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source arecredited.",Non-OADS,/arxiv_data1/oa_pdf/fd/57/main.PMC3898267.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, eight ﬁgures, and three tables and can be found with this article online athttp://dx.doi.org/10.1016/j.celrep.2013.11.032 .",Non-OADS,/arxiv_data1/oa_pdf/fd/57/main.PMC3898267.pdf
"NationalAcademies Press: Washington, D.C. http://www.nap.edu/openbook.php?isbn= 0309100054 (accessed 9 September 2013).",Non-OADS,/arxiv_data1/oa_pdf/f1/d7/ejcn2013176a.PMC3898278.pdf
http://www.ers.usda .gov/dataﬁles/Food_Expenditures/ 2010table13.xls.,OADS,/arxiv_data1/oa_pdf/f1/d7/ejcn2013176a.PMC3898278.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Assessment of individual diet cost P Monsivais et al 1225 &2013 Macmillan Publishers Limited European Journal of Clinical Nutrition (2013) 1220 – 1225",Non-OADS,/arxiv_data1/oa_pdf/f1/d7/ejcn2013176a.PMC3898278.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)Ubiquitination controls Bcl-B function B van de Kooij et al 5448 Oncogene (2013) 5439 – 5448 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/7b/df/onc201399a.PMC3898306.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)Cell transformation by SATB1 R Agrelo et al 5500 Oncogene (2013) 5492 – 5500 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/e5/0b/onc2013158a.PMC3898308.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Activation of ALT in EBV-infected cells SA Kamranvar et al 5530 Oncogene (2013) 5522 – 5530 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/6d/da/onc2013189a.PMC3898310.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Bone changes after lactation in Gambian women Y Sawo et al 1146 European Journal of Clinical Nutrition (2013) 1142 – 1146 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/0c/93/ejcn2013162a.PMC3898312.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/JA Lister et al.",Non-OADS,/arxiv_data1/oa_pdf/bb/fd/jid2013293a.PMC3898314.pdf
"However, 680 patients of 1164 enrolled patients had urinary protein test by dipstickhttp://www.kidney-international.org letter to the editor &2013 International Society of Nephrology Urinary protein /p46+1 Urinary protein – or ±  HR= 1.13 (95% CI 0.61 – 2.09), P=0.7034 HR= 3.31 (95% CI 1.12 – 9.8), P=0.0254 (%) (%) 30 20 10 0Patients with primary events0 6 12 18 24 30 36 Time (months)30High-dose ARB (15 patients) ARB plus CCB (5 patients)High-dose ARB (21 patients) ARB plus CCB (20 patients) 20 10 0Patients with primary events0 Number at risk Number at risk High-dose ARB71 4569 44 4259 54 41 3849 45 36 3443 ARB plus CCBHigh-dose ARB277 267 284254 272248 264243 254238 248231 244 287ARB plus CCB6 Time (months)12 18 24 30 36 Figure 1 | Kaplan–Meier curves.",Non-OADS,/arxiv_data1/oa_pdf/8b/22/ki2013313a.PMC3898315.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Why are complements activated in anti-neutrophil cytoplasmicantibody–associated vasculitis?",Non-OADS,/arxiv_data1/oa_pdf/8b/22/ki2013313a.PMC3898315.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Almonds and snacking SY Tan et al 1214 European Journal of Clinical Nutrition (2013) 1205 – 1214 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/60/62/ejcn2013184a.PMC3898316.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/EMP2 regulates tumor neoangiogenesis LK Gordon et al 5376 Oncogene (2013) 5369 – 5376 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/91/a8/onc2012622a.PMC3898317.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)FANCD2 and sister chromatid exchange P Gravells et al 5346 Oncogene (2013) 5338 – 5346 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/7d/d1/onc2012627a.PMC3898318.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)Imiquimod directly inhibits Hedgehog signalling F Wolff et al 5581 &2013 Macmillan Publishers Limited Oncogene (2013) 5574 – 5581",Non-OADS,/arxiv_data1/oa_pdf/18/7e/onc2013343a.PMC3898320.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)Hypermethylation of tumor suppressor genes and nucleosomes A Portela et al 5428 Oncogene (2013) 5421 – 5428 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/5d/fa/onc2013162a.PMC3898323.pdf
(http://www.ncbi.nlm.nih.gov/sites/entrez).,OADS,/arxiv_data1/oa_pdf/b1/1e/onc2012590a.PMC3898328.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)CRKL-YES as a critical signal for tumor growth CL Yeung et al 5438 Oncogene (2013) 5429 – 5438 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/b1/1e/onc2012590a.PMC3898328.pdf
"Table 6 Completed or ongoing clinical trials to investigate effects of DPP-4 inhibitors on cardiovascular morbidity and mortality Study drug/ comparatorClinicalTrials identiﬁer (NAME)(Estimated) number enrolled(Estimated) completion dateStudy design Key inclusion criteria Alogliptin/ placeboNCT00968708 (EXAMINE)5,380 June 2013 (completed)4.75-year, double-blind, randomized, placebo-controlledPatients with T2DM receiving monotherapy or combination antidiabetes therapy; HbA1c C6.5% and B11.0%; HbA1c C7.0% andB11.0% if on insulin; diagnosis of acute coronary syndrome within 15–90 days prior to randomization Linagliptin/ placeboNCT01897532 (CARMELINA)8,300 January 2018 (recruiting)4-year, double-blind, randomized, placebo-controlledPatients with T2DM who are drug-naı ¨ve or receiving monotherapy or combination antidiabetes therapy; HbA1c C6.5% and B10.0%; high risk of cardiovascular events deﬁned by: (1) albuminuria(UACR C30 mg/g) plus previous macrovascular disease and/or (2) impaired renal function patients with eGFR 15 to \45 mL/min/ 1.73 m 2are eligible with any UACR level, those with eGFR C45–75 mL/min/1.73 m2are required to have a UACR [200 mg/g)a Linagliptin/ glimepirideNCT01243424 (CAROLINA)6,000 September 2018(ongoing)7.7-year, double-blind, randomized, activecontrolledPatients with T2DM; HbA1c C6.5% and B8.5% if treatment-naı ¨ve or mono-/dual therapy with metformin and/or alpha-glucosidaseinhibitor; HbA1c C6.5% and B7.5% if treatment with sulfonylurea/glinides in mono- or dual therapy with metforminand/or alpha-glucosidase inhibitor; pre-existing cardiovasculardisease OR speciﬁed diabetes end-organ damage OR age C70 years ORC2 speciﬁed cardiovascular risk factors Saxagliptin/ placeboNCT01107886 (SAVOR-TIMI 53)16,492 May 2013 (completed)4-year, double-blind, randomized, placebo-controlledPatients with T2DM; HbA1c C6.5%; high risk for cardiovascular events Sitagliptin/ placeboNCT00790205 (TECOS)14,000 December 2014(ongoing)4–5-year, double-blind, randomized, placebo-controlledPatients with T2DM; HbA1c C6.5% and B8.0% on stable dose(s) of antihyperglycemic agent(s), including insulin; pre-existing cardiovascular disease T2DM type 2 diabetes mellitus, HbA1c glycated hemoglobin, UACR urinary albumin creatinine ratio, eGFR estimated glomerular ﬁltration rate aAdditional study details from https://investor.lilly.com/releasedetail.cfm?ReleaseID=781539Adv Ther (2013) 30:1067–1085 1079 123",Non-OADS,/arxiv_data1/oa_pdf/23/76/12325_2013_Article_71.PMC3898344.pdf
http://www.idf.org/sites/default/ﬁles/IDF- Guideline-for-Type-2-Diabetes.pdf (Accessed 25 Oct 2013).,Non-OADS,/arxiv_data1/oa_pdf/23/76/12325_2013_Article_71.PMC3898344.pdf
http://www.ncbi.nlm.nih.gov/ pubmed/22220323 (Accessed 25 Oct 2013).,OADS,/arxiv_data1/oa_pdf/23/76/12325_2013_Article_71.PMC3898344.pdf
http://www.healthquality.va.gov/diabetes/ DM2010_FUL-v4e.pdf (Accessed 25 Oct 2013).,Non-OADS,/arxiv_data1/oa_pdf/23/76/12325_2013_Article_71.PMC3898344.pdf
http://packageinserts.bms.com/pi/pi_gluco phage.pdf (Accessed 25 Oct 2013).,Non-OADS,/arxiv_data1/oa_pdf/23/76/12325_2013_Article_71.PMC3898344.pdf
http://bidocs.boehringer-ingelheim.com/BIWebAccess/ViewServlet.ser?docBase=ren etnt&folderPath=/Prescrib ing?Information/PIs/Tradjenta/Tradjenta.pdf (Acces- sed 25 Oct 2013).,Non-OADS,/arxiv_data1/oa_pdf/23/76/12325_2013_Article_71.PMC3898344.pdf
http://www.merck.com/ product/usa/pi_circulars/j/januvia/januvia_pi.pdf (Accessed 25 Oct 2013).,OADS,/arxiv_data1/oa_pdf/23/76/12325_2013_Article_71.PMC3898344.pdf
http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/23/76/12325_2013_Article_71.PMC3898344.pdf
http://www.census.gov/popest/ data/national/asrh/2011/index.html (Accessed 25 Oct 2013).,OADS,/arxiv_data1/oa_pdf/23/76/12325_2013_Article_71.PMC3898344.pdf
Projections of the population by selected age group and sex for the United States: 2010 to 2050. http://www.census.gov/population/ projections/data/national/2008/summarytables.html(Accessed 25 Oct 2013).,OADS,/arxiv_data1/oa_pdf/23/76/12325_2013_Article_71.PMC3898344.pdf
"(2013) Typology of the primary outcome construc-tion in dermatology: a systematic reviewof published randomized controlled trials.J Invest Dermatol 133:371–6 National Heart, Lung, and Blood Institute (2002) Third report of the expert panel on detection, evaluation, and treatment of high blood cho- lesterol in adults (ATP III Final Report) http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3_rpt.htm, accessed 4 March 2013 Shadish W, Cook T, Campbell D (2002) Experi- mental and Quasi-Experimental Designs forGenerilized Causal Inference Boston: Houghton Mifﬂin Streiner DL (2002) Breaking up is hard to do: the heartbreak of dichotomizing continuous data.",Non-OADS,/arxiv_data1/oa_pdf/dd/ec/jid2013289a.PMC3898345.pdf
"Can J Psychiatry 52:121–8 World Health Organization (2006) BMI classiﬁca- tion http://apps.who.int/bmi/index.jsp?intro-Page=intro_3.html, accessed 2 March 2013 Treatment-Related Restoration of Langerhans Cell M i g r a t i o ni nP s o r i a s i s Journal of Investigative Dermatology (2014) 134, 268–271; doi:10.1038/jid.2013.289; published online 25 July 2013 TO THE EDITOR The mobilization and migration of epi-dermal Langerhans cells (LCs) todraining lymph nodes is dependent upon receipt of (at least) two indepen-dent cytokine signals; one provided byIL-1band the second by tumor necrosis factor- a(TNF-a)( C u m b e r b a t c h et al.",Non-OADS,/arxiv_data1/oa_pdf/dd/ec/jid2013289a.PMC3898345.pdf
"Available at: http://www.itrcweb.org/Documents/GSR-2.pdf M o r i oM ,S c h ä d l e rS ,F i n k e lM ,J u s t e nA ,B l e i c h e rA ,B a r t k eS& Gross M. 2011.",Non-OADS,/arxiv_data1/oa_pdf/5a/2b/11270_2013_Article_1706.PMC3898352.pdf
"Available: http://www.safira-mmt.de/ Network of Industrially Contaminated Land in Europe (NICOLE), 2010.",Non-OADS,/arxiv_data1/oa_pdf/5a/2b/11270_2013_Article_1706.PMC3898352.pdf
"Available at: http://www.nicole.org/documen ts/DocumentList.aspx?w=SR Petruzzi, N. M. (2011).",Non-OADS,/arxiv_data1/oa_pdf/5a/2b/11270_2013_Article_1706.PMC3898352.pdf
"Available athttp://www.clu-in.org/download/remed/green-remediation- primer.pdf Worrall, R., Neil, D., Brereton, D., & Mulligan, D. (2009).",OADS,/arxiv_data1/oa_pdf/5a/2b/11270_2013_Article_1706.PMC3898352.pdf
http://onlinelibrary.wiley.com/doi/ 10.1002/j.1532-2149.2011.00102.x/abstract 13.,Non-OADS,/arxiv_data1/oa_pdf/89/0d/701_2013_Article_1895.PMC3898361.pdf
http://www.unaids.org/ en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf (Data accessed: 12/2013).,OADS,/arxiv_data1/oa_pdf/56/ed/srep03796.PMC3898414.pdf
http://apps.who.int/iris/ bitstream/10665/85321/1/9789241505727_eng.pdf (Data accessed: 12/2013).,OADS,/arxiv_data1/oa_pdf/56/ed/srep03796.PMC3898414.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: U.D.,Non-OADS,/arxiv_data1/oa_pdf/56/ed/srep03796.PMC3898414.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3796 | DOI: 10.1038/srep03796 9",Non-OADS,/arxiv_data1/oa_pdf/56/ed/srep03796.PMC3898414.pdf
http://www.emea.europa.eu/ docs/en_GB/document_library/Scientiﬁc_guideline/ 2009/09/WC500003658.pdf .,Non-OADS,/arxiv_data1/oa_pdf/dc/b8/12325_2013_Article_76.PMC3898428.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on European Journal of Clinical Nutrition website (http://www.nature.com/ejcn)Food ingredients and gall bladder emptying L Marciani et al 1187 &2013 Macmillan Publishers Limited European Journal of Clinical Nutrition (2013) 1182 – 1187",Non-OADS,/arxiv_data1/oa_pdf/e7/ce/ejcn2013168a.PMC3898429.pdf
Available from: http://www.unicef.,Non-OADS,/arxiv_data1/oa_pdf/d3/49/IJPVM-4-1395.PMC3898445.pdf
Available from: http://articles.timesofindia.,Non-OADS,/arxiv_data1/oa_pdf/d3/49/IJPVM-4-1395.PMC3898445.pdf
Available from: http://censusindia.gov.in/ Dist_File/datasheet-2422.pdf.,OADS,/arxiv_data1/oa_pdf/d3/49/IJPVM-4-1395.PMC3898445.pdf
Available  from: http://www.censusindia.gov.in/2011-prov-results/ data_files/gujarat/ Table  1.xls.,OADS,/arxiv_data1/oa_pdf/d3/49/IJPVM-4-1395.PMC3898445.pdf
Available from:  http://www.suratmunicipal.gov.in/content/city/stmt3.,Non-OADS,/arxiv_data1/oa_pdf/d3/49/IJPVM-4-1395.PMC3898445.pdf
Available from: http://www.nihfw.org/ pdf/NCHRC-Publications/ImmuniHandbook.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d3/49/IJPVM-4-1395.PMC3898445.pdf
Available from: http://www.who.int/childgrowth/standards/technical_report/en.,Non-OADS,/arxiv_data1/oa_pdf/5a/7f/IJPVM-4-1414.PMC3898447.pdf
Available  from: http://www.ERS-USDA_Briefing_Room-Food_ security_in_the_United_States.htm.,Non-OADS,/arxiv_data1/oa_pdf/8a/0e/IJPVM-4-1421.PMC3898448.pdf
Available from: http://www.who.int/violence_injury_ prevention/road_safety_status/2009/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/59/40/IJPVM-4-1442.PMC3898451.pdf
Available from: http://www.who.int/violence_injury_ prevention/publications/road_traffic/world_ report/en/ index.html.,Non-OADS,/arxiv_data1/oa_pdf/59/40/IJPVM-4-1442.PMC3898451.pdf
Available from: http://www.who.int/violence_ injury_prevention/publications/road_traffic/world_ report/en.,Non-OADS,/arxiv_data1/oa_pdf/59/40/IJPVM-4-1442.PMC3898451.pdf
Available from: http://data.worldbank.,OADS,/arxiv_data1/oa_pdf/59/40/IJPVM-4-1442.PMC3898451.pdf
Available from: http://www.who.int/ gho/countries/en.,Non-OADS,/arxiv_data1/oa_pdf/59/40/IJPVM-4-1442.PMC3898451.pdf
Available from: http://search.worldbank.org/ data?qterm=ppp and language=EN.,OADS,/arxiv_data1/oa_pdf/59/40/IJPVM-4-1442.PMC3898451.pdf
Available from:  http://www.who.int/violence_injury_prevention/road_ safety_status/2009/en.,Non-OADS,/arxiv_data1/oa_pdf/59/40/IJPVM-4-1442.PMC3898451.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/3d/c1/IJPVM-4-1451.PMC3898452.pdf
Available  from: http://www.cdc.gov/GSHS/.,OADS,/arxiv_data1/oa_pdf/3d/c1/IJPVM-4-1451.PMC3898452.pdf
Available from: http://www.who.int/mediacentre/factsheets/ fs317/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/26/00/IJPVM-4-1461.PMC3898453.pdf
Available from: http://www.who.int/ publications/cra/chapters/volume1/0497‑0596.pdf.,Non-OADS,/arxiv_data1/oa_pdf/26/00/IJPVM-4-1461.PMC3898453.pdf
Available from:  http://www.icmr.nic.in/annual/2005-2006/dmrc/a1h.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0a/11/IJPVM-4-1480.PMC3898457.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)Snail function in glioblastoma K Savary et al 5420 Oncogene (2013) 5409 – 5420 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/af/8e/onc201367a.PMC3898470.pdf
Published by Elsevier Ltd. http://dx.doi.org/10.1016/j.brat.2013.10.010Behaviour Research and Therapy 52 (2014) 61 e63 Open access under CC BY-NC-ND license .,Non-OADS,/arxiv_data1/oa_pdf/2b/7c/main.PMC3898473.pdf
"Sia,5Lauryn S. Bracken,5Racquel Collins-Underwood,6Christina Drenberg,7 Laura B. Ramsey,7Sara C. Meyer,8Megumi Takiguchi,9Ross A. Dickins,9Ross Levine,8Jacques Ghysdael,2,3,4 Mark A. Dawson,10,11Richard B. Lock,5Charles G. Mullighan,6and Ricky W. Johnstone1,12,* 1Cancer Therapeutics Program, The Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, 3002 VIC, Australia 2Institut Curie, Centre Universitaire, Bat 110, 91405 Orsay, France 3Centre National de la Recherche Scientiﬁque, Unite Mixte de Recherche 3306, Centre Universitaire, Bat 110, 91405 Orsay, France 4Institut National de la Sante et al Recherche Medicale, Unite 1005, Centre Universitaire, Bat 110, 91405 Orsay, France 5Children’s Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW, Sydney, 2052 NSW, Australia 6Department of Pathology, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA 7Department of Pharmaceutical Sciences, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA 8Department of Medicine, Human Oncology and Pathogenesis Program and Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA 9Molecular Medicine Division, Walter and Eliza Hall Institute of Medical Research, Parkville, 3052 VIC, Australia 10Gurdon Institute and Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QN, UK 11Department of Haematology, Cambridge Institute for Medical Research and Addenbrooke’s Hospital, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK 12Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, 3052 VIC, Australia 13These authors contributed equally to this work *Correspondence: ricky.johnstone@petermac.org http://dx.doi.org/10.1016/j.celrep.2013.10.038 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and sourceare credited.",Non-OADS,/arxiv_data1/oa_pdf/9d/e4/main.PMC3898474.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, six ﬁgures, and eight tables and can be found with this article online athttp://dx.doi.org/10.1016/j.celrep.2013.10.038 .",Non-OADS,/arxiv_data1/oa_pdf/9d/e4/main.PMC3898474.pdf
"Jones,2Simon Raffel,3,4Jan-Philipp Mallm,5Kristin M. Junge,6 Dieter Weichenhan,7Tobias Bauer,1Naveed Ishaque,1,21Marcel Kool,2Paul A. Northcott,2Andrey Korshunov,8,9 Ruben M. Drews,1Jan Koster,10Rogier Versteeg,10Julia Richter,11Michael Hummel,12Stephen C. Mack,13 Michael D. Taylor,13Hendrik Witt,2,14Benedict Swartman,15Dietrich Schulte-Bockholt,15Marc Sultan,16 Marie-Laure Yaspo,16Hans Lehrach,16Barbara Hutter,1Benedikt Brors,1Stephan Wolf,17Christoph Plass,7 Reiner Siebert,11Andreas Trumpp,3,4,18Karsten Rippe,5Irina Lehmann,6Peter Lichter,18,19,21Stefan M. Pﬁster,2,14,18 and Roland Eils1,20,21,* 1Division of Theoretical Bioinformatics 2Division of Pediatric Neurooncology 3Division of Stem Cells and Cancer German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany 4Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGBMH), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany 5Research Group Genome Organization and Function, DKFZ and BioQuant, 69120 Heidelberg, Germany 6UFZ, Helmholtz Centre for Environmental Research Leipzig, Department of Environmental Immunology, 04318 Leipzig, Germany 7Division of Epigenomics and Cancer Risk Factors, DKFZ, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany 8Department of Neuropathology, University of Heidelberg, Im Neuenheimer Feld 224, 69120 Heidelberg, Germany 9Clinical Cooperation Unit Neuropathology, DKFZ, Im Neuenheimer Feld 224, 69120 Heidelberg, Germany 10Department of Oncogenomics, AMC, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, Netherlands 11Institute of Human Genetics, Christian-Albrechts-University, Schwanenweg 24, 24105 Kiel, Germany 12Institute of Pathology, Charite ´-University Medicine Berlin, Charite ´platz 1, 10117 Berlin, Germany 13Division of Neurosurgery and The Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, 555 University Avenue, Toronto M5G 1X8, Canada 14Department of Pediatric Oncology, Hematology, and Immunology, Heidelberg University Hospital, Im Neuenheimer Feld 430, 69120 Heidelberg, Germany 15Department of Trauma and Orthopaedic Surgery, BG Trauma Centre, 67071 Ludwigshafen, Germany 16Max Planck Institute for Molecular Genetics, Ihnestrasse 63-73, 14195 Berlin, Germany 17Genomics and Proteomics Core Facility, DKFZ, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany 18German Cancer Consortium (DKTK), 69120 Heidelberg, Germany 19Division of Molecular Genetics, DKFZ, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany 20Institute of Pharmacy and Molecular Biotechnology, Bioquant Center, University of Heidelberg, Im Neuenheimer Feld 267, 69120 Heidelberg, Germany 21Heidelberg Center for Personalized Oncology, DKFZ-HIPO, DKFZ, Im Neuenheimer Feld 580, 69120 Heidelberg, Germany *Correspondence: r.eils@dkfz-heidelberg.de http://dx.doi.org/10.1016/j.cell.2013.09.042 SUMMARY Mutation is a fundamental process in tumorigenesis.",Non-OADS,/arxiv_data1/oa_pdf/a1/17/main.PMC3898475.pdf
"ACCESSION NUMBERS Next-generation sequencing data have been deposited at the European Genome-phenome Archive (EGA, https://www.ebi.ac.uk/ega/ ) hosted by the EBI under accession numbers EGAS00001000394 and EGAS00001000565.",OADS,/arxiv_data1/oa_pdf/a1/17/main.PMC3898475.pdf
"Such questions are usually answered by investigator-initiated trials, which, because of funding con- straints and limited infrastructural support, are frequentlysmall, short-duration studies limited to one or a few centers.A recent evaluation of interventional trials registered onhttp://www.kidney-international.org policy forum &2013 International Society of Nephrology Correspondence: Alicia T. Morrish, Australasian Kidney Trials Network, School of Medicine, University of Queensland, Ground Floor, Building 33, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Brisbane,Queensland 4102, Australia.",Non-OADS,/arxiv_data1/oa_pdf/a5/52/ki2013391a.PMC3898483.pdf
The UK’s National Institute for Health Research implemented a ClinicalResearch Network in 2008 to provide funding and networksupport to investigator-initiated trials in the United Kingdom(http://www.crncc.nihr.ac.uk/).,Non-OADS,/arxiv_data1/oa_pdf/a5/52/ki2013391a.PMC3898483.pdf
Available at http://www.usrds.org/2011/pdf/v2_ch011_11.pdf (29 May 2012).,Non-OADS,/arxiv_data1/oa_pdf/a5/52/ki2013391a.PMC3898483.pdf
Available at http://www.usrds.org/2011/pdf/v2_ch012_11.pdf (29 May 2012).,Non-OADS,/arxiv_data1/oa_pdf/a5/52/ki2013391a.PMC3898483.pdf
Available at http://www.nhi.gov.tw/webdata/webdata.aspx?menu=17&menu_id=661&WD_ID=689& webdata_id=3351(29 May 2012).,OADS,/arxiv_data1/oa_pdf/a5/52/ki2013391a.PMC3898483.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ 30 Kidney International (2014) 85,2 3 – 3 0policy forum AT Morrish et al.",Non-OADS,/arxiv_data1/oa_pdf/a5/52/ki2013391a.PMC3898483.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)Par-4/THAP1 regulates CCAR1 transcription CL u et al 5613 &2013 Macmillan Publishers Limited Oncogene (2013) 5602 – 5613",Non-OADS,/arxiv_data1/oa_pdf/fa/22/onc2013349a.PMC3898485.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)FER promotes breast cancer metastasis IA Ivanova et al 5592 Oncogene (2013) 5582 – 5592 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/ec/40/onc2013277a.PMC3898493.pdf
"Integration of efﬁciency of repair with protein interactions The human protein interactome was built with data downloaded from the NCBI database 13, February 13 (ftp://ftp.ncbi.nih.gov/gene/GeneRIF).Interactions were formatted in the Cytoscape readable simple interactionformat and loaded into Cytoscape.",OADS,/arxiv_data1/oa_pdf/05/92/onc201338a.PMC3898496.pdf
"56For the siRNA targets that showed differences in repair activities in BALB/c- Trp53þ//C0versus C57BL/6- Trp53þ//C0MEFs (Table 1, Po0.01), the mouse Gene IDs were converted from Mouse Entrez Gene IDs to Human Entrez Gene IDs (HomoloGeneBuild 65; ftp://ftp.ncbi.nih.gov/pub/HomoloGene/build65/) and mappedonto the protein interactome.",OADS,/arxiv_data1/oa_pdf/05/92/onc201338a.PMC3898496.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)Fanconi anemia pathway defect in BALB/c mice MB o¨hringer et al 5470 Oncogene (2013) 5458 – 5470 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/05/92/onc201338a.PMC3898496.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/REFERENCES 1 Falk E, Shah PK, Fuster V. Coronary plaque disruption.",Non-OADS,/arxiv_data1/oa_pdf/3b/15/heartasia-2013-010328.PMC3898547.pdf
"Clinical research 446dominantly in patients older than 65 years.4These patients also inherit 60% to 80% of their risk for late- onset AD, although it is not connected to the aforemen- tioned genes, with the remainder being environmental.4,5 In late-onset AD many different genes—some still unidentified—are involved, each only attributing a minor fraction of the individual’s overall risk, making it a pos- sible example of antagonistic pleiotropy.6Recently, sev- eral genome-wide association studies have identified new candidates (for reviews and databases see http://www.alz- gene.org).",Non-OADS,/arxiv_data1/oa_pdf/86/ad/DialoguesClinNeurosci-15-445.PMC3898682.pdf
Published by Elsevier Ltd. http://dx.doi.org/10.1016/j.socscimed.2013.10.013Social Science & Medicine 98 (2013) 361 e370 Open access under CC BY-NC-ND license.,Non-OADS,/arxiv_data1/oa_pdf/e3/f1/main.PMC3898703.pdf
The 10/90 report on health research 2001 e 2002. http://www.globalforumhealth.org/pages/index.asp Accessed 22.08.03.,Non-OADS,/arxiv_data1/oa_pdf/e3/f1/main.PMC3898703.pdf
Available http://www.nacc.or.,Non-OADS,/arxiv_data1/oa_pdf/e3/f1/main.PMC3898703.pdf
Available http://www.unhabitat.org/content.asp?cid ¼2275&catid ¼5&ty peid¼6&subMenuId ¼0Accessed 13.03.09.,Non-OADS,/arxiv_data1/oa_pdf/e3/f1/main.PMC3898703.pdf
This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc13-1397/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/a4/cb/419.PMC3898748.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Adela Hruby,1James B. Meigs,2 Christopher J. O ’Donnell,3,4Paul F. Jacques,1and Nicola M. McKeown1Diabetes Care Volume 37, February 2014 419EPIDEMIOLOGY/HEALTH SERVICES RESEARCH",Non-OADS,/arxiv_data1/oa_pdf/a4/cb/419.PMC3898748.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Tamara J. LeCaire, Barbara E.K.",Non-OADS,/arxiv_data1/oa_pdf/d8/6f/381.PMC3898749.pdf
This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc13-0997/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/48/1a/521.PMC3898750.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Amy C. Alman,1David M. Maahs,2Marian J. Rewers,2and Janet K. Snell-Bergeon2Diabetes Care Volume 37, February 2014 521CARDIOVASCULAR AND METABOLIC RISK",Non-OADS,/arxiv_data1/oa_pdf/48/1a/521.PMC3898750.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Luohua Jiang,1Spero M. Manson,2 Janette Beals,2William G. Henderson,3 Haixiao Huang,2Kelly J. Acton,4 Yvette Roubideaux,5and the Special Diabetes Program for Indians Diabetes Prevention Demonstration ProjectDiabetes Care Volume 37, February 2014 e35eLETTERS –COMMENTS AND RESPONSES",Non-OADS,/arxiv_data1/oa_pdf/09/f6/e35.PMC3898751.pdf
This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc13-0449/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/a6/23/325.PMC3898752.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Laura B. Smith,1Kristian F. Lynch,2 Judith Baxter,3,4Barbro Lernmark,5 Roswith Roth,6Tuula Simell,7Suzanne Bennett Johnson,8and the TEDDY Study Group*Diabetes Care Volume 37, February 2014 325CLIN CARE/EDUCATION/NUTRITION/PSYCHOSOCIAL",Non-OADS,/arxiv_data1/oa_pdf/a6/23/325.PMC3898752.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Paul A. McAuley,1Enrique G. Artero,2 Xuemei Sui,3Carl J. Lavie,4 M. Joao Almeida,5and Steven N. Blair3,6Diabetes Care Volume 37, February 2014 529CARDIOVASCULAR AND METABOLIC RISK",Non-OADS,/arxiv_data1/oa_pdf/a8/e6/529.PMC3898753.pdf
Available from http://www.diabetes.org/diabetes-basics/diabetes-statistics/.,Non-OADS,/arxiv_data1/oa_pdf/a8/e6/529.PMC3898753.pdf
This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc13-1458/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/9e/1f/475.PMC3898754.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Cosimo Giannini,1Chiara Dalla Man,2 Leif Groop,3Claudio Cobelli,2 Hongyu Zhao,4Melissa M. Shaw,1 Elvira Duran,1Bridget Pierpont,1 Allen E. Bale,5Sonia Caprio,1 and Nicola Santoro1Diabetes Care Volume 37, February 2014 475PATHOPHYSIOLOGY/COMPLICATIONS",Non-OADS,/arxiv_data1/oa_pdf/9e/1f/475.PMC3898754.pdf
"The allele frequencies wereconsistent with those shown in similarethnic groups in the Allele FrequencyDatabase (ALFRED, http://alfred.med.yale.edu) as well as in HAPMAP(http://hapmap.ncbi.nlm.nih.gov/)(Supplementary Table 1).",OADS,/arxiv_data1/oa_pdf/9e/1f/475.PMC3898754.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Marisa E. Hilliard,1Jessamyn G. Perlus,2 Loretta M. Clark,3Denise L. Haynie,2 Leslie P. Plotnick,1Ines Guttmann-Bauman,3 and Ronald J. Iannotti2346 Diabetes Care Volume 37, February 2014CLIN CARE/EDUCATION/NUTRITION/PSYCHOSOCIAL",Non-OADS,/arxiv_data1/oa_pdf/b9/6b/346.PMC3898755.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Elizabeth Buschur,1Aruna V. Sarma,2 Massimo Pietropaolo,1Rodney L. Dunn,2Barbara H. Braffett,3Patricia A. Cleary,3Catherine Cowie,4Mary E. Larkin,5Hunter Wessells,6 David M. Nathan,5and Catherine Kim,7 for the DCCT/EDIC Research Group*e28 Diabetes Care Volume 37, February 2014eLETTERS –OBSERVATIONS",Non-OADS,/arxiv_data1/oa_pdf/61/8e/e28.PMC3898756.pdf
This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc13-1203/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/ef/d8/569.PMC3898757.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Ming Ding,1Shilpa N. Bhupathiraju,1 Mu Chen,1Rob M. van Dam,1,2 and Frank B. Hu1,3,4Diabetes Care Volume 37, February 2014 569META-ANALYSIS",Non-OADS,/arxiv_data1/oa_pdf/ef/d8/569.PMC3898757.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Naama Barnea-Goraly,1Mira Raman,1 Paul Mazaika,1Matthew Marzelli,1 Tamara Hershey,2Stuart A. Weinzimer,3 Tandy Aye,4Bruce Buckingham,4 Nelly Mauras,5Neil H. White,6 Larry A. Fox,5Michael Tansey,7 Roy W. Beck,8Katrina J. Ruedy,8 Craig Kollman,8Peiyao Cheng,8and Allan L. Reiss,1,4,9for the Diabetes Research in Children Network (DirecNet)*332 Diabetes Care Volume 37, February 2014CLIN CARE/EDUCATION/NUTRITION/PSYCHOSOCIAL",Non-OADS,/arxiv_data1/oa_pdf/2b/c2/332.PMC3898758.pdf
This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc13-1571/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/d5/b7/317.PMC3898759.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Mary Savoye,1,2Sonia Caprio,1 James Dziura,3Anne Camp,4 Greg Germain,5Craig Summers,6 Fangyong Li,7Melissa Shaw,1 Paulina Nowicka,8Romy Kursawe,1 Fredrick DePourcq,2Grace Kim,1and William V. Tamborlane1Diabetes Care Volume 37, February 2014 317CLIN CARE/EDUCATION/NUTRITION/PSYCHOSOCIAL",Non-OADS,/arxiv_data1/oa_pdf/d5/b7/317.PMC3898759.pdf
This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc13-1838/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/52/a2/402.PMC3898760.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.David J. Pettitt,1Jennifer Talton,2 Dana Dabelea,3Jasmin Divers,2 Giuseppina Imperatore,4 Jean M. Lawrence,5Angela D. Liese,6 Barbara Linder,7 Elizabeth J. Mayer-Davis,8,9 Catherine Pihoker,10Sharon H. Saydah,4 Debra A. Standiford,11and Richard F. Hamman,3for the SEARCH for Diabetes in Youth Study Group402 Diabetes Care Volume 37, February 2014EPIDEMIOLOGY/HEALTH SERVICES RESEARCH",Non-OADS,/arxiv_data1/oa_pdf/52/a2/402.PMC3898760.pdf
"To derive civilian population denominators for the geographiccenters, denominators for the youthaged 17 –19 years were adjusted by subtracting the age-, sex-, racial/ethnic-,and county-speci ﬁc number of active- duty military personnel derived fromthe information from the Military FamilyResource Center (http://www.mfrc.org) and the Census Bureau.",OADS,/arxiv_data1/oa_pdf/52/a2/402.PMC3898760.pdf
2013.Available from http://www.cdc.gov/nchs/ nvss/bridged_race/data_documentation.,OADS,/arxiv_data1/oa_pdf/52/a2/402.PMC3898760.pdf
Available from http://www.childhealthdata.org/browse/ survey/results?q=2460&g=456&r=1.,Non-OADS,/arxiv_data1/oa_pdf/52/a2/402.PMC3898760.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Gregory L. Kinney,1Jennifer L. Black- Shinn,1Emily S. Wan,2Barry Make,3 Elizabeth Regan,3Sharon Lutz,1 Xavier Soler,4Edwin K. Silverman,2 James Crapo,3John E. Hokanson,1and the COPDGene InvestigatorsDiabetes Care Volume 37, February 2014 389EPIDEMIOLOGY/HEALTH SERVICES RESEARCH",Non-OADS,/arxiv_data1/oa_pdf/dd/c2/389.PMC3898761.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.William C. Knowler1and Ronald T. Ackermann2Diabetes Care Volume 37, February 2014 e37eLETTERS –COMMENTS AND RESPONSES",Non-OADS,/arxiv_data1/oa_pdf/8a/16/e37.PMC3898762.pdf
This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc13-0933/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/8c/b3/355.PMC3898763.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Daniela Grimaldi,1,2Guglielmo Beccuti,1,3 Carol Touma,1,3Eve Van Cauter,1,3and Babak Mokhlesi1,2Diabetes Care Volume 37, February 2014 355CLIN CARE/EDUCATION/NUTRITION/PSYCHOSOCIAL",Non-OADS,/arxiv_data1/oa_pdf/8c/b3/355.PMC3898763.pdf
Availablefrom http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8c/b3/355.PMC3898763.pdf
This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc13-0626/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/96/d5/453.PMC3898764.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Mark D. Pescovitz,1,†Carla J. Greenbaum,2 Brian Bundy,3Dorothy J. Becker,4Stephen E. Gitelman,5Robin Goland,6Peter A. Gottlieb,7Jennifer B. Marks,8 Antoinette Moran,9Philip Raskin,10 Henry Rodriguez,1,3Desmond A. Schatz,11 Diane K. Wherrett,12Darrell M. Wilson,13 Jeffrey P. Krischer,3Jay S. Skyler,8and the Type 1 Diabetes TrialNet Anti-CD20 Study Group*Diabetes Care Volume 37, February 2014 453EMERGING TECHNOLOGIES AND THERAPEUTICS",Non-OADS,/arxiv_data1/oa_pdf/96/d5/453.PMC3898764.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Julie A. Schmittdiel,1Sara R. Adams,1 Jodi Segal,2Marie R. Grif ﬁn,3 Christianne L. Roumie,3Kris Ohnsorg,4 Richard W. Grant,1 and Patrick J. O ’Connor4Diabetes Care Volume 37, February 2014 565NOVEL COMMUNICATIONS IN DIABETES",Non-OADS,/arxiv_data1/oa_pdf/ad/c4/565.PMC3898765.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Nasrin Azad,1Lily Agrawal,1Nicholas V. Emanuele,1Ronald Klein,2Gideon D. Bahn,3Madeline McCarren,4 Peter Reaven,5Rodney Hayward,6 William Duckworth,5and the VADT Study GroupDiabetes Care Volume 37, February 2014 501PATHOPHYSIOLOGY/COMPLICATIONS",Non-OADS,/arxiv_data1/oa_pdf/27/b5/501.PMC3898766.pdf
"At present, more than 350 unique mem- brane protein structures solved by X-ray crystallography ( http://blanco.biomol.uci.edu/mpstruc/exp/list , Ste- phen White Lab at UC Irvine) are available in the Protein Data Bank.",OADS,/arxiv_data1/oa_pdf/46/4d/main.PMC3898769.pdf
Published by Elsevier B.V.http://dx.doi.org/10.1016/j.bbamem.2013.07.010 Contents lists available at ScienceDirect Biochimica et Biophysica Acta journal homepage: www.elsevier.com/locate/bbamem Open access under CC BY-NC-ND license .,OADS,/arxiv_data1/oa_pdf/46/4d/main.PMC3898769.pdf
"Since then more than 300 unique mem- brane protein structures have been solved using the same method(http://blanco.biomol.uci.edu/mpstruc/exp/list, Stephen White Lab at UC Irvine).",OADS,/arxiv_data1/oa_pdf/46/4d/main.PMC3898769.pdf
"Since then, more than 114 membrane protein structures have been solved using the in meso method ( http://cherezov.scripps.edu/structures.htm ).",OADS,/arxiv_data1/oa_pdf/46/4d/main.PMC3898769.pdf
A full collection of assays and methods relating to the behavior of membrane proteins and their interaction with lipids in LCP can be found in http://cherezov.scripps.edu/resources.htm .,Non-OADS,/arxiv_data1/oa_pdf/46/4d/main.PMC3898769.pdf
"Today, more than 120 MX beamlines from 22 different synchrotrons around the world are available to re-searchers ( http://biosync.sbkb.org/ )[29,119] .",OADS,/arxiv_data1/oa_pdf/46/4d/main.PMC3898769.pdf
The lab combines recently developed high throughput tech- nologies for protein production and crystallization with the latest developments in X-ray diffraction data collection systems at Diamond MX beamlines ( http://www.diamond.ac.uk/Home/MPL.html ) 4.1.,Non-OADS,/arxiv_data1/oa_pdf/46/4d/main.PMC3898769.pdf
"The use of microfocus beamlines Microfocus beamlines combined with modern developments in sample handling [121] , sample visualization [122] , automatic crystal centering [123,124] , cryo-cooling systems [125,126] , fast readout detec- tors[127 –129], new data collection strategies [130] and the appearance of new algorithms for merging data collected from different crystals[131] have recently yielded many novel high-resolution membrane pr otein structures ( http://blanco.biomol.uci.edu/mpstruc/listAll/list ).",OADS,/arxiv_data1/oa_pdf/46/4d/main.PMC3898769.pdf
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.ypmed.2013.11.017 Contents lists available at ScienceDirect Preventive Medicine journal homepage: www.elsevier.com/locate/ypmed Open access under CC BY-NC-ND license .,Non-OADS,/arxiv_data1/oa_pdf/27/d4/main.PMC3898883.pdf
Available: http://nccd.cdc.gov/gtssdata/Ancillary/DataReports.aspx?,OADS,/arxiv_data1/oa_pdf/27/d4/main.PMC3898883.pdf
Available: http://nccd.cdc.gov/gtssdata/Default/ CountryResults.aspx?TYPE=A&SRCH=&SUID=GATS&SYID=RY&CAID=&SCID= TT&QUID=QQ&WHID=&COID=ch&LOID= ch100&DCOL=&DSRT=DEFAULT&DODR= ASC&DSHO=&DCIV=&DCSZ=&FCHL=&FSEL=&FPRL=&FAGL=&FREL=&FDSC=&MPVW= (Accessed June 13 2013).,OADS,/arxiv_data1/oa_pdf/27/d4/main.PMC3898883.pdf
http://dx.doi.org/10.1136/tobaccocontrol-2012-050817 .,Non-OADS,/arxiv_data1/oa_pdf/27/d4/main.PMC3898883.pdf
Available: http://www.who.int/nmh/events/un_ncd_summit2011/political_declaration_en.pdf (Accessed June 5 2013).,Non-OADS,/arxiv_data1/oa_pdf/27/d4/main.PMC3898883.pdf
Available: http://www.who.int/fctc/signatories_parties/en/index.,OADS,/arxiv_data1/oa_pdf/27/d4/main.PMC3898883.pdf
Available: http://www.who.int/tobacco/surveillance/gats/ en/(Accessed May 31 2013).,Non-OADS,/arxiv_data1/oa_pdf/27/d4/main.PMC3898883.pdf
Available:http://www.worldlungfoundation.org/ht/display/ReleaseDetails/i/22993/pid/6858 (Accessed June 13 2013).53 G.P.,Non-OADS,/arxiv_data1/oa_pdf/27/d4/main.PMC3898883.pdf
Commun Integr Biol 2013; 6:e24792; http://dx.doi.org/10.4161/cib.24792; PMID:23940825 MAGEA11 is a cancer germline (CG) antigen  and androgen receptor (AR) co-activator.,Non-OADS,/arxiv_data1/oa_pdf/de/e3/nucl-4-341.PMC3899121.pdf
Epigenetics 2013; 8:849-63; http://dx.doi.org/10.4161/epi.25500; PMID:23839233,Non-OADS,/arxiv_data1/oa_pdf/de/e3/nucl-4-341.PMC3899121.pdf
"Cell Cycle 2013; 12:2297-308; http://dx.doi.org/10.4161/cc.25379 rad4p regulates heterochromatin structure and gene silencing in yeast DNA in eukaryotes is packed into chromatin,  which exists in two different forms, euchroma-tin and heterochromatin.",OADS,/arxiv_data1/oa_pdf/de/e3/nucl-4-341.PMC3899121.pdf
Cell Cycle 2013; 12:2435-42; http://dx.doi.org/10.4161/cc.25457; PMID:23839037,OADS,/arxiv_data1/oa_pdf/de/e3/nucl-4-341.PMC3899121.pdf
"www.landesbioscience.com  Nucleus  343Nucleus 4:5, 343–348; September/Oc tober 2013; © 2013 Landes Bioscience COMMENTAR y COMMENTAR y Keywords:  chromatin, nucleosome, his - tone, post-translational modification, lat - eral surface, acetylation, transcription Submitted: 06/30/13Revised: 07/31/13Accepted: 08/05/13http://dx.doi.org/10.4161/nucl.26051 *Correspondence to: Antonis Kirmizis;   Email: kirmizis@ucy.ac.cyPost-translational modifications  (Ptms) of hi stones have been  implicated in cellular processes such as transcription, replication and  dna   repai r. these  processes normally involve  dynamic changes in chromatin struc - ture and dna  acc essibility.",Non-OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Cell 2013; 152:859-72; PMID:23415232; http://dx.doi.org/10.1016/j.cell.2013.01.032,OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Cell 2013; 152:859-72; PMID:23415232; http://dx.doi.org/10.1016/j.cell.2013.01.032 2.,OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Nat Struct Mol Biol 2013; 20:259-66; PMID:23463310; http://dx.doi.org/10.1038/nsmb.2470 3.,OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Cell Res 2011; 21:381-95; PMID:21321607; http://dx.doi.org/10.1038/cr.2011.22 4.,OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Nat Struct Mol Biol 2012; 19:1218-27; PMID:23211769; http://dx.doi.org/10.1038/nsmb.2436 5.,OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Nat Struct Mol Biol 2008; 15:1122-4; PMID:18794842; http://dx.doi.org/10.1038/nsmb.1489 6.,OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Science 2006; 311:844-7; PMID:16469925; http://dx.doi.org/10.1126/science.1124000 7.,OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Epigenetics 2010; 5:112-7; PMID:20160509; http://dx.doi.org/10.4161/epi.5.2.11075 8.,Non-OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Nature 1997; 389:251-60; PMID:9305837; http://dx.doi.org/10.1038/38444 9.,Non-OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Nat Struct Mol Biol 2004; 11:1037-43; PMID:15523479; http://dx.doi.org/10.1038/nsmb851 10.,OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
EMBO J 2004; 23:343-53; PMID:14726954; http://dx.doi.org/10.1038/sj.emboj.7600047 11.,OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Genes Dev 1995; 9:2770-9; PMID:7590252; http://dx.doi.org/10.1101/gad.9.22.277012.,Non-OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Biophys J 2010; 99:1577-85; PMID:20816070; http://dx.doi.org/10.1016/j.bpj.2010.06.046 13.,OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Nat Struct Mol Biol 2009; 16:124-9; PMID:19136959; http://dx.doi.org/10.1038/nsmb.1526 14.,OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
J Biol Chem 2009; 284:23312-21; PMID:19520870; http://dx.doi.org/10.1074/jbc.M109.003202 16.,OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Genes Dev 2007; 21:1519-29; PMID:17575053; http://dx.doi.org/10.1101/gad.1547707 18.,Non-OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Nat Genet 2009; 41:941-5; PMID:19633671; http://dx.doi.org/10.1038/ng.409 19.,Non-OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Curr Opin Struct Biol 2008; 18:282-9; PMID:18534842; http://dx.doi.org/10.1016/j.sbi.2008.04.003 20.,OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Mol Cell Biol 2010; 30:657-74; PMID:19933844; http://dx.doi.org/10.1128/MCB.01117-09 21.,Non-OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Mol Cell 2010; 38:590-602; PMID:20513433; http://dx.doi.org/10.1016/j.molcel.2010.02.04022.,OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Mol Cell Biol 2002; 22:2974-83; PMID:11940655; http://dx.doi.org/10.1128/MCB.22.9.2974-2983.2002 24.,Non-OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Mol Cell Biol 2000; 20:8933-43; PMID:11073993; http://dx.doi.org/10.1128/MCB.20.23.8933-8943.2000 25.,Non-OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
J Biol Chem 2007; 282:14158-64; PMID:17369253; http://dx.doi.org/10.1074/jbc.M700611200 26.,OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
EMBO J 2007; 26:2868-79; PMID:17510629; http://dx.doi.org/10.1038/sj.emboj.7601728 28.,Non-OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Biophys J 2009; 97:195-204; PMID:19580757; http://dx.doi.org/10.1016/j.bpj.2009.04.030 29.,OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Nat Struct Mol Biol 2004; 11:763-9; PMID:15258568; http://dx.doi.org/10.1038/nsmb801 30.,OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
J Mol Biol 2011; 411:430-48; PMID:21669206; http://dx.doi.org/10.1016/j.jmb.2011.05.044 31.,OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Nucleic Acids Res 2012; 40:10215-27; PMID:22965129; http://dx.doi.org/10.1093/nar/gks747,Non-OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Genes Dev 2011; 25:1359-64; PMID:21724829; http://dx.doi.org/10.1101/gad.2055511 47.,OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Science 2013; 340:195-9; PMID:23580526; http://dx.doi.org/10.1126/science.1229758 48.,OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Nucleic Acids Res 2006; 34:2653-62; PMID:16714444; http://dx.doi.org/10.1093/nar/gkl338 49.,OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
J Cell Biochem 2004; 92:691-700; PMID:15211567; http://dx.doi.org/10.1002/jcb.20106 50.,Non-OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Mol Cell 2005; 18:123-30; PMID:15808514; http://dx.doi.org/10.1016/j.molcel.2005.02.031 51.,OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Trends Genet 2011; 27:389-96; PMID:21764166; http://dx.doi.org/10.1016/j.tig.2011.06.006 52.,OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Trends Genet 2012; 28:436-44; PMID:22633123; http://dx.doi.org/10.1016/j.tig.2012.04.00339.,OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Mol Cell Proteomics 2012; 11:100-7; PMID:22389435; http://dx.doi.org/10.1074/mcp.M111.015875 40.,Non-OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Nat Struct Mol Biol 2009; 16:777-81; PMID:19561610; http://dx.doi.org/10.1038/nsmb.1629 41.,OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Chromosoma 2003; 112:77-86; PMID:12937907; http://dx.doi.org/10.1007/s00412-003-0244-6 42.,Non-OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Nat Struct Mol Biol 2013; 20:657-61; PMID:23739170; http://dx.doi.org/10.1038/nsmb.2581 43.,OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Nucleic Acids Res 2011; 39:6465-74; PMID:21576235; http://dx.doi.org/10.1093/nar/gkr304 44.,OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Mol Cell Biol 2005; 25:10060-70; PMID:16260619; http://dx.doi.org/10.1128/MCB.25.22.10060-10070.2005 45.,Non-OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
J Struct Biol 2012; 180:1-9; PMID:22771717; http://dx.doi.org/10.1016/j.jsb.2012.06.01232.,OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
J Mol Biol 2011; 408:187-204; PMID:21310161; http://dx.doi.org/10.1016/j.jmb.2011.01.003 33.,OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Cell Stem Cell 2013; 12:180-92; PMID:23260488; http://dx.doi.org/10.1016/j.stem.2012.11.003 34.,OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Genes Dev 2010; 24:171-82; PMID:20080953; http://dx.doi.org/10.1101/gad.552910 36.,OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Nature 2013; 498:516-20; PMID:23728302; http://dx.doi.org/10.1038/nature12210 37.,Non-OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
J Biol Chem 2007; 282:7641-55; PMID:17194708; http://dx.doi.org/10.1074/jbc.M607900200 38.,OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
Cell 2011; 146:1016-28; PMID:21925322; http://dx.doi.org/10.1016/j.cell.2011.08.008,OADS,/arxiv_data1/oa_pdf/d5/89/nucl-4-343.PMC3899122.pdf
"Cell Rep 2012; 2:1645-56; PMID:23246002; http://dx.doi.org/10.1016/j.celrep.2012.11.008Keywords:  nucleosome fiber (10-nm  fiber), 30-nm chromatin fiber, fluores - cence correlation spectroscopy (FCS),  Monte Carlo computer simulations, single nucleosome imaging, nucleosome fluctuation, polymer-melt, irregular fold - ing, interphase chromatin, mitotic chro - mosomes, transcriptional regulation Submitted: 05/30/13Revised: 07/28/13Accepted: 08/05/13http://dx.doi.org/10.4161/nucl.26053 *Correspondence to: Kazuhiro Maeshima;   Email: kmaeshim@lab.nig.ac.jpgenomic dna  is organized three  dime nsionally within cells as chro - matin and is searched and read by vari - ous proteins by an unknown mechanism;  this mediates diverse cell functions.",OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
Science 1974; 184:868- 71; PMID:4825889; http://dx.doi.org/10.1126/sci - ence.184.4139.868 2.,Non-OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
Exp Cell Res 1976; 97:101-10; PMID:812708; http://dx.doi.org/10.1016/0014-4827(76)90659-5 3.,OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
Science 1974; 183:330-2; PMID:4128918; http://dx.doi.org/10.1126/science.183.4122.330 4.,Non-OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
J Cell Biol 1984; 99:42-52; PMID:6736132; http://dx.doi.org/10.1083/jcb.99.1.42 6.,OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
Cold Spring Harb Symp Quant Biol 1978; 42:331-50; PMID:98280; http://dx.doi.org/10.1101/SQB.1978.042.01.035 7.,OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
J Cell Biol 1987; 105:77-92; PMID:3112167; http://dx.doi.org/10.1083/jcb.105.1.77 8.,OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
Curr Opin Cell Biol 2010; 22:291-7; PMID:20346642; http://dx.doi.org/10.1016/j.ceb.2010.03.001 11.,OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
Trends Biochem Sci 2011; 36:1-6; PMID:20926298; http://dx.doi.org/10.1016/j.tibs.2010.09.002,OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
Nucleic Acids Res 2012; 40:e119; PMID:22844090; http://dx.doi.org/10.1093/nar/gks701 40.,OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
Crit Rev Eukaryot Gene Expr 2000; 10:179-212; PMID:11186332; http://dx.doi.org/10.1615/CritRevEukarGeneExpr.v10.i2.60 42.,Non-OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
Nat Rev Genet 2001; 2:292-301; PMID:11283701; http://dx.doi.org/10.1038/35066075 43.,OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
Chromosome Res 2001; 9:77-80; PMID:11272795; http://dx.doi.org/10.1023/A:1026799818566 44.,OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
Adv Enzyme Regul 2005; 45:17-26; PMID:16139341; http://dx.doi.org/10.1016/j.adven - zreg.2005.02.013 45.,OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
Chromosome Res 2006; 14:707-33; PMID:17115328; http://dx.doi.org/10.1007/s10577-006-1086-x 46.,OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
Nature 2012; 485:381-5; PMID:22495304; http://dx.doi.org/10.1038/nature11049 47.,Non-OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
Nature 2012; 485:376-80; PMID:22495300; http://dx.doi.org/10.1038/nature11082 48.,Non-OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
Cell 2012; 148:458-72; PMID:22265598; http://dx.doi.org/10.1016/j.cell.2012.01.010 49.,OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
Nat Methods 2008; 5:695-702; PMID:18641657; http://dx.doi.org/10.1038/nmeth.123726.,OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
J Cell Biol 1999; 144:813-21; PMID:10085283; http://dx.doi.org/10.1083/jcb.144.5.813 27.,OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
PLoS One 2009; 4:e5041; PMID:19347038; http://dx.doi.org/10.1371/journal.pone.0005041 28.,Non-OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
EMBO J 2009; 28:3785-98; PMID:19927119; http://dx.doi.org/10.1038/emboj.2009.340 29.,Non-OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
J Mol Biol 2003; 334:229-40; PMID:14607115; http://dx.doi.org/10.1016/j.jmb.2003.08.063 30.,OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
Biochem Cell Biol 2003; 81:91-9; PMID:12897842; http://dx.doi.org/10.1139/o03-037 31.,Non-OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
Biochim Biophys Acta 2008; 1783:2061-79; PMID:18722483; http://dx.doi.org/10.1016/j.bbam - cr.2008.07.022 32.,OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
J Chem Phys 2009; 131:064905; PMID:19691409; http://dx.doi.org/10.1063/1.3205100 33.,Non-OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
Chromosome Res 2011; 19:63-81; PMID:21116704; http://dx.doi.org/10.1007/s10577-010-9168-1 34.,OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
Trends Cell Biol 2009; 19:555-65; PMID:19836954; http://dx.doi.org/10.1016/j.tcb.2009.09.003 35.,OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
J Cell Biol 2001; 153:1341-53; PMID:11425866; http://dx.doi.org/10.1083/jcb.153.7.1341 37.,Non-OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
Nat Methods 2008; 5:159-61; PMID:18176568; http://dx.doi.org/10.1038/nmeth1171 38.,OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
Phys Biol 2007; 4:220-7; PMID:17928660; http://dx.doi.org/10.1088/1478-3975/4/3/00812.,Non-OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
EMBO J 2012; 31:1644-53; PMID:22343941; http://dx.doi.org/10.1038/emboj.2012.35 13.,Non-OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
Nucleus 2012; 3:404-10; PMID:22825571; http://dx.doi.org/10.4161/nucl.21222 14.,OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
EMBO Rep 2012; 13:992-6; PMID:22986547; http://dx.doi.org/10.1038/embor.2012.139 15.,Non-OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
Chromosoma 2013; PMID:23818178; http://dx.doi.org/10.1007/s00412-013-0423-z 16.,Non-OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
Laser & Photonics Reviews 2011; 5:52-67; http://dx.doi.org/10.1002/lpor.200910041 18.,OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
Biophys J 2001; 80:2396-408; PMID:11325739; http://dx.doi.org/10.1016/S0006-3495(01)76209-1 19.,OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
EMBO J 2000; 19:892-901; PMID:10698931; http://dx.doi.org/10.1093/emboj/19.5.892 20.,Non-OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
Nat Cell Biol 2000; 2:168-72; PMID:10707088; http://dx.doi.org/10.1038/35004044 21.,OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
J Chem Phys 2008; 129:054112; PMID:18698893; http://dx.doi.org/10.1063/1.2958287 23.,Non-OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
Cell Rep 2012; 2:1645-56; PMID:23246002; http://dx.doi.org/10.1016/j.celrep.2012.11.008 24.,OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
Biophys J 2006; 91:3921-36; PMID:16950841; http://dx.doi.org/10.1529/bio - physj.105.079467 25.,OADS,/arxiv_data1/oa_pdf/ef/2e/nucl-4-349.PMC3899123.pdf
"www.landesbioscience.com  Nucleus  361Nucleus 4:5, 361–366; September/Oc tober 2013; © 2013 Landes Bioscience EXTRA  VIEW EXTRA  VIEW Keywords:  genome architecture, chro - mosome dynamics, homologous recom - bination, polymer physics, computational  model, nucleolus, chromosome structure, DNA repair, budding yeast, chromosome conformation capture Submitted: 07/22/13Accepted: 08/20/13http://dx.doi.org/10.4161/nucl.26226 *Correspondence to: Christophe Zimmer;   Email: czimmer@pasteur.frbiological functions including gene  expression and dna  rep air are  affected by the 3 d arc hitecture of the  genome, but the underlying mechanisms are still unknown.",Non-OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
Curr Biol 2012; 22:1881-90; PMID:22940469; http://dx.doi.org/10.1016/j.cub.2012.07.069,OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
Nat Rev Genet 2001; 2:292-301; PMID:11283701; http://dx.doi.org/10.1038/35066075 2.,OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
Semin Cancer Biol 2007; 17:80-90; PMID:17137790; http://dx.doi.org/10.1016/j.sem - cancer.2006.10.008 3.,Non-OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
Nat Biotechnol 2011; 29:1109-13; PMID:22101486; http://dx.doi.org/10.1038/nbt.2049 4.,Non-OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
Development 2005; 132:2215-23; PMID:15829525; http://dx.doi.org/10.1242/dev.01813 5.,OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
Nat Rev Mol Cell Biol 2010; 11:317-28; PMID:20414256; http://dx.doi.org/10.1038/nrm28946.,OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
Nat Genet 2004; 36:1065-71; PMID:15361872; http://dx.doi.org/10.1038/ng1423 7.,Non-OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
J Cell Biol 2011; 192:723-33; PMID:21383075; http://dx.doi.org/10.1083/jcb.201010058 8.,OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
Cold Spring Harb Perspect Biol 2010; 2:a000612; PMID:20554704; http://dx.doi.org/10.1101/cshperspect.a000612 9.,Non-OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
Mol Plant 2010; 3:678-90; PMID:20601371; http://dx.doi.org/10.1093/mp/ssq034 10.,OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
Nature 1998; 394:592-5; PMID:9707122; http://dx.doi.org/10.1038/2910011.,Non-OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
Nature 2006; 441:770-3; PMID:16760982; http://dx.doi.org/10.1038/nature04752 12.,OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
Nature 2006; 441:774-8; PMID:16760983; http://dx.doi.org/10.1038/nature04845 13.,Non-OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
J Cell Biol 2006; 172:189-99; PMID:16418532; http://dx.doi.org/10.1083/jcb.200505159 14.,OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
Nat Cell Biol 2013; 15:694-9; PMID:23644470; http://dx.doi.org/10.1038/ncb2745,OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
PLoS Comput Biol 2008; 4:e1000153; PMID:18725929; http://dx.doi.org/10.1371/journal.pcbi.1000153 36.,Non-OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
Nat Rev Genet 2008; 9:27-37; PMID:18040271; http://dx.doi.org/10.1038/nrg2224 38.,OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
Biophys J 2012; 102:296-304; PMID:22339866; http://dx.doi.org/10.1016/j.bpj.2011.12.005 39.,OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
Genome Res 2012; 22:1295-305; PMID:22619363; http://dx.doi.org/10.1101/gr.129437.111 40.,OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
Nucleus 2012; 3:370-83; PMID:22688649; http://dx.doi.org/10.4161/nucl.20971 41.,OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
Fungal Genet Biol 2009; 46:879-86; PMID:19628047; http://dx.doi.org/10.1016/j.fgb.2009.07.006 42.,OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
J Cell Biol 2005; 168:375-87; PMID:15684028; http://dx.doi.org/10.1083/jcb.200409091 43.,OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
Curr Opin Cell Biol 2007; 19:305-10; PMID:17467257; http://dx.doi.org/10.1016/j.ceb.2007.04.012 44.,OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
Curr Opin Cell Biol 2011; 23:338-45; PMID:21292462; http://dx.doi.org/10.1016/j.ceb.2011.01.00124.,OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
Mol Cell Biol 2008; 28:4576-87; PMID:18474615; http://dx.doi.org/10.1128/MCB.00127-08 25.,Non-OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
Nat Methods 2008; 5:1031-7; PMID:18978785; http://dx.doi.org/10.1038/nmeth.1266 26.,OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
Science 2009; 326:289-93; PMID:19815776; http://dx.doi.org/10.1126/science.1181369 29.,Non-OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
Biophys J 2010; 98:2410-9; PMID:20513384; http://dx.doi.org/10.1016/j.bpj.2010.01.054 30.,OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
J Cell Biol 2013; 202:201-10; PMID:23878273; http://dx.doi.org/10.1083/jcb.201208186 31.,Non-OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
Science 2001; 294:2181-6; PMID:11739961; http://dx.doi.org/10.1126/science.1065366 32.,OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
Curr Biol 1997; 7:930-9; PMID:9382846; http://dx.doi.org/10.1016/S0960-9822(06)00412-X 33.,OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
Genes Dev 2012; 26:369-83; PMID:22345518; http://dx.doi.org/10.1101/gad.176156.11115.,OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
Nat Cell Biol 2012; 14:502-9; PMID:22484486; http://dx.doi.org/10.1038/ncb2465 16.,OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
Nat Cell Biol 2012; 14:510-7; PMID:22484485; http://dx.doi.org/10.1038/ncb2472 17.,OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
Curr Biol 2012; 22:1881-90; PMID:22940469; http://dx.doi.org/10.1016/j.cub.2012.07.069 18.,OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
Nucleus 2012; 3:404-10; PMID:22825571; http://dx.doi.org/10.4161/nucl.21222 19.,OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
J Biol Chem 2008; 283:34532-40; PMID:18930918; http://dx.doi.org/10.1074/jbc.M806479200 20.,OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
Curr Biol 2002; 12:2076-89; PMID:12498682; http://dx.doi.org/10.1016/S0960-9822(02)01338-6 21.,OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
Chromosoma 1999; 108:103-13; PMID:10382072; http://dx.doi.org/10.1007/s004120050357 22.,Non-OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
Nature 2010; 465:363-7; PMID:20436457; http://dx.doi.org/10.1038/nature08973,Non-OADS,/arxiv_data1/oa_pdf/14/df/nucl-4-361.PMC3899125.pdf
"The c hanges  that occur to the player’s structure are not to the extent that arms or legs are removed—albeit sometimes they are broken—but rather the spatial arrangement differs from minute to minute *Correspondence to: Justin M O’Sullivan;   Email: justin.osullivan@auckland.ac.nz Submitted: 07/23/2013; Revised: 09/12/2013; Accepted: 09/17/2013http://dx.doi.org/10.4161/nucl.26513The statistical-mechanics   of chromosome conformation capture Justin M O’Sullivan1,*, Michael D Hendy2, Tatyana Pichugina1, Graeme C Wake3, and Jörg Langowski4 1Liggins Institute; University of Auckland; Auckland, New Zealand; 2Mathematics and Statistics; University of Otago; Dunedin, New Zealand; 3Institute of Natural and  Mathematical Sciences; Massey University; Auckland, New Zealand; 4Deutsches Krebsforschungszentrum; Biophysics of Macromolecules; Heidelberg, Germany Keywords:  chromosome conformation capture, chromosome organization, proximity ligation, genome organization abbrev iations: 3C, chromosome conformation capture; 3D, three dimensional Since Jacob and Monod’s characterization of the role of  DNA elements in gene control, it has been recognized that the  linear organization of genome structure is important for the regulation of gene transcription and hence the manifestation of phenotypes.",Non-OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
"For example at  the moment captured in figu re 1a the pl ayer’s (i.e., Ma’a Nonu)  right hand is positioned next to his head as he participates in a ritualized challenge (e.g., haka; http://www.allblacks.com/index.cfm?layout=haka) performed at the beginning of the game.",Non-OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
PLoS Biol 2005; 3:e157; PMID:15839726 ;  http://dx.doi.org/10.1371/journal.pbio.0030157 2.,Non-OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Nat Methods 2008; 5:1031-7; PMID:18978785 ; http://dx.doi.org/10.1038/ nmeth.1266 4.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Mol Cell 2011; 44:252-64; PMID:22017872 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Nucleic Acids Res 2013; 41:6058-71;  PMID:23632166 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Fungal Genet Biol 2009; 46:879-86;  PMID:19628047 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Cell 2012; 148:908-21;  PMID:22341456 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Science 2009; 326:289-93;  PMID :19815776 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Nat Genet 2006; 38:1348-54; PMID:17033623 ; http://dx.doi.org/10.1038/ng189613.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Curr Opin Genet Dev 2012; 22:125-31; PMID:22265226 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Semin Cell Dev Biol 2012; 23:213-21; PMID:22120510 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Science 2002; 295:1306-11;  PMID:11847345 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
PLoS One 2012; 7:e30943; PMID:22292080 ; http://dx.doi.org/10.1371/jour- nal.pone.0030943 18.,Non-OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
PLoS One 2011; 6:e29267; PMID:22206006 ; http://dx.doi.org/10.1371/jour- nal.pone.0029267 19.,Non-OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Nature 2012; 485:376-80; PMID:22495300 ;  http://dx.doi.org/10.1038/nature11082 20.,Non-OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Nat Biotechnol 2012; 30:90-8; PMID:22198700 ; http://dx.doi.org/10.1038/ nbt.2057,Non-OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Nucleus 2012; 3:370-83;  PMID:22688649 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Nat Struct Mol Biol 2011; 18:107-14; PMID:21131981 ;  http://dx.doi.org/10.1038/nsmb.1936 23.,Non-OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Semin Cell Dev Biol 2007; 18:659-67;  PMID:17936653 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Genome Biol 2004; 5:R44;  PMID :15239829 ; http://dx.doi.org/10.1186/ gb-2004-5-7-r44 27.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Genome Biol 2009; 10:R37; PMID:19374771 ;  http://dx.doi.org/10.1186/gb-2009-10-4-r37 28.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Cell Stem Cell 2013; 13:30-5;  PMID:23747202 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Science 2013; 340:1234167;  PMID:23744951 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Curr Opin Genet Dev 1997; 7:259-63; PMID:9115425 ; http://dx.doi.org/10.1016/ S0959-437X(97)80136-0 32.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
"J Cell Sci 2009; 122:577-86; PMID:19225124 ; http://dx.doi.org/10.1242/ jcs.037622 33.  de Laa t W, Dekker J.",OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Methods 2012; 58:189-91; PMID:23199640 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Annu Rev Genomics Hum Genet 2012; 13:59-82; PMID:22703176 ; http://dx.doi.org/10.1146/ annurev-genom-090711-163818 36.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Nature 2007; 450:683-94;  PMID:18046405 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
"Nucleic Acids Res 2013; 41:2191-201; PMID:23303780 ;  http://dx.doi.org/10.1093/nar/gks1360 38.  de Laa t W, Grosveld F. Spatial organization of gene  expression: the active chromatin hub.",OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
EMBO J 1999; 18:2241-53;  PMID:10205177 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Mol Biol Cell 1998; 9:1523-36; PMID:9614191 ; http://dx.doi.org/10.1091/ mbc.9.6.1523 43.,Non-OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Science 2011; 333:1445-9; PMID:21903814 ; http://dx.doi.org/10.1126/ science.1204697 45.,Non-OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Nucleic Acids Res 2013; 41:3563-75; PMID:23396278 ; http://dx.doi.org/10.1093/nar/ gkt067 46.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
EMBO J 1999; 18:6630-41; PMID:10581237 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
PLoS One 2013; 8:e60403; PMID:23555968 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Nat Genet 2011; 43:1059-65;  PMID:22001755 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Nucleic Acids Res 1983; 11:7853-71;  PMID:6359064 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Methods 2012; 58:192-203; PMID:22903059 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Mol Cell Biol 2005; 25:3220-31; PMID :15798207 ; http://dx.doi.org/10.1128/ MCB.25.8.3220-3231.2005 54.,Non-OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Protein Eng Des Sel 2013; 26:471-8; http://dx.doi.org/10.1093/protein/gzt024 ; PMID:23754529 57.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Annu Rev  Biophys Biophys Chem 1988; 17:265-86;   PMID:3293588 ; http://dx.doi.org/10.1146/annurev.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Proc Natl Acad Sci U S A 1981; 78:4833-7; PMID:6272277 ; http://dx.doi.org/10.1073/ pnas.78.8.4833 59.,Non-OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Science 2012; 337:1097-101; PMID:22936778 ; http://dx.doi.org/10.1126/ science.1224139 60.,Non-OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
J Cell Sci 2004; 117:4025-32; PMID :15316078 ; http://dx.doi.org/10.1242/ jcs.01363 61.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Genome Biol 2011; 12:R18;  PMID:21338519 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Nucleic Acids Res 2012; 40:e72; PMID:22323520 ;  http://dx.doi.org/10.1093/nar/gks001 63.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Nucleic Acids Res 2008; 36:e105; PMID :18660515 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
BMC Genomics 2010; 11:464;  PMID:20691090 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Front Zool 2008; 5:12; PMID:18638418 ;  http://dx.doi.org/10.1186/1742-9994-5-12,Non-OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Proc Biol Sci 2012; 279:5048-57; PMID :22977152 ;  http://dx.doi.org/10.1098/rspb.2012.1108 69.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Genome Res 2012; 22:1295-305;  PMID:22619363 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Nucleus 2013; 4:216-28; PMID:23674068 ; http://dx.doi.org/10.4161/ nucl.24875 71.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Nucleic Acids Res 2012; 40:972-80; PMID:21976727 ; http://dx.doi.org/10.1093/nar/ gkr77972.,OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
Nat Protoc 2007; 2:988-1002; PMID:17446898 ; http://dx.doi.org/10.1038/ nprot.2007.116,Non-OADS,/arxiv_data1/oa_pdf/ee/67/nucl-4-390.PMC3899129.pdf
"Human Vaccines & Immunotherapeutics 9:5, 1032–1038; May 2013; © 2013 Landes Bioscience CoMMentary 1032 Human Vaccines & Immunotherapeutics Volume 9 Issue 5Keywords:  autoimmune disease,   experimental autoimmune encephalomy - elitis, immune, multiple sclerosis, myelin,  neuroantigen, T lymphocytes, therapy, tolerance, vaccine Abbreviations:  CFA, complete Freund’s  adjuvant; CNS, central nervous system;  EAE, experimental autoimmune enceph - alomyelitis; GM-CSF, granulocyte-mac - rophage colony stimulating factor; MBP, myelin basic protein; MOG, myelin oligodendrocyte glycoprotein; MS, mul - tiple sclerosis; NAg, neuroantigen; PLP, proteolipid protein Submitted: 01/12/13Accepted: 01/20/13http://dx.doi.org/10.4161/hv.23685 *Correspondence to: Mark D. Mannie;   Email: manniem@ecu.eduTolerogenic vaccines represent a new  class of vaccine designed to re-estab - lish immunological tolerance, restore immune homeostasis, and thereby reverse autoimmune disease.",Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
Mol Immunol 2011; 48:1332- 7; PMID:21146219; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
Semin Immunopathol  2010; 32:197-209; PMID:20237782; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
Adv Immunol 2008; 98:121-49; PMID:18772005;  http://dx.doi.org/10.1016/S0065-2776(08)00404-5.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
J  Neuroimmunol 2007; 191:79-85; PMID:17920696;  http://dx.doi.org/10.1016/j.jneuroim.2007.09.011.,OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
Neurol Res 2006; 28:256-61; PMID:16687050; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
Curr Drug Targets Inflamm Allergy 2005; 4:239-45; PMID:15853746; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
J Neurol  2012; 259:1375-82; PMID:22222856; http://dx.doi.org/10.1007/s00415-011-6361-x.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
Front Immunol 2012;  3:255; PMID:22934095; http://dx.doi.org/10.3389/ fimmu.2012.00255.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
Nat Biotechnol 2012; 30:1217- 24; PMID:23159881; http://dx.doi.org/10.1038/ nbt.2434.,OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
Gene Ther 2012; PMID:22951454; http://dx.doi.org/10.1038/ gt.2012.73.,OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
PLoS One  2011; 6:e27860; PMID:22140475; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
J Immunol  2011; 187:2405-17; PMID:21821796; http://dx.doi.org/10.4049/jimmunol.1004175.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
J Autoimmun 2010; 35:107-13;  PMID:20579844; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
J Interferon  Cytokine Res 2011; 31:907-16; PMID:21936633;  http://dx.doi.org/10.1089/jir.2011.0072.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
Pathophysiology 2011; 18:21-9; PMID:20537877; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
APMIS  2011; 119:819-30; PMID:22085358; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
Prog Neurobiol 2010; 92:386-404;  PMID:20558237; http://dx.doi.org/10.1016/j.pneu - robio.2010.06.005.,OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
Bettelli E. Building different mouse models for human MS. Ann N Y Acad Sci 2007; 1103:11- 8; PMID:17376825; http://dx.doi.org/10.1196/ annals.1394.021.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
Brain 2006; 129:1953-71; PMID:16632554; http://dx.doi.org/10.1093/brain/awl075.MS.,OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
J Exp Med  2002; 196:1627-38; PMID:12486105; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
Front Immunol 2011; 2:39; PMID:22566829; http://dx.doi.org/10.3389/fimmu.2011.00039.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
Autoimmun Rev 2011; 11:104-11; PMID:21875694; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
Clin Immunol 2012; 144:117-26; PMID:22717772; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
Autoimmun Rev  2009; 8:650-3; PMID:19393199; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
Ann Neurol 1999; 45:33-9; PMID:9894874; http://dx.doi.org/10.1002/1531- 8249(199901)45:1<33::AID-ART7>3.0.CO;2-G. 59.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
J Clin Invest  1998; 101:725-30; PMID:9466965; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
Clin Exp Immunol 1998; 111:186-92; PMID:9472680; http://dx.doi.org/10.1046/j.1365-2249.1998.00457.x.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
Ther Adv Neurol Disord 2012; 5:147-59; PMID:22590479; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
N Engl J Med  2012; 367:115-23; PMID:22784115; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
J Exp Med 2011; 208:81-90;  PMID:21220453; http://dx.doi.org/10.1084/ jem.20101574.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
Immunol Rev 2011; 241:228-40;  PMID:21488900; http://dx.doi.org/10.1111/j.1600- 065X.2011.01016.x.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
J Neuroimmune Pharmacol 2010; 5:176-88;  PMID:19904613; http://dx.doi.org/10.1007/s11481- 009-9181-3.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
BMC Immunol 2011; 12:72; PMID:22208499; http://dx.doi.org/10.1186/1471- 2172-12-72.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
J Leukoc Biol 2010; 87:509-21; PMID:20007248; http://dx.doi.org/10.1189/jlb.0709520.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
Eur J Clin Microbiol Infect Dis 1994;  13(Suppl 2):S47-53; PMID:7875153; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
Nat Med  2000; 6:1167-75; PMID:11017150; http://dx.doi.org/10.1038/80516.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
Front Immunol  2012; 3:233; PMID:22876246; http://dx.doi.org/10.3389/fimmu.2012.00233.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
Methods Mol  Biol 2011; 677:113-26; PMID:20941606; http://dx.doi.org/10.1007/978-1-60761-869-0_8.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
Eur J Immunol  2010; 40:2016-25; PMID:20405475; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
J Exp Med 2003; 198:737- 46; PMID:12939344; http://dx.doi.org/10.1084/ jem.20030686.24.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
Proc Natl Acad Sci U S A 2010;  107:17280-5; PMID:20855626; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
Curr Opin Immunol 2010; 22:609- 15; PMID:20850958; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
J Neuroimmunol  2010; 227:10-7; PMID:20580440; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
Immunity 2004; 20:695-705; PMID:15189735;  http://dx.doi.org/10.1016/j.immuni.2004.05.002.,OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
Immunity  2003; 19:317-28; PMID:14499108; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
Immunol Rev 2012; 245:227-38; PMID:22168423; http://dx.doi.org/10.1111/j.1600- 065X.2011.01076.x.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
J Neurol Neurosurg Psychiatry  2011; 82:1142-8; PMID:21836034; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
Curr Opin Neurol  2009; 22:201-6; PMID:19359987; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
Arthritis Res Ther 2008; 10:R119; PMID:18826638; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
Nat Med  2005; 11:335-9; PMID:15735651; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
J Exp Med 2012; 209:335-52; PMID:22312112;  http://dx.doi.org/10.1084/jem.20111485.,OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
PLoS One  2012; 7:e32562; PMID:22412888; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
Nat Genet 1999; 23:343-7;  PMID:10610182; http://dx.doi.org/10.1038/15525.268.,OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
J Autoimmun 2011; 37:122-8; PMID:21632210;  http://dx.doi.org/10.1016/j.jaut.2011.05.001.66.,OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
J Immunol 2009; 183:4067-76; PMID:19687098; http://dx.doi.org/10.4049/jim - munol.0801888.,Non-OADS,/arxiv_data1/oa_pdf/0d/dc/hvi-9-1032.PMC3899137.pdf
"Human Vaccines & Immunotherapeutics 9:5, 1142–1145; May 2013; © 2013 Landes Bioscience SHort report 1142 Human Vaccines & Immunotherapeutics Volume 9 Issue 5*Correspondence to: Federico Marchetti; Email: fem75838@gsk.com Submitted: 11/26/12; Revised: 01/18/13; Accepted: 01/26/13http://dx.doi.org/10.4161/hv.23795Pertussis (whooping cough) is still a major public health prob - lem,1 even in countries with high rates of vaccination coverage as  Italy.",Non-OADS,/arxiv_data1/oa_pdf/d7/cc/hvi-9-1142.PMC3899151.pdf
(available at http://ecdc.europa.eu/en/eurovaccine/Pages/call_posters.aspx - last accessed November 2012).Which lessons did we learn from this cocoon pilot experi - ence?,Non-OADS,/arxiv_data1/oa_pdf/d7/cc/hvi-9-1142.PMC3899151.pdf
Pediatr Infect Dis J 2005; 24:761-5; PMID:16148840; http://dx.doi.org/10.1097/01.,OADS,/arxiv_data1/oa_pdf/d7/cc/hvi-9-1142.PMC3899151.pdf
"ATTI della XII Conferenza Nazionale di Sanità  Pubblica, 2011; POSTER 758 page 528 (available at  http://www.siti2011.org/ita/; last accessed November  2012).",Non-OADS,/arxiv_data1/oa_pdf/d7/cc/hvi-9-1142.PMC3899151.pdf
Eur J Pediatr 2012; 171:1651-5; PMID:22790868; http://dx.doi.org/10.1007/s00431-012-1791-8.6.,Non-OADS,/arxiv_data1/oa_pdf/d7/cc/hvi-9-1142.PMC3899151.pdf
J Infect Dis 2000; 182:1409-16; PMID:11023464;  http://dx.doi.org/10.1086/315863.,OADS,/arxiv_data1/oa_pdf/d7/cc/hvi-9-1142.PMC3899151.pdf
J Infect Dis 2001; 183:1353-9; PMID:11294666; http://dx.doi.org/10.1086/319853.,OADS,/arxiv_data1/oa_pdf/d7/cc/hvi-9-1142.PMC3899151.pdf
Clin Infect Dis 2010; 50:1339-45; PMID:20370464;  http://dx.doi.org/10.1086/652281.,Non-OADS,/arxiv_data1/oa_pdf/d7/cc/hvi-9-1142.PMC3899151.pdf
Pediatr Infect Dis J 2007; 26:293- 9; PMID:17414390; http://dx.doi.org/10.1097/01.,OADS,/arxiv_data1/oa_pdf/d7/cc/hvi-9-1142.PMC3899151.pdf
Med Mal Infect  2008; 38:477-82; PMID:18715731; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/cc/hvi-9-1142.PMC3899151.pdf
Vaccine 2007; 25:2634-42; PMID:17280745; http://dx.doi.org/10.1016/j.vac- cine.2006.12.017.,Non-OADS,/arxiv_data1/oa_pdf/d7/cc/hvi-9-1142.PMC3899151.pdf
Arch Pediatr 2011; 18:362- 9; PMID:21353770; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d7/cc/hvi-9-1142.PMC3899151.pdf
Pediatr Infect Dis J 2012; 31:1304- 7; PMID:22863911; http://dx.doi.org/10.1097/ INF .0b013e31826b7110.21.,OADS,/arxiv_data1/oa_pdf/d7/cc/hvi-9-1142.PMC3899151.pdf
Clin Infect  Dis 2012; 54:78-84; PMID:22075790; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/cc/hvi-9-1142.PMC3899151.pdf
Clin Infect Dis 2011; 52:157-62; PMID:21288837;  http://dx.doi.org/10.1093/cid/ciq001.,OADS,/arxiv_data1/oa_pdf/d7/cc/hvi-9-1142.PMC3899151.pdf
Gynecol Obstet Fertil 2010; 38:380-4; PMID:20576545;  http://dx.doi.org/10.1016/j.gyobfe.2010.04.002.,Non-OADS,/arxiv_data1/oa_pdf/d7/cc/hvi-9-1142.PMC3899151.pdf
Clin Ther  2010; 32:1479-95; PMID:20728761; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d7/cc/hvi-9-1142.PMC3899151.pdf
Vaccine 2012; 30:5472-81;  PMID:22771510; http://dx.doi.org/10.1016/j.vac- cine.2012.06.071.,Non-OADS,/arxiv_data1/oa_pdf/d7/cc/hvi-9-1142.PMC3899151.pdf
"www.landesbioscience.com Human Vaccines & Immunotherapeutics 1153Human Vaccines & Immunotherapeutics 9:5, 1153–1157; May 2013; © 2013 Landes Bioscience SHort report SHort report *Correspondence to: Kumanan Wilson; Email: kwilson@ohri.ca Submitted: 10/05/12; Revised: 12/13/12; Accepted: 01/08/13http://dx.doi.org/10.4161/hv.23533Introduction In Ontario, Canada, the routine pediatric immunization sched - ule includes vaccines against diphtheria, pertussis, tetanus, polio,  hemophilus influenzae type b (Hib) and pneumococcus admin - istered at 2, 4 and 6 mo of age, and vaccines against measles, mumps and rubella (MMR vaccine) and meningococcal disease (type C) administered at 12 mo of age.",Non-OADS,/arxiv_data1/oa_pdf/3a/27/hvi-9-1153.PMC3899153.pdf
J Comp Pathol 2007; 137(Suppl 1):S46- 50; PMID:17559869; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3a/27/hvi-9-1153.PMC3899153.pdf
PLoS One 2011;  6:e27897; PMID:22174753; http://dx.doi.org/10.1371/ journal.pone.0027897.,Non-OADS,/arxiv_data1/oa_pdf/3a/27/hvi-9-1153.PMC3899153.pdf
Pediatrics 2000; 106:E62; PMID:11061799; http://dx.doi.org/10.1542/ peds.106.5.e62.,Non-OADS,/arxiv_data1/oa_pdf/3a/27/hvi-9-1153.PMC3899153.pdf
Hum  Vaccin Immunother 2012; 8:592-5; PMID:22634444;  http://dx.doi.org/10.4161/hv.19377.,Non-OADS,/arxiv_data1/oa_pdf/3a/27/hvi-9-1153.PMC3899153.pdf
Am J Epidemiol 2012; 176:1035- 42; PMID:23118103; http://dx.doi.org/10.1093/aje/ kws167.,Non-OADS,/arxiv_data1/oa_pdf/3a/27/hvi-9-1153.PMC3899153.pdf
CMAJ  2006; 174:177-83; PMID:16415462; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3a/27/hvi-9-1153.PMC3899153.pdf
Am J Public Health 1992;  82:816-20; PMID:1585961; http://dx.doi.org/10.2105/ AJPH.82.6.816.,Non-OADS,/arxiv_data1/oa_pdf/3a/27/hvi-9-1153.PMC3899153.pdf
Br Med J 1975;  3:522; PMID:1080682; http://dx.doi.org/10.1136/ bmj.3.5982.522.,Non-OADS,/arxiv_data1/oa_pdf/3a/27/hvi-9-1153.PMC3899153.pdf
Nat Rev Immunol 2008;  8:737-44; PMID:18728636; http://dx.doi.org/10.1038/ nri2394.,Non-OADS,/arxiv_data1/oa_pdf/3a/27/hvi-9-1153.PMC3899153.pdf
J  Nutr 2009; 139:2154S-218S; PMID:19793845; http://dx.doi.org/10.3945/jn.109.105312.,OADS,/arxiv_data1/oa_pdf/3a/27/hvi-9-1153.PMC3899153.pdf
Vaccine  2012; 30:6115-20; PMID:22709951; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3a/27/hvi-9-1153.PMC3899153.pdf
Lancet 1995; 345:567-9; PMID:7619183; http://dx.doi.org/10.1016/ S0140-6736(95)90471-9.,Non-OADS,/arxiv_data1/oa_pdf/3a/27/hvi-9-1153.PMC3899153.pdf
Stat Med 2006; 25:1768-97; PMID:16220518;  http://dx.doi.org/10.1002/sim.2302.,OADS,/arxiv_data1/oa_pdf/3a/27/hvi-9-1153.PMC3899153.pdf
Vaccine 2011; 29:3746- 52; PMID:21443964; http://dx.doi.org/10.1016/j.vac- cine.2011.03.044.,Non-OADS,/arxiv_data1/oa_pdf/3a/27/hvi-9-1153.PMC3899153.pdf
Ann Emerg  Med 1999; 34:155-9; PMID:10424915; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3a/27/hvi-9-1153.PMC3899153.pdf
Epidemiology 2005; 16:526- 31; PMID:15951671; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/3a/27/hvi-9-1153.PMC3899153.pdf
"4-11 It is caused by the TBE virus (TBEV)2-13 belonging to  *Correspondence to: Daniela Amicizia; Email: daniela.amicizia@unige.it Submitted: 11/28/12; Revised: 01/21/13; Accepted: 01/28/13http://dx.doi.org/10.4161/hv.23802Tick-borne Encephalitis (TBE), which is caused by a Flavivirus,  is the most common tick-transmitted disease in Central and Eastern Europe and Russia.",Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Ticks Tick Borne Dis 2011; 2:2-15; PMID:21771531;  http://dx.doi.org/10.1016/j.ttbdis.2010.10.007.,OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Med Mal Infect 2004;  34(Suppl 1):S28-30; PMID:15676240; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
J Gen Virol  2009; 90:1781-94; PMID:19420159; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Available at: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Clin Infect Dis 1999; 28:882-90; PMID:10825054;  http://dx.doi.org/10.1086/515195.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Rev Med Virol 2012; 22:69-87;  PMID:22086854; http://dx.doi.org/10.1002/rmv.712.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Available at: http://www.ictvonline.org/virusTaxonomy.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
J Med Virol 2010; 82:965- 76; PMID:20419810; http://dx.doi.org/10.1002/ jmv.21765.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Available at: http://unstats.un.org/unsd/methods/ m49/m49regin.htm.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Microbes Infect 2008; 10:209-16;  PMID:18316221; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
J Med  Virol 2001; 65:730-5; PMID:11745938; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Emerg Infect Dis  2006; 12:1568-71; PMID:17176574; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Emerg Infect Dis  2007; 13:1215-8; PMID:17953095; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Med Vet  Entomol 2012; In press; PMID:22924442; http://dx.doi.org/10.1111/j.1365-2915.2012.01037.x.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Brain 1999; 122:2067-78; PMID:10545392; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Antiviral Res 2003; 57:129-46;  PMID:12615309; http://dx.doi.org/10.1016/S0166- 3542(02)00206-1.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Vaccine 2003; 21(Suppl 1):S62-5; PMID:12628816; http://dx.doi.org/10.1016/ S0264-410X(02)00818-6.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Available at: http://www.governoitalia- no.it/backoffice/allegati/67507-7587.pdf.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Available at: http://data.euro.who.int/ cisid/?TabID=290643.,OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Available at: http://rospotrebnadzor.ru/c/journal/ view_article_content?groupId=10156&articleId=3008 58&version=1.0.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
"Available at: http://www.who.int/immu- nization/sage/SAGE_April_2011_tbe_Kollaritsch.pdf  Accessed: January 3, 2013.",Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Vaccine 2003; 21(Suppl 1):S41-9;  PMID:12628813; http://dx.doi.org/10.1016/S0264- 410X(02)00814-9.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Expert Rev Vaccines 2005;  4:747-55; PMID:16221075; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Hum Vaccin 2009; 5:551-6; PMID:19430202;  http://dx.doi.org/10.4161/hv.5.8.8571.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Vaccine 2009; 27:1661-6;  PMID:18940221; http://dx.doi.org/10.1016/j.vac- cine.2008.10.003.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Vaccine 2003; 22:217-23;  PMID:14615149; http://dx.doi.org/10.1016/S0264- 410X(03)00563-2.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Vaccine 2010; 28:4680-5; PMID:20433803;  http://dx.doi.org/10.1016/j.vaccine.2010.04.047.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Vaccine  2011; 29:7307-19; PMID:21843576; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Eur J Neurol 2012; 19:62-8; PMID:21615626;  http://dx.doi.org/10.1111/j.1468-1331.2011.03434.x.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Parasit  Vectors 2012; 5:177; PMID:22913287; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Scand J Infect Dis 2003; 35:354-7; PMID:12875531;  http://dx.doi.org/10.1080/00365540310005305.,OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Vaccine 2011; 29:5178-83; PMID:21620916;  http://dx.doi.org/10.1016/j.vaccine.2011.05.033.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
PLoS  One 2009; 4:e4336; PMID:19183811; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Vector Borne Zoonotic Dis 2007;  7:611-5; PMID:18171108; http://dx.doi.org/10.1089/vbz.2007.0107.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Vaccine 2011; 29:4556-64;  PMID:21549781; http://dx.doi.org/10.1016/j.vac- cine.2011.04.061.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Available at: http://venice.cineca.org/ final_report_TBE_19-01-2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Available at: http://www.moz.gov.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Parasit Vectors 2012; 5:184;  PMID:22937961; http://dx.doi.org/10.1186/1756-3305-5-184.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
J Gen Virol 2010; 91:2706-12; PMID:20660147;  http://dx.doi.org/10.1099/vir.0.023663-0.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Emerg Infect Dis 2006; 12:1136- 8; PMID:16836835; http://dx.doi.org/10.3201/ eid1207.051567.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Vaccine 2003; 21(Suppl 1):S50-5; PMID:12628814; http://dx.doi.org/10.1016/S0264-410X(02)00813-7.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
T ravel Med Infect  Dis 2008; 6:380-3; PMID:18984485; http://dx.doi.org/10.1016/j.tmaid.2008.06.004.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Wien Med Wochenschr 2012; 162:230-8; PMID:22699708; http://dx.doi.org/10.1007/s10354- 012-0100-5.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
J Med Virol 2011; 83:853-63; PMID:21412794;  http://dx.doi.org/10.1002/jmv.21993.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
T ravel Med Infect Dis 2010; 8:233- 45; PMID:20970726; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Int J Med Microbiol 2006; 296(Suppl 40):76- 9; PMID:16530480; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Wien Med Wochenschr 2007; 157:228- 32; PMID:17564770; http://dx.doi.org/10.1007/ s10354-007-0424-8.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Emerg Infect  Dis 2013; 19:69-76; PMID:23259984; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Vaccine 2012;  30:6301-6; PMID:22885012; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Vaccine 2011; 29:1355-6; PMID:21199705;  http://dx.doi.org/10.1016/j.vaccine.2010.12.048.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Vaccine  2011; 29:8769-70; PMID:21777636; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Vaccine 2007; 25:895- 901; PMID:17011677; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Vaccine 1999; 17:1532-9; PMID:10195790;  http://dx.doi.org/10.1016/S0264-410X(98)00360-0.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Vaccine 2012; 30:1165-9;  PMID:22178103; http://dx.doi.org/10.1016/j.vac- cine.2011.12.013.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Vaccine 2001; 19:4774-9;  PMID:11535329; http://dx.doi.org/10.1016/S0264-410X(01)00218-3.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
J Infect Dis 2011; 203:1556-64;  PMID:21592984; http://dx.doi.org/10.1093/infdis/ jir122.90.,OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Int J Med Microbiol 2006; 296(Suppl 1):213- 4; http://dx.doi.org/10.1016/j.ijmm.2006.01.019.,OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Vaccine 2003; 21:3584-92; PMID:12922086; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Vaccine 2009; 27:853-6; PMID:19071180;  http://dx.doi.org/10.1016/j.vaccine.2008.11.082.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Vaccine  2003; 21:738-41; PMID:12531352; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Hum Vaccin 2007;  3:42-7; PMID:17297298; http://dx.doi.org/10.4161/ hv.3.2.3747.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Vaccine 2004; 22:2743-9;  PMID:15246606; http://dx.doi.org/10.1016/j.vac-cine.2004.01.041.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
Hum Vaccin  Immunother 2012; 8:736-42; PMID:22699436;  http://dx.doi.org/10.4161/hv.20058.,Non-OADS,/arxiv_data1/oa_pdf/58/ba/hvi-9-1163.PMC3899155.pdf
"www.landesbioscience.com Human Vaccines & Immunotherapeutics 1177Human Vaccines & Immunotherapeutics 9:5, 1177–1184; May 2013; © 2013 Landes Bioscience CoMMentary CoMMentary Keywords:  herpes zoster, postherpectic  neuralgia, vaccination, cost-effectiveness,  burden of illness Submitted: 12/21/12Accepted: 01/04/13http://dx.doi.org/10.4161/hv.23491 *Correspondence to: Mélanie Drolet;   Email: melanie.drolet@uresp.ulaval.caAlthough progress has been made in  the treatment of herpes zoster (HZ)  and postherpetic neuralgia (PHN), avail - able therapeutic options are only partially effective.",Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
N Engl J Med  1983; 309:1434-40; PMID:6195526; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
N Engl J Med 2002; 347:340-6;  PMID:12151472; http://dx.doi.org/10.1056/ NEJMcp013211.,OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Rev Med Virol 1997; 7:131-43; PMID:10398478; http://dx.doi.org/10.1002/(SICI)1099- 1654(199709)7:3<131::AID-RMV198>3.0.CO;2-7.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Pain 1996; 67:241-51;  PMID:8951917; http://dx.doi.org/10.1016/0304- 3959(96)03122-3.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
J Pain 2004; 5:344-56; PMID:15336639; http://dx.doi.org/10.1016/j.jpain.2004.06.001.,OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Drugs Aging 2008;  25:991-1006; PMID:19021299; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Med Mal Infect 2012; 42:53-8; PMID:22169279; http://dx.doi.org/10.1016/j.med - mal.2011.11.001.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Curr Med Res Opin 2012; 28:937-51;  PMID:22551228; http://dx.doi.org/10.1185/030079 95.2012.690339.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Lancet Neurol  2008; 7:1106-12; PMID:18977178; http://dx.doi.org/10.1016/S1474-4422(08)70228-X.and its efficacy at reducing the burden  of illness due to HZ and the incidence of PHN have been clearly demonstrated in large placebo-controlled trials.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
CMAJ  2010; 182:1731-6; PMID:20921251; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
BMC  Med 2010; 8:37; PMID:20565946; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Vaccine  2006; 24:1308-14; PMID:16352376; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
J Med Econ 2011; 14:639-45;  PMID:21838599; http://dx.doi.org/10.3111/13696998.2011.607482.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Pharmacoeconomics 2009;  27:781-92; PMID:19757871; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
J Epidemiol Community Health 2000; 54:502- 9; PMID:10846192; http://dx.doi.org/10.1136/ jech.54.7.502.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
J Occup Environ Med 2011; 53:735-42; PMID:21691220; http://dx.doi.org/10.1097/ JOM.0b013e318222af48.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
BMJ 2000; 321:794- 6; PMID:11009518; http://dx.doi.org/10.1136/ bmj.321.7264.794.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
J Infect  Dis 1999; 179:9-15; PMID:9841816; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Fam Pract  2002; 19:471-5; PMID:12356697; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Eur J Pain 2006; 10:695-700; PMID:16427792; http://dx.doi.org/10.1016/j.ejpain.2005.11.002.,OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
J Med Virol 2008; 80:1646-52; PMID:18649332; http://dx.doi.org/10.1002/ jmv.21254.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Clin J Pain 2002;  18:350-4; PMID:12441828; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
BMC Public Health 2005; 5:68; PMID:15960856; http://dx.doi.org/10.1186/1471- 2458-5-68.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Vaccine 2011; 29:8580-4;  PMID:21939721; http://dx.doi.org/10.1016/j.vac - cine.2011.09.024.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Clin J Pain 1999; 15:78-84; PMID:10382920;  http://dx.doi.org/10.1097/00002508-199906000- 00003.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Pain 2001; 94:113-9; PMID:11576750; http://dx.doi.org/10.1016/S0304-3959(01)00347-5.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Neurology 2004; 62:1545-51;  PMID:15136679; http://dx.doi.org/10.1212/01.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Eur J Pain  2011; 15:1100-6; PMID:21600819; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
J Pain 2008; 9(Suppl 1):S37- 44; PMID:18166464; http://dx.doi.org/10.1016/j.jpain.2007.10.008.,OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Int J Infect Dis 2007; 11(Suppl 2):S43-8; PMID:18162246; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Antimicrob Agents Chemother 1995; 39:1546-53; PMID:7492102; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Arch Fam Med 2000; 9:863-9;  PMID:11031393; http://dx.doi.org/10.1001/arch - fami.9.9.863.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Clin J Pain  2007; 23:490-6; PMID:17575488; http://dx.doi.org/10.1097/AJP.0b013e318065b6c9.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Clin J Pain  2012; 28:101-7; PMID:21753727; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
N Engl J Med  2005; 352:2271-84; PMID:15930418; http://dx.doi.org/10.1056/NEJMoa051016.,OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Vaccine 2001; 19:3076-90; PMID:11312002; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Epidemiol Infect 2001; 127:305-14;  PMID:11693508; http://dx.doi.org/10.1017/ S0950268801005921.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
AMA Arch Derm  1957; 75:193-6; PMID:13393787; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
J Pain 2010; 11:1211-21; PMID:20434957;  http://dx.doi.org/10.1016/j.jpain.2010.02.020.,OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Mayo Clin Proc  2007; 82:1341-9; PMID:17976353; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Clin Infect Dis 2011; 52:332-40; PMID:21217180; http://dx.doi.org/10.1093/cid/ ciq077.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Epidemiol Infect 2005; 133:245-53;  PMID:15816149; http://dx.doi.org/10.1017/ S095026880400281X.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Vaccine 2002; 20:2500-7; PMID:12057605;  http://dx.doi.org/10.1016/S0264-410X(02)00180-9.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Lancet  2002; 360:678-82; PMID:12241874; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
J Infect Dis  2005; 191:2002-7; PMID:15897984; http://dx.doi.org/10.1086/430325.,OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
J Med Econ 2010;  13:537-51; PMID:20707768; http://dx.doi.org/10.3 111/13696998.2010.502854.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Vaccine 2012; 30:1225- 34; PMID:22119592; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
BMC Health Serv  Res 2010; 10:237; PMID:20707884; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Pharmacoeconomics  2007; 25:155-69; PMID:17249857; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Clin Infect Dis 2012; 55:1320- 8; PMID:22828595; http://dx.doi.org/10.1093/cid/ cis638.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Vaccine 2012; 30:2795-800; PMID:21964056; http://dx.doi.org/10.1016/j.vac - cine.2011.09.079.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Clin Infect Dis 2007; 44:1280-8; PMID:17443464; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Vaccine 2007; 25:8326- 37; PMID:17980938; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Pharmacoeconomics 2009; 27:991-1004; PMID:19908924; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Cost Eff Resour Alloc 2010; 8:7; PMID:20433704; http://dx.doi.org/10.1186/1478- 7547-8-7.56.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Pain 2012; 153:342-9;  PMID:22138256; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Vaccine 2009; 27:1454-67; PMID:19135492;  http://dx.doi.org/10.1016/j.vaccine.2008.12.024.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Hum Vaccin 2008; 4:238-45; PMID:18382137;  http://dx.doi.org/10.4161/hv.4.3.5686.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Clin Infect Dis 2012; 54:922- 8; PMID:22291101; http://dx.doi.org/10.1093/cid/cir970.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
Clin  Infect Dis 2007; 45:1527-9; PMID:17990240;  http://dx.doi.org/10.1086/523011.,Non-OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
J Am Geriatr Soc 2010; 58:1634-41;  PMID:20863322; http://dx.doi.org/10.1111/j.1532- 5415.2010.03021.x.,OADS,/arxiv_data1/oa_pdf/0c/46/hvi-9-1177.PMC3899157.pdf
"Letter from the Editor ronald Ellis1,* and Eva M. r iedmann2 1senior Vice President r &d and c hief t echnology o fficer; n asVax, Ltd.; n ess Ziona, i srael; 2Acquisitions Editor; Landes Bioscience; Vienna, Austria *Correspondence to: Ronald Ellis; Email: rellis@landesbioscience.com Submitted: 4/22/12; Accepted: 4/22/12http://dx.doi.org/10.4161/hv.25150",Non-OADS,/arxiv_data1/oa_pdf/38/e6/hvi-9-939.PMC3899158.pdf
Pediatrics 2013; 131:e1389-96; PMiD:  23545380; http://dx.doi.org/10.1542/peds.2012-3303 Again—no link between vaccines and autism A lot of the mistrust and scepticism against  vaccines has its roots in reports from the 1990s  falsely linking autism to vaccines.,Non-OADS,/arxiv_data1/oa_pdf/a8/2b/hvi-9-941.PMC3899159.pdf
"J Pediatr 2013; s0022- 3476:00144-3; PMiD: 23545349; http://dx.doi.org/  10.1016/j.jpeds.2013.02.001 Experimental ovarian cancer vaccine successful in phase 1 A novel immunotherapy for treating ovarian  cancer has shown promise in a phase 1 study,  and has apparently produced complete remis- sion for one patient with advanced stage dis-ease.",Non-OADS,/arxiv_data1/oa_pdf/a8/2b/hvi-9-941.PMC3899159.pdf
http://www.guardian.,Non-OADS,/arxiv_data1/oa_pdf/a8/2b/hvi-9-941.PMC3899159.pdf
Gastroenterology 2010; 139:1156- 64; PMiD: 20638937;  http://dx.doi.org/10.1053/j.,Non-OADS,/arxiv_data1/oa_pdf/a8/2b/hvi-9-941.PMC3899159.pdf
J Public Health 2012;  34:489-97; PMiD: 22611261; http://dx.doi.org/10.1093/pubmed/fds032 Cancer vaccine failures due to the adjuvant IFA?,Non-OADS,/arxiv_data1/oa_pdf/a8/2b/hvi-9-941.PMC3899159.pdf
Nat Med 2013; 19:465-72; PMiD:  23455713; http://dx.doi.org/10.1038/nm.3105 Novartis’ typhoid vaccine make good progress Novartis has successfully completed phase 2 safety studies for its typhoid vaccine candidate  and now considers a wider rollout as it pushes  to develop a vaccine to eliminate typhoid fever.,Non-OADS,/arxiv_data1/oa_pdf/a8/2b/hvi-9-941.PMC3899159.pdf
" Portrait www.landesbioscience.com Human Vaccines & i mmunotherapeutics 945Human Vaccines & i mmunotherapeutics 9:5, 945–945; May 2013; © 2013 Landes BiosciencePortrait  articLe addenduM Keywords:  Jonas Salk, Haemophilus  influenzae, Neisseria meningitidis,   vaccine, biography Submitted: 04/20/13Accepted: 04/20/13http://dx.doi.org/10.4161/hv.25151 Correspondence to: Dan M. Granoff;   Email: dgranoff@chori.orgBorn in 1944, I grew up in a world  in which polio was both a gripping  fear and real threat.",Non-OADS,/arxiv_data1/oa_pdf/f0/98/hvi-9-945.PMC3899160.pdf
Exp Neurol 1968; 22:661-73; PMID:5709812; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/98/hvi-9-945.PMC3899160.pdf
J Pediatr 1969; 75:732-3; PMID:5809852; http://dx.doi.org/10.1016/S0022- 3476(69)80480-4 6.,OADS,/arxiv_data1/oa_pdf/f0/98/hvi-9-945.PMC3899160.pdf
Brain Res  1969; 14:697-706; PMID:5822439; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/98/hvi-9-945.PMC3899160.pdf
J Infect Dis  1980; 141:40-6; PMID:6965975; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/98/hvi-9-945.PMC3899160.pdf
J Clin Invest 1983; 72:677-84;  PMID:6603479; http://dx.doi.org/10.1172/JCI111017 14.,Non-OADS,/arxiv_data1/oa_pdf/f0/98/hvi-9-945.PMC3899160.pdf
J Infect Dis  1981; 143:668-76; PMID:6972422; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/98/hvi-9-945.PMC3899160.pdf
J  Infect Dis 1981; 144:210-7; PMID:6974205; http://dx.doi.org/10.1093/infdis/144.3.210 16.,Non-OADS,/arxiv_data1/oa_pdf/f0/98/hvi-9-945.PMC3899160.pdf
J Pediatr 1984; 105:22-7; PMID:6610736;  http://dx.doi.org/10.1016/S0022-3476(84)80350-9 17.,OADS,/arxiv_data1/oa_pdf/f0/98/hvi-9-945.PMC3899160.pdf
Lancet 1986; 2:299-302; PMID:2874327; http://dx.doi.org/10.1016/S0140- 6736(86)90001-220.,OADS,/arxiv_data1/oa_pdf/f0/98/hvi-9-945.PMC3899160.pdf
J Infect Dis 1992; 165(Suppl 1):S7- 10; PMID:1588181; http://dx.doi.org/10.1093/infdis/165-Supplement_1-S7 21.,OADS,/arxiv_data1/oa_pdf/f0/98/hvi-9-945.PMC3899160.pdf
N Engl J Med  1986; 315:1584-90; PMID:3491315; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/98/hvi-9-945.PMC3899160.pdf
JAMA 1993; 269:246-8; PMID:8417244; http://dx.doi.org/10.1001/ jama.1993.03500020080036 24.,OADS,/arxiv_data1/oa_pdf/f0/98/hvi-9-945.PMC3899160.pdf
J Pediatr 1993; 122:517-23; PMID:8463894; http://dx.doi.org/10.1016/S0022-3476(05)83529-2 25.,OADS,/arxiv_data1/oa_pdf/f0/98/hvi-9-945.PMC3899160.pdf
J Clin  Invest 1991; 88:1811-8; PMID:1752943; http://dx.doi.org/10.1172/JCI115502 26.,Non-OADS,/arxiv_data1/oa_pdf/f0/98/hvi-9-945.PMC3899160.pdf
J Clin Invest 1993; 91:788- 96; PMID:8450060; http://dx.doi.org/10.1172/ JCI116298 27.,Non-OADS,/arxiv_data1/oa_pdf/f0/98/hvi-9-945.PMC3899160.pdf
Lancet 2003; 361:1902-4;  PMID:12788589; http://dx.doi.org/10.1016/S0140- 6736(03)13494-0 30.,Non-OADS,/arxiv_data1/oa_pdf/f0/98/hvi-9-945.PMC3899160.pdf
Science 2000; 287:1816-20; PMID:10710308; http://dx.doi.org/10.1126/science.287.5459.1816 31.,OADS,/arxiv_data1/oa_pdf/f0/98/hvi-9-945.PMC3899160.pdf
Infect Immun  2009; 77:764-9; PMID:19047406; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/98/hvi-9-945.PMC3899160.pdf
J Immunol 2011; 186:3606-14; PMID:21325619; http://dx.doi.org/10.4049/jimmu - nol.1003470 35.,Non-OADS,/arxiv_data1/oa_pdf/f0/98/hvi-9-945.PMC3899160.pdf
PLoS Pathog 2012; 8:e1002688;  PMID:22589720; http://dx.doi.org/10.1371/jour - nal.ppat.1002688 36.,Non-OADS,/arxiv_data1/oa_pdf/f0/98/hvi-9-945.PMC3899160.pdf
"Human Vaccines & Immunotherapeutics 9:5, 950–956; May 2013; © 2013 Landes Bioscience ReseaR cH PaPeR 950 Human Vaccines & Immunotherapeutics Volume 9 Issue 5*Correspondence to: Anne S. De Groot; Email: AnnieD@EpiVax.com Submitted: 04/03/13; Revised: 05/03/13; Accepted: 05/04/13http://dx.doi.org/10.4161/hv.24939a new avian-origin influenza virus emerged near shanghai in February 2013, and by the beginning of May it had  caused over 130 human infections and 36 deaths.",Non-OADS,/arxiv_data1/oa_pdf/83/57/hvi-9-950.PMC3899161.pdf
Four human H7N9 influenza sequences  were downloaded from GISAID (http://platform.gisaid.org/).,OADS,/arxiv_data1/oa_pdf/83/57/hvi-9-950.PMC3899161.pdf
N Engl J Med 2013; In  press;  PMID:23577628 ; http://dx.doi.org/10.1056/ NEJMoa1304459 .,OADS,/arxiv_data1/oa_pdf/83/57/hvi-9-950.PMC3899161.pdf
Retrieved from: http://www.who.int/csr/don/2013_05_17/en/ index.html 3.,OADS,/arxiv_data1/oa_pdf/83/57/hvi-9-950.PMC3899161.pdf
Retrieved from: http://www.who.int/influenza/ human_animal_interface/influenza_h7n9/04_ReportWebH7N9Number.pdf   5.,Non-OADS,/arxiv_data1/oa_pdf/83/57/hvi-9-950.PMC3899161.pdf
N Engl  J Med 2013; PMID:23614499 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/57/hvi-9-950.PMC3899161.pdf
Retrieved from: http://www.medpagetoday.com/ InfectiousDisease/URItheFlu/38553 8.,Non-OADS,/arxiv_data1/oa_pdf/83/57/hvi-9-950.PMC3899161.pdf
Retrieved from: http://www.cdc.gov.,OADS,/arxiv_data1/oa_pdf/83/57/hvi-9-950.PMC3899161.pdf
Retrieved from: http://www.nature.com/news/mapping-the-h7n9-avian-flu-outbreaks-1.12863 10.,Non-OADS,/arxiv_data1/oa_pdf/83/57/hvi-9-950.PMC3899161.pdf
N Engl J Med  2009; 361:1945-52;  PMID:19745214 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/83/57/hvi-9-950.PMC3899161.pdf
JAMA 2003; 289:179-86; PMID:12517228 ;  http://dx.doi.org/10.1001/jama.289.2.179 13.,Non-OADS,/arxiv_data1/oa_pdf/83/57/hvi-9-950.PMC3899161.pdf
JAMA 2004; 292:1333-40;  PMID:15367555 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/57/hvi-9-950.PMC3899161.pdf
Vaccine  2009; 27:5740-7;  PMID:19660593 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/83/57/hvi-9-950.PMC3899161.pdf
Clin Immunol 2009; 131:189-201;  PMID:19269256 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/83/57/hvi-9-950.PMC3899161.pdf
Clin Immunol  2007; 124:26-32;  PMID:17490912 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/83/57/hvi-9-950.PMC3899161.pdf
PLoS One  2012; 7:e49704;  PMID:23239968 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/57/hvi-9-950.PMC3899161.pdf
PLoS One 2012; 7:e50830;  PMID:23239987 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/83/57/hvi-9-950.PMC3899161.pdf
Cell Immunol 2006; 244:148-53;  PMID:17445787 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/57/hvi-9-950.PMC3899161.pdf
Curr Opin Pharmacol 2008; 8:620- 6; PMID :18775515 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/83/57/hvi-9-950.PMC3899161.pdf
Vaccine 2012; 30:7547-60;  PMID:23102976 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/83/57/hvi-9-950.PMC3899161.pdf
N  Engl J Med 2013; PMID:23577629 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/57/hvi-9-950.PMC3899161.pdf
Vaccine 2011; 29:3299-309;  PMID:21349362 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/83/57/hvi-9-950.PMC3899161.pdf
Vaccine 2011; 29:3335-9; PMID:20840835 ;  http://dx.doi.org/10.1016/j.vaccine.2010.08.067 28.,Non-OADS,/arxiv_data1/oa_pdf/83/57/hvi-9-950.PMC3899161.pdf
Proc Natl Acad Sci U S A 2009; 106:3877-82; PMID:19237568 ; http://dx.doi.org/10.1073/ pnas.0813390106 29.,OADS,/arxiv_data1/oa_pdf/83/57/hvi-9-950.PMC3899161.pdf
Vaccine  2001; 19:4385-95;  PMID:11483263 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/83/57/hvi-9-950.PMC3899161.pdf
AIDS Res  Hum Retroviruses 1997; 13:529-31; PMID:9135870 ;  http://dx.doi.org/10.1089/aid.1997.13.529 31.,Non-OADS,/arxiv_data1/oa_pdf/83/57/hvi-9-950.PMC3899161.pdf
"www.landesbioscience.com Human Vaccines & Immunotherapeutics 993Human Vaccines & Immunotherapeutics 9:5, 993–1001; May 2013; © 2013 Landes Bioscience ReseaR cH papeR ReseaR cH papeR *Correspondence to: Thomas Aagaard Rasmussen; Email: thomrasm@rm.dk Submitted: 11/15/12; Revised: 01/22/13; Accepted: 01/27/13http://dx.doi.org/10.4161/hv.23800Introduction The inability of highly active antiretroviral treatment (HAART)  to eradicate HIV-infection has renewed interest in the search for a cure.",Non-OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
Nat Med 2009; 15:893- 900; PMID:19543283; http://dx.doi.org/10.1038/ nm.1972.,OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
Proc Natl Acad Sci U S A 1997; 94:13193-7; PMID:9371822; http://dx.doi.org/10.1073/ pnas.94.24.13193.,OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
AIDS Res Hum Retroviruses  2009; 25:207-12; PMID:19239360; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
Immunity 2012; 36:491- 501; PMID:22406268; http://dx.doi.org/10.1016/j.immuni.2012.01.014.,OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
EMBO J 2006; 25:139- 49; PMID:16319923; http://dx.doi.org/10.1038/ sj.emboj.7600900.,OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
J  Biol Chem 2006; 281:12495-505; PMID:16540471;  http://dx.doi.org/10.1074/jbc.M511773200.,OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
J Virol 2007; 81:10914- 23; PMID:17670825; http://dx.doi.org/10.1128/ JVI.01208-07.,Non-OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
EMBO J  2003; 22:6550-61; PMID:14657027; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
J Acquir Immune Defic Syndr 2010;  54:1-9; PMID:20300007; http://dx.doi.org/10.1097/ QAI.0b013e3181d3dca3.,OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
PLoS  One 2009; 4:e6093; PMID:19564922; http://dx.doi.org/10.1371/journal.pone.0006093.,Non-OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
AIDS 2004; 18:1101-8; PMID:15166525;  http://dx.doi.org/10.1097/00002030-200405210-00003.,Non-OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
Mol Biol Rep 2011; 38:5071-8; PMID:21181272;  http://dx.doi.org/10.1007/s11033-010-0653-6.,Non-OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
Immunol Cell Biol  2012; 90:47-54; PMID:22083528; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
Mol Med 2011; 17:466-72;  PMID:21424110; http://dx.doi.org/10.2119/mol- med.2011.00076.,Non-OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
Leukemia 2011; 25:161-8; PMID:21102427;  http://dx.doi.org/10.1038/leu.2010.244.,Non-OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
J Acquir Immune Defic Syndr Hum Retrovirol  1996; 11:95-104; PMID:8528739; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
Mol Med 2011; 17:333-52;  PMID:21556484; http://dx.doi.org/10.2119/mol-med.2011.00116.,Non-OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
Crit Rev  Immunol 2011; 31:233-63; PMID:21740352; http://dx.doi.org/10.1615/CritRevImmunol.v31.i3.40.,Non-OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
Nat Rev Drug  Discov 2006; 5:769-84; PMID:16955068; http://dx.doi.org/10.1038/nrd2133.,Non-OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
J Virol 2009; 83:4749- 56; PMID:19279091; http://dx.doi.org/10.1128/ JVI.02585-08.,Non-OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
Blood 2007; 110:4161-4; PMID:17881634;  http://dx.doi.org/10.1182/blood-2007-06-097907.,Non-OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
J Infect Dis  2012; 206:765-9; PMID:22732922; http://dx.doi.org/10.1093/infdis/jis412.,OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
Mol  Med 2005; 11:1-15; PMID:16557334; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
AIDS 2007; 21:1317- 22; PMID:17545708; http://dx.doi.org/10.1097/ QAD.0b013e32815278ea.,Non-OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
Cancer Chemother Pharmacol 2011; 67:1273-9;  PMID:20706839; http://dx.doi.org/10.1007/s00280-010-1419-5.,Non-OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
Cancer Res 2006; 66:5781- 9; PMID:16740717; http://dx.doi.org/10.1158/0008- 5472.CAN-05-4186.,Non-OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
Cancer  Res 2009; 69:8693-9; PMID:19861533; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
AIDS  2013; 27:29-37; PMID:23221426; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
Blood 2012; 119:2443-51;  PMID:22246031; http://dx.doi.org/10.1182/blood- 2011-10-292003.21.,Non-OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
Lancet  2005; 366:549-55; PMID:16099290; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
PLoS  One 2010; 5:e9390; PMID:20186346; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
AIDS 2008; 22:1131-5; PMID:18525258; http://dx.doi.org/10.1097/QAD.0b013e3282fd6df4.,OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
HIV Med 2012; 13:291-6;  PMID:22276680; http://dx.doi.org/10.1111/j.1468- 1293.2011.00975.x.,Non-OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
Nature 2012; 487:482-5; PMID:22837004;  http://dx.doi.org/10.1038/nature11286.,Non-OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
Cancer Chemother Pharmacol 2010; 66:181-9;  PMID:20217089; http://dx.doi.org/10.1007/s00280- 010-1289-x.,Non-OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
Br J Haematol 2009; 147:97-101; PMID:19663825; http://dx.doi.org/10.1111/j.1365-2141.2009.07837.x.,Non-OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
Clin Cancer Res 2008; 14:4500-10;  PMID:18628465; http://dx.doi.org/10.1158/1078- 0432.CCR-07-4262.,Non-OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
Clin Cancer Res  2009; 15:3958-69; PMID:19509172; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
Future Oncol 2009; 5:601-12; PMID:19519200;  http://dx.doi.org/10.2217/fon.09.36.,Non-OADS,/arxiv_data1/oa_pdf/fc/7d/hvi-9-993.PMC3899169.pdf
"www.landesbioscience.com Cell Cycle 2705Cell Cycle 12:17, 2705–2706; September 1, 2013; © 2013 Landes Bioscience EditoriaLS : CELL  CyCLE  FEaturES EditoriaLS : CELL  CyCLE  FEaturES *Correspondence to: Powel H Brown, Email: phbrown@mdanderson.org   Submitted: 06/20/13; Accepted: 06/24/13  http://dx.doi.org/10.4161/cc.25871   Comment on: Hartman ZC, et al.",Non-OADS,/arxiv_data1/oa_pdf/a4/69/cc-12-2705.PMC3899176.pdf
"Cancer Res 2013; 73:3470-80; PMID:23633491; http://dx.doi.org/10.1158/0008-5472.CAN-12-4524-TBreast cancer is second only to non- melanoma skin cancers as the most preva - lent and lethal malignancy among women  worldwide.1 Upon diagnosis, cases are  clinically stratified based upon their estro - gen-, progesterone-, and HER2-receptor status.",Non-OADS,/arxiv_data1/oa_pdf/a4/69/cc-12-2705.PMC3899176.pdf
Int J Cancer 2010; 127:2893-917;  PMID:21351269 ; http://dx.doi.org/10.1002/ ijc.25516 2.,Non-OADS,/arxiv_data1/oa_pdf/a4/69/cc-12-2705.PMC3899176.pdf
Cancer Genome Atlas Network Nature 2012; 490:61- 70; PMID:23000897 ; http://dx.doi.org/10.1038/ nature11412 4.,Non-OADS,/arxiv_data1/oa_pdf/a4/69/cc-12-2705.PMC3899176.pdf
Clin Cancer Res 2009; 15:6327-40; PMID:19808870 ; http://dx.doi.org/10.1158/1078- 0432.CCR-09-1107 6.,Non-OADS,/arxiv_data1/oa_pdf/a4/69/cc-12-2705.PMC3899176.pdf
Cancer Res 2013; 73:3470-80;  PMID:23633491 ; http://dx.doi.org/10.1158/0008- 5472.CAN-12-4524-T 7.,Non-OADS,/arxiv_data1/oa_pdf/a4/69/cc-12-2705.PMC3899176.pdf
J Clin Invest 2011; 121:2723-35; PMID:21633165 ; http://dx.doi.org/10.1172/ JCI44745 8.,Non-OADS,/arxiv_data1/oa_pdf/a4/69/cc-12-2705.PMC3899176.pdf
Mol Cell 2012; 47:570-84; PMID:22819326 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a4/69/cc-12-2705.PMC3899176.pdf
"www.landesbioscience.com Cell Cycle 2707Cell Cycle 12:17, 2707–2708; September 1, 2013; © 2013 Landes Bioscience EditoriaLS : CELL  CyCLE  FEaturES EditoriaLS : CELL  CyCLE  FEaturES *Correspondence to: Alicia Lundby; Email: alicia.lundby@cpr.ku.dk; Jesper V Olsen; Email: jesper.olsen@cpr.ku.dk Submitted: 06/20/13; Accepted: 07/12/13http://dx.doi.org/10.4161/cc.25883Comment on: Lundby A, et al.",Non-OADS,/arxiv_data1/oa_pdf/89/70/cc-12-2707.PMC3899177.pdf
"Sci Signal 2013; 6:rs11; PMID:23737553; http://dx.doi.org/10.1126/scisignal.2003506The last decade has witnessed a tre - mendous advance in mass spectrometric  instrumentation, sample preparation, and computational proteomics developments that now make it possible to analyze pro - teins 1 or post-translational modifications  (PTMs) of proteins2 on a global scale  and compare their relative abundance between different cell states.",OADS,/arxiv_data1/oa_pdf/89/70/cc-12-2707.PMC3899177.pdf
Nature 2008; 455:1251-4;  PMID:18820680 ; http://dx.doi.org/10.1038/ nature07341 2.,Non-OADS,/arxiv_data1/oa_pdf/89/70/cc-12-2707.PMC3899177.pdf
Sci Signal 2010; 3:ra3; PMID:20068231 ; http://dx.doi.org/10.1126/ scisignal.2000475 3.,OADS,/arxiv_data1/oa_pdf/89/70/cc-12-2707.PMC3899177.pdf
Cell 2006; 127:635-48; PMID:17081983 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/89/70/cc-12-2707.PMC3899177.pdf
Cell Rep 2012; 2:419-31;  PMID:22902405 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/89/70/cc-12-2707.PMC3899177.pdf
Nat Commun 2012; 3:876; PMID:22673903 ; http://dx.doi.org/10.1038/ ncomms1871 6.,OADS,/arxiv_data1/oa_pdf/89/70/cc-12-2707.PMC3899177.pdf
"Sci Signal 2013; 6:rs11; PMID:23737553 ; http://dx.doi.org/10.1126/ scisignal.2003506 7. den Hoed M, et al.",OADS,/arxiv_data1/oa_pdf/89/70/cc-12-2707.PMC3899177.pdf
Nat Genet 2013; 45:621-31; PMID:23583979 ; http://dx.doi.org/10.1038/ ng.2610Figure 1.,OADS,/arxiv_data1/oa_pdf/89/70/cc-12-2707.PMC3899177.pdf
"www.landesbioscience.com Cell Cycle 2709Cell Cycle 12:17, 2709–2710; September 1, 2013; © 2013 Landes Bioscience EditoriaLS : CELL  CyCLE  FEaturES EditoriaLS : CELL  CyCLE  FEaturES Correspondence to: Mikhail V Blagosklonny; Email: blagosklonny@oncotarget.com Submitted: 06/20/13; Accepted: 07/01/13http://dx.doi.org/10.4161/cc.26015The United States Patent Office has  made an official policy of refusing to grant  patents for perpetual motion machines (perpetuum mobile) without a working model.",Non-OADS,/arxiv_data1/oa_pdf/9c/3f/cc-12-2709.PMC3899178.pdf
Cell Cycle 2006; 5:2087-102;  PMID:17012837 ; http://dx.doi.org/10.4161/ cc.5.18.3288 2.,OADS,/arxiv_data1/oa_pdf/9c/3f/cc-12-2709.PMC3899178.pdf
Genes Dev 2008; 22:3236-41;  PMID:19056880 ; http://dx.doi.org/10.1101/ gad.504808 3.,OADS,/arxiv_data1/oa_pdf/9c/3f/cc-12-2709.PMC3899178.pdf
Cell Mol Life Sci 200; 67:1-8;  PMID:19730800 ; http://dx.doi.org/10.1007/ s00018-009-0138-8 4.,OADS,/arxiv_data1/oa_pdf/9c/3f/cc-12-2709.PMC3899178.pdf
"Gems D, et l. Annu Rev Physiol 2013; 75:621- 44; PMID:23190075 ; http://dx.doi.org/10.1146/ annurev-physiol-030212-183712 5.",Non-OADS,/arxiv_data1/oa_pdf/9c/3f/cc-12-2709.PMC3899178.pdf
Antioxid Rdox Signal 2013; 19:321- 9; PMID:22870907 ; http://dx.doi.org/10.1089/ ars.2012.4840 6. de Magalhães JP.,Non-OADS,/arxiv_data1/oa_pdf/9c/3f/cc-12-2709.PMC3899178.pdf
FASEB J 2012; 26:481-6;  PMID:22964300 ; http://dx.doi.org/10.1096/ fj.12-210872 7.,Non-OADS,/arxiv_data1/oa_pdf/9c/3f/cc-12-2709.PMC3899178.pdf
Aging Cell 2008;  7:13-22;  PMID:17996009 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/3f/cc-12-2709.PMC3899178.pdf
"www.landesbioscience.com Cell Cycle 2711Cell Cycle 12:17, 2711–2712; September 1, 2013; © 2013 Landes Bioscience EditoriaLS : CELL  CyCLE  FEaturES EditoriaLS : CELL  CyCLE  FEaturES *Correspondence to: Dongsheng Cai; Email: dongsheng.cai@einstein.yu.edu Submitted: 07/29/13; Accepted: 08/05/13http://dx.doi.org/10.4161/cc.26054Comment on: Zhang G, et al.",Non-OADS,/arxiv_data1/oa_pdf/c4/80/cc-12-2711.PMC3899179.pdf
"Nature 2013; 497:211-6; PMID:23636330; http://dx.doi.org/10.1038/nature12143At cellular level, aging is often referred  to as senescence and characterized by irre - versible cell cycle arrest, morphological  transformation, induction of senescence- associated β-galactosidase and hetero - chromatic foci, and secretory phenotype.",Non-OADS,/arxiv_data1/oa_pdf/c4/80/cc-12-2711.PMC3899179.pdf
Cell 2013; 153:1194-217;  PMID:23746838 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c4/80/cc-12-2711.PMC3899179.pdf
Nature 2000; 408:239- 47; PMID:11089981 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/80/cc-12-2711.PMC3899179.pdf
Mech Ageing Dev 2005; 126:913-22; PMID :15885745 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c4/80/cc-12-2711.PMC3899179.pdf
Nature 2013; 497:211-6;  PMID:23636330 ; http://dx.doi.org/10.1038/ nature12143 5.,Non-OADS,/arxiv_data1/oa_pdf/c4/80/cc-12-2711.PMC3899179.pdf
Cell 2008; 135:61-73; PMID :18854155 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c4/80/cc-12-2711.PMC3899179.pdf
Nat Med 2011; 17:883-7; PMID:21642978 ; http://dx.doi.org/10.1038/ nm.2372 7.,OADS,/arxiv_data1/oa_pdf/c4/80/cc-12-2711.PMC3899179.pdf
Nat Cell Biol 2012; 14:999-1012;  PMID:22940906 ; http://dx.doi.org/10.1038/ ncb2562 8.,OADS,/arxiv_data1/oa_pdf/c4/80/cc-12-2711.PMC3899179.pdf
Nat Rev Immunol 2011; 11:775-87; PMID:22025055 ; http://dx.doi.org/10.1038/ nri3086Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/c4/80/cc-12-2711.PMC3899179.pdf
"www.landesbioscience.com Cell Cycle 2713Cell Cycle 12:17, 2713–2714; September 1, 2013; © 2013 Landes Bioscience EditoriaLS : CELL  CyCLE  FEaturES EditoriaLS : CELL  CyCLE  FEaturES *Correspondence to: Robert A Weinberg; Email: weinberg@wi.mit.edu; Christine L Chaffer; Email: chaffer@wi.mit.edu Submitted: 07/30/13; Accepted: 08/07/13http://dx.doi.org/10.4161/cc.26075Comment on: Chaffer CL, et al.",Non-OADS,/arxiv_data1/oa_pdf/1c/65/cc-12-2713.PMC3899180.pdf
"Cell 2013; 154:61-74; PMID:23827675; http://dx.doi.org/10.1016/j.cell.2013.06.005Individual carcinomas are composed of  multiple, distinct subpopulations of neo - plastic cells that exhibit distinct biological  properties.",Non-OADS,/arxiv_data1/oa_pdf/1c/65/cc-12-2713.PMC3899180.pdf
Nat Med 1997; 3:730-7;  PMID:9212098 ; http://dx.doi.org/10.1038/ nm0797-730 2.,Non-OADS,/arxiv_data1/oa_pdf/1c/65/cc-12-2713.PMC3899180.pdf
Proc Natl Acad Sci U S A 2003;  100:3983-8;  PMID:12629218 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1c/65/cc-12-2713.PMC3899180.pdf
Cell Stem Cell 2012; 10:717-28; PMID:22704512 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1c/65/cc-12-2713.PMC3899180.pdf
Cell 2010; 141:583-94;  PMID:20478252 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1c/65/cc-12-2713.PMC3899180.pdf
Proc Natl Acad Sci U S A 2011;  108:7950-5;  PMID:21498687 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1c/65/cc-12-2713.PMC3899180.pdf
Cell 2011; 146:633-44; PMID:21854987 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1c/65/cc-12-2713.PMC3899180.pdf
Cell 2013; 154:61-74; PMID:23827675 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1c/65/cc-12-2713.PMC3899180.pdf
Cell 2008; 133:704-15; PMID:18485877 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1c/65/cc-12-2713.PMC3899180.pdf
Cell 2006; 125:315-26; PMID:16630819 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1c/65/cc-12-2713.PMC3899180.pdf
"www.landesbioscience.com Cell Cycle 2715Cell Cycle 12:17, 2715–2716; September 1, 2013; © 2013 Landes Bioscience EditoriaLS : CELL  CyCLE  FEaturES EditoriaLS : CELL  CyCLE  FEaturES *Correspondence to: Martin J Simard; Email: Martin.Simard@crhdq.ulaval.ca Submitted: 06/07/13; Accepted: 06/10/13http://dx.doi.org/10.4161/cc.26076Comment on: Bossé GD, et al.",Non-OADS,/arxiv_data1/oa_pdf/98/4a/cc-12-2715.PMC3899181.pdf
Mol Cell 2013; 50:281-7; PMID:23541767; http://dx.doi.org/10.1016/j.molcel.2013.02.023MicroRNAs are small non-coding  RNA able to silence posttranscriptionally  gene expression of targeted mRNAs through partial base-pairing interactions.,OADS,/arxiv_data1/oa_pdf/98/4a/cc-12-2715.PMC3899181.pdf
Mol Cell 2010; 38:323-32;  PMID:20471939 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/98/4a/cc-12-2715.PMC3899181.pdf
Trends Biochem Sci 2012; 37:436- 46; PMID:22921610 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/98/4a/cc-12-2715.PMC3899181.pdf
Mol Cell 2013; 50:281-7;  PMID:23541767 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/98/4a/cc-12-2715.PMC3899181.pdf
Mol Cell 2000; 5:659-69;  PMID:10882102 ; http://dx.doi.org/10.1016/ S1097-2765(00)80245-2 5.,OADS,/arxiv_data1/oa_pdf/98/4a/cc-12-2715.PMC3899181.pdf
Adv Exp Med Biol 2010;  700:67-75; PMID:21755474 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/4a/cc-12-2715.PMC3899181.pdf
Dev Cell 2011; 20:388-96;  PMID:21397849 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/98/4a/cc-12-2715.PMC3899181.pdf
Proc Natl Acad Sci U S A 2012; 109:8264-9;  PMID:22570495 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/4a/cc-12-2715.PMC3899181.pdf
Mol Cell 2013; 50:344-55;  PMID:23664376 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/98/4a/cc-12-2715.PMC3899181.pdf
"www.landesbioscience.com Cell Cycle 2717Cell Cycle 12:17, 2717–2718; September 1, 2013; © 2013 Landes Bioscience EditoriaLS : CELL  CyCLE  FEaturES EditoriaLS : CELL  CyCLE  FEaturES *Correspondence to: Alessandro A Sartori; Email: sartori@imcr.uzh.ch Submitted: 06/18/13; Accepted: 06/20/13http://dx.doi.org/10.4161/cc.26077Comment on: Steger M, et al.",Non-OADS,/arxiv_data1/oa_pdf/7d/41/cc-12-2717.PMC3899182.pdf
Mol Cell 2013; 50:333-43; PMID:23623683; http://dx.doi.org/10.1016/j.molcel.2013.03.023The repair of DNA double-strand  breaks (DSBs) is highly complex.,OADS,/arxiv_data1/oa_pdf/7d/41/cc-12-2717.PMC3899182.pdf
Mol Cell 2012; 47:497-510;  PMID:22920291 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7d/41/cc-12-2717.PMC3899182.pdf
Front Genet 2013; 4:99;  PMID:23760669 ; http://dx.doi.org/10.3389/ fgene.2013.00099 3.,OADS,/arxiv_data1/oa_pdf/7d/41/cc-12-2717.PMC3899182.pdf
Science 1997; 278:1957-60; PMID:9395400 ; http://dx.doi.org/10.1126/ science.278.5345.1957 4.,Non-OADS,/arxiv_data1/oa_pdf/7d/41/cc-12-2717.PMC3899182.pdf
Trends Biochem Sci 2011; 36:501- 14; PMID:21852138 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7d/41/cc-12-2717.PMC3899182.pdf
Mol Cell 2013; 50:333-43; PMID:23623683 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7d/41/cc-12-2717.PMC3899182.pdf
Cancer Cell 2007; 11:175-89; PMID:17292828 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7d/41/cc-12-2717.PMC3899182.pdf
Mol Cell 2012; 47:320-9; PMID:22841003 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7d/41/cc-12-2717.PMC3899182.pdf
Cell 2010; 141:243-54;  PMID:20362325 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7d/41/cc-12-2717.PMC3899182.pdf
"www.landesbioscience.com Cell Cycle 2719Cell Cycle 12:17, 2719–2720; September 1, 2013; © 2013 Landes Bioscience EditoriaLS : CELL  CyCLE  FEaturES EditoriaLS : CELL  CyCLE  FEaturES *Correspondence to: Liisa Kauppi; Email: liisa.kauppi@helsinki.fi Submitted: 06/17/13; Accepted: 06/20/13http://dx.doi.org/10.4161/cc.26079Comment on: Kauppi L, et al.",Non-OADS,/arxiv_data1/oa_pdf/d3/96/cc-12-2719.PMC3899183.pdf
"Genes Dev 2013; 27:873-86; PMID:23599345; http://dx.doi.org/10.1101/gad.213652.113During meiosis, chromosomes undergo  the remarkable choreography of develop - mentally programmed breakage, pairing  with their homologous partners and sub - sequent DNA exchange.",Non-OADS,/arxiv_data1/oa_pdf/d3/96/cc-12-2719.PMC3899183.pdf
Nat Cell Biol 2012; 14:424-30;  PMID:22388890 ; http://dx.doi.org/10.1038/ ncb2451 2.,OADS,/arxiv_data1/oa_pdf/d3/96/cc-12-2719.PMC3899183.pdf
Genes Dev 2013; 27:873-86;  PMID:23599345 ; http://dx.doi.org/10.1101/ gad.213652.113 3.,OADS,/arxiv_data1/oa_pdf/d3/96/cc-12-2719.PMC3899183.pdf
Dev Cell 2008; 15:401-15;  PMID:18691940 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d3/96/cc-12-2719.PMC3899183.pdf
Nature 2008; 454:479-85;  PMID :18615017 ; http://dx.doi.org/10.1038/ nature07135 5.,Non-OADS,/arxiv_data1/oa_pdf/d3/96/cc-12-2719.PMC3899183.pdf
PLoS Genet 2007; 3:1894-906; PMID:17937504 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/d3/96/cc-12-2719.PMC3899183.pdf
Proc Natl Acad Sci U S A 1996;  93:5920-4;  PMID:8650194 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/96/cc-12-2719.PMC3899183.pdf
EMBO J 1997; 16:5207-15;  PMID:9311981 ; http://dx.doi.org/10.1093/ emboj /16.17.5207 8.,Non-OADS,/arxiv_data1/oa_pdf/d3/96/cc-12-2719.PMC3899183.pdf
"Genes Dev 1995; 9:925-34;  PMID:7774810 ; http://dx.doi.org/10.1101/ gad.9.8.925 Figure 1.  dSB numbers in different species, listed by genome size.",OADS,/arxiv_data1/oa_pdf/d3/96/cc-12-2719.PMC3899183.pdf
"Cell Cycle 2013; 12:2277–90;  PMID:23797582; http://dx.doi.org/10.4161/cc.25371 Brian K Kennedy; Buck Institute for Research on Aging; Novato, CA USA; Email: bkennedy@buckinstitute.org; http://dx.doi.org/10.4161/cc.26158 A-type nuclear lamins, all encoded by the  LMNA  gene through alternative splicing, are  targets for mutation in a wide range of rare  diseases, including a dominant mutation that  enhances production of lamin A splice variant  progerin, causing Hutchinson-Gilford proge - ria syndrome (HGP s).1 Often ignored, how - ever, is the complex and poorly understood  connection between A-type lamins and can - cer.2 expression of the 2 main A-type lamins  (lamins A and C) vary in inconsistent patterns  in a wide range of cancers.",Non-OADS,/arxiv_data1/oa_pdf/71/f5/cc-12-2721.PMC3899184.pdf
Cell 2013; 152:1365-75;   PMiD:23498943; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/71/f5/cc-12-2721.PMC3899184.pdf
Mol Cell 2010; 40:294-309; PMiD:20965423; http://dx.doi.org/10.1016/j.mol- cel.2010.09.022 5.,OADS,/arxiv_data1/oa_pdf/71/f5/cc-12-2721.PMC3899184.pdf
Cancer Res 2009; 69:9056-64;  PMi D:19920202 ; http://dx.doi.org/10.1158/0008- 5472.CAN-09-1770 6.,Non-OADS,/arxiv_data1/oa_pdf/71/f5/cc-12-2721.PMC3899184.pdf
Proc Natl Acad s ci U s A 2009;  106:14391-6;  PM iD:19706526 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/71/f5/cc-12-2721.PMC3899184.pdf
Mol Biol Cell 2008; 19:5238-48;  PMiD:18843043; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/71/f5/cc-12-2721.PMC3899184.pdf
Nature 2005; 437:564-8;   PMiD:16079796; http://dx.doi.org/10.1038/ nature04019,Non-OADS,/arxiv_data1/oa_pdf/71/f5/cc-12-2721.PMC3899184.pdf
"Cell Cycle 12:17, 2794–2808; September 1, 2013; © 2013 Landes Bioscience PaPer ty Pe 2794 Cell Cycle Volume 12 Issue 17*Correspondence to: Roberta Fraschini; Email: roberta.fraschini@unimib.it Submitted: 04/26/2013; Revised: 07/22/2013; Accepted: 07/23/2013   http://dx.doi.org/10.4161/cc.25869Cytokinesis completion in the budding yeast S. cerevisiae  is driven by tightly regulated pathways, leading to acto - myosin ring contraction coupled to plasma membrane constriction and to centripetal growth of the primary septum,  respectively.",Non-OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
Curr Opin Cell Biol 2010; 22:50-6;  PMID:20031383 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
J Cell Biol 1991; 114:111-23; PMID:2050738 ;  http://dx.doi.org/10.1083/jcb.114.1.111 4.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
J Cell Biol 2010; 191:1333- 50; PMID:21173112 ; http://dx.doi.org/10.1083/ jcb.201005134 5.,Non-OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
J Cell Biol 1998; 142:1301-12; PMID:9732290 ;  http://dx.doi.org/10.1083/jcb.142.5.1301 6.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
J Cell Biol 1998a; 140:355-66; PMID:9442111 ;  http://dx.doi.org/10.1083/jcb.140.2.355 7.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
Mol Biol Cell 2012; 23:45-58; PMID:22072794 ; http://dx.doi.org/10.1091/ mbc.E11-05-0434 8.,Non-OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
BMC  Genet 2005; 6:8; PMID :15715908 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
Mol  Microbiol 2005; 55:1325-31; PMID:15720543 ;  http://dx.doi.org/10.1111/j.1365-2958.2005.04507.x 10.,Non-OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
Cell Struct Funct 2001; 26:529-37;  PMID:11942606 ; http://dx.doi.org/10.1247/ csf.26.529 11.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
J Cell Biol  1998b; 143:1947-60;  PMID:9864366 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
Mol Biol Cell 2000; 11:593-611; PMID:10679017 ; http://dx.doi.org/10.1091/ mbc.11.2.593 13.,Non-OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
Genes Dev 2011; 25:875-88;  PMID:21498574 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
EMBO J 2005; 24:1440-52; PMID:15775961 ;  http://dx.doi.org/10.1038/sj.emboj.7600627 15.,Non-OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
Curr Biol 2000; 10:947-50;  PMID:10959846 ; http://dx.doi.org/10.1016/ S0960-9822(00)00626-6 16.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
Mol Biol Cell 2007;  18:5139-53;  PMID:17942599 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
Mol Biol Cell 2012; 23:2445-56;  PMID:22573892 ; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
Nat Cell Biol 2008; 10:395-406; PMID:18344988 ;  http://dx.doi.org/10.1038/ncb1701 19.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
Mol Genet Genomics 2009; 282:437- 51; PMID:19707790 ; http://dx.doi.org/10.1007/ s00438-009-0476-0 20.,Non-OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
J  Cell Biol 2009; 185:995-1012; PMID:19528296 ;  http://dx.doi.org/10.1083/jcb.200903125 21.,Non-OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
Annu Rev Genet 2004; 38:203-32; PMID :15568976 ; http://dx.doi.org/10.1146/ annurev.genet.38.072902.09305122.,Non-OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
EMBO J  2000; 19:6475-88;  PMID:11101520 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
Mol Biol Cell 2003; 14:4734-43;  PMID:12937277 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
Cell Cycle 2005; 4:961-71;  PMID :15917648 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
Mol Cell Biol 2000; 20:286-98; PMID:10594031 ; http://dx.doi.org/10.1128/ MCB.20.1.286-298.2000 29.,Non-OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
Curr Biol 2000; 10:329- 32; PMID:10744974 ; http://dx.doi.org/10.1016/ S0960-9822(00)00382-1 30.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
Mol Biol Cell 1999; 10:283- 96; PMID:9950677 ; http://dx.doi.org/10.1091/ mbc.10.2.283 31.,Non-OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
Cell Mol Life Sci 2008; 65:3458- 66; PMID:18597043 ; http://dx.doi.org/10.1007/ s00018-008-8220-1 32.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
Mol Biol Cell 2004;  15:3796-810;  PMID :15146058 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
PLoS Genet 2012;  8:e1002670;  PMID:22570619 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
Cell Cycle 2008; 7:96-105; PMID:18202552 ;  http://dx.doi.org/10.4161/cc.7.1.5113 35.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
Mol Biol Cell  2011; 22:2185-97;  PMID:21562220 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
Cell Cycle 2013; 12:1000-8;  PMID:23442799 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
Curr Biol 2001; 11:345- 50; PMID:11267871 ; http://dx.doi.org/10.1016/ S0960-9822(01)00095-1 38.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
Eur J Cell Biol 2006; 85:1201-15;  PMID:17005296 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
J Cell Biol  2009; 187:497-511;  PMID:19948498 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
Sci Signal 2010;  3:rs4;  PMID:21177495 ; http://dx.doi.org/10.1126/ scisignal.200118241.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
J Cell Sci  2010; 123:1851-61;  PMID:20442249 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
Methods Enzymol 2005; 399:51-64;  PMID:16338348 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
Oncogene 2008; 27:1355-65; PMID:17724460 ; http://dx.doi.org/10.1038/ sj.onc.1210782 44.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
Dev Cell  2002; 3:779-90;  PMID:12479804 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
Yeast  1994; 10:1793-808;  PMID:7747518 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
Yeast 2004; 21:947-62; PMID:15334558 ;  http://dx.doi.org/10.1002/yea.114250.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
Cell 1993; 75:791-803;  PMID:8242750 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
J Cell Biol 2006;  172:335-46;  PMID:16449187 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
Nat Methods 2012; 9:676-82;  PMID:22743772 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
Genes Dev 1996; 10:1516-31; PMID:8666235 ;  http://dx.doi.org/10.1101/gad.10.12.1516 54.,Non-OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
J Cell Biol 1999; 145:979- 91; PMID:10352016 ; http://dx.doi.org/10.1083/ jcb.145.5.979,Non-OADS,/arxiv_data1/oa_pdf/18/e6/cc-12-2794.PMC3899193.pdf
"Cell Cycle 12:17, 2876–2887; September 1, 2013; © 2013 Landes Bioscience PaPer ty Pe 2876 Cell Cycle Volume 12 Issue 17*Correspondence to: Patricia TW Cohen; Email: p.t.w.cohen@dundee.ac.uk Submitted: 06/20/2013; Accepted: 07/26/2013http://dx.doi.org/10.4161/cc.25919Many pharmaceuticals used to treat cancer target the cell cycle or mitotic spindle dynamics, such as the anti-tumor  drug, paclitaxel, which stabilizes microtubules.",Non-OADS,/arxiv_data1/oa_pdf/81/cc/cc-12-2876.PMC3899200.pdf
"t he predicted molecular sizes are  human r 3a 95.4 kDa, r 2 46.9 kDa and Ppp4c 35.1 kDa (Q6IN85, Q9N27, P60510 at http://www.uniprot.org/).",Non-OADS,/arxiv_data1/oa_pdf/81/cc/cc-12-2876.PMC3899200.pdf
Med Res Rev 2011; 31:443- 81; PMID:21381049 ; http://dx.doi.org/10.1002/ med.20242 2.,Non-OADS,/arxiv_data1/oa_pdf/81/cc/cc-12-2876.PMC3899200.pdf
Nat  Rev Mol Cell Biol 2011; 12:709-21; PMID:21993292 ;  http://dx.doi.org/10.1038/nrm3209 4.,OADS,/arxiv_data1/oa_pdf/81/cc/cc-12-2876.PMC3899200.pdf
J Cell Sci 2012; 125:4445- 56; PMID:23132930 ; http://dx.doi.org/10.1242/ jcs.106971 5.,OADS,/arxiv_data1/oa_pdf/81/cc/cc-12-2876.PMC3899200.pdf
J Cell Biol 1998; 141:663-74; PMID:9566967 ; http://dx.doi.org/10.1083/ jcb.141.3.663 6.,OADS,/arxiv_data1/oa_pdf/81/cc/cc-12-2876.PMC3899200.pdf
J Cell Sci 2012; 125:2805-14; PMID:22736044 ;  http://dx.doi.org/10.1242/jcs.092429 7.,OADS,/arxiv_data1/oa_pdf/81/cc/cc-12-2876.PMC3899200.pdf
J Cell Biol 2012; 197:59-74; PMID:22472440 ;  http://dx.doi.org/10.1083/jcb.201111123 9.,OADS,/arxiv_data1/oa_pdf/81/cc/cc-12-2876.PMC3899200.pdf
Mol Cell Biol 2007; 27:79-91;  PMID:17060460 ; http://dx.doi.org/10.1128/ MCB.00799-06 13.,Non-OADS,/arxiv_data1/oa_pdf/81/cc/cc-12-2876.PMC3899200.pdf
Int J Biochem Cell Biol 2008; 40:2315- 32; PMID:18487071 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/81/cc/cc-12-2876.PMC3899200.pdf
FEBS Lett 2005; 579:3278-86; PMID :15913612 ;  http://dx.doi.org/10.1016/j.febslet.2005.04.070 15.,OADS,/arxiv_data1/oa_pdf/81/cc/cc-12-2876.PMC3899200.pdf
Mol Cell Proteomics 2005; 4:1725-40;  PMID:16085932 ; http://dx.doi.org/10.1074/mcp.,OADS,/arxiv_data1/oa_pdf/81/cc/cc-12-2876.PMC3899200.pdf
Biochem J 2000;  347:845-55;  PMID:10769191 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/cc/cc-12-2876.PMC3899200.pdf
J Cell Sci 2003; 116:1905- 13; PMID:12668731 ; http://dx.doi.org/10.1242/ jcs.00409 19.,OADS,/arxiv_data1/oa_pdf/81/cc/cc-12-2876.PMC3899200.pdf
Chem Biol 1999; 6:R65-9; PMID:10074470 ; http://dx.doi.org/10.1016/ S1074-5521(99)89002-4 21.,OADS,/arxiv_data1/oa_pdf/81/cc/cc-12-2876.PMC3899200.pdf
Nat Cell Biol 2009; 11:1081-92; PMID:19648910 ;  http://dx.doi.org/10.1038/ncb1921 22.,OADS,/arxiv_data1/oa_pdf/81/cc/cc-12-2876.PMC3899200.pdf
Proc Natl Acad Sci U S A 2007;  104:2199-204;  PMID:17287340 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/cc/cc-12-2876.PMC3899200.pdf
J Cell Biochem  2009; 106:937-55;  PMID:19180585 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/cc/cc-12-2876.PMC3899200.pdf
Nat Cell Biol 2003; 5:143-8; PMID:12524548 ;  http://dx.doi.org/10.1038/ncb918 26.,OADS,/arxiv_data1/oa_pdf/81/cc/cc-12-2876.PMC3899200.pdf
J Cell Sci 2009; 122:4218-27;  PMID:19861490 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/cc/cc-12-2876.PMC3899200.pdf
Cell Cycle 2008; 7:1449- 61; PMID:18418077 ; http://dx.doi.org/10.4161/ cc.7.10.5880 28.,Non-OADS,/arxiv_data1/oa_pdf/81/cc/cc-12-2876.PMC3899200.pdf
Cancer Biol Ther 2007; 6:1853- 7; PMID:18087219 ; http://dx.doi.org/10.4161/ cbt.6.12.5164 29.,Non-OADS,/arxiv_data1/oa_pdf/81/cc/cc-12-2876.PMC3899200.pdf
J Biol Chem 2004; 279:31164-70;  PMID :15150265 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/81/cc/cc-12-2876.PMC3899200.pdf
PLoS One 2011; 6:e19700; PMID :21573187 ;  http://dx.doi.org/10.1371/journal.pone.0019700 32.,Non-OADS,/arxiv_data1/oa_pdf/81/cc/cc-12-2876.PMC3899200.pdf
J Cell Biol 2007; 177:253-64; PMID:17452529 ;  http://dx.doi.org/10.1083/jcb.200609166 33.,OADS,/arxiv_data1/oa_pdf/81/cc/cc-12-2876.PMC3899200.pdf
Nat Protoc 2006; 1:2856-60;  PMID:17406544 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/cc/cc-12-2876.PMC3899200.pdf
Mol  Cell Proteomics 2006; 5:337-46; PMID:16260767 ;  http://dx.doi.org/10.1074/mcp.M500210-MCP20035.,OADS,/arxiv_data1/oa_pdf/81/cc/cc-12-2876.PMC3899200.pdf
Methods  Enzymol 2003; 366:135-44; PMID:14674246 ;  http://dx.doi.org/10.1016/S0076-6879(03)66012-X 36.,OADS,/arxiv_data1/oa_pdf/81/cc/cc-12-2876.PMC3899200.pdf
Cell Cycle  2009; 8:4005-6;  PMID:19949293 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/cc/cc-12-2876.PMC3899200.pdf
" PaPer ty Pe www.landesbioscience.com Cell Cycle 2899Cell Cycle 12:17, 2899–2913; September 1, 2013; © 2013 Landes BiosciencerePort *Correspondence to: Hua-chuan Zheng; Email: zheng_huachuan@hotmail.com Submitted: 05/09/2013; Revised: 07/26/2013; Accepted: 07/29/2013http://dx.doi.org/10.4161/cc.25950Purpose: e xtracellular matrix metalloproteinase inducer ( eMMP rIN) was reported to involve in the invasion and  metastasis of malignancies by regulating the expression of vascular endothelial growth factor (V eGF) and matrix  metalloproteinases (MMPs) in stromal and cancer cells.",Non-OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
Cancer Invest 2009; 27:329-33;  PMID:19160100 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
Hum  Cell 2005; 18:1-16; PMID:16130895 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
Pathol Int 2006; 56:359-67;  PMID:16792544 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
Clin Exp  Metastasis 2003; 20:621-31; PMID:14669793 ;  http://dx.doi.org/10.1023/A:1027347932543 9.,Non-OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
Cancer 2004; 101:1994-2000;  PMID:15372476 ;  http://dx.doi.org/10.1002/cncr.20593 10.,Non-OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
Cancer Res 2004; 64:1229-32; PMID:14983875 ; http://dx.doi.org/10.1158/0008- 5472.CAN-03-2832 11.,Non-OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
Int J Cancer 2006; 118:2991-8; PMID:16425263 ; http://dx.doi.org/10.1002/ ijc.21778 13.,Non-OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
Cancer Lett 2006; 237:289-97; PMID:16046057 ;  http://dx.doi.org/10.1016/j.canlet.2005.06.009 15.,OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
Oncology 2007; 72:197-204; PMID:18160808 ;  http://dx.doi.org/10.1159/000112826 16.,Non-OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
Pathol Oncol Res 2009; 15:369- 74; PMID:19048397 ; http://dx.doi.org/10.1007/ s12253-008-9131-z 17.,Non-OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
J Surg Res 2010; 160:260- 7; PMID:19286191 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
Arch Histol Cytol  2007; 70:267-77;  PMID:18431027 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
Br J Cancer  2006; 95:1371-8;  PMID:17088917 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
J Cancer Res Clin Oncol 2011; 137:585- 96; PMID:20514493 ; http://dx.doi.org/10.1007/ s00432-010-0919-323.,Non-OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
Cell Mol Life Sci 2008; 65:2933-42;  PMID:18695939 ; http://dx.doi.org/10.1007/ s00018-008-8315-8 24.,OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
Cell Biol Int 2009; 33:199- 206; PMID:19059491 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
Oncogene 2011; 30:4410-27; PMID :21532623 ;  http://dx.doi.org/10.1038/onc.2011.149 26.,Non-OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
Oncogene 2010; 29:4145-56; PMID:20514014 ;  http://dx.doi.org/10.1038/onc.2010.166 27.,Non-OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
Cell Cycle  2013; 12:972-86;  PMID:23442798 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
Cell Cycle 2011; 10:3834-40; PMID:22071625 ; http://dx.doi.org/10.4161/ cc.10.22.18294 33.,Non-OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
Mod Pathol 2004; 17:1141-9; PMID :15167936 ;  http://dx.doi.org/10.1038/modpathol.3800165 34.,Non-OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
Biochimie  2005a; 87:361-8;  PMID :15781323 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
Histochem Cell Biol 2008; 130:1091- 103; PMID:18987874 ; http://dx.doi.org/10.1007/ s00418-008-0530-8 37.,Non-OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
Cell Cycle  2012; 11:2793-8;  PMID:22801544 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
Curr Top Dev Biol 2003; 54:371-89;  PMID:12696756 ; http://dx.doi.org/10.1016/ S0070-2153(03)54015-7 39.,OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
Front Biosci 2008; 13:5571-9; PMID:18508606 ;  http://dx.doi.org/10.2741/3100 40.,Non-OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
Trends Cell Biol 2010; 20:346-54;  PMID:20359892 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
Mol Biol Cell 2004; 15:4043-50; PMID :15201341 ;  http://dx.doi.org/10.1091/mbc.E04-05-040244.,Non-OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
Am J Pathol 2013; 182:577-85;  PMID:23178078 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
Cell Death Differ 2012; 19:1779-90; PMID:22595757 ; http://dx.doi.org/10.1038/ cdd.2012.60 47.,Non-OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
Neoplasma  2011; 58:449-54;  PMID:21745000 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
J Exp Clin Cancer Res  2010; 29:61;  PMID:20525232 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
Clin Transl Oncol 2012; 14:190-6; PMID:22374422 ;  http://dx.doi.org/10.1007/s12094-012-0783-5 52.,Non-OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
Pathol  Oncol Res 2011; 17:705-11; PMID:21448785 ;  http://dx.doi.org/10.1007/s12253-011-9373-z 53.,Non-OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
Med Oncol 2011; 28:1363- 72; PMID:20509007 ; http://dx.doi.org/10.1007/ s12032-010-9582-4 54.,Non-OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
Transl Res 2008;  152:143-9;  PMID:18774544 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
Eur J Cancer Prev  2007; 16:196-202;  PMID:17415090 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a2/9b/cc-12-2899.PMC3899202.pdf
"Ascore values weredetermined post-database search, using the identifiedphosphopeptides from Mascot and extracting theircorresponding MS/MS as input for the Ascore webserver(http://ascore.med.harvard.edu/ascore.html ).",OADS,/arxiv_data1/oa_pdf/9b/d7/13361_2013_Article_770.PMC3899453.pdf
October 2012. http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/000528/WC500036662.pdf .,Non-OADS,/arxiv_data1/oa_pdf/98/8f/40261_2013_Article_154.PMC3899454.pdf
October 2012. http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/000088/WC500050332.pdf .,Non-OADS,/arxiv_data1/oa_pdf/98/8f/40261_2013_Article_154.PMC3899454.pdf
2003. http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/98/8f/40261_2013_Article_154.PMC3899454.pdf
http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/98/8f/40261_2013_Article_154.PMC3899454.pdf
Available from: http://www.kidney.org/professionals/KDOQI/guidelines_ diabetesUp/diabetes-ckd-update-2012.pdf .,Non-OADS,/arxiv_data1/oa_pdf/67/b1/40262_2013_Article_113.PMC3899495.pdf
Available from: http://www.kidney.org/professionals/kdoqi/pdf/ Diabetes_AJKD_FebSuppl_07.pdf .,Non-OADS,/arxiv_data1/oa_pdf/67/b1/40262_2013_Article_113.PMC3899495.pdf
Available from: http://www.ema.europa.eu/docs/ en_GB/document_library/EPAR_-_Product_Information/human/000528/WC500036662.pdf .,Non-OADS,/arxiv_data1/oa_pdf/67/b1/40262_2013_Article_113.PMC3899495.pdf
Available from: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAd-visoryCommittee/UCM327017.pdf .,Non-OADS,/arxiv_data1/oa_pdf/67/b1/40262_2013_Article_113.PMC3899495.pdf
Available from: http://www.ema.europa.eu/docs/en_GB/document_ library/EPAR_-_Product_Information/human/000284/WC5000 36082.pdf .,Non-OADS,/arxiv_data1/oa_pdf/67/b1/40262_2013_Article_113.PMC3899495.pdf
Available from: http://www.medicines.org.uk/ emc/medicine/26470/SPC/Insuman ?Comb ?15?100?IU?ml?,Non-OADS,/arxiv_data1/oa_pdf/67/b1/40262_2013_Article_113.PMC3899495.pdf
Available from: http://www.medicines.org.uk/ emc/medicine/3425/SPC/Humulin ?Vials% 2c?Cartridges ?and?KwikPens/ .,Non-OADS,/arxiv_data1/oa_pdf/67/b1/40262_2013_Article_113.PMC3899495.pdf
Available from: http://www.medicines.org.uk/emc/ medicine/3512/SPC/Insulatard ?100?IU?ml%2c ?Insulatard ?,Non-OADS,/arxiv_data1/oa_pdf/67/b1/40262_2013_Article_113.PMC3899495.pdf
Available from: http://www.ema.europa.eu/docs/en_ GB/document_library/EPAR_- _Product_Information/human/ 002498/WC500138940.pdf .,Non-OADS,/arxiv_data1/oa_pdf/67/b1/40262_2013_Article_113.PMC3899495.pdf
SNPs wereselected with the use of the genome browsers of the International HapMap Consortium ( http://www.hapmap.,OADS,/arxiv_data1/oa_pdf/a8/e5/40291_2013_Article_59.PMC3899496.pdf
"org/index.html.en ), University of California Santa Cruz (UCSC; http://genome.ucsc.edu ), and dbSNP database (http://www.ncbi.nlm.nih.gov/projects/SNP/ ).",OADS,/arxiv_data1/oa_pdf/a8/e5/40291_2013_Article_59.PMC3899496.pdf
Available from: http://www.iowapath.com/documents/ IPA‑Histology‑Specimen‑Collection‑Guide.pdf.,Non-OADS,/arxiv_data1/oa_pdf/61/dd/NJS-19-68.PMC3899551.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/ 3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/65/TORJ-7-125.PMC3899588.pdf
"For the aim of our analysis the residential areas were divided into urban and rural which was calculated with data provided from the National Statistical Service of Greece according to the 2001 population census (National Statistical Service, http://www.statistics.gr/portal/page/portal/ESYE).",OADS,/arxiv_data1/oa_pdf/44/23/TORMJ-7-77.PMC3899589.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/44/23/TORMJ-7-77.PMC3899589.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d3/ab/srep03832.PMC3899596.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3832 | DOI: 10.1038/srep03832 6",Non-OADS,/arxiv_data1/oa_pdf/d3/ab/srep03832.PMC3899596.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/0a/0f/srep03842.PMC3899598.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3842 | DOI: 10.1038/srep03842 7",Non-OADS,/arxiv_data1/oa_pdf/0a/0f/srep03842.PMC3899598.pdf
"Ottawa Hospital Research Institute (OHRI) 2013;  Available from: http://www.ohri.ca/ Programs/clinical_epidemiolog  y/oxford.asp  [23] Böhning D. Computer-assisted analysis of mixtures and  applications: meta-analysis, disease mapping and others.",Non-OADS,/arxiv_data1/oa_pdf/d0/b7/CDS-8-333.PMC3899599.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/3d/b9/srep03836.PMC3899600.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3836 | DOI: 10.1038/srep03836 7",Non-OADS,/arxiv_data1/oa_pdf/3d/b9/srep03836.PMC3899600.pdf
Average densitometric values were obtained by using the ImageJ software (http://rsb.info.nih.gov/ij/) from 2 images where both structurescould be unequivocally defined (see Figure 3).,OADS,/arxiv_data1/oa_pdf/2e/0d/srep03839.PMC3899601.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/2e/0d/srep03839.PMC3899601.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3839 | DOI: 10.1038/srep03839 10",Non-OADS,/arxiv_data1/oa_pdf/2e/0d/srep03839.PMC3899601.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/8a/fa/srep03834.PMC3899630.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3834 | DOI: 10.1038/srep03834 7",Non-OADS,/arxiv_data1/oa_pdf/8a/fa/srep03834.PMC3899630.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c6/1d/srep03830.PMC3899631.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3830 | DOI: 10.1038/srep03830 9",Non-OADS,/arxiv_data1/oa_pdf/c6/1d/srep03830.PMC3899631.pdf
http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9e/2c/JCB-5-21671.PMC3899633.pdf
Available online at: http://physics.nist.gov/PhysRefData/XrayMassCoef/tab4.html.,OADS,/arxiv_data1/oa_pdf/78/73/JCB-5-21940.PMC3899641.pdf
"Joint AAPM/RPC Registry of Brachytherapy Sources Meet-ing the AAPM Dosimetric Prerequisites, available online at: http://rpc.mdanderson.org/rpc/BrachySeeds/Source_Reg-istry.htm (last accessed November, 27 2013).",OADS,/arxiv_data1/oa_pdf/78/73/JCB-5-21940.PMC3899641.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3837 | DOI: 10.1038/srep03837 10",Non-OADS,/arxiv_data1/oa_pdf/1c/69/srep03837.PMC3899642.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ce/26/srep03826.PMC3899643.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3826 | DOI: 10.1038/srep03826 8",Non-OADS,/arxiv_data1/oa_pdf/ce/26/srep03826.PMC3899643.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/93/1b/srep03793.PMC3899644.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3793 | DOI: 10.1038/srep03793 7",Non-OADS,/arxiv_data1/oa_pdf/93/1b/srep03793.PMC3899644.pdf
The subjects gave informed consent for their participationin the experiments which were conducted according to the principles in the Declaration of Helsinki and approved by the ethics committee at Advanced Telecommunication Research Institute (http://www.atr.jp/).,Non-OADS,/arxiv_data1/oa_pdf/3b/14/srep03824.PMC3899645.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: Japanese patent  2011-027711 (pending) on the use of collaborative paradigms for sports and rehabilitation.,Non-OADS,/arxiv_data1/oa_pdf/3b/14/srep03824.PMC3899645.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3824 | DOI: 10.1038/srep03824 7",Non-OADS,/arxiv_data1/oa_pdf/3b/14/srep03824.PMC3899645.pdf
The Survey monkey link was also circulated in an RCGP newsletter and participants invited to pass the link on to interested parties (https://www.surveymonkey.com/s/QCL6R3K).,Non-OADS,/arxiv_data1/oa_pdf/d1/f6/10.1177_2042533313510155.PMC3899736.pdf
Available from: http://dx.doi.org/10.1017/ S1463423612000576 (last accessed 28 October 2013).,Non-OADS,/arxiv_data1/oa_pdf/d1/f6/10.1177_2042533313510155.PMC3899736.pdf
Available from: http://www.napcrg.org/ 2012Abstracts.pdf (last accessed 18 September 2013).,Non-OADS,/arxiv_data1/oa_pdf/d1/f6/10.1177_2042533313510155.PMC3899736.pdf
The Ward hierarchical clustering algorithm and Euclidean distance metrics (http://www.eisenlab.org/eisen/) were used for clustering the results.,OADS,/arxiv_data1/oa_pdf/71/63/srep03828.PMC3899747.pdf
http://pdsp.med.unc.edu/pdsp.php.48.,Non-OADS,/arxiv_data1/oa_pdf/71/63/srep03828.PMC3899747.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: Y.F., A.M.F.",Non-OADS,/arxiv_data1/oa_pdf/71/63/srep03828.PMC3899747.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3828 | DOI: 10.1038/srep03828 11",Non-OADS,/arxiv_data1/oa_pdf/71/63/srep03828.PMC3899747.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors have no competing financial interest.,Non-OADS,/arxiv_data1/oa_pdf/42/49/srep03838.PMC3899748.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3838 | DOI: 10.1038/srep03838 11",Non-OADS,/arxiv_data1/oa_pdf/42/49/srep03838.PMC3899748.pdf
"Affymetrix U133 Plus 2.0 CEL files for 46 HNSCC patient samples (24 survivors and 22 non-survivors) were downloaded from a publicly available microarray data set (http://bioinformatics.picr.man.ac .uk/vice/PublicProject.vice?pid=361) and normalised in BioConductor-R (version 2.15.1) (Bioconductor, Seattle, WA, USA).",OADS,/arxiv_data1/oa_pdf/2b/23/bjc2013639a.PMC3899750.pdf
org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Improving outcome prediction in OPSCC 500 www.bjcancer.com | DOI:10.1038/bjc.2013.639,Non-OADS,/arxiv_data1/oa_pdf/2b/23/bjc2013639a.PMC3899750.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.640 509,Non-OADS,/arxiv_data1/oa_pdf/e8/8f/bjc2013640a.PMC3899751.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER EIF5A2 in melanoma prognosis 408 www.bjcancer.com | DOI:10.1038/bjc.2013.688,Non-OADS,/arxiv_data1/oa_pdf/9e/99/bjc2013688a.PMC3899752.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Pancreatic stellate cells taxi cancer cells 420 www.bjcancer.com | DOI:10.1038/bjc.2013.706,Non-OADS,/arxiv_data1/oa_pdf/6f/f9/bjc2013706a.PMC3899756.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)DAP3 promotes chemotherapy-induced apoptosis BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.712 429,Non-OADS,/arxiv_data1/oa_pdf/50/80/bjc2013712a.PMC3899757.pdf
"All statistical analyses were performed using Microsoft Excel, SAS (http://www.pauldickman.com), and SPSS software packages.Group comparisons were assessed with t- and w 2tests.",OADS,/arxiv_data1/oa_pdf/84/dd/bjc2013714a.PMC3899758.pdf
"(BTEC; http://epi.grants.cancer.gov/btec/) as an inspiring scientific forum, fostering the development of multi-center, international and inter-disciplinary collaborations.",Non-OADS,/arxiv_data1/oa_pdf/84/dd/bjc2013714a.PMC3899758.pdf
ABTR looks forward to ongoing collaboration with the Society of Austrian Neurooncology (SANO; http://sano.co.at).,Non-OADS,/arxiv_data1/oa_pdf/84/dd/bjc2013714a.PMC3899758.pdf
"Israel National Cancer Registry (2013), http://www.health.gov.il/English/ MinistryUnits/HealthDivision/Icdc/Icrc/Pages/default.aspx, last assessed 03/07/2013.",Non-OADS,/arxiv_data1/oa_pdf/84/dd/bjc2013714a.PMC3899758.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER MicroRNA-29a targets KLF4 in colorectal cancer 458 www.bjcancer.com | DOI:10.1038/bjc.2013.724,Non-OADS,/arxiv_data1/oa_pdf/f2/6e/bjc2013724a.PMC3899762.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Dose-escalated weekly paclitaxel for advanced gastric cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.726 277,Non-OADS,/arxiv_data1/oa_pdf/69/6e/bjc2013726a.PMC3899763.pdf
"sanger.ac.uk), TargetScan (http://genes.mit.edu/targetscan), and PicTar (http://pictar.bio.nyu.edu) target prediction programs (Lewis et al , 2003; Krek et al , 2005; Griffiths-Jones et al , 2008; Zheng et al, 2012).",OADS,/arxiv_data1/oa_pdf/03/e3/bjc2013728a.PMC3899764.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER MicroRNA-7 in non-small-cell lung cancer 362 www.bjcancer.com | DOI:10.1038/bjc.2013.728,Non-OADS,/arxiv_data1/oa_pdf/03/e3/bjc2013728a.PMC3899764.pdf
"A data set consisting of the 476 differentially expressed genes was imported into the Ingenuity Pathway Analysis Tool (IPA Tool; IngenuitySystems, Redwood City, CA, USA; http://www.ingenuity.",OADS,/arxiv_data1/oa_pdf/6f/6c/bjc2013729a.PMC3899765.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER The cholinic phenotype in ovarian cancer 340 www.bjcancer.com | DOI:10.1038/bjc.2013.729,Non-OADS,/arxiv_data1/oa_pdf/6f/6c/bjc2013729a.PMC3899765.pdf
Conclusion: All updates have been implemented in a new version of the BOADICEA web interface that is now available for general use: http://ccge.medschl.cam.ac.uk/boadicea/.,OADS,/arxiv_data1/oa_pdf/64/86/bjc2013730a.PMC3899766.pdf
"To address this problem, we developed the BOADICEA web application (BWA; http://ccge.medschl.cam.ac.uk/boadicea/), (Cunningham et al, 2012), a user-friendly web interface to the BFP that makes it much easier for health-care professionals andmembers of the public to run BOADICEA calculations.",OADS,/arxiv_data1/oa_pdf/64/86/bjc2013730a.PMC3899766.pdf
"In recent years, we have compiled previous versions of the BOADICEA program with the GNU FORTRAN compiler (http://www.gnu.org) (version 4.4.3).",Non-OADS,/arxiv_data1/oa_pdf/64/86/bjc2013730a.PMC3899766.pdf
"Similarly, we have extended the BOADICEA import/ export format (described in Appendix A of the BWA v3 user guide: https://pluto.srl.cam.ac.uk/bd3/v3/docs/BWA_v3_user_guide.pdf) so that users can include the new pathology parameters in the datafiles that they upload for processing.",Non-OADS,/arxiv_data1/oa_pdf/64/86/bjc2013730a.PMC3899766.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Novel therapeutic targets in mesothelioma BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.731 519,Non-OADS,/arxiv_data1/oa_pdf/a7/99/bjc2013731a.PMC3899767.pdf
"Lyon, France: International Agencyfor Research on Cancer; Available from http://globocan.iarc.fr.",Non-OADS,/arxiv_data1/oa_pdf/35/4f/bjc2013741a.PMC3899769.pdf
"National Cancer Institute: Bethesda, MD, USAhttp://seer.cancer.gov/csr/1975_2010/ (based on November 2012 SEER data submission, posted to the SEER web site, 2013).",OADS,/arxiv_data1/oa_pdf/35/4f/bjc2013741a.PMC3899769.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)CTC in breast cancer subtypes BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.743 383,Non-OADS,/arxiv_data1/oa_pdf/e3/48/bjc2013743a.PMC3899770.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Expression profile of angiogenic factors in stroma of colorectal cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.745 449,Non-OADS,/arxiv_data1/oa_pdf/76/88/bjc2013745a.PMC3899771.pdf
"National data (http://info.cancerresearchuk.org/cancerstats/types/), arbitrarily divides SCCHN into laryngeal and oral cancer, the latter comprising a heterogeneous group of tumours including lip, tongue, mouth, oropharynx, piriform sinus, hypopharynx and other sites.",Non-OADS,/arxiv_data1/oa_pdf/99/9f/bjc2013746a.PMC3899772.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Plasma miR-9 in nasopharyngeal carcinoma 398 www.bjcancer.com | DOI:10.1038/bjc.2013.751,Non-OADS,/arxiv_data1/oa_pdf/99/88/bjc2013751a.PMC3899774.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Potentiation of cisplatin-induced apoptosis in NSCLC by gambogic acid 352 www.bjcancer.com | DOI:10.1038/bjc.2013.752,Non-OADS,/arxiv_data1/oa_pdf/4d/d3/bjc2013752a.PMC3899775.pdf
org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)FGFR inhibitor in pancreatic cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.754 329,Non-OADS,/arxiv_data1/oa_pdf/a4/2a/bjc2013754a.PMC3899776.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)HER3 and PTEN in HER2-positive metastatic breast cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.757 391,Non-OADS,/arxiv_data1/oa_pdf/44/9a/bjc2013757a.PMC3899777.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Transcriptome profiling of squamous cell carcinoma BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.760 529,Non-OADS,/arxiv_data1/oa_pdf/c4/22/bjc2013760a.PMC3899778.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER ALDH1 predicts poor prognosis in RC 434 www.bjcancer.com | DOI:10.1038/bjc.2013.767,Non-OADS,/arxiv_data1/oa_pdf/56/6d/bjc2013767a.PMC3899780.pdf
http://www.telegraph.co.uk/earth/earthcomment/country-diary/10117911/ Country-diary-badgers-are-out-of-control.html.,Non-OADS,/arxiv_data1/oa_pdf/6d/ac/srep03809.PMC3899851.pdf
"(Game and Wildlife Conservation Trust, Fordingbridge, 2011) (http://www.gwct.org.uk/ngcmammals).",Non-OADS,/arxiv_data1/oa_pdf/6d/ac/srep03809.PMC3899851.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3809 | DOI: 10.1038/srep03809 8",Non-OADS,/arxiv_data1/oa_pdf/6d/ac/srep03809.PMC3899851.pdf
"Key words: human copeptin; endogenous stress ; diagnostic accuracy; prognosis Received: November 29, 2012 Accepted: May 01, 2013Copeptin and its potential role in diagnosis and prognosis of various diseases Lidija Dobša*1, Kido Cullen Edozien2 1Health Institution Varaždin County, Medical Biochemistry Laboratory, Varaždin, Croatia 2Mater Dei Hospital, Msida, Malta *Corresponding author: lidijadobsa@gmail.com Biochemia Medica 2013;23(2):172–90  http://dx.doi.org/10.11613/BM.2013.021 172Review Introduction Copeptin, a 39-aminoacid glycopeptide is a C-ter- minal part of pre-provasopressin (pre-proAVP).",Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
"http://dx.doi.org/10.11613/BM.2013.021 Biochemia Medica 2013;23(2):172–90   173Dobša L, Edozien KC.",Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
"Biochemia Medica 2013;23(2):172–90  http://dx.doi.org/10.11613/BM.2013.021 174Dobša L, Edozien KC.",Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
"http://dx.doi.org/10.11613/BM.2013.021 Biochemia Medica 2013;23(2):172–90   175Dobša L, Edozien KC.",Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
"Biochemia Medica 2013;23(2):172–90  http://dx.doi.org/10.11613/BM.2013.021 176Dobša L, Edozien KC.",Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
"http://dx.doi.org/10.11613/BM.2013.021 Biochemia Medica 2013;23(2):172–90   177Dobša L, Edozien KC.",Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
"Biochemia Medica 2013;23(2):172–90  http://dx.doi.org/10.11613/BM.2013.021 178Dobša L, Edozien KC.",Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
"http://dx.doi.org/10.11613/BM.2013.021 Biochemia Medica 2013;23(2):172–90   179Dobša L, Edozien KC.",Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
"Biochemia Medica 2013;23(2):172–90  http://dx.doi.org/10.11613/BM.2013.021 180Dobša L, Edozien KC.",Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
"http://dx.doi.org/10.11613/BM.2013.021 Biochemia Medica 2013;23(2):172–90   181Dobša L, Edozien KC.",Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
"Biochemia Medica 2013;23(2):172–90  http://dx.doi.org/10.11613/BM.2013.021 182Dobša L, Edozien KC.",Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
"http://dx.doi.org/10.11613/BM.2013.021 Biochemia Medica 2013;23(2):172–90   183Dobša L, Edozien KC.",Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
"Biochemia Medica 2013;23(2):172–90  http://dx.doi.org/10.11613/BM.2013.021 184Dobša L, Edozien KC.",Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
"http://dx.doi.org/10.11613/BM.2013.021 Biochemia Medica 2013;23(2):172–90   185Dobša L, Edozien KC.",Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
"Biochemia Medica 2013;23(2):172–90  http://dx.doi.org/10.11613/BM.2013.021 186Dobša L, Edozien KC.",Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
"http://dx.doi.org/10.11613/BM.2013.021 Biochemia Medica 2013;23(2):172–90   187Dobša L, Edozien KC.",Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
"Biochemia Medica 2013;23(2):172–90  http://dx.doi.org/10.11613/BM.2013.021 188Dobša L, Edozien KC.",Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
http://dx.doi.org/10.1210/jc.2005-2830.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
http://dx.doi.org/10.1210/jc.2006-2046.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
http://dx.doi.org/10.1210/jc.2007-0232.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
Trends Endo-crinol Metab 2008;19:43-9. http://dx.doi.org/10.1016/j.tem.2007.11.001.,OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
http://dx.doi.org/10.1016/j.peptides.2005.04.019.,OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
http://dx.doi.org/10.1210/jc.2010-2499.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
Crit Care 2008;12:117. http://dx.doi.org/10.1186/cc6799.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
Circulation 2007;115:2103-10. http://dx.doi.org/10.1161/CIRCULATIONAHA.106.685503.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
Malar J 2012;11:26. http://dx.doi.org/10.1186/1475-2875-11-26.11.,OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
http://dx.doi.org/10.1093/eurheartj/ehp098.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
http://dx.doi.org/10.1042/CS20080140.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
http://dx.doi.org/10.1515/cclm-2011-0845.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
J Pharmacol Sci 2009;109:44-9. http://dx.doi.org/10.1254/jphs.08R14FM.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
J Bras Pneumol 2011;37:495-503. http://dx.doi.org/10.1590/S1806-37132011000400012.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
Circulation 2010;121:2102-8. http://dx.doi.org/10.1161/CIRCULATIONAHA.109.909663.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
http://dx.doi.org/10.1016/j.peptides.2011.11.017.,OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
http://dx.doi.org/10.1159/000335888.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
http://dx.doi.org/10.1111/j.1365-2362.2006.01724.x.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
BMC Med 2012;10:7. http://dx.doi.org/10.1186/1741-7015-10-7.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
Clin Chem 2006;52:112-9. http://dx.doi.org/10.1373/clinchem.2005.060038.,OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
J Clin Invest 1973;52:2340-52. http://dx.doi.org/10.1172/JCI107423.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
"http://dx.doi.org/10.11613/BM.2013.021 Biochemia Medica 2013;23(2):172–90   189Dobša L, Edozien KC.",Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
http://dx.doi.org/10.1016/j.ajem.2011.12.008.,OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
http://dx.doi.org/10.1007/s00392-011-0343-y.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
Int J Cardiol 2012;162:27-32. http://dx.doi.org/10.1016/j.ijcard.2011.12.105.,OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
J Am Coll Cardiol 2009;54:60-8. http://dx.doi.org/10.1016/j.jacc.2009.01.076.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
Arch Cardiovasc Dis 2011;104:4-10. http://dx.doi.org/10.1016/j.acvd.2010.11.002.,OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
http://dx.doi.org/10.2147/VHRM.S21753.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
http://dx.doi.org/10.1016/j.jacc.2010.01.029.,OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
JAMA 2011;305:2088-95. http://dx.doi.org/10.1001/jama.2011.666.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
http://dx.doi.org/10.1373/clinchem.2009.125856.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
http://dx.doi.org/10.1016/j.jacc.2008.03.050.34.,OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
http://dx.doi.org/10.1210/jc.2008-1426.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
Crit Care Med 2009;37:476-82. http://dx.doi.org/10.1097/CCM.0b013e3181957532.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
http://dx.doi.org/10.1186/cc9102.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
J Crit Care 2012;27:523. http://dx.doi.org/10.1016/j.jcrc.2011.07.081.,OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
http://dx.doi.org/10.1111/j.1365-2362.2007.01762.x.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
http://dx.doi.org/10.1093/jac/dkp148.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
http://dx.doi.org/10.1164/rccm.201003-0415OC.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
http://dx.doi.org/10.1186/cc6780.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
http://dx.doi.org/10.1373/clinchem.2007.085688.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
Chest 2007;131:1058-67. http://dx.doi.org/10.1378/chest.06-2336.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
"Biochemia Medica 2013;23(2):172–90  http://dx.doi.org/10.11613/BM.2013.021 190Dobša L, Edozien KC.",Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
http://dx.doi.org/10.1186/cc9336.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
http://dx.doi.org/10.2215/CJN.04560510.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
http://dx.doi.org/10.1210/jc.2008-2278.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
Int J Obes (Lond) 2013;37:598-603. http://dx.doi.org/10.1038/ijo.2012.88.50.,OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
BMC Neurol 2010;10:34. http://dx.doi.org/10.1186/1471-2377-10-34.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
http://dx.doi.org/10.1016/j.peptides.2012.01.011.,OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
http://dx.doi.org/10.1016/j.peptides.2010.11.021.,OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
http://dx.doi.org/10.1186/cc10575.,Non-OADS,/arxiv_data1/oa_pdf/45/42/biochem_med-23-2-172-6.PMC3900057.pdf
"Key words:  Chi-square; non-parametric; assumptions;  categorical data; statistical analysis Received:  April 1, 2013 Accepted: May 6, 2013 http://dx.doi.org/10.11613/BM.2013.018 Biochemia Medica 2013;23(2):143–9   143Lessons in biostatistics Introduction The Chi-square test of independence (also known  as the Pearson Chi-square test, or simply the Chi-square) is one of the most useful statistics for test-ing hypotheses when the variables are nominal, as often happens in clinical research.",Non-OADS,/arxiv_data1/oa_pdf/72/10/biochem_med-23-2-143-3.PMC3900058.pdf
Biochemia Medica 2013;23(2):143–9  http://dx.doi.org/10.11613/BM.2013.018 144McHugh ML.,Non-OADS,/arxiv_data1/oa_pdf/72/10/biochem_med-23-2-143-3.PMC3900058.pdf
http://dx.doi.org/10.11613/BM.2013.018 Biochemia Medica 2013;23(2):143–9    145McHugh ML.,Non-OADS,/arxiv_data1/oa_pdf/72/10/biochem_med-23-2-143-3.PMC3900058.pdf
Biochemia Medica 2013;23(2):143–9  http://dx.doi.org/10.11613/BM.2013.018 146McHugh ML.,Non-OADS,/arxiv_data1/oa_pdf/72/10/biochem_med-23-2-143-3.PMC3900058.pdf
http://dx.doi.org/10.11613/BM.2013.018 Biochemia Medica 2013;23(2):143–9    147McHugh ML.,Non-OADS,/arxiv_data1/oa_pdf/72/10/biochem_med-23-2-143-3.PMC3900058.pdf
Biochemia Medica 2013;23(2):143–9  http://dx.doi.org/10.11613/BM.2013.018 148McHugh ML.,Non-OADS,/arxiv_data1/oa_pdf/72/10/biochem_med-23-2-143-3.PMC3900058.pdf
http://dx.doi.org/10.11613/BM.2013.018 Biochemia Medica 2013;23(2):143–9    149McHugh ML.,Non-OADS,/arxiv_data1/oa_pdf/72/10/biochem_med-23-2-143-3.PMC3900058.pdf
Biometrics 1982;38:1101-6. http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/72/10/biochem_med-23-2-143-3.PMC3900058.pdf
Crit Care 2004;8:46-53. http://dx.doi.org/10.1186/cc2428.,Non-OADS,/arxiv_data1/oa_pdf/72/10/biochem_med-23-2-143-3.PMC3900058.pdf
"Key words: plagiarism; editorial policy; scientifi  c misconduct Received: April 20, 2013 Accepted: April 28, 2013Biochemia Medica  has started using the CrossCheck plagiarism detection  software powered by iThenticate Vesna Šupak-Smolčić, Ana-Maria Šimundić Biochemia Medica , Zagreb, Croatia http://dx.doi.org/10.11613/BM.2013.016 Biochemia Medica 2013;23(2):139–40   139Editorial In addition to the recent changes of our policies  towards the research integrity issues (1), in Febru-ary 2013, Biochemia Medica  has joined CrossRef, a  non-profi  t organization for promotion of scholarly  publication research through reference linking (www.crossref.org).",Non-OADS,/arxiv_data1/oa_pdf/cf/72/biochem_med-23-2-139-1.PMC3900059.pdf
"Biochemia Medica 2013;23(2):139–40  http://dx.doi.org/10.11613/BM.2013.016 140Šupak-Smolčić V, Šimundić AM.",OADS,/arxiv_data1/oa_pdf/cf/72/biochem_med-23-2-139-1.PMC3900059.pdf
Biochem Med 2013;23:5-6. http://dx.doi.org/10.11613/BM.2013.001.,OADS,/arxiv_data1/oa_pdf/cf/72/biochem_med-23-2-139-1.PMC3900059.pdf
Biochem Med 2013;23:16-8. http://dx.doi.org/10.11613/BM.2013.004.,OADS,/arxiv_data1/oa_pdf/cf/72/biochem_med-23-2-139-1.PMC3900059.pdf
Biochem Med 2013; 23:150-3. http://dx.doi.org/10.11613/BM.2013.019.,Non-OADS,/arxiv_data1/oa_pdf/cf/72/biochem_med-23-2-139-1.PMC3900059.pdf
"Biochemia Medica 2013;23(2):218–23  http://dx.doi.org/10.11613/BM.2013.026 218Abstract Procedures involving phlebotomy are critical for obtaining diag nostic blood specimens and represent a well known and recognized  problem, pro- bably among the most important issues in laboratory medicine.",Non-OADS,/arxiv_data1/oa_pdf/30/c1/biochem_med-23-2-218-11.PMC3900060.pdf
http://dx.doi.org/10.11613/BM.2013.026 Biochemia Medica 2013;23(2):218–23   219Lima-Oliveira G. et al.,Non-OADS,/arxiv_data1/oa_pdf/30/c1/biochem_med-23-2-218-11.PMC3900060.pdf
Biochemia Medica 2013;23(2):218–23  http://dx.doi.org/10.11613/BM.2013.026 220Lima-Oliveira G. et al.,Non-OADS,/arxiv_data1/oa_pdf/30/c1/biochem_med-23-2-218-11.PMC3900060.pdf
http://dx.doi.org/10.11613/BM.2013.026 Biochemia Medica 2013;23(2):218–23   221Lima-Oliveira G. et al.,Non-OADS,/arxiv_data1/oa_pdf/30/c1/biochem_med-23-2-218-11.PMC3900060.pdf
Biochemia Medica 2013;23(2):218–23  http://dx.doi.org/10.11613/BM.2013.026 222Lima-Oliveira G. et al.,Non-OADS,/arxiv_data1/oa_pdf/30/c1/biochem_med-23-2-218-11.PMC3900060.pdf
Biochem Med 2012;22:145-9. http://dx.doi.org/10.11613/BM.2012.017.,Non-OADS,/arxiv_data1/oa_pdf/30/c1/biochem_med-23-2-218-11.PMC3900060.pdf
Biochem Med 2010;20:64-74. http://dx.doi.org/10.11613/BM.2010.008.,OADS,/arxiv_data1/oa_pdf/30/c1/biochem_med-23-2-218-11.PMC3900060.pdf
Semin Thromb He-most 2012;38:565-75. http://dx.doi.org/10.1055/s-0032-1315961.,Non-OADS,/arxiv_data1/oa_pdf/30/c1/biochem_med-23-2-218-11.PMC3900060.pdf
Lab Med 2012;43:17-21. http://dx.doi.org/10.1309/LMZ7YARD6ZS-DIID.,OADS,/arxiv_data1/oa_pdf/30/c1/biochem_med-23-2-218-11.PMC3900060.pdf
Biochem Med 2010;20:5-8. http://dx.doi.org/10.11613/BM.2010.001.,OADS,/arxiv_data1/oa_pdf/30/c1/biochem_med-23-2-218-11.PMC3900060.pdf
Biochem Med 2011;21:152-9. http://dx.doi.org/10.11613/BM.2011.024.,Non-OADS,/arxiv_data1/oa_pdf/30/c1/biochem_med-23-2-218-11.PMC3900060.pdf
Clin Chim Acta 2011;412:1482-4. http://dx.doi.org/10.1016/j.cca.2011.04.008.,OADS,/arxiv_data1/oa_pdf/30/c1/biochem_med-23-2-218-11.PMC3900060.pdf
2012; Available at: http://www.westgard.com/biodataba-se1.htm.,Non-OADS,/arxiv_data1/oa_pdf/30/c1/biochem_med-23-2-218-11.PMC3900060.pdf
Biochem Med 2012;22:342-51. http://dx.doi.org/10.11613/BM.2012.036.,Non-OADS,/arxiv_data1/oa_pdf/30/c1/biochem_med-23-2-218-11.PMC3900060.pdf
J Clin Pa-thol 2011;64:1019-20. http://dx.doi.org/10.1136/jclinpath-2011-200206.,Non-OADS,/arxiv_data1/oa_pdf/30/c1/biochem_med-23-2-218-11.PMC3900060.pdf
Clin Biochem 2012;45:683-7. http://dx.doi.org/10.1016/j.clinbiochem.2012.03.007.,OADS,/arxiv_data1/oa_pdf/30/c1/biochem_med-23-2-218-11.PMC3900060.pdf
Bi-ochem Med 2012;22:180-6. http://dx.doi.org/10.11613/BM.2012.021.,Non-OADS,/arxiv_data1/oa_pdf/30/c1/biochem_med-23-2-218-11.PMC3900060.pdf
Blood Coagul Fibrinolysis 2013;24:252-5. http://dx.doi.org/10.1097/MBC.0b013e32835b72ea.,Non-OADS,/arxiv_data1/oa_pdf/30/c1/biochem_med-23-2-218-11.PMC3900060.pdf
http://dx.doi.org/10.11613/BM.2013.026 Biochemia Medica 2013;23(2):218–23   223Lima-Oliveira G. et al.,Non-OADS,/arxiv_data1/oa_pdf/30/c1/biochem_med-23-2-218-11.PMC3900060.pdf
Ann Clin Biochem 2008;45:601-3. http://dx.doi.org/10.1258/acb.2008.007241.,Non-OADS,/arxiv_data1/oa_pdf/30/c1/biochem_med-23-2-218-11.PMC3900060.pdf
Ann Clin Biochem 2010;47:485-6. http://dx.doi.org/10.1258/acb.2010.009306.,OADS,/arxiv_data1/oa_pdf/30/c1/biochem_med-23-2-218-11.PMC3900060.pdf
Scand J Clin Lab Invest 1999;59:491-500. http://dx.doi.org/10.1080/00365519950185229.,Non-OADS,/arxiv_data1/oa_pdf/30/c1/biochem_med-23-2-218-11.PMC3900060.pdf
Clin Chem Lab Med 2010;48:1447-54. http://dx.doi.org/10.1515/cclm.2010.286.,OADS,/arxiv_data1/oa_pdf/30/c1/biochem_med-23-2-218-11.PMC3900060.pdf
Scand J Clin Lab Invest 2004;64:175-84. http://dx.doi.org/10.1080/00365510410004885.,OADS,/arxiv_data1/oa_pdf/30/c1/biochem_med-23-2-218-11.PMC3900060.pdf
Biochemia Medica 2013;23(2):150–3  http://dx.doi.org/10.11613/BM.2013.019 150Abstract Self-plagiarism is a controversial issue in scientifi  c writing an d presentation of research data.,Non-OADS,/arxiv_data1/oa_pdf/77/df/biochem_med-23-2-150-4.PMC3900061.pdf
"http://dx.doi.org/10.11613/BM.2013.019 Biochemia Medica 2013;23(2):150–3   151Šupak-Smolčić V, Bilić-Zulle L. How do we handle self-plagiarism?",Non-OADS,/arxiv_data1/oa_pdf/77/df/biochem_med-23-2-150-4.PMC3900061.pdf
COPE fl  owcharts can be accessed  from the offi   cial COPE web page (http://www.pub- licationethics.org) and are available to both editors and authors.,OADS,/arxiv_data1/oa_pdf/77/df/biochem_med-23-2-150-4.PMC3900061.pdf
"Biochemia Medica 2013;23(2):150–3  http://dx.doi.org/10.11613/BM.2013.019 152Šupak-Smolčić V, Bilić-Zulle L. How do we handle self-plagiarism?",Non-OADS,/arxiv_data1/oa_pdf/77/df/biochem_med-23-2-150-4.PMC3900061.pdf
"http://dx.doi.org/10.11613/BM.2013.019 Biochemia Medica 2013;23(2):150–3   153Šupak-Smolčić V, Bilić-Zulle L. How do we handle self-plagiarism?",Non-OADS,/arxiv_data1/oa_pdf/77/df/biochem_med-23-2-150-4.PMC3900061.pdf
Available at: http://publicationethics.org/text-recycling- guidelines.,Non-OADS,/arxiv_data1/oa_pdf/77/df/biochem_med-23-2-150-4.PMC3900061.pdf
Biochem Med 2010;20:295-300. http://dx.doi.org/10.11613/BM.2010.037.,OADS,/arxiv_data1/oa_pdf/77/df/biochem_med-23-2-150-4.PMC3900061.pdf
Avai-lable at: http://publicationethics.org/fi  les/u2/01A_Redun-dant_Submitted.pdf.,Non-OADS,/arxiv_data1/oa_pdf/77/df/biochem_med-23-2-150-4.PMC3900061.pdf
Available at: http://publicationethics.org/fi  les/u2/01B_Redundant_Pu-blished.pdf.,Non-OADS,/arxiv_data1/oa_pdf/77/df/biochem_med-23-2-150-4.PMC3900061.pdf
Available at: http://publicationethics.org/fi  les/retracti-on%20guidelines.pdf.,Non-OADS,/arxiv_data1/oa_pdf/77/df/biochem_med-23-2-150-4.PMC3900061.pdf
Biochem Med 2012;22:271. http://dx.doi.org/10.11613/BM.2012.028.,OADS,/arxiv_data1/oa_pdf/77/df/biochem_med-23-2-150-4.PMC3900061.pdf
http://dx.doi.org/10.11613/BM.2013.017 Biochemia Medica 2013;23(2):141–2   141Abstract One of the more frequent activities in health sciences is the measurement of biological quantities.,Non-OADS,/arxiv_data1/oa_pdf/c6/4e/biochem_med-23-2-141-2.PMC3900062.pdf
Biochemia Medica 2013;23(2):141–2  http://dx.doi.org/10.11613/BM.2013.017 142Fuentes-Arderiu X.,Non-OADS,/arxiv_data1/oa_pdf/c6/4e/biochem_med-23-2-141-2.PMC3900062.pdf
Accred Qual Assur 2007;12:497-8. http://dx.doi.org/10.1007/s00769-007-0273-6.,Non-OADS,/arxiv_data1/oa_pdf/c6/4e/biochem_med-23-2-141-2.PMC3900062.pdf
Availa-ble at: http://goldbook.iupac.org.,Non-OADS,/arxiv_data1/oa_pdf/c6/4e/biochem_med-23-2-141-2.PMC3900062.pdf
Available at: http://www.bipm.org/utils/common/documents/jcgm/JCGM_200_2012.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c6/4e/biochem_med-23-2-141-2.PMC3900062.pdf
Pure Appl Chem 2011;83:1873-935. http://dx.doi.org/10.1351/PAC-REP-07-09-39.,OADS,/arxiv_data1/oa_pdf/c6/4e/biochem_med-23-2-141-2.PMC3900062.pdf
"Biochemia Medica 2013;23(2):206–10  http://dx.doi.org/10.11613/BM.2013.024 206Original papers The eff  ects of transport by pneumatic tube system on blood cell count,  erythrocyte sedimentation and coagulation tests Fatma Emel Koçak1*, Mustafa Yöntem2, Özlem Yücel2, Mustafa Çilo2, Özlem Genç3, Ayfer Meral1 1Kütahya Evliya Celebi Training and Research Hospital of Faculty of Medicine of Dumlupınar University, Department of Biochemistr y  and Clinical Biochemistry, Kütahya, Turkey 2Institute of Science of Dumlupınar University, Department of Molecular Biology, Kütahya, Turkey 3Kütahya Evliya Celebi Training and Research Hospital of Faculty of Medicine of Dumlupınar University, Department of Medical  Microbiology, Kütahya, Turkey *Corresponding author: dremelk@hotmail.com Introduction The pneumatic tube system (PTS) has become a  commonly used method of transport in hospitals; it is inexpensive and effi   cient.",Non-OADS,/arxiv_data1/oa_pdf/90/59/biochem_med-23-2-206-9.PMC3900063.pdf
http://dx.doi.org/10.11613/BM.2013.024 Biochemia Medica 2013;23(2): 206–10   207Koçak FE.,Non-OADS,/arxiv_data1/oa_pdf/90/59/biochem_med-23-2-206-9.PMC3900063.pdf
Biochemia Medica 2013;23(2):206–10  http://dx.doi.org/10.11613/BM.2013.024 208Koçak FE.,Non-OADS,/arxiv_data1/oa_pdf/90/59/biochem_med-23-2-206-9.PMC3900063.pdf
http://dx.doi.org/10.11613/BM.2013.024 Biochemia Medica 2013;23(2): 206–10   209Koçak FE.,Non-OADS,/arxiv_data1/oa_pdf/90/59/biochem_med-23-2-206-9.PMC3900063.pdf
Biochemia Medica 2013;23(2):206–10  http://dx.doi.org/10.11613/BM.2013.024 210Koçak FE.,Non-OADS,/arxiv_data1/oa_pdf/90/59/biochem_med-23-2-206-9.PMC3900063.pdf
Biochem Med  2008;18:311-9. http://dx.doi.org/10.11613/BM.2008.027.,Non-OADS,/arxiv_data1/oa_pdf/90/59/biochem_med-23-2-206-9.PMC3900063.pdf
Lab medicine 2009;40:728-31. http://dx.doi.org/10.1309/LMZNZ2Y1P3KRDQYL.,Non-OADS,/arxiv_data1/oa_pdf/90/59/biochem_med-23-2-206-9.PMC3900063.pdf
Am J Emerg Med 1995;13:484. http://dx.doi.org/10.1016/0735-6757(95)90145-0.,OADS,/arxiv_data1/oa_pdf/90/59/biochem_med-23-2-206-9.PMC3900063.pdf
Clin Chem 2011;57:1349-50. http://dx.doi.org/10.1373/clinchem.2011.172452.,Non-OADS,/arxiv_data1/oa_pdf/90/59/biochem_med-23-2-206-9.PMC3900063.pdf
Ann Clin Biochem 2004;41:237-40. http://dx.doi.org/10.1258/000456304323019631.,Non-OADS,/arxiv_data1/oa_pdf/90/59/biochem_med-23-2-206-9.PMC3900063.pdf
Clin  Biochem 1980;13:259-61. http://dx.doi.org/10.1016/S0009-9120(80)80005-1.,OADS,/arxiv_data1/oa_pdf/90/59/biochem_med-23-2-206-9.PMC3900063.pdf
Clin Bio-chem 2009;42:1265-69. http://dx.doi.org/10.1016/j.clinbiochem.2009.05.002.11.,OADS,/arxiv_data1/oa_pdf/90/59/biochem_med-23-2-206-9.PMC3900063.pdf
J Clin Pathol 2002;55:105-7. http://dx.doi.org/10.1136/jcp.55.2.105.,Non-OADS,/arxiv_data1/oa_pdf/90/59/biochem_med-23-2-206-9.PMC3900063.pdf
J  Emerg Nurs 2006;32:139-43. http://dx.doi.org/10.1016/j.jen.2005.11.013.,OADS,/arxiv_data1/oa_pdf/90/59/biochem_med-23-2-206-9.PMC3900063.pdf
Clin Chem Lab Med 2011;49:1303-09. http://dx.doi.org/10.1515/cclm.2011.611.,OADS,/arxiv_data1/oa_pdf/90/59/biochem_med-23-2-206-9.PMC3900063.pdf
Transfus Apher Sci 2012;47:81-3. http://dx.doi.org/10.1016/j.transci.2012.05.005.,OADS,/arxiv_data1/oa_pdf/90/59/biochem_med-23-2-206-9.PMC3900063.pdf
Transfus Med Hemother 2003;30:157-62. http://dx.doi.org/10.1159/000073324.,Non-OADS,/arxiv_data1/oa_pdf/90/59/biochem_med-23-2-206-9.PMC3900063.pdf
Clin Chem Lab Med 2008;46:1443-9. http://dx.doi.org/10.1515/CCLM.2008.288.,OADS,/arxiv_data1/oa_pdf/90/59/biochem_med-23-2-206-9.PMC3900063.pdf
Biochemia Medica 2013;23(2):154–71  http://dx.doi.org/10.11613/BM.2013.020 154Abstract Type 2 diabetes mellitus (T2DM) is a worldwide epidemic with cons iderable health and economic consequences.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
http://dx.doi.org/10.11613/BM.2013.020 Biochemia Medica 2013;23(2):154–71   155Semiz S. et al.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Biochemia Medica 2013;23(2):154–71  http://dx.doi.org/10.11613/BM.2013.020 156Semiz S. et al.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
http://dx.doi.org/10.11613/BM.2013.020 Biochemia Medica 2013;23(2):154–71   157Semiz S. et al.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Biochemia Medica 2013;23(2):154–71  http://dx.doi.org/10.11613/BM.2013.020 158Semiz S. et al.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
http://dx.doi.org/10.11613/BM.2013.020 Biochemia Medica 2013;23(2):154–71   159Semiz S. et al.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Biochemia Medica 2013;23(2):154–71  http://dx.doi.org/10.11613/BM.2013.020 160Semiz S. et al.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
http://dx.doi.org/10.11613/BM.2013.020 Biochemia Medica 2013;23(2):154–71   161Semiz S. et al.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Biochemia Medica 2013;23(2):154–71  http://dx.doi.org/10.11613/BM.2013.020 162Semiz S. et al.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
http://dx.doi.org/10.11613/BM.2013.020 Biochemia Medica 2013;23(2):154–71   163Semiz S. et al.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Biochemia Medica 2013;23(2):154–71  http://dx.doi.org/10.11613/BM.2013.020 164Semiz S. et al.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
http://dx.doi.org/10.11613/BM.2013.020 Biochemia Medica 2013;23(2):154–71   165Semiz S. et al.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Biochemia Medica 2013;23(2):154–71  http://dx.doi.org/10.11613/BM.2013.020 166Semiz S. et al.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Diabetes Res Clin Pract 2011;94:311-21. http://dx.doi.org/10.1016/j.diabres.2011.10.029.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Pharmacogenet Genomics 2012;22:812-9. http://dx.doi.org/10.1097/FPC.0b013e328358d92b.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Expert Opin Drug Metab Toxicol 2012;8:371-82. http://dx.doi.org/10.1517/17425255.2012.657626.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Mol Diagn Ther 2012;16:285-302. http://dx.doi.org/10.1007/s40291-012-0002-7.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Annu Rev Pharmacol Toxicol 2012; 53: 581-612. http://dx.doi.org/10.1146/annurev-pharmtox-011112-140309.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Expert Opin Drug Metab Toxicol 2012;8:723-43. http://dx.doi.org/10.1517/17425255.2012.678048.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Epigenetics 2012;7:841-52. http://dx.doi.org/10.4161/epi.21238.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Circ Res 2010;107:810-7. http://dx.doi.org/10.1161/CIRCRESAHA.110.226357.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Cell 2012;148:1293-307. http://dx.doi.org/10.1016/j.cell.2012.02.009.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Clin Pharmacol Ther 2012;92:437-9. http://dx.doi.org/10.1038/clpt.2012.125.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
J Physiol 2010;588:3201-9. http://dx.doi.org/10.1113/jphysiol.2010.191767.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Hum Mutat 2009;30:170-80. http://dx.doi.org/10.1002/humu.20838.13.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
N Engl J Med 2004;350:1838-49. http://dx.doi.org/10.1056/NEJMoa032922.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
N Engl J Med 2006;355:467-77. http://dx.doi.org/10.1056/NEJMoa061759.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
J Clin Endocrinol Metab 2004;89:5504-7. http://dx.doi.org/10.1210/jc.2004-1241.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Diabetes 2008;57:244-54. http://dx.doi.org/10.2337/db07-0615.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
J Hum Genet 2009;54:433-5. http://dx.doi.org/10.1038/jhg.2009.54.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
J Clin Endocrinol Metab 2006;91:2334-9. http://dx.doi.org/10.1210/jc.2005-2323.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Diabetes 2009;58:1869-78. http://dx.doi.org/10.2337/db09-0025.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Eur J In-tern Med 2012;23:245-9. http://dx.doi.org/10.1016/j.ejim.2011.10.018.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
J Pediatr Endocri- nol Metab 2011;24:1077-80. http://dx.doi.org/10.1515/JPEM.2011.250.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
J Pediatr Endocrinol Metab 2012;25:367-70. http://dx.doi.org/10.1515/jpem-2011-0191.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Am J Hum Genet  2007;81:375-82. http://dx.doi.org/10.1086/519174.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
http://dx.doi.org/10.11613/BM.2013.020 Biochemia Medica 2013;23(2):154–71   167Semiz S. et al.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Diabetes Obes Me-tab 2007;9 Suppl 2:28-39. http://dx.doi.org/10.1111/j.1463-1326.2007.00772.x.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Diabetes Care 2008;31:1939-44. http://dx.doi.org/10.2337/dc07-2248.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Pharmacogenomics 2012;13:5-7; aut- hor reply 9-10. http://dx.doi.org/10.2217/pgs.11.150.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Pharma-cogenomics 2010;11:1743-50. http://dx.doi.org/10.2217/pgs.10.135.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Arch Med Res 2009;40:387-92. http://dx.doi.org/10.1016/j.arcmed.2009.06.006.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Genet Test Mol Biomarkers 2012;16:924-30. http://dx.doi.org/10.1089/gtmb.2011.0337.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Am J Med Ge-net 2001;101:4-8. http://dx.doi.org/10.1002/ajmg.1297.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Diabetes 2012;61:241-9. http://dx.doi.org/10.2337/db11-0371.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Pharmacogenet Genomics 2012;22:206-14. http://dx.doi.org/10.1097/FPC.0b013e32835001e7.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Diabet Med 2000;17:543-5. http://dx.doi.org/10.1046/j.1464-5491.2000.00305.x.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
http://dx.doi.org/10.12659/MSM.881850.35.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Di-abetes Care 2004;27:1394-8. http://dx.doi.org/10.2337/diacare.27.6.1394.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Mech Dev 2001;101:3-9. http://dx.doi.org/10.1016/S0925-4773-(00)00557-8.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
J Mol Med (Berl) 2007;85:777-82. http://dx.doi.org/10.1007/ s00109-007-0203-4.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
BMC Med Genet 2009;10:15. http://dx.doi.org/10.1186/1471-2350-10-15.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Diabetes Obes Metab 2011;13:89-91. http://dx.doi.org/10.1111/j.1463-1326.2010.01324.x.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Diabetes 2007;56:2178-82. http://dx.doi.org/10.2337/db07-0440.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
BMC Med Genet 2011;12:30. http://dx.doi.org/10.1186/1471-2350-12-30.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Clin Pharmacol Ther 2008;83:288-92. http://dx.doi.org/10.1038/sj.clpt.6100273.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Pharmacogenomics 2009;10:1781-7. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Br J Clin Phar-macol 2005;60:103-6. http://dx.doi.org/10.1111/j.1365-2125.2005.02379.x.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Biochemia Medica 2013;23(2):154–71  http://dx.doi.org/10.11613/BM.2013.020 168Semiz S. et al.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Mol Diagn Ther 2007;11:291-302. http://dx.doi.org/10.1007/BF03256250.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Pharmaceuticals (Basel) 2010;3:2610-46. http://dx.doi.org/10.3390/ph3082610.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Clin Phar-macol Ther 2002;71:286-96. http://dx.doi.org/10.1067/mcp.2002.122476.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Clin Phar- macol Ther 2002;72:326-32. http://dx.doi.org/10.1067/mcp.2002.127495.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Pharmacogenomics 2010;11:1517-23. http://dx.doi.org/10.2217/pgs.10.121.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Clin Pharmacol Ther 2010;87:52-6. http://dx.doi.org/10.1038/clpt.2009.176.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Drug Saf 2007;30:741-53. http://dx.doi.org/10.2165/00002018-200730090-00002.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
N Engl J Med 2007;356:2457-71. http://dx.doi.org/10.1056/NEJMoa072761.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Am J Cardiovasc Drugs 2011;11:357-62. http://dx.doi.org/10.2165/11595990-000000000-00000.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Expert Opin  Drug Saf 2011;10:419-28. http://dx.doi.org/10.1517/14740338.2011.534982.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Cardiovasc Drug  Rev 2002;20:329-40. http://dx.doi.org/10.1111/j.1527-3466.2002.tb00100.x.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Nat Rev Urol 2012;9:353. http://dx.doi.org/10.1038/nrurol.2012.131.60.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
http://dx.doi.org/10.1503/cmaj.112102.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Clin Pharmacol Ther 2005;78:202-8. http://dx.doi.org/10.1016/j.clpt.2005.04.013.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
J Clin Pharmacol 2010;50:1022-30. http://dx.doi.org/10.1177/0091270009355159.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Endocr J 2009;56:1049-58. http://dx.doi.org/10.1507/endocrj.K08E-320.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Br J Clin Pharmacol 2008;65:917-26. http://dx.doi.org/10.1111/j.1365-2125.2008.03145.x.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Eur J Clin Pharmacol 2008;64:663-71. http://dx.doi.org/10.1007/s00228-008-0483-9.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Basic Clin Phar-macol Toxicol 2006;99:44-51. http://dx.doi.org/10.1111/j.1742-7843.2006.pto_437.x.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Clin Pharmacoki-net 2005;44:1209-25. http://dx.doi.org/10.2165/00003088-200544120-00002.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
http://dx.doi.org/10.11613/BM.2013.020 Biochemia Medica 2013;23(2):154–71   169Semiz S. et al.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Clin Pharmacol Ther 2006;80:657-67. http://dx.doi.org/10.1016/j.clpt.2006.09.008.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
http://dx.doi.org/10.2337/dc12-s011.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
"El-Mir MY , Nogueira V, Fontaine E, Averet N, Rigoulet M, Le- verve X. Dimethylbiguanide inhibits cell respiration via an indirect eff  ect targeted on the respiratory chain complex  I. J Biol Chem 2000;275:223-8. http://dx.doi.org/10.1074/jbc.275.1.223.",Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Biochem J 2000;348 Pt 3:607-14. http://dx.doi.org/10.1042/0264-6021:3480607.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Clin Sci (Lond) 2012;122:253-70. http://dx.doi.org/10.1042/CS20110386.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Sci- ence 2005;310:1642-6. http://dx.doi.org/10.1126/scien-ce.1120781.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
J Clin Invest 2010;120:2355-69. http://dx.doi.org/10.1172/JCI40671.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Diabetes Metab 2003;29:279-83. http://dx.doi.org/10.1016/S1262-3636-(07)70037-X.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Pharmacogenetics 2003;13:581-4. http://dx.doi.org/10.1097/00008571-200309000-00007.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
J Clin Pharmacol 2006;46:157-63. http://dx.doi.org/10.1177/0091270005283838.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Clin Pharmacokinet 2011;50:81-98. http://dx.doi.org/10.2165/11534750-000000000-00000.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Drug Metab Dispos 2007;35:1956-62. http://dx.doi.org/10.1124/dmd.107.015495.85.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
J Phar-macol Exp Ther 2002;302:510-5. http://dx.doi.org/10.1124/jpet.102.034140.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Pharm Res 2005;22:255-9. http://dx.doi.org/10.1007/s11095-004-1193-3.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
J Am Soc Nephrol 2006;17:2127-35. http://dx.doi.org/10.1681/ASN.2006030205.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Clin Phar-macol Ther 2011;89:837-44. http://dx.doi.org/10.1038/clpt.2011.36.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
N Engl J Med 2006;355 :2427-43.  http://dx.doi.org/10.1056/NEJMoa066224.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
J Clin Invest 2007;117:1422-31. http://dx.doi.org/10.1172/JCI30558.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Clin Phar-macol Ther 2008;83:273-80. http://dx.doi.org/10.1038/sj.clpt.6100275.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Clin Pharmacol Ther 2009;86:299-306. http://dx.doi.org/10.1038/clpt.2009.92.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Diabetes 2009;58:1434-9. http://dx.doi.org/10.2337/db08-0896.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Pharmacogenomics J 2009;9:242-7. http://dx.doi.org/10.1038/tpj.2009.15.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Pharmacoge-net Genomics 2011;21:837-50. http://dx.doi.org/10.1097/FPC.0b013e32834c0010.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Biochemia Medica 2013;23(2):154–71  http://dx.doi.org/10.11613/BM.2013.020 170Semiz S. et al.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Pharmacoge-net Genomics 2012;22:659-66. http://dx.doi.org/10.1097/FPC.0b013e3283561666.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Xenobiotica 1994;24:49-57. http://dx.doi.org/10.3109/00498259409043220.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Biochem Pharmacol 2005;70:1851-60. http://dx.doi.org/10.1016/j.bcp.2005.09.011.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Clin Pharmacol Ther 2008;84:559-62. http://dx.doi.org/10.1038/clpt.2008.61.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Pharmacogenet Genomics 2008;18:637-45. http://dx.doi.org/10.1097/FPC.0b013e328302cd41.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Pharmacogenet Genomics 2009;19:497-504. http://dx.doi.org/10.1097/FPC.0b013e32832cc7e9.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Diabetes 2009;58:745-9. http://dx.doi.org/10.2337/db08-1028.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Diabetes 2010;59:2672-81. http://dx.doi.org/10.2337/db10-0543.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Clin Phar-macol Ther 2011;90:674-84. http://dx.doi.org/10.1038/clpt.2011.165.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Pharmacogenet Ge-nomics 2010;20:687-99. http://dx.doi.org/10.1097/FPC.0b013e32833fe789.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Nat Genet 2011;43:117-20. http://dx.doi.org/10.1038/ng.735.108.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
J Biol Chem 2006;281:33403-13. http://dx.doi.org/10.1074/jbc.M605195200.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
J Med Chem 1984;27:79-81. http://dx.doi.org/10.1021/jm00367a016.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Diabetes 1998;47:345-51. http://dx.doi.org/10.2337/diabetes.47.3.345.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Br J Clin Phar-macol 2008;66:818-25. http://dx.doi.org/10.1111/j.1365-2125.2008.03287.x.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Br J Clin Pharmacol 2006;62:567-72. http://dx.doi.org/10.1111/j.1365-2125.2006.02686.x.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
J Clin Pharmacol 2008;48:311-21. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Pharmacogenet Genomics 2008;18:937-42. http://dx.doi.org/10.1097/FPC.0b013e32830d733e.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Eur J Clin Pharmacol 2013;69:407-13. http://dx.doi.org/10.1007/s00228-012-1364-9.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Br J Clin Phar-macol 2003;56:305-14. http://dx.doi.org/10.1046/j.0306-5251.2003.01862.x.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Drug Metab Dispos 2011;39:927-32. http://dx.doi.org/10.1124/dmd.110.036921.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Pharmacology 2012;89:105-10. http://dx.doi.org/10.1159/000336345.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Clin Exp Pharmacol Physiol 2012;39:462-8. http://dx.doi.org/10.1111/j.1440-1681.2012.05701.x.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
http://dx.doi.org/10.11613/BM.2013.020 Biochemia Medica 2013;23(2):154–71   171Semiz S. et al.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Nat Genet 2008;40:1092-7. http://dx.doi.org/10.1038/ng.207.,OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Clin Pharmacol Ther 2011;89:437-42. http://dx.doi.org/10.1038/clpt.2010.351.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Eur J Clin Pharmacol 2010;66:1207-15. http://dx.doi.org/10.1007/s00228-010-0882-6.123.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Clin Pharmacol Ther 2010;87:330-5. http://dx.doi.org/10.1038/clpt.2009.242.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
Clin Exp Pharmacol Physiol 2011;38:550-4. http://dx.doi.org/10.1111/j.1440-1681.2011.05548.x.,Non-OADS,/arxiv_data1/oa_pdf/17/57/biochem_med-23-2-154-5.PMC3900064.pdf
"Biochemia Medica 2013;23(2):A56–A61  http://dx.doi.org/10.11613/BM.2013.027 A5624th Symposyum Croatian Society of Medical Biochemistry and Laboratory Medicine Laboratory medicine in sports Faculty of Pharmacy and Biochemistry Lecture Hall, Ante Kovačića 1, Zagreb May 1 1th, 2013 Organizers Clinical Department of Laboratory Diagnostics, Dubrava University Hospital, Zagreb Croatian Society of Medical Biochemistry and Laboratory Medicine, Zagreb Faculty of Pharmacy and Biochemistry, Zagreb Organizing Committee Željko Romić, president Sanda Berženji Marina Čeprnja Nataša Hodak-Samovojska Tamara Knežević Tihana Serdar Scientifi  c Committee Rajko Kušec, president Jasna Juriček Jasna Lovreček Željko Romić Branka Vitunjski-Englert Marcela Živković",Non-OADS,/arxiv_data1/oa_pdf/a1/ec/biochem_med-23-2-a56-12.PMC3900065.pdf
"http://dx.doi.org/10.11613/BM.2013.027 Biochemia Medica 2013;23(2):A56–A61  A57Abstracts of the 24th Symposyum Croatian Society of Medical Biochemistry and Laboratory Medicine Role of biocemical diagnostics in sports Igor Jukić*, Josip Zekić, Vlatko Vučetić Faculty of Kinesiology, University of Zagreb, Zagreb, Croatia Introduction: Intensive exercising may signifi  - cantly damage muscles which is refl  ected in pain,  fatigue and the increase of muscle proteins con-centrations in blood such are creatinin kinase (CK), lactic dehydrogenase (LD), myoglobin (MB) and other biochemical parameters including urea se-rum concentration (SU).",Non-OADS,/arxiv_data1/oa_pdf/a1/ec/biochem_med-23-2-a56-12.PMC3900065.pdf
Biochemia Medica 2013;23(2):A56–A61  http://dx.doi.org/10.11613/BM.2013.027 A58Abstracts of the 24th Symposyum Croatian Society of Medical Biochemistry and Laboratory Medicine of some sports.,Non-OADS,/arxiv_data1/oa_pdf/a1/ec/biochem_med-23-2-a56-12.PMC3900065.pdf
http://dx.doi.org/10.11613/BM.2013.027 Biochemia Medica 2013;23(2):A56–A61  A59Abstracts of the 24th Symposyum Croatian Society of Medical Biochemistry and Laboratory Medicine minimal sample size.,OADS,/arxiv_data1/oa_pdf/a1/ec/biochem_med-23-2-a56-12.PMC3900065.pdf
"Biochemia Medica 2013;23(2):A56–A61  http://dx.doi.org/10.11613/BM.2013.027 A60Abstracts of the 24th Symposyum Croatian Society of Medical Biochemistry and Laboratory Medicine Infl ammatory markers in monitoring  training and sports injuries Adriana Unić Department of Laboratory Diagnosis, Dubrava University  Hospital, Zagreb, Croatia Every exercise lasting at least six minutes causes  an acute phase infl  ammatory response.",Non-OADS,/arxiv_data1/oa_pdf/a1/ec/biochem_med-23-2-a56-12.PMC3900065.pdf
http://dx.doi.org/10.11613/BM.2013.027 Biochemia Medica 2013;23(2):A56–A61  A61Abstracts of the 24th Symposyum Croatian Society of Medical Biochemistry and Laboratory Medicine ment of the increase or decrease in a redox-sensi- tive molecule that responds to oxidative stress.,OADS,/arxiv_data1/oa_pdf/a1/ec/biochem_med-23-2-a56-12.PMC3900065.pdf
"http://dx.doi.org/10.11613/BM.2013.022 Biochemia Medica 2013;23(2):193–200   193Abstract Background:  A number of preanalytical activities strongly infl  uence sample quality, especially those relate d to sample collection.",Non-OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
Biochemia Medica 2013;23(2):193–200  http://dx.doi.org/10.11613/BM.2013.022 194Lippi G. et al.,Non-OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
http://dx.doi.org/10.11613/BM.2013.022 Biochemia Medica 2013;23(2):193–200   195Lippi G. et al.,OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
Biochemia Medica 2013;23(2):193–200  http://dx.doi.org/10.11613/BM.2013.022 196Lippi G. et al.,Non-OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
http://dx.doi.org/10.11613/BM.2013.022 Biochemia Medica 2013;23(2):193–200   197Lippi G. et al.,Non-OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
Biochemia Medica 2013;23(2):193–200  http://dx.doi.org/10.11613/BM.2013.022 198Lippi G. et al.,Non-OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
http://dx.doi.org/10.11613/BM.2013.022 Biochemia Medica 2013;23(2):193–200   199Lippi G. et al.,Non-OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
Clin Chem Lab Med 2011;49:1113-26. http://dx.doi.org/10.1515/cclm.2011.600.,OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
Biochem Med 2012;22:145-9. http://dx.doi.org/10.11613/BM.2012.017.,Non-OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
Semin Thromb Hemost 2012;38:565-75. http://dx.doi.org/10.1055/s-0032-1315961.,Non-OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
Biochem Med 2010;20:154-9. http://dx.doi.org/10.11613/BM.2010.018.,OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
Crit Rev Clin Lab Sci 2011;48:143-53. http://dx.doi.org/10.3109/10408363.2011.600228.,Non-OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
Clin Chem Lab Med 2008;46:764-72. http://dx.doi.org/10.1515/CCLM.2008.170.,OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
Bi-ochem Med 2011;21:297-305. http://dx.doi.org/10.11613/BM.2011.040.,Non-OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
Clin Chem Lab Med 2011;49:2097-100. http://dx.doi.org/10.1515/CCLM.2011.703.,OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
Clin Biochem 2012;45:1012-32. http://dx.doi.org/10.1016/j.clinbiochem.2012.08.002.,OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
Am J Crit Care 2009;18:474-8. http://dx.doi.org/10.4037/ajcc2009686.,Non-OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
Biochem Med 2012;22:7-14. http://dx.doi.org/10.11613/BM.2012.002.,OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
BMC Med Res Methodol 2003;3:25. http://dx.doi.org/10.1186/1471-2288-3-25.14.,Non-OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
Lab Medicine 2002;33:378-80. http://dx.doi.org/10.1309/PGM4-4F8L-2P1M-LKPB.,Non-OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
http://dx.doi.org/10.1016/j.jen.2012.11.002.,OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
J Clin Nurs 2008;17:2343-51. http://dx.doi.org/10.1111/j.1365-2702.2006.02057.x.,OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
J Emerg Nurs 2003;29:116-21. http://dx.doi.org/10.1067/men.2003.66.,Non-OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
J Emerg Nurs 2003;29:406. http://dx.doi.org/10.1016/S0099-1767(03)00356-8.,OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
J Emerg Nurs 1996;22:566-9. http://dx.doi.org/10.1016/S0099-1767(96)80213-3.,OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
J Emerg Nurs 2008;34:26-32. http://dx.doi.org/10.1016/j.jen.2007.02.006.,OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
Clin Chem Lab Med 2011;49:157-8. http://dx.doi.org/10.1515/cclm.2011.012.,OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
Intern Emerg Med 2011;6:357-9. http://dx.doi.org/10.1007/s11739-011-0568-9.,Non-OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
http://dx.doi.org/10.1016/j.clinbiochem.2013.01.021.,OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
Biochemia Medica 2013;23(2):193–200  http://dx.doi.org/10.11613/BM.2013.022 200Lippi G. et al.,Non-OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
J Emerg Nurs 2005;31:338-45. http://dx.doi.org/10.1016/j.jen.2005.05.004.,OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
Biochem Med 2013;23:64-9. http://dx.doi.org/10.11613/BM.2013.008.,OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
Clin Chem Lab Med 2009;47:899-902. http://dx.doi.org/10.1515/CCLM.2009.229.,OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
Clin Chem Lab Med 2009;47:1361-5. http://dx.doi.org/10.1515/CCLM.2009.306.32.,OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
Clin Chem Lab Med 2009;47:934-9. http://dx.doi.org/10.1515/CCLM.2009.218.,OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
Available at: http://efcclm.eu/science/wg-preanalytical-phase.,Non-OADS,/arxiv_data1/oa_pdf/4b/7d/biochem_med-23-2-193-7.PMC3900066.pdf
"Biochemia Medica 2013;23(2):224  http://dx.doi.org/10.11613/BM.2013.028 224Erratum Background : The complexity of the preanalytical  (PA) phase has precluded standardisation of PA  processes, despite its impact on sample quality,  laboratory effi   ciency, or patient & healthcare work- er safety.",Non-OADS,/arxiv_data1/oa_pdf/db/d8/biochem_med-23-2-224-13.PMC3900067.pdf
"http://dx.doi.org/10.11613/BM.2013.025 Biochemia Medica 2013;23(2):211–7   211Diagnostic accuracy of UriSed automated urine microscopic sediment analyzer  and dipstick parameters in predicting urine culture test results Kağan Huysal1, Yasemin U. Budak2*, Ayse Ulusoy Karaca3, Murat Aydos4, Serdar Kahvecioğlu5, Mehtap Bulut6, Murat Polat7 1Department of Clinical Laboratory, Yuksek Ihtisas Education and Research Hospital, Bursa, Turkey 2Department of Clinical Laboratory, Sevket Yilmaz Education and Research Hospital, Bursa, Turkey 3Department of Clinical Microbiology, Sevket Yilmaz Education and Research Hospital, Bursa, Turkey 4Department of Urology, Sevket Yilmaz Education and Research Hospital, Bursa, Turkey 5Department of Nephrology, Sevket Yilmaz Education and Research Hospital, Bursa, Turkey 6Department of Emergency Medicine, Sevket Yilmaz Education and Research Hospital, Bursa, Turkey 7Department of General Surgery, Sevket Yilmaz Education and Research Hospital, Bursa, Turkey *Corresponding author: yaseminbudak2000@yahoo.com Abstract Introduction:  Urinary tract infection (UTI) is one of the most common types of infection.",Non-OADS,/arxiv_data1/oa_pdf/8f/51/biochem_med-23-2-211-10.PMC3900068.pdf
Biochemia Medica 2013;23(2):211–7  http://dx.doi.org/10.11613/BM.2013.025Huysal K. et al.,OADS,/arxiv_data1/oa_pdf/8f/51/biochem_med-23-2-211-10.PMC3900068.pdf
http://dx.doi.org/10.11613/BM.2013.025 Biochemia Medica 2013;23(2):211–7   213Huysal K. et al.,OADS,/arxiv_data1/oa_pdf/8f/51/biochem_med-23-2-211-10.PMC3900068.pdf
Biochemia Medica 2013;23(2):211–7  http://dx.doi.org/10.11613/BM.2013.025Huysal K. et al.,OADS,/arxiv_data1/oa_pdf/8f/51/biochem_med-23-2-211-10.PMC3900068.pdf
http://dx.doi.org/10.11613/BM.2013.025 Biochemia Medica 2013;23(2):211–7   215Huysal K. et al.,OADS,/arxiv_data1/oa_pdf/8f/51/biochem_med-23-2-211-10.PMC3900068.pdf
Biochemia Medica 2013;23(2):211–7  http://dx.doi.org/10.11613/BM.2013.025Huysal K. et al.,OADS,/arxiv_data1/oa_pdf/8f/51/biochem_med-23-2-211-10.PMC3900068.pdf
Nat Rev Urol 2010;12:653-60. http://dx.doi.org/10.1038/nrurol.2010.190.,Non-OADS,/arxiv_data1/oa_pdf/8f/51/biochem_med-23-2-211-10.PMC3900068.pdf
Clin Infect Dis 2004;15:1150-8. http://dx.doi.org/10.1086/383029.,OADS,/arxiv_data1/oa_pdf/8f/51/biochem_med-23-2-211-10.PMC3900068.pdf
J Clin Microbiol 2012;50:1427-9. http://dx.doi.org/10.1128/JCM.06003-11.,OADS,/arxiv_data1/oa_pdf/8f/51/biochem_med-23-2-211-10.PMC3900068.pdf
Clin J Am Soc Nephrol 2009;4:567-71. http://dx.doi.org/10.2215/CJN.05331008.,Non-OADS,/arxiv_data1/oa_pdf/8f/51/biochem_med-23-2-211-10.PMC3900068.pdf
Diagn Microbiol Infect Dis 2013;75:5-8. http://dx.doi.org/10.1016/j.diagmicrobio.2012.08.026.,OADS,/arxiv_data1/oa_pdf/8f/51/biochem_med-23-2-211-10.PMC3900068.pdf
J Clin Microbiol 2011;49:1025-9. http://dx.doi.org/10.1128/JCM.01669-10.,OADS,/arxiv_data1/oa_pdf/8f/51/biochem_med-23-2-211-10.PMC3900068.pdf
http://dx.doi.org/10.1007/s00345-012-0883-4.,Non-OADS,/arxiv_data1/oa_pdf/8f/51/biochem_med-23-2-211-10.PMC3900068.pdf
J Clin Microbiol 2010;48:3117-21. http://dx.doi.org/10.1128/JCM.00617-10.,OADS,/arxiv_data1/oa_pdf/8f/51/biochem_med-23-2-211-10.PMC3900068.pdf
Clin Chim Acta 2010;411:147-54. http://dx.doi.org/10.1016/j.cca.2009.10.018.,OADS,/arxiv_data1/oa_pdf/8f/51/biochem_med-23-2-211-10.PMC3900068.pdf
"St. Louis, MO: Elsevier Saunders, 2011.p 1247-8. http://dx.doi.org/10.1016/B978-1-4377-0974-2.00063-4.",Non-OADS,/arxiv_data1/oa_pdf/8f/51/biochem_med-23-2-211-10.PMC3900068.pdf
J Clin Pathol 2001;54:911-9. http://dx.doi.org/10.1136/jcp.54.12.911.,OADS,/arxiv_data1/oa_pdf/8f/51/biochem_med-23-2-211-10.PMC3900068.pdf
http://dx.doi.org/10.11613/BM.2013.025 Biochemia Medica 2013;23(2):211–7   217Huysal K. et al.,OADS,/arxiv_data1/oa_pdf/8f/51/biochem_med-23-2-211-10.PMC3900068.pdf
Braz J Infect Dis 2007;11:479-81. http://dx.doi.org/10.1590/S1413-86702007000500008.,OADS,/arxiv_data1/oa_pdf/8f/51/biochem_med-23-2-211-10.PMC3900068.pdf
Am J Clin Pathol 2006;126:428-36. http://dx.doi.org/10.1309/C69RW1BT7E4QAFPV.,OADS,/arxiv_data1/oa_pdf/8f/51/biochem_med-23-2-211-10.PMC3900068.pdf
BMC Pediatr 2005; 5: 4. http://dx.doi.org/10.1186/1471-2431-5-4.,OADS,/arxiv_data1/oa_pdf/8f/51/biochem_med-23-2-211-10.PMC3900068.pdf
J Clin Microbiol 2010;48:3117-21. http://dx.doi.org/10.1128/JCM.00617-10.21.,OADS,/arxiv_data1/oa_pdf/8f/51/biochem_med-23-2-211-10.PMC3900068.pdf
Pathology 2000;34:170-7. http://dx.doi.org/10.1080/003130201201117990.,Non-OADS,/arxiv_data1/oa_pdf/8f/51/biochem_med-23-2-211-10.PMC3900068.pdf
Handb Exp Pharmacol 2010;196:111-30. http://dx.doi.org/10.1007/978-3-642-00663-0_5.,Non-OADS,/arxiv_data1/oa_pdf/8f/51/biochem_med-23-2-211-10.PMC3900068.pdf
J Clin Micr 2001;39:4169-71. http://dx.doi.org/10.1128/JCM.39.11.4169-4171.2001.,OADS,/arxiv_data1/oa_pdf/8f/51/biochem_med-23-2-211-10.PMC3900068.pdf
Am J Med 1987;83:739-45. http://dx.doi.org/10.1016/0002-9343(87)90907-7.,OADS,/arxiv_data1/oa_pdf/8f/51/biochem_med-23-2-211-10.PMC3900068.pdf
http://dx.doi.org/10.11613/BM.2013.023 Biochemia Medica 2013;23(2):201–5   201Abstract Background: It is still uncertain whether or not avoidance to let disinfectant  alcohol dry at the site of venipuncture is a source of spuri ous hemolysis  when drawing venous blood.,Non-OADS,/arxiv_data1/oa_pdf/8b/0a/biochem_med-23-2-201-8.PMC3900069.pdf
Biochemia Medica 2013;23(2):201–5  http://dx.doi.org/10.11613/BM.2013.023Salvagno GL.,Non-OADS,/arxiv_data1/oa_pdf/8b/0a/biochem_med-23-2-201-8.PMC3900069.pdf
http://dx.doi.org/10.11613/BM.2013.023 Biochemia Medica 2013;23(2):201–5   203Salvagno GL.,Non-OADS,/arxiv_data1/oa_pdf/8b/0a/biochem_med-23-2-201-8.PMC3900069.pdf
Biochemia Medica 2013;23(2):201–5  http://dx.doi.org/10.11613/BM.2013.023Salvagno GL.,Non-OADS,/arxiv_data1/oa_pdf/8b/0a/biochem_med-23-2-201-8.PMC3900069.pdf
http://dx.doi.org/10.11613/BM.2013.023 Biochemia Medica 2013;23(2):201–5   205Salvagno GL.,Non-OADS,/arxiv_data1/oa_pdf/8b/0a/biochem_med-23-2-201-8.PMC3900069.pdf
Semin Thromb Hemost 2012;38:565-75. http://dx.doi.org/10.1055/s-0032-1315961.,Non-OADS,/arxiv_data1/oa_pdf/8b/0a/biochem_med-23-2-201-8.PMC3900069.pdf
Biochem Med 2012;22:145-9. http://dx.doi.org/10.11613/BM.2012.017.,Non-OADS,/arxiv_data1/oa_pdf/8b/0a/biochem_med-23-2-201-8.PMC3900069.pdf
Clin Chem Lab Med 2012;50:2065-8. http://dx.doi.org/10.1515/cclm-2012-0374.,OADS,/arxiv_data1/oa_pdf/8b/0a/biochem_med-23-2-201-8.PMC3900069.pdf
Bi-ochem Med 2010;20:154-9. http://dx.doi.org/10.11613/BM.2010.018.,Non-OADS,/arxiv_data1/oa_pdf/8b/0a/biochem_med-23-2-201-8.PMC3900069.pdf
Crit Rev Clin Lab Sci 2011;48:143-53. http://dx.doi.org/10.3109/10408363.2011.600228.10.,Non-OADS,/arxiv_data1/oa_pdf/8b/0a/biochem_med-23-2-201-8.PMC3900069.pdf
Biochem Med  2012;22:342-51. http://dx.doi.org/10.11613/BM.2012.036.,Non-OADS,/arxiv_data1/oa_pdf/8b/0a/biochem_med-23-2-201-8.PMC3900069.pdf
Clin Chem Lab Med 2009;47:934-9. http://dx.doi.org/10.1515/CCLM.2009.218.,OADS,/arxiv_data1/oa_pdf/8b/0a/biochem_med-23-2-201-8.PMC3900069.pdf
J Clin Microbiol 2002;40:1660-5. http://dx.doi.org/10.1128/JCM.40.5.1660-1665.2002.,OADS,/arxiv_data1/oa_pdf/8b/0a/biochem_med-23-2-201-8.PMC3900069.pdf
Clin Chem Lab Med 2011;49:215-28. http://dx.doi.org/10.1515/cclm.2011.034.,OADS,/arxiv_data1/oa_pdf/8b/0a/biochem_med-23-2-201-8.PMC3900069.pdf
Biochem Med 2011;21:152-9. http://dx.doi.org/10.11613/BM.2011.024.,Non-OADS,/arxiv_data1/oa_pdf/8b/0a/biochem_med-23-2-201-8.PMC3900069.pdf
"Biochemia Medica 2013;23(3):316–20  http://dx.doi.org/10.11613/BM.2013.038  316Abstract Introduction : We hypothesized that patients are poorly informed about proper procedure for 24-hour urine specimen collection and its relevance  in determination of biochemical analytes, despite availability of leaflets and webpage with instruction for collection.",Non-OADS,/arxiv_data1/oa_pdf/65/d8/biochem-23-3-316-10.PMC3900070.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/65/d8/biochem-23-3-316-10.PMC3900070.pdf
"http://dx.doi.org/10.11613/BM.2013.038 Biochemia Medica 2013;23(3):316–20    317Miler M, Šimundić AM.",Non-OADS,/arxiv_data1/oa_pdf/65/d8/biochem-23-3-316-10.PMC3900070.pdf
"Biochemia Medica 2013;23(3):316–20  http://dx.doi.org/10.11613/BM.2013.038  318Miler M, Šimundić AM.",Non-OADS,/arxiv_data1/oa_pdf/65/d8/biochem-23-3-316-10.PMC3900070.pdf
"http://dx.doi.org/10.11613/BM.2013.038 Biochemia Medica 2013;23(3):316–20    319Miler M, Šimundić AM.",Non-OADS,/arxiv_data1/oa_pdf/65/d8/biochem-23-3-316-10.PMC3900070.pdf
"Biochemia Medica 2013;23(3):316–20  http://dx.doi.org/10.11613/BM.2013.038  320Miler M, Šimundić AM.",Non-OADS,/arxiv_data1/oa_pdf/65/d8/biochem-23-3-316-10.PMC3900070.pdf
Avialable at: http://klinkemija.kbcsm.hr/bolesnici.php.,Non-OADS,/arxiv_data1/oa_pdf/65/d8/biochem-23-3-316-10.PMC3900070.pdf
Biochem Med 2010;20:179-83. http://dx.doi.org/10.11613/BM.2010.022.,OADS,/arxiv_data1/oa_pdf/65/d8/biochem-23-3-316-10.PMC3900070.pdf
http://dx.doi.org/10.11613/BM.2013.039 Biochemia Medica 2013;23(3):321–5    321Abstract Introduction : Studies about vitamin D [25(OH)D] stability in plasma are limited and preanalytical variables such as tube type may affect results.,Non-OADS,/arxiv_data1/oa_pdf/3b/a2/biochem-23-3-321-11.PMC3900071.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/a2/biochem-23-3-321-11.PMC3900071.pdf
Biochemia Medica 2013;23(3):321–5  http://dx.doi.org/10.11613/BM.2013.039  322Colak A. et al.,Non-OADS,/arxiv_data1/oa_pdf/3b/a2/biochem-23-3-321-11.PMC3900071.pdf
http://dx.doi.org/10.11613/BM.2013.039 Biochemia Medica 2013;23(3):321–5    323Colak A. et al.,OADS,/arxiv_data1/oa_pdf/3b/a2/biochem-23-3-321-11.PMC3900071.pdf
Biochemia Medica 2013;23(3):321–5  http://dx.doi.org/10.11613/BM.2013.039  324Colak A. et al.,OADS,/arxiv_data1/oa_pdf/3b/a2/biochem-23-3-321-11.PMC3900071.pdf
Pediatrics 2004;113:179-80. http://dx.doi.org/10.1542/peds.113.1.179.,Non-OADS,/arxiv_data1/oa_pdf/3b/a2/biochem-23-3-321-11.PMC3900071.pdf
J Clin Epidemiol 1995;48:1077-85. http://dx.doi.org/10.1016/0895-4356(94)00232-F .,Non-OADS,/arxiv_data1/oa_pdf/3b/a2/biochem-23-3-321-11.PMC3900071.pdf
http://dx.doi.org/10.11613/BM.2013.039 Biochemia Medica 2013;23(3):321–5    325Colak A. et al.,OADS,/arxiv_data1/oa_pdf/3b/a2/biochem-23-3-321-11.PMC3900071.pdf
Clin Chem 2008;54:1931-2. http://dx.doi.org/10.1373/clinchem.2008.,Non-OADS,/arxiv_data1/oa_pdf/3b/a2/biochem-23-3-321-11.PMC3900071.pdf
Clin Biochem 2012;45:707-8. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3b/a2/biochem-23-3-321-11.PMC3900071.pdf
Clin Chem 2005;51:258-61. http://dx.doi.org/10.1373/ clinchem.2004.041954.10.,OADS,/arxiv_data1/oa_pdf/3b/a2/biochem-23-3-321-11.PMC3900071.pdf
Cancer Causes Control 2010;21:643-8.  http://dx.doi.org/10.1007/s10552-009-9485-x.,Non-OADS,/arxiv_data1/oa_pdf/3b/a2/biochem-23-3-321-11.PMC3900071.pdf
J Steroid Biochem Mol Biol 2008;112:164-8. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3b/a2/biochem-23-3-321-11.PMC3900071.pdf
Biochemia Medica 2013;23(3):308–15  http://dx.doi.org/10.11613/BM.2013.037  308Abstract Introduction : The phlebotomists’ procedures are a still source of laboratory variability.,Non-OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
http://dx.doi.org/10.11613/BM.2013.037 Biochemia Medica 2013;23(3):308–15    309Lima-Oliveira G. et al.,Non-OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
Biochemia Medica 2013;23(3):308–15  http://dx.doi.org/10.11613/BM.2013.037  310Lima-Oliveira G. et al.,Non-OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
http://dx.doi.org/10.11613/BM.2013.037 Biochemia Medica 2013;23(3):308–15    311Lima-Oliveira G. et al.,Non-OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
Biochemia Medica 2013;23(3):308–15  http://dx.doi.org/10.11613/BM.2013.037  312Lima-Oliveira G. et al.,Non-OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
http://dx.doi.org/10.11613/BM.2013.037 Biochemia Medica 2013;23(3):308–15    313Lima-Oliveira G. et al.,Non-OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
Biochemia Medica 2013;23(3):308–15  http://dx.doi.org/10.11613/BM.2013.037  314Lima-Oliveira G. et al.,Non-OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
2012 Available from:  http://www.clsi.org/Content/NavigationMenu/AboutCLSI/ VisionMissionandValues/Vision_Mission_Value.htm.,Non-OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
Lab Med 2012;43:17-21. http://dx.doi.org/10.1309/LMZ7YARD6ZS - DIID .,OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
Biochem Med 2012;22:342-51. http://dx.doi.org/10.11613/BM.2012.036.,Non-OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
Clin Chim Acta 2011;412:1482-4. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
Semin Thromb He - most 2012;38:565-75. http://dx.doi.org/10.1055/s-0032- 1315961.,Non-OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
Clin Chem Lab Med 2011;49:2061-3. http://dx.doi.org/10.1515/CCLM.2011.705.,OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
Available from: http://www.dicq.org.br/pdfs/manual_dicq_2011.pdf: Brazilian Society of Clinical Analyses; 2011.,Non-OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
Clin Chem Lab Med 2005;43:869-75. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
Clin Lab Haematol 2006;28:332-7. http://dx.doi.org/10.1111/ j.1365-2257.2006.00818.x.,Non-OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
Blood Coagul Fibrinolysis 2005;16:453-8. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
Clin Chem Lab Med 2013;51:303-10. http://dx.doi.org/10.1515/cclm-2012-0159 .,OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
J Emerg Nurs 2008;34:26-32. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
Ann  Clin Biochem 2008;45:266-9. http://dx.doi.org/10.1258/ acb.2007.007123.,Non-OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
Intern Emerg Med 2011;6:357-9. http://dx.doi.org/10.1007/ s11739-011-0568-9.,Non-OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
Clin Chem Lab Med 2011;49:215-28. http://dx.doi.org/10.1515/ cclm.2011.034.,OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
Clin Biochem 2012;45:683-7.  http://dx.doi.org/10.1016/j.clinbiochem.2012.03.007.,OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
http://dx.doi.org/10.11613/BM.2013.037 Biochemia Medica 2013;23(3):308–15    315Lima-Oliveira G. et al.,Non-OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
Bi-ochem Med 2012;22:180-6. http://dx.doi.org/10.11613/ BM.2012.021.,Non-OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
ISRN Hema-tology 2012;2012:875357. http://dx.doi.org/10.5402/  2012/875357.,OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
Accred Qual Assur 2013;18:429-34. http://dx.doi.org/10.1007/s00769-013-0995-6.,Non-OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
Clin Biochem 2011;44:1028-9. http://dx.doi.org/10.1016/j.clinbiochem.,OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
Clin Bi- ochem 2013;46:250-4. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
Clin  Chem Lab Med 2006;44:358-65. http://dx.doi.org/10.1515/ CCLM.2006.073.,OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
Clin Biochem 2010;43:4-25. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
Scand J Clin Lab Invest 2009;69:815-6. http://dx.doi.org/10.3109/00365510903307970.,Non-OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
Clin Chem 2007;53:1338-42. http://dx.doi.org/10.1373/clinchem.2007.088344.,Non-OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
Clin Chem Lab Med 2007;45:720-7. http://dx.doi.org/10.1515/CCLM.2007.167.,OADS,/arxiv_data1/oa_pdf/6a/87/biochem-23-3-308-9.PMC3900072.pdf
"http://dx.doi.org/10.11613/BM.2013.034 Biochemia Medica 2013;23(3):281–95    281Abstract Over the past three decades, the goal of many researchers is analysis of exhaled breath condensate (EBC) as noninvasively obtained sample.",Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
"Biochemia Medica 2013;23(3):281–95  http://dx.doi.org/10.11613/BM.2013.034  282Dodig S, Čepelak I. Exhaled breath condensate – an overview language in 1980 (4).",Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
"http://dx.doi.org/10.11613/BM.2013.034 Biochemia Medica 2013;23(3):281–95    283Dodig S, Čepelak I. Exhaled breath condensate – an overview ducting zone (airways) and the respiratory zone  (respiratory bronchioles, alveolar  ducts, and alve - oli) (12).",Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
"Biochemia Medica 2013;23(3):281–95  http://dx.doi.org/10.11613/BM.2013.034  284Dodig S, Čepelak I. Exhaled breath condensate – an overview let (21).",Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
"http://dx.doi.org/10.11613/BM.2013.034 Biochemia Medica 2013;23(3):281–95    285Dodig S, Čepelak I. Exhaled breath condensate – an overview 14.7 kPa, whereas pCO2 in the alveoles is about 5.3  kPa.",OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
"Biochemia Medica 2013;23(3):281–95  http://dx.doi.org/10.11613/BM.2013.034  286Dodig S, Čepelak I. Exhaled breath condensate – an overview Ta b l e  1.",Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
"http://dx.doi.org/10.11613/BM.2013.034 Biochemia Medica 2013;23(3):281–95    287Dodig S, Čepelak I. Exhaled breath condensate – an overview DMS) (51).",OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
"Biochemia Medica 2013;23(3):281–95  http://dx.doi.org/10.11613/BM.2013.034  288Dodig S, Čepelak I. Exhaled breath condensate – an overview Data handling Normalization factor for analytes in EBC To account for the fluctuation of constituents in  extremely diluted biological samples, laboratory medicine specialists try to normalize (i.e.",Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
"http://dx.doi.org/10.11613/BM.2013.034 Biochemia Medica 2013;23(3):281–95    289Dodig S, Čepelak I. Exhaled breath condensate – an overview Analyte Values References Hydrogen peroxide  (μmol/L) Adults, range 0-0.9 17 Children, M(IQR) 0.045 (0.017-0.082) 60 pH Adults, mean ± SD 7.70 ± 0.49 34 Adults, mean ± SD 7.85 ± 0.02 70 Adults, M (IQR) 7.72 (7.63-7.76) 43 Children, mean ± SD 7.05 ± 0.35 45 8-isoprostane (ng/L) Adults, mean ± SD 6.2 ± 0.4 71 Adults, mean ± SD 4.7 ± 1.8 72 Children, mean ± SD 5.2 ± 0.7 73 Malondialdehyde   (nmol/L) Adults, M (IQR) 15.6 (4-25) 75 Children, mean ± SD 19.4 ± 1.9 74 IL-6  (ng/L) Adults, mean ± SD 2.7 ± 0.6 73 Children, mean ± SD 2.6 ± 0.1 76 Nitrite  (μmol/L) Adults, M (IQR) 2.9 (1.6-5.3) 77 Children, M (IQR) 0.41 (0.13-1.83) 78 M – median; IQR – interquartile range; SD – standard  deviation; IL – interleukin.Ta b l e  3.",Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
"Biochemia Medica 2013;23(3):281–95  http://dx.doi.org/10.11613/BM.2013.034  290Dodig S, Čepelak I. Exhaled breath condensate – an overview Comparison with  healthy subjectsCorrelation with After treatment Hydrogen peroxide acute asthma ↑ Positive with sputum eosinophils ↓ COPD ↑ Positive with sputum neutrophils ↓ CF ↔ NA ↓ pH acute asthma ↓ Inverse with FEV1 ↑ COPD ↓ NA ↑ CF ↓ NA ↑ Bronchiectasis ↓ NA ↔ GERD ↔ NA ↔ OSA ↓ NA NA Adenosine acute asthma ↑ Asthma severity, FeNO NA COPD ↔ NA NA CF ↔ NA NA Adenosine/urea acute asthma ↑ NA NA COPD ↑ COPD severity, Inverse with FEV1 ↓ CF ↑ Inverse with FEV1 ↔ 8-isoprostane acute asthma ↑ NA Resistant COPD ↑ NA ↓ Nitrite/nitrate acute asthma ↑ Inverse with FEV1 ↓ COPD ↑ Inverse with FEV1 NA IL-4 ↑ acute asthma NA ↓ IL-6 acute asthma ↑ NA NA COPD ↑ NA NA GER ↑ NA NA COPD – chronic obstructive pulmonary disease; CF – cystic fibrosis; GER – gastroesophageal reflux; GERD –  gastroesophageal reflux disease; FeNO – fractional exhaled nitric oxide; FEV1 – forced exhaled volume in 1 second; ↑  – increased, ↓ – decreased, ↔ – no difference, not detectable or absence; NA – not available.Ta b l e  4.",Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
"http://dx.doi.org/10.11613/BM.2013.034 Biochemia Medica 2013;23(3):281–95    291Dodig S, Čepelak I. Exhaled breath condensate – an overview phases of the analytical process should be contin - ued to allow appropriate interpretation of the re - sults obtained.",Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Anesthesiology 1992;76:703-10. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Biochem Med 2012;22:145-9. http://dx.doi.org/10.11613/BM.2012.017.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Pediatr Res 2010;68:75-80. http://dx.doi.org/10.1203/ PDR.0b013e3181df4ea0.,OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Aerosol Sci Technol 2013;47:444-51. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
http://dx.doi.org/10.1164/ rccm.200406-710ST .,OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Am Ind Hyg Assoc J 1987;48:948-9. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Lung 2004;182:297-317. http://dx.doi.org/10.1007/s00408-004-2511-6.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Eur Respir J 1997;10:1914-17. http://dx.doi.org/10.1183/09031936.97.1 0081914.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
http://dx.doi.org/10.1067/ mai.2002.124966.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
http://dx.doi.org/10.1164/ rccm.200307-920OC.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
"Biochemia Medica 2013;23(3):281–95  http://dx.doi.org/10.11613/BM.2013.034  292Dodig S, Čepelak I. Exhaled breath condensate – an overview 16.",Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
J Breath Res 2009;3:1-5. http://dx.doi.org/10.1088/1752- 7155/3/1/016005.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
http://dx.doi.or g/10.1183/09031936.05.00029705.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Respir Med 2008;102:720-5.   http://dx.doi.org/10.1016/j.rmed.2007.12.013.,OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Thorax 2004;59:694-8. http://dx.doi.org/10.1136/ thx.2003.016949.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
J Aero - sol Med Pulm Drug Deliv 2011;24:253-60. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Respirology 2010;15:155-9.  http://dx.doi.org/10.1111/j.1440-1843.2009.01664.x.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Respiration 2007;74:142-5. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Clin Chem Lab Med  2007;45:945-52. http://dx.doi.org/10.1515/CCLM.2007.326.,OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Am J Physi- ol Lung Cell Mol Physiol 2004;287:1037-80. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
J Breath Res 2012;6:027102.  http://dx.doi.org/10.1088/1752-7155/6/2/027102.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Respir Med 2009;103:187-93. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
J Breath Res 2013;7:017101. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Eur Respir J 2007;29:496-501. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Thorax 2005;60:22-6.  http://dx.doi.org/10.1136/thx.2003.017327.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Proc Am Thorac Soc 2006;3:131-45. http://dx.doi.org/10.1513/pats.200406-710ST .,OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
BMJ 1998;317:1302-6. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Eur Res - pir J 2003;22:889-94. http://dx.doi.org/10.1183/09031936.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
http://dx.doi.org/10.1186/cc6911 .,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
J Chromatogr B Anal-yt Technol Biomed Life Sci 2011;879:2220-8. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
J Allergy Clin Immunol 2007;120:1216-7. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
J Chromatogr B Analyt Te - chnol Biomed Life Sci 2012;893-894:144-9. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Eur Respir J 2008;31:380-4. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Am J Respir Crit Care Med 2006;173:386-92. http://dx.doi.org/10.1164/rccm.200507- 1059OC.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Respir Med 2005;99:1229-40. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
"http://dx.doi.org/10.11613/BM.2013.034 Biochemia Medica 2013;23(3):281–95    293Dodig S, Čepelak I. Exhaled breath condensate – an overview 43.",Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Arh Hig Rada Toksikol 2009;60:87-97. http://dx.doi.org/10.2478/10004-1254-60-2009-1897.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
J Asthma 2009b;46:81-5. http://dx.doi.org/10.1080/02770900802513007.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
J Asthma 2011;48:667-73. http://dx.doi.org/10.310 9/02770903.2011.599907.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Ther Adv Respir Dis 2007;1:5-23.  http://dx.doi.org/10.1177/1753465807082373.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
J Appl Physiol 2005;99:1286-92. http://dx.doi.org/10.1152/ japplphysiol.00362.2005.,OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Int J Mol Sci 2010;11:4631-59. http://dx.doi.org/10.3390/ijms11114631.,OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Analytica Chimica Acta 2008;628:155- 61. http://dx.doi.org/10.1016/j.aca.2008.09.010.,OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
IEEE Sensors J 2010;10:114-22. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Redox Rep 2006;11:78-84. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Respir Med 2005;99:1132-7.  http://dx.doi.org/10.1016/j.rmed.2005.02.020.,OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Chest 2011;140:954-60.  http://dx.doi.org/10.1378/chest.10-2471.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Eur Respir J 2012;39:498-500. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
J Occup Med Toxicol 2006;1:5. http://dx.doi.org/10.1186/1745-6673-1-5.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Inflamm Res  2012;61:1141-7. http://dx.doi.org/10.1007/s00011-012-0508-9 .,OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Nitric Oxide 2012;15:169-75. http://dx.doi.org/10.1016/j.niox.2012.06.007.,OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Respir Med 2008;102:299-306. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Lab Med 2010;41:728-30. http://dx.doi.org/10.1309/ LMTA9ZE2RZ4USKNP .,OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Chest 2004;125:2005-10. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
"Biochemia Medica 2013;23(3):281–95  http://dx.doi.org/10.11613/BM.2013.034  294Dodig S, Čepelak I. Exhaled breath condensate – an overview 71.",Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Thorax 2003;58:294-8. http://dx.doi.org/10.1136/thorax.58.4.294.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Eur J Pharmacol 2004;28:169-75. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
http://dx.doi.org/10.1097/ PCC.0b013e3181dbeac6 .,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Am J Respir Crit Care Med 2003;167:395-9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Mediators Inflamm 2011;2011:891752. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Am J Respir Crit Care Med 2003;167:1109-12. http://dx.doi.org/10.1164/ rccm.200203-179OC.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
J Clin Lab Anal 2010;24:317-22. http://dx.doi.org/10.1002/jcla.20408.,OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Curr Med Chem 2008;15:620-30. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Biochem Med 2011;21:139-44. http://dx.doi.org/10.11613/BM.2011.022.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
J Bre - ath Res 2012;6:016004. http://dx.doi.org/10.1088/1752- 7155/6/1/016004.,OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Arch Med Sci 2012;9:277-85. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Eur Respir J 1998;12:483-5. http://dx.doi.org/10.1183/09031936.98.12020483.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Eur Respir J 2005;25:269-74. http://dx.doi.org /10.1183/09031936.05.00085804.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Respir Med 2007;101:2271-8. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Am J Respir Crit Care Med 2002;166:1345-9. http://dx.doi.org/10.1164/rccm.200203-233OC .,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
http://dx.doi.org/10.1164/ ajrccm.158.5.9803102.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Chest 1998;114:1653-9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Chest 2002;122:1162-7. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Am J Respir Crit Care Med 2002;165:1290-3. http://dx.doi.org/10.1164/ rccm.2108082.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
"http://dx.doi.org/10.11613/BM.2013.034 Biochemia Medica 2013;23(3):281–95    295Dodig S, Čepelak I. Exhaled breath condensate – an overview 96.",Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
Eur Respir J 2003;21:589-93. http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
J Biomed Biotechnol 2011;2011:403260. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/19/4d/biochem-23-3-281-6.PMC3900073.pdf
"Biochemia Medica 2013;23(3):266–80  http://dx.doi.org/10.11613/BM.2013.033  266Diabetes and beta cell function: from mechanisms to evaluation and clinical  implications Simona Cernea*1, Minodora Dobreanu2,3 1Diabetes, Nutrition and Metabolic Diseases Outpatient Unit, Emergency County Clinical Hospital, Târgu Mureş, Romania 2Department of Clinical Biochemistry-Immunology, University of Medicine and Pharmacy, Târgu Mureş, Romania 3Department of Clinical Laboratory, Emergency County Clinical Hospital, Târgu Mureş, Romania *Corresponding author: simonacernea@yahoo.com Abstract Diabetes is a complex, heterogeneous condition that has beta cell dysfunction at its core.",Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
"http://dx.doi.org/10.11613/BM.2013.033 Biochemia Medica 2013;23(3):266–80    267Cernea S, Dobreanu M. Diabetes and beta cell function sible to be measured) presence of diabetes-specif - ic autoantibodies are used, but none of these cri - teria have definite thresholds that would allow a  precise distinction between the two types, nor are they exclusively correlated with either type (4).",Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
"Biochemia Medica 2013;23(3):266–80  http://dx.doi.org/10.11613/BM.2013.033  268Cernea S, Dobreanu M. Diabetes and beta cell function expression, secondary to the diminished activ - ity of the key regulators of insulin promoter ac - tivity (such as insulin gene transcriptor activa - tors) and other beta-cell specific genes (14-17).",Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
"http://dx.doi.org/10.11613/BM.2013.033 Biochemia Medica 2013;23(3):266–80    269Cernea S, Dobreanu M. Diabetes and beta cell function to mechanisms associated with oxidative and  ER stress (13,18,31).",Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
"Biochemia Medica 2013;23(3):266–80  http://dx.doi.org/10.11613/BM.2013.033  270Cernea S, Dobreanu M. Diabetes and beta cell function production of cytokines and chemokines (45).",Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
"http://dx.doi.org/10.11613/BM.2013.033 Biochemia Medica 2013;23(3):266–80    271Cernea S, Dobreanu M. Diabetes and beta cell function product of beta cells co-secreted and stored with  insulin in secretory granules (55).",Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
"Biochemia Medica 2013;23(3):266–80  http://dx.doi.org/10.11613/BM.2013.033  272Cernea S, Dobreanu M. Diabetes and beta cell function creatic beta cell preservation are not fully elucidat - ed, but data indicate that cAMP/PKA, phosphati - dylinositide 3-kinases (PI-3K)/PKB pathways and  PDX-1 transcription factor are involved (69).",Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
"http://dx.doi.org/10.11613/BM.2013.033 Biochemia Medica 2013;23(3):266–80    273Cernea S, Dobreanu M. Diabetes and beta cell function nique requiring trained personnel) which make  their use in clinical practice difficult (even for some  research purposes) (82,84).",Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
"Biochemia Medica 2013;23(3):266–80  http://dx.doi.org/10.11613/BM.2013.033  274Cernea S, Dobreanu M. Diabetes and beta cell function Method Comment Basal measurements Fasting insulin•	 Poor index of beta cell function; used in clinical practice; there is no standardized  method to measure serum insulin and current measures are poorly harmonized; total CV for insulin immunoassays: 5-12%.",Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
"http://dx.doi.org/10.11613/BM.2013.033 Biochemia Medica 2013;23(3):266–80    275Cernea S, Dobreanu M. Diabetes and beta cell function Mechanisms Tests Comments Hyperglycemia /glucotoxicityFBGOGTT Glycated hemoglobin (HbA1c)All three tests are used in clinical practice for diagnosis of  DM; FBG and HbA1c are routinely used for monitoring the  glucose metabolism and treatment efficacy in subjects DM.",Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
"Biochemia Medica 2013;23(3):266–80  http://dx.doi.org/10.11613/BM.2013.033  276Cernea S, Dobreanu M. Diabetes and beta cell function gressive reduction of insulin production capacity  and deterioration of glycemic control over time (94).",Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
"http://dx.doi.org/10.11613/BM.2013.033 Biochemia Medica 2013;23(3):266–80    277Cernea S, Dobreanu M. Diabetes and beta cell function References  1.",Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
http://dx.doi.org/10.2337/diabetes.50.2007.S154.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Pediatr Diabetes 2007;8 Suppl 9:16-27. http://dx.doi.org/10.1111/j.1399- 5448.2007.00330.x.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Clin Chem 2011;57:158-61. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
http://dx.doi.org/10.2337/diabetes.54.suppl_2.S32.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Diabet Med 2012;29:972-9. http://dx.doi.org/10.1111/ j.1464-5491.2012.03655.x.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
http://dx.doi.org/10.2337/diabe - tes.54.suppl_2.S97 11.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Endocrine Rev 2007;28:187-218. http://dx.doi.org/10.1210/10.1210/er.2006-0038.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Diabetes 2003;52:581-7. http://dx.doi.org/10.2337/ diabetes.52.3.581.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Di- abetes Metab J 2011;35:444-50. http://dx.doi.org/10.4093/ dmj.2011.35.5.444.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
J Clin Invest 1996;97:1041-6. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
J Clin Invest 2006;116:1802-12. http://dx.doi.org/10.1172/ JCI29103.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Endocr Rev 2008;29:42- 61. http://dx.doi.org/10.1210/er.2007-0015.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Diabetes 2005;54:727-35. http://dx.doi.org/10.2337/diabetes.54.3.727.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Islets 2010;2:225-35. http://dx.doi.org/10.4161/ isl.2.4.12219.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Diabetes Obes Metab 2010;12 Suppl 2:66-75.  http://dx.doi.org/10.1111/j.1463-1326.2010.01280.x.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Diabetes Obes Metab  2010;12 Suppl 2:99-107. http://dx.doi.org/10.1111/j.1463- 1326.2010.01281.x.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Islets  2012;4:233-42. http://dx.doi.org/10.4161/isl.20516.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
"Biochemia Medica 2013;23(3):266–80  http://dx.doi.org/10.11613/BM.2013.033  278Cernea S, Dobreanu M. Diabetes and beta cell function 30.",Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Diabetes Obes Metab 2012;14  Suppl 3:136-42. http://dx.doi.org/10.1111/j.1463-1326 .2012.01649.x.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Int J Clin Pract Suppl 2004;143:9-21. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Traffi c 2011;12:349-362. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
http://dx.doi.org/10.2337/ diabetes.51.2007.S405.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Diabetologia 2003;46:1297-312. http://dx.doi.org/10.1007/s00125-003-1207-4.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Endocrinolo - gy 2002;143:3449-53. http://dx.doi.org/10.1210/en.2002- 220273.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Diabetologia 2007;50:1304-14. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Di- abetes 2012;61:659-64. http://dx.doi.org/10.2337/db11- 1341.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Endocrinolo - gy 2009;150:4521-30. http://dx.doi.org/10.1210/en.2009- 0252.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Clin Exp Immu-nol 2012;167:40-6. http://dx.doi.org/10.1111/j.1365-2249 .2011.04501.x.,OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
http://dx.doi.org/10.2337/dc10-0579.42.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Eur  J Endocrinol 2006;154:441-7. http://dx.doi.org/10.1530/ eje.1.02115.,OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Di-abetologia 2001;44:914-22. http://dx.doi.org/10.1007/ s001250100548.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Islets 2009;1:256-9. http://dx.doi.org/10.4161/ isl.1.3.9110.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
J Clin Endocrinol Metab 2009;94:3171-82. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Diabetologia 2011;54:617-26. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
J Biol Chem 2010;285:33623-31. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Nat Med 2011;17:55-63. http://dx.doi.org/10.1038/nm.2277.,OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
J Clin Endocrinol Metab 2004;89:3629-43. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Physiol Rev 2011;91:795-826. http://dx.doi.org/10.1152/ physrev.00042.2009.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
"http://dx.doi.org/10.11613/BM.2013.033 Biochemia Medica 2013;23(3):266–80    279Cernea S, Dobreanu M. Diabetes and beta cell function 56.",Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Diabetologia 2004;47:157-69. http://dx.doi.org/10.1007/ s00125-003-1304-4.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Biochemistr y 2002;41:11338-43. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Nat Immunol 2010;11:897- 904. http://dx.doi.org/10.1038/ni.1935.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Am J Pathol 2011;178:2632-40. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Diabetes Care 2003;26:791-8. http://dx.doi.org/10.2337/diacare.26.3.791.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
J Clin Endocrinol Metab  2005;90:5991-7. http://dx.doi.org/10.1210/jc.2005-1093.,OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Cell  Metab 2006;3:153-5. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Proc Natl Acad Sci U S A 1987;84:3434-8. http://dx.doi.org/10.1073/ pnas.84.10.3434.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Diabetologia 2004;47:806-15. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Endocrinology 2002;143:3152-61. http://dx.doi.org/10.1210/en.143.8.3152.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Diabetes 2010;59:1117-25. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Rev Diabet Stud 2011;8:323-38. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Diabetes 2007;56:1551-8. http://dx.doi.org/10.2337/db06-1033.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Diabetes 1996;45:1701-5. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Diabetologia 2011;54:10-8. http://dx.doi.org/10.1007/s00125-010-1896-4.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Diabetes 2009;58:773-95. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Diabetes 2011;60:306-14. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Obesity (Silver Spring) 2008;16:1901-7. http://dx.doi.org/10.1038/ oby.2008.307.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
"Biochemia Medica 2013;23(3):266–80  http://dx.doi.org/10.11613/BM.2013.033  280Cernea S, Dobreanu M. Diabetes and beta cell function 82.",Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Eur J Endocrinol  2004;150:97-104. http://dx.doi.org/10.1530/eje.0.1500097.,OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
7-27. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Diabetolo - gia 2004;47:943-56. http://dx.doi.org/10.1007/s00125-004 -1381-z.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
http://dx.doi.org/10.2337/dc13-S011.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Clin Chem 2007;53:1462-9.  http://dx.doi.org/10.1373/clinchem.2007.088393.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Di- abetologia 2012;55:1577-96. http://dx.doi.org/10.1007/ s00125-012-2534-0.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Diabetes 1996;45:622-6. http://dx.doi.org/10.2337/ diabetes.45.5.622.91.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Lancet 2008;371:1753-60. http://dx.doi.org/10.1016/S0140-6736- (08)60762- X.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
J Autoimmun 1996;9:341-8. http://dx.doi.org/10.1006/ jaut.1996.0046.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Int J Clin Pract Suppl 2007;61:20-7.  http://dx.doi.org/10.1111/j.1742-1241.2007.01361.x.,OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Diabetologia 2004;47:806-15. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Diabetes Technol Ther 2006;8:18-27. http://dx.doi.org/10.1089/dia.2006.8.18.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Tren-ds Mol Med 2012;18:173-81. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Diabeto - logia 2011;54:1756-65. http://dx.doi.org/10.1007/s00125- 011-2143-3.,Non-OADS,/arxiv_data1/oa_pdf/47/92/biochem-23-3-266-5.PMC3900074.pdf
Biochemia Medica 2013;23(3):332–41  http://dx.doi.org/10.11613/BM.2013.041  332Abstract Introduction : Continuing professional development (CPD) with corresponding crediting system is recognized as essential for the laboratory me - dicine specialists to provide optimal service for the patients.,Non-OADS,/arxiv_data1/oa_pdf/7b/f5/biochem-23-3-332-13.PMC3900075.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/f5/biochem-23-3-332-13.PMC3900075.pdf
http://dx.doi.org/10.11613/BM.2013.041 Biochemia Medica 2013;23(3):332–41    333Topic E. et al.,Non-OADS,/arxiv_data1/oa_pdf/7b/f5/biochem-23-3-332-13.PMC3900075.pdf
Biochemia Medica 2013;23(3):332–41  http://dx.doi.org/10.11613/BM.2013.041  334Topic E. et al.,OADS,/arxiv_data1/oa_pdf/7b/f5/biochem-23-3-332-13.PMC3900075.pdf
http://dx.doi.org/10.11613/BM.2013.041 Biochemia Medica 2013;23(3):332–41    335Topic E. et al.,OADS,/arxiv_data1/oa_pdf/7b/f5/biochem-23-3-332-13.PMC3900075.pdf
Biochemia Medica 2013;23(3):332–41  http://dx.doi.org/10.11613/BM.2013.041  336Topic E. et al.,OADS,/arxiv_data1/oa_pdf/7b/f5/biochem-23-3-332-13.PMC3900075.pdf
http://dx.doi.org/10.11613/BM.2013.041 Biochemia Medica 2013;23(3):332–41    337Topic E. et al.,OADS,/arxiv_data1/oa_pdf/7b/f5/biochem-23-3-332-13.PMC3900075.pdf
Biochemia Medica 2013;23(3):332–41  http://dx.doi.org/10.11613/BM.2013.041  338Topic E. et al.,OADS,/arxiv_data1/oa_pdf/7b/f5/biochem-23-3-332-13.PMC3900075.pdf
http://dx.doi.org/10.11613/BM.2013.041 Biochemia Medica 2013;23(3):332–41    339Topic E. et al.,OADS,/arxiv_data1/oa_pdf/7b/f5/biochem-23-3-332-13.PMC3900075.pdf
Biochemia Medica 2013;23(3):332–41  http://dx.doi.org/10.11613/BM.2013.041  340Topic E. et al.,OADS,/arxiv_data1/oa_pdf/7b/f5/biochem-23-3-332-13.PMC3900075.pdf
Biochem Med 2011;21:1:15-21. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7b/f5/biochem-23-3-332-13.PMC3900075.pdf
Eur J Nucl Med Mol Imaging 2013;40:470-4. http://dx.doi.org/10.1007/s00259-012- 2317-3.,Non-OADS,/arxiv_data1/oa_pdf/7b/f5/biochem-23-3-332-13.PMC3900075.pdf
Jugo - slov Med Biohem 2005;24:181-6. http://dx.doi.org/10.2298/ JMH0503181S.,OADS,/arxiv_data1/oa_pdf/7b/f5/biochem-23-3-332-13.PMC3900075.pdf
Clin Chim Acta 2008;393:5-8. http://dx.doi.org/10.1016/j.cca.2008.03.019.,OADS,/arxiv_data1/oa_pdf/7b/f5/biochem-23-3-332-13.PMC3900075.pdf
http://dx.doi.org/10.11613/BM.2013.041 Biochemia Medica 2013;23(3):332–41    341Topic E. et al.,OADS,/arxiv_data1/oa_pdf/7b/f5/biochem-23-3-332-13.PMC3900075.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/f5/biochem-23-3-332-13.PMC3900075.pdf
Clin Chim Acta 2009;404:46-51. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7b/f5/biochem-23-3-332-13.PMC3900075.pdf
Available at: http://www.repath.org/index.,Non-OADS,/arxiv_data1/oa_pdf/7b/f5/biochem-23-3-332-13.PMC3900075.pdf
Available at: http://www.repath.org/index.,Non-OADS,/arxiv_data1/oa_pdf/7b/f5/biochem-23-3-332-13.PMC3900075.pdf
Available at: http://www.komorabiohemsrbije.org.rs .,Non-OADS,/arxiv_data1/oa_pdf/7b/f5/biochem-23-3-332-13.PMC3900075.pdf
Available at:  http://www.lkcr.cz/.,Non-OADS,/arxiv_data1/oa_pdf/7b/f5/biochem-23-3-332-13.PMC3900075.pdf
Available at: http://www.admin.uems.net/ uploadedfiles/1497.pdf .,Non-OADS,/arxiv_data1/oa_pdf/7b/f5/biochem-23-3-332-13.PMC3900075.pdf
Available at: http://www.europeancmeforum.eu/ecf2008/presentations/2_eborman_paper.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7b/f5/biochem-23-3-332-13.PMC3900075.pdf
Available at: http://www.uems.net/ uploads/media/UEMS_2013.16_-_UEMS_Statement_on_Promoting_Continuing_Professional_Development_in_the_EU_-_ADOPTED.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7b/f5/biochem-23-3-332-13.PMC3900075.pdf
Available at: http://www.dubrovnik- course.org/past_courses .,Non-OADS,/arxiv_data1/oa_pdf/7b/f5/biochem-23-3-332-13.PMC3900075.pdf
Ava-ilable at: http://www.dmbj.org.rs/pdf/9th_EFLM_Symposi- um_program.pdf .,Non-OADS,/arxiv_data1/oa_pdf/7b/f5/biochem-23-3-332-13.PMC3900075.pdf
Clin Chem Lab Med 2013;51:775-80.  http://dx.doi.org/10.1515/cclm-2013-0095.,OADS,/arxiv_data1/oa_pdf/7b/f5/biochem-23-3-332-13.PMC3900075.pdf
"http://dx.doi.org/10.11613/BM.2013.032 Biochemia Medica 2013;23(3):255–65    255Abstract Polycyclic aromatic hydrocarbons (PAHs) are among the most prevalent environmental pollutants and result from the incomplete combustion of  hydrocarbons (coal and gasoline, fossil fuel combustion, byproducts of industrial processing, natural emission, cigarette smoking, etc.).",Non-OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Biochemia Medica 2013;23(3):255–65  http://dx.doi.org/10.11613/BM.2013.032  256Marinković N. et al.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
http://dx.doi.org/10.11613/BM.2013.032 Biochemia Medica 2013;23(3):255–65    257Marinković N. et al.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Biochemia Medica 2013;23(3):255–65  http://dx.doi.org/10.11613/BM.2013.032  258Marinković N. et al.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
http://dx.doi.org/10.11613/BM.2013.032 Biochemia Medica 2013;23(3):255–65    259Marinković N. et al.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Biochemia Medica 2013;23(3):255–65  http://dx.doi.org/10.11613/BM.2013.032  260Marinković N. et al.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
http://dx.doi.org/10.11613/BM.2013.032 Biochemia Medica 2013;23(3):255–65    261Marinković N. et al.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Biochemia Medica 2013;23(3):255–65  http://dx.doi.org/10.11613/BM.2013.032  262Marinković N. et al.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
http://dx.doi.org/10.11613/BM.2013.032 Biochemia Medica 2013;23(3):255–65    263Marinković N. et al.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Toxi- col Sci 2013;131:351-9. http://dx.doi.org/10.1093/toxsci/ kfs316.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Biodegradation 1992;3:351-68. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Sci Total Environ 2012;423:125-31. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Arh Hig Rada Toksikol 2011;62:357-70. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Chem Res Toxi-col 2012;25:952-64. http://dx.doi.org/10.1021/tx300043k .,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Am J Nephrol 2012;35:271-8.  http://dx.doi.org/10.1159/000336310.,Non-OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
EXS 2012;101:107-31. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Toxicol In Vi-tro 2010;24:1993-2002. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
J Geriatr Cardiol 2012;9:305- 17. http://dx.doi.org/10.3724/SP .J.1263.2012.02132.14.,Non-OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Ann N Y Acad Sci 2001;947:271-92. http://dx.doi.org/10.1111/ j.1749-6632.2001.tb03949.x.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
J Biol Chem 2012;287:4041- 52. http://dx.doi.org/10.1074/jbc.M111.319970.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Drug Metabol Drug Interact 2012;27:3-8. http://dx.doi.org/10.1515/dmdi-2011-0035.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
J Comp Physiol B 2005;175:221-30. http://dx.doi.org/10.1007/s00360-005- 0483-3.,Non-OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Biochim Biophys Acta  2003;1619:263-8. http://dx.doi.org/10.1016/S0304-4165- (02)00485-3.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Drug Metab Pharmacokinet  2006;21:257-76. http://dx.doi.org/10.2133/dmpk.21.257.,Non-OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
J Toxi- col Environ Health 1995;46:271-92. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Environ Health Perspect 2012;120:733-8.  http://dx.doi.org/10.1289/ehp.1104056.,Non-OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
J Pharmacol Exp Ther  2002;300:361-6. http://dx.doi.org/10.1124/jpet.300.2.361.,Non-OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
J Biol  Chem 2012;287:41608-18. http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Biochemia Medica 2013;23(3):255–65  http://dx.doi.org/10.11613/BM.2013.032  264Marinković N. et al.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Can J Physiol Pharmacol 1995;73:1407-13. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Arch Pharm Res 2000;23:605-12. http://dx.doi.org/10.1007/ BF02975249.,Non-OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Mutagenesis 2008;23:299-308.  http://dx.doi.org/10.1093/mutage/gen012.,Non-OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
BMC Evol Biol 2010;10:281.  http://dx.doi.org/10.1186/1471-2148-10-281.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Chem Res Toxicol 2012;25:952-64. http://dx.doi.org/10.1021/ tx300043k .,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Biochem Biophys Res Commun 2005;335:220-6. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Biochem Biophys Res Commun 2005;337:708-12. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Diabetologia 2009;52:1352-62.  http://dx.doi.org/10.1007/s00125-009-1366-z.,Non-OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Mutat Res 2007;621:31-41.  http://dx.doi.org/10.1016/j.mrfmmm.2006.12.010.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
J Mol Neurosci 2007;32:155-9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Curr  Opin Pharmacol 2007;7:367-4. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Mutat Res 2012;736:130-7. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Cancer 2008;112:1964-73. http://dx.doi.org/10.1002/cn- cr.23392.,Non-OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
J Exp Clin Cancer Res  2011;30:99. http://dx.doi.org/10.1186/1756-9966-30-99.,Non-OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
1991;19:4797. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Curr Drug Metab 2006;7:613-28.  http://dx.doi.org/10.2174/138920006778017786.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
DNA Cell Biol 2012;31:211-8. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Atherosclero - sis 2002;162:391-7. http://dx.doi.org/10.1016/S0021-9150-(01)00723-7.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
http://dx.doi.org/10.11613/BM.2013.032 Biochemia Medica 2013;23(3):255–65    265Marinković N. et al.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
World J Surg 2005;29:344-53. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Circ Car - diovasc Genet 2011;4:418-28. http://dx.doi.org/10.1161/ CIRCGENETICS.111.959809.,Non-OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
http://dx.doi.org/10.1016/j.carpath.2009.12.004.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
At-herosclerosis 2009;206:204-8. http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Pharmacogenomics 2009;10:29-34. http://dx.doi.org/10.2217/14622416.10.1.29.,Non-OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Mutat Res 2007;621:106-12. http://dx.doi.org/10.1016/j.mrfmmm.2007.02.014.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Atherosclerosis 2006;184:404-12. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Atherosc- lerosis 2003;171:265-72. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
J Lipid Res 2012;53:1738-54. http://dx.doi.org/10.1194/ jlr.R024505.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Carcinogenesis 2003;24:875-82. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Int J Hyg Environ Health 2008;211:471-503. http://dx.doi.org/10.1016/j.ijheh.2007.09.012.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Mutat Res 2007;620:49-61. http://dx.doi.org/10.1016/j.mrfmmm.2007.02.022.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
http://dx.doi.org/10.1016/j.mrfmmm.2006.12.012.,OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Arh Hig Rada Toksikol 2012;63:395-405. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a4/17/biochem-23-3-255-4.PMC3900076.pdf
Biochemia Medica 2013;23(3):296–302  http://dx.doi.org/10.11613/BM.2013.035  296Abstract Background : Overcrowding and prolonged length of stay in emergency departments (ED) are increasing problems in hospitals.,Non-OADS,/arxiv_data1/oa_pdf/33/c5/biochem-23-3-296-7.PMC3900077.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/33/c5/biochem-23-3-296-7.PMC3900077.pdf
http://dx.doi.org/10.11613/BM.2013.035 Biochemia Medica 2013;23(3):296–302    297Dimeski G. et al.,OADS,/arxiv_data1/oa_pdf/33/c5/biochem-23-3-296-7.PMC3900077.pdf
Biochemia Medica 2013;23(3):296–302  http://dx.doi.org/10.11613/BM.2013.035  298Dimeski G. et al.,OADS,/arxiv_data1/oa_pdf/33/c5/biochem-23-3-296-7.PMC3900077.pdf
http://dx.doi.org/10.11613/BM.2013.035 Biochemia Medica 2013;23(3):296–302    299Dimeski G. et al.,OADS,/arxiv_data1/oa_pdf/33/c5/biochem-23-3-296-7.PMC3900077.pdf
Biochemia Medica 2013;23(3):296–302  http://dx.doi.org/10.11613/BM.2013.035  300Dimeski G. et al.,OADS,/arxiv_data1/oa_pdf/33/c5/biochem-23-3-296-7.PMC3900077.pdf
http://dx.doi.org/10.11613/BM.2013.035 Biochemia Medica 2013;23(3):296–302    301Dimeski G. et al.,OADS,/arxiv_data1/oa_pdf/33/c5/biochem-23-3-296-7.PMC3900077.pdf
Clin Chim Acta 2002;315:125-35. http://dx.doi.org/10.1016/S0009-8981- (01)00714-8.,OADS,/arxiv_data1/oa_pdf/33/c5/biochem-23-3-296-7.PMC3900077.pdf
Orthope - dics 2011;34:877-81. http://dx.doi.org/10.3928/01477447- 20110922-22.,Non-OADS,/arxiv_data1/oa_pdf/33/c5/biochem-23-3-296-7.PMC3900077.pdf
Biochemia Medica 2013;23(3):296–302  http://dx.doi.org/10.11613/BM.2013.035  302Dimeski G. et al.,OADS,/arxiv_data1/oa_pdf/33/c5/biochem-23-3-296-7.PMC3900077.pdf
Ther Drug Monit 2000;22:93-7. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/33/c5/biochem-23-3-296-7.PMC3900077.pdf
Emer Med  J 2003;20:25-8. http://dx.doi.org/10.1136/emj.20.1.25.12.,Non-OADS,/arxiv_data1/oa_pdf/33/c5/biochem-23-3-296-7.PMC3900077.pdf
Arch Intern Med 1987;147:133-7. http://dx.doi.org/10.1001/archinte.1987.00370010131028.,Non-OADS,/arxiv_data1/oa_pdf/33/c5/biochem-23-3-296-7.PMC3900077.pdf
BMC Emerg Med 2009;9:5. http://dx.doi.org/10.1186/1471-227X-9-5.,Non-OADS,/arxiv_data1/oa_pdf/33/c5/biochem-23-3-296-7.PMC3900077.pdf
Am J Clin Path 2008;129:796-801. http://dx.doi.org/10.1309/59681R72JDTCCD2B .,OADS,/arxiv_data1/oa_pdf/33/c5/biochem-23-3-296-7.PMC3900077.pdf
"Key words : periodicals as topi c; language; database; science Received: September 10, 2013 Accepted: September 15, 2013ScienceCentral: open access full-text archive of scientific journals based on  Journal Article Tag Suite regardless of their languages Sun Huh Department of Parasitology and Institute of Medical Education, College of Medicine, Hallym University, Chuncheon, Korea Corresponding author: shuh@hallym.ac.kr http://dx.doi.org/10.11613/BM.2013.029 Biochemia Medica 2013;23(3):235–6    235Editorial It is possible to trace 56 biomedical journals from  Croatia, referenced in the NCBI databases.",Non-OADS,/arxiv_data1/oa_pdf/48/61/biochem-23-3-235-1.PMC3900078.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/61/biochem-23-3-235-1.PMC3900078.pdf
"Biochemia Medica 2013;23(3):235–6  http://dx.doi.org/10.11613/BM.2013.0029  236Huh S.  based full text database, it accepts all languages,  according to Unicode Transformation Format 8-bit  encoding (3).",OADS,/arxiv_data1/oa_pdf/48/61/biochem-23-3-235-1.PMC3900078.pdf
Availa- ble at: http://www.ncbi.nlm.nih.gov/nlmcatalog/journals/.,Non-OADS,/arxiv_data1/oa_pdf/48/61/biochem-23-3-235-1.PMC3900078.pdf
Available at: http://jats.nlm.nih.gov/.,Non-OADS,/arxiv_data1/oa_pdf/48/61/biochem-23-3-235-1.PMC3900078.pdf
http://dx.doi.org/10.1087/20110408.,Non-OADS,/arxiv_data1/oa_pdf/48/61/biochem-23-3-235-1.PMC3900078.pdf
J Educ Eval Health Prof 2013;10:3. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/48/61/biochem-23-3-235-1.PMC3900078.pdf
J Kore - an Med Assoc 2010;53:659-67. http://dx.doi.org/10.5124/ jkma.2010.53.8.659.,OADS,/arxiv_data1/oa_pdf/48/61/biochem-23-3-235-1.PMC3900078.pdf
http://dx.doi.org/10.11613/BM.2013.036 Biochemia Medica 2013;23(3):303–7    303Abstract Introduction : Blood collection through intravenous lines frequently causes spurious hemolysis.,Non-OADS,/arxiv_data1/oa_pdf/59/3e/biochem-23-3-303-8.PMC3900079.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/59/3e/biochem-23-3-303-8.PMC3900079.pdf
Biochemia Medica 2013;23(3):303–7  http://dx.doi.org/10.11613/BM.2013.036  304Lippi G. et al.,Non-OADS,/arxiv_data1/oa_pdf/59/3e/biochem-23-3-303-8.PMC3900079.pdf
http://dx.doi.org/10.11613/BM.2013.036 Biochemia Medica 2013;23(3):303–7    305Lippi G. et al.,OADS,/arxiv_data1/oa_pdf/59/3e/biochem-23-3-303-8.PMC3900079.pdf
Biochemia Medica 2013;23(3):303–7  http://dx.doi.org/10.11613/BM.2013.036  306Lippi G. et al.,Non-OADS,/arxiv_data1/oa_pdf/59/3e/biochem-23-3-303-8.PMC3900079.pdf
http://dx.doi.org/10.11613/BM.2013.036 Biochemia Medica 2013;23(3):303–7    307Lippi G. et al.,OADS,/arxiv_data1/oa_pdf/59/3e/biochem-23-3-303-8.PMC3900079.pdf
Biochem Med  2012;22:145-9. http://dx.doi.org/10.11613/BM.2012.017.,Non-OADS,/arxiv_data1/oa_pdf/59/3e/biochem-23-3-303-8.PMC3900079.pdf
Bi-ochem Med 2010;20:154-9. http://dx.doi.org/10.11613/ BM.2010.018.,Non-OADS,/arxiv_data1/oa_pdf/59/3e/biochem-23-3-303-8.PMC3900079.pdf
Crit Rev Clin Lab Sci 2011;48:143- 53. http://dx.doi.org/10.3109/10408363.2011.600228.,Non-OADS,/arxiv_data1/oa_pdf/59/3e/biochem-23-3-303-8.PMC3900079.pdf
Bi-ochem Med 2011;21:297-305. http://dx.doi.org/10.11613/ BM.2011.040.,Non-OADS,/arxiv_data1/oa_pdf/59/3e/biochem-23-3-303-8.PMC3900079.pdf
Biochem Med 2013;23:193-200. http://dx.doi.org/10.11613/BM.2013.022.,OADS,/arxiv_data1/oa_pdf/59/3e/biochem-23-3-303-8.PMC3900079.pdf
J Emerg Nurs 2004;30:529-33. http://dx.doi.org/10.1016/j.jen.2004.10.004.,OADS,/arxiv_data1/oa_pdf/59/3e/biochem-23-3-303-8.PMC3900079.pdf
Biochem Med 2013;23:64-9. http://dx.doi.org/10.11613/BM.2013.008.,OADS,/arxiv_data1/oa_pdf/59/3e/biochem-23-3-303-8.PMC3900079.pdf
Clin Biochem 2013;46:561-4. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/59/3e/biochem-23-3-303-8.PMC3900079.pdf
Clin Chem Lab Med 2009;47:934-9. http://dx.doi.org/10.1515/ CCLM.2009.218.,OADS,/arxiv_data1/oa_pdf/59/3e/biochem-23-3-303-8.PMC3900079.pdf
Biochemia Medica 2013;23(3):342–50  http://dx.doi.org/10.11613/BM.2013.042  342Abstract Introduction : The aim of the study was to identify biomarkers of alteration in bone mineral density (BMD) in patients on haemodialysis (HD) and  peritoneal dialysis (PD).,Non-OADS,/arxiv_data1/oa_pdf/d3/5a/biochem-23-3-342-14.PMC3900080.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d3/5a/biochem-23-3-342-14.PMC3900080.pdf
http://dx.doi.org/10.11613/BM.2013.042 Biochemia Medica 2013;23(3):342–50    343Nybo M. et al.,OADS,/arxiv_data1/oa_pdf/d3/5a/biochem-23-3-342-14.PMC3900080.pdf
Biochemia Medica 2013;23(3):342–50  http://dx.doi.org/10.11613/BM.2013.042  344Nybo M. et al.,OADS,/arxiv_data1/oa_pdf/d3/5a/biochem-23-3-342-14.PMC3900080.pdf
http://dx.doi.org/10.11613/BM.2013.042 Biochemia Medica 2013;23(3):342–50    345Nybo M. et al.,OADS,/arxiv_data1/oa_pdf/d3/5a/biochem-23-3-342-14.PMC3900080.pdf
Biochemia Medica 2013;23(3):342–50  http://dx.doi.org/10.11613/BM.2013.042  346Nybo M. et al.,OADS,/arxiv_data1/oa_pdf/d3/5a/biochem-23-3-342-14.PMC3900080.pdf
http://dx.doi.org/10.11613/BM.2013.042 Biochemia Medica 2013;23(3):342–50    347Nybo M. et al.,OADS,/arxiv_data1/oa_pdf/d3/5a/biochem-23-3-342-14.PMC3900080.pdf
Biochemia Medica 2013;23(3):342–50  http://dx.doi.org/10.11613/BM.2013.042  348Nybo M. et al.,Non-OADS,/arxiv_data1/oa_pdf/d3/5a/biochem-23-3-342-14.PMC3900080.pdf
http://dx.doi.org/10.11613/BM.2013.042 Biochemia Medica 2013;23(3):342–50    349Nybo M. et al.,OADS,/arxiv_data1/oa_pdf/d3/5a/biochem-23-3-342-14.PMC3900080.pdf
J Bone Miner Res 2002;17:2094-105. http://dx.doi.org/10.1359/jbmr.2002.,OADS,/arxiv_data1/oa_pdf/d3/5a/biochem-23-3-342-14.PMC3900080.pdf
Kidney Int 2005;58:396-9. http://dx.doi.org/10.1046/j.1523-1755.2000.00178.x.,OADS,/arxiv_data1/oa_pdf/d3/5a/biochem-23-3-342-14.PMC3900080.pdf
Nephrol Dial Transplant 2009;24:239- 46. http://dx.doi.org/10.1093/ndt/gfn466.,Non-OADS,/arxiv_data1/oa_pdf/d3/5a/biochem-23-3-342-14.PMC3900080.pdf
Calcif Tissue Int 2009;85:310-6. http://dx.doi.org/10.1007/s00223-009-9278-y .,OADS,/arxiv_data1/oa_pdf/d3/5a/biochem-23-3-342-14.PMC3900080.pdf
BMJ 1996;312:1254-9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d3/5a/biochem-23-3-342-14.PMC3900080.pdf
Calcif Tissue Int 2005;76:256-60. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/5a/biochem-23-3-342-14.PMC3900080.pdf
Am J Kidney Dis 1999;33:287-93. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d3/5a/biochem-23-3-342-14.PMC3900080.pdf
J Bone Miner Res 2006;21:543-8. http://dx.doi.org/10.1359/ jbmr.060105.,Non-OADS,/arxiv_data1/oa_pdf/d3/5a/biochem-23-3-342-14.PMC3900080.pdf
Nephrol Dial Transplant 1999;14:1922-8. http://dx.doi.org/10.1093/ ndt/14.8.1922.,Non-OADS,/arxiv_data1/oa_pdf/d3/5a/biochem-23-3-342-14.PMC3900080.pdf
Osteoporos Int 2010;21:619-25. http://dx.doi.org/10.1007/s00198-009-0988-9.,OADS,/arxiv_data1/oa_pdf/d3/5a/biochem-23-3-342-14.PMC3900080.pdf
Nephrology 2005;10:393-9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d3/5a/biochem-23-3-342-14.PMC3900080.pdf
Biochemia Medica 2013;23(3):342–50  http://dx.doi.org/10.11613/BM.2013.042  350Nybo M. et al.,OADS,/arxiv_data1/oa_pdf/d3/5a/biochem-23-3-342-14.PMC3900080.pdf
Nephron 2002;91:94-102. http://dx.doi.org/10.1159/000057610.,OADS,/arxiv_data1/oa_pdf/d3/5a/biochem-23-3-342-14.PMC3900080.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d3/5a/biochem-23-3-342-14.PMC3900080.pdf
Hemodial Int 2010;14:182-92. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d3/5a/biochem-23-3-342-14.PMC3900080.pdf
Clin Biochem 2012;45:436-9. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d3/5a/biochem-23-3-342-14.PMC3900080.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d3/5a/biochem-23-3-342-14.PMC3900080.pdf
Acta Radiologica 2005;5:514-8. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/5a/biochem-23-3-342-14.PMC3900080.pdf
Scand J Clin Lab Invest 1993;53:649-52. http://dx.doi.org/10.3109/00365519309092566.,Non-OADS,/arxiv_data1/oa_pdf/d3/5a/biochem-23-3-342-14.PMC3900080.pdf
Life Sci 2005;77:1130-9. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/5a/biochem-23-3-342-14.PMC3900080.pdf
Nephrol Dial Transplant 1998;13:2077-80. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d3/5a/biochem-23-3-342-14.PMC3900080.pdf
Clin Nephrol 2005;64:288-94. http://dx.doi.org/10.5414/CNP64288.,OADS,/arxiv_data1/oa_pdf/d3/5a/biochem-23-3-342-14.PMC3900080.pdf
Osteoporos Int 2002;13:777-87. http://dx.doi.org/10.1007/ s001980200108.,OADS,/arxiv_data1/oa_pdf/d3/5a/biochem-23-3-342-14.PMC3900080.pdf
Biochemia Medica 2013;23(3):326–31  http://dx.doi.org/10.11613/BM.2013.040  326Abstract Introduction : Proper preparation of the individual is a key prerequisite for ensuring the quality of laboratory testing.,Non-OADS,/arxiv_data1/oa_pdf/53/89/biochem-23-3-326-12.PMC3900081.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/53/89/biochem-23-3-326-12.PMC3900081.pdf
http://dx.doi.org/10.11613/BM.2013.040 Biochemia Medica 2013;23(3):326–31    327Kackov S. et al.,OADS,/arxiv_data1/oa_pdf/53/89/biochem-23-3-326-12.PMC3900081.pdf
Biochemia Medica 2013;23(3):326–31  http://dx.doi.org/10.11613/BM.2013.040  328Kackov S. et al.,OADS,/arxiv_data1/oa_pdf/53/89/biochem-23-3-326-12.PMC3900081.pdf
http://dx.doi.org/10.11613/BM.2013.040 Biochemia Medica 2013;23(3):326–31    329Kackov S. et al.,OADS,/arxiv_data1/oa_pdf/53/89/biochem-23-3-326-12.PMC3900081.pdf
Biochemia Medica 2013;23(3):326–31  http://dx.doi.org/10.11613/BM.2013.040  330Kackov S. et al.,OADS,/arxiv_data1/oa_pdf/53/89/biochem-23-3-326-12.PMC3900081.pdf
http://dx.doi.org/10.11613/BM.2013.040 Biochemia Medica 2013;23(3):326–31    331Kackov S. et al.,OADS,/arxiv_data1/oa_pdf/53/89/biochem-23-3-326-12.PMC3900081.pdf
Biochem Med  2012;22:145-9. http://dx.doi.org/10.11613/BM.2012.017.,Non-OADS,/arxiv_data1/oa_pdf/53/89/biochem-23-3-326-12.PMC3900081.pdf
2003. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/53/89/biochem-23-3-326-12.PMC3900081.pdf
Ann Lab Med  2012;32:250-6. http://dx.doi.org/10.3343/alm.2012.32.,OADS,/arxiv_data1/oa_pdf/53/89/biochem-23-3-326-12.PMC3900081.pdf
Biochem Med 2011;21:71-8.  http://dx.doi.org/10.11613/BM.2011.014.,Non-OADS,/arxiv_data1/oa_pdf/53/89/biochem-23-3-326-12.PMC3900081.pdf
Bi- ochem Med 2011;21:55-64. http://dx.doi.org/10.11613/ BM.2011.012.,Non-OADS,/arxiv_data1/oa_pdf/53/89/biochem-23-3-326-12.PMC3900081.pdf
Int J Endocrinol Metab  2013;11:88-94. http://dx.doi.org/10.5812/ijem.9602.,OADS,/arxiv_data1/oa_pdf/53/89/biochem-23-3-326-12.PMC3900081.pdf
Biochem Med 2011;21:160-6.  http://dx.doi.org/10.11613/BM.2011.025.,Non-OADS,/arxiv_data1/oa_pdf/53/89/biochem-23-3-326-12.PMC3900081.pdf
Available at: http://ec.europa.eu/public_opinion/archives/quali/ql_ 5937_patient_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/53/89/biochem-23-3-326-12.PMC3900081.pdf
"Biochemia Medica 2013;23(3):242–54  http://dx.doi.org/10.11613/BM.2013.031  242Abstract Phlebotomy is one of the most complex medical procedures in the diagnosis, management and treatment of patients in healthcare.",Non-OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
"http://dx.doi.org/10.11613/BM.2013.031 Biochemia Medica 2013;23(3):242–54    243Nikolac N, et al.",OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
"Biochemia Medica 2013;23(3):242–54  http://dx.doi.org/10.11613/BM.2013.031  244Nikolac N, et al.",OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
"http://dx.doi.org/10.11613/BM.2013.031 Biochemia Medica 2013;23(3):242–54    245Nikolac N, et al.",OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
"Biochemia Medica 2013;23(3):242–54  http://dx.doi.org/10.11613/BM.2013.031  246Nikolac N, et al.",OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
"http://dx.doi.org/10.11613/BM.2013.031 Biochemia Medica 2013;23(3):242–54    247Nikolac N, et al.",OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
"Biochemia Medica 2013;23(3):242–54  http://dx.doi.org/10.11613/BM.2013.031  248Nikolac N, et al.",OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
"http://dx.doi.org/10.11613/BM.2013.031 Biochemia Medica 2013;23(3):242–54    249Nikolac N, et al.",OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
"Biochemia Medica 2013;23(3):242–54  http://dx.doi.org/10.11613/BM.2013.031  250Nikolac N, et al.",OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
"http://dx.doi.org/10.11613/BM.2013.031 Biochemia Medica 2013;23(3):242–54    251Nikolac N, et al.",OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
"Biochemia Medica 2013;23(3):242–54  http://dx.doi.org/10.11613/BM.2013.031  252Nikolac N, et al.",OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
"http://dx.doi.org/10.11613/BM.2013.031 Biochemia Medica 2013;23(3):242–54    253Nikolac N, et al.",OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
http://dx.doi.org/10.1515/cclm-2012-0597.,Non-OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
Nurs Stand 2005;19:55-65. http://dx.doi.org/10.7748/ ns2005.08.19.49.55.c3936.,Non-OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
Am J Clin Pathol 2010;133:180-6. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
http://dx.doi.org/10.1016/j.clinbiochem.2013.06.001.,OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
Clin Chem Lab Med  2013;51:1-9. http://dx.doi.org/10.1515/cclm-2013-0283.,OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
Available at: http://pairl.ie/doc/PAI_Guideli-nes_PDF.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
Available at: https://tools.skillsforhealth.org.uk/competence/show/html/code/CHS132/.,Non-OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
Available at:  http://www.vardhandboken.se/Texter/Blodprov-venos- provtagning/Oversikt/.,Non-OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
Available at: http://www.hkmb.hr/povjerenstva/strucna-pitanja.html#1.,Non-OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
Biochem Med 2011;21:15-21. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
Acad Emerg Med 2008;15:641-8. http://dx.doi.org/10.1111/j.1553-2712.2008.00148.x.,OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
Clin J Oncol Nurs 2008;12:495-8. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
Available at: http://www.jointcommission.org/standards_information/npsgs.aspx.,Non-OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
Ann  Lab Med 2012;32:250-6. http://dx.doi.org/10.3343/ alm.2012.32.4.250.,OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
Biochem Med 2011;21:160-6. http://dx.doi.org/10.11613/BM.2011.025.,Non-OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
Am J Clin Pathol 2003;120:127-37. http://dx.doi.org/10.1309/ P024K7VRDDPJCTVN.,OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
Lab Med 2006;37:551-3. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
JAMA 1992;267:1652-60. http://dx.doi.org/10.1001/ jama.267.12.1652.,Non-OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
Diabetes Care 2001;24:775-8. http://dx.doi.org/10.2337/ diacare.24.4.775.,Non-OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
"Biochemia Medica 2013;23(3):242–54  http://dx.doi.org/10.11613/BM.2013.031  254Nikolac N, et al.",OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
Thyroid 1993;3:81-5. http://dx.doi.org/10.1089/ thy.1993.3.81.,Non-OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
J Gen Intern Med 2005;20:520-4. http://dx.doi.org/10.1111/j.1525-1497.2005.0094.x.,Non-OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
J Emerg Nurs 2005;31:338-45. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
Biochem Med  2012;22:342-51. http://dx.doi.org/10.11613/BM.2012.036.,Non-OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
Clin Chem Lab Med 2005;43:869-75. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
Biochem Med 2011;21:152-9. http://dx.doi.org/10.11613/BM.2011.024.,Non-OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
Clin Chem Lab Med 2009;47:769-76. http://dx.doi.org/10.1515/ CCLM.2009.157.,OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
Available at: http://www.clinlabnavigator.com/ammonia.html.,Non-OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
Biochem Med 2013;23:201-5.  http://dx.doi.org/10.11613/BM.2013.023.,Non-OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
Am J Clin Pathol 2012;137:900-3.  http://dx.doi.org/10.1309/AJCPL3LZZN9WJGZT .,OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
Biochem Med 2013;23:218-23. http://dx.doi.org/10.11613/ BM.2013.026.,OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
Available at: http://www.bd.com/vacutainer/pdfs/plus_plastic_tubes_wallchart_orderofdraw_VS5729.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
Available at: http://www.gbo.com/documents/980200B_0722001R2_IFU_VenousBloodCollection_11-12-10_US.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
Am J  Clin Pathol 2010;133:331-5. http://dx.doi.org/10.1309/AJC- P9ATB0AXPFJC C. 51.,Non-OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
Blood Coagul Fi-brinolysis 2010;21:279-82. http://dx.doi.org/10.1097/ MBC.0b013e3283380d12.,Non-OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
http://dx.doi.org/10.1309/RQ00WJ60- KQXAM9B0.,OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
Clin Chem 2004;50:2150-2. http://dx.doi.org/10.1373/ clinchem.2004.036244.,OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
Am J Clin Pathol 2010;134:851. http://dx.doi.org/10.1309/AJCP9HIFFC6FWKY F. 55.,Non-OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
Available at: http://www.mayomedicallaboratories.com/specimen-transport/domestic/light-protection.html.,Non-OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
Available at:  http://www.bd.com/vacutainer/pdfs/plus_plastic_tubes_instructions_lightsensitive_VS5732.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1b/32/biochem-23-3-242-3.PMC3900082.pdf
"http://dx.doi.org/10.11613/BM.2013.043 Biochemia Medica 2013;23(3):351–9    351Abstract Aim : The aim of study was to: 1) examine the relationship between ABO blood groups and extent of coronary atherosclerosis in patients with chronic  coronary artery disease (CAD), 2) compare ABO blood groups distribution in CAD patients and general population, 3) examine possible differences in  traditional risk factors frequency in CAD patients with different ABO blood groups.",Non-OADS,/arxiv_data1/oa_pdf/58/61/biochem-23-3-351-15.PMC3900083.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/58/61/biochem-23-3-351-15.PMC3900083.pdf
Biochemia Medica 2013;23(3):351–9  http://dx.doi.org/10.11613/BM.2013.043  352Karabuva S. et al.,Non-OADS,/arxiv_data1/oa_pdf/58/61/biochem-23-3-351-15.PMC3900083.pdf
http://dx.doi.org/10.11613/BM.2013.043 Biochemia Medica 2013;23(3):351–9    353Karabuva S. et al.,Non-OADS,/arxiv_data1/oa_pdf/58/61/biochem-23-3-351-15.PMC3900083.pdf
Biochemia Medica 2013;23(3):351–9  http://dx.doi.org/10.11613/BM.2013.043  354Karabuva S. et al.,Non-OADS,/arxiv_data1/oa_pdf/58/61/biochem-23-3-351-15.PMC3900083.pdf
http://dx.doi.org/10.11613/BM.2013.043 Biochemia Medica 2013;23(3):351–9    355Karabuva S. et al.,OADS,/arxiv_data1/oa_pdf/58/61/biochem-23-3-351-15.PMC3900083.pdf
Biochemia Medica 2013;23(3):351–9  http://dx.doi.org/10.11613/BM.2013.043  356Karabuva S. et al.,Non-OADS,/arxiv_data1/oa_pdf/58/61/biochem-23-3-351-15.PMC3900083.pdf
http://dx.doi.org/10.11613/BM.2013.043 Biochemia Medica 2013;23(3):351–9    357Karabuva S. et al.,Non-OADS,/arxiv_data1/oa_pdf/58/61/biochem-23-3-351-15.PMC3900083.pdf
Biochemia Medica 2013;23(3):351–9  http://dx.doi.org/10.11613/BM.2013.043  358Karabuva S. et al.,Non-OADS,/arxiv_data1/oa_pdf/58/61/biochem-23-3-351-15.PMC3900083.pdf
Lan- cet 1977;1:295-7. http://dx.doi.org/10.1016/S0140-6736- (77)91838-4.,OADS,/arxiv_data1/oa_pdf/58/61/biochem-23-3-351-15.PMC3900083.pdf
Transfus Med 2001;11:343-51. http://dx.doi.org/10.1046/j.1365-3148.2001.00315.x.,Non-OADS,/arxiv_data1/oa_pdf/58/61/biochem-23-3-351-15.PMC3900083.pdf
Atherosclerosis 1976;25:311-8. http://dx.doi.org/10.1016/0021-9150(76)90036-8.,OADS,/arxiv_data1/oa_pdf/58/61/biochem-23-3-351-15.PMC3900083.pdf
J Thromb Ha-emost 2004;2:2053-4. http://dx.doi.org/10.1111/j.1538- 7836.,Non-OADS,/arxiv_data1/oa_pdf/58/61/biochem-23-3-351-15.PMC3900083.pdf
Arterioscler Thromb Vasc Biol 2012;32:2045-51. http://dx.doi.org/10.1161/ ATVBAHA.108.179705.,Non-OADS,/arxiv_data1/oa_pdf/58/61/biochem-23-3-351-15.PMC3900083.pdf
Transfusion 1998;38:975-88. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/61/biochem-23-3-351-15.PMC3900083.pdf
Glycoconj J 1997;14:159-73. http://dx.doi.org/10.1023/A:1018581503164.,Non-OADS,/arxiv_data1/oa_pdf/58/61/biochem-23-3-351-15.PMC3900083.pdf
Circ Cardiovasc Genet 2011;4:681-6. http://dx.doi.org/10.1161/ CIRCGENETICS.111.960682.11.,Non-OADS,/arxiv_data1/oa_pdf/58/61/biochem-23-3-351-15.PMC3900083.pdf
Nature 2010;466:707-13. http://dx.doi.org/10.1038/nature09270.,Non-OADS,/arxiv_data1/oa_pdf/58/61/biochem-23-3-351-15.PMC3900083.pdf
Atherosclerosis 2010;211:461-6. http://dx.doi.org/10.1016/j.atherosclero - sis.,OADS,/arxiv_data1/oa_pdf/58/61/biochem-23-3-351-15.PMC3900083.pdf
Thromb Res 2002;108:195-6. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/61/biochem-23-3-351-15.PMC3900083.pdf
Croat Med J 2009;50:550-8. http://dx.doi.org/10.3325/cmj.2009.50.550.,OADS,/arxiv_data1/oa_pdf/58/61/biochem-23-3-351-15.PMC3900083.pdf
http://dx.doi.org/10.11613/BM.2013.043 Biochemia Medica 2013;23(3):351–9    359Karabuva S. et al.,Non-OADS,/arxiv_data1/oa_pdf/58/61/biochem-23-3-351-15.PMC3900083.pdf
Circulation 2003;107:149-58. http://dx.doi.org/10.1161/01.CIR.0000047041.66447.29.,Non-OADS,/arxiv_data1/oa_pdf/58/61/biochem-23-3-351-15.PMC3900083.pdf
Am J Cardi-ol 1983;51:606. http://dx.doi.org/10.1016/S0002-9149- (83)80105-2.,OADS,/arxiv_data1/oa_pdf/58/61/biochem-23-3-351-15.PMC3900083.pdf
J Thromb Haemost 2008;6:62-9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/61/biochem-23-3-351-15.PMC3900083.pdf
J Thromb Haemost  2005;3:2105-8. http://dx.doi.org/10.1111/j.1538-7836.,Non-OADS,/arxiv_data1/oa_pdf/58/61/biochem-23-3-351-15.PMC3900083.pdf
Arterioscler Thromb Vasc  Biol 2012;32;2314-20. http://dx.doi.org/10.1161/ATVBAHA.,Non-OADS,/arxiv_data1/oa_pdf/58/61/biochem-23-3-351-15.PMC3900083.pdf
Int J Cardiol 2006;110:256-8. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/58/61/biochem-23-3-351-15.PMC3900083.pdf
Blood 2001;10:3159-61. http://dx.doi.org/10.1182/blood.,Non-OADS,/arxiv_data1/oa_pdf/58/61/biochem-23-3-351-15.PMC3900083.pdf
"Accessed September 13,  2013, from http://dx.doi.org/10.1155/2012/641917.",Non-OADS,/arxiv_data1/oa_pdf/58/61/biochem-23-3-351-15.PMC3900083.pdf
"http://dx.doi.org/10.11613/BM.2013.030 Biochemia Medica 2013;23(3):137–41    237Abstract Salami publication or segmented publication is a distinct form of redundant publication which is usually characterized by similarity of hypothesis,  methodology or results but not text similarity.",Non-OADS,/arxiv_data1/oa_pdf/5a/15/biochem-23-3-237-2.PMC3900084.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/15/biochem-23-3-237-2.PMC3900084.pdf
"Biochemia Medica 2013;23(3):237–41  http://dx.doi.org/10.11613/BM.2013.030  238Šupak-Smolčić V. Salami publication cal or similar sample size, hypothesis, research  methodology and results , and very often have the  same authors (4).",Non-OADS,/arxiv_data1/oa_pdf/5a/15/biochem-23-3-237-2.PMC3900084.pdf
http://dx.doi.org/10.11613/BM.2013.030 Biochemia Medica 2013;23(3):237–41    239Šupak-Smolčić V. Salami publication significantly distort the final outcome of meta- analysis or other systematic reviews and therefore have a direct impact on clinical practice (8) .,Non-OADS,/arxiv_data1/oa_pdf/5a/15/biochem-23-3-237-2.PMC3900084.pdf
Biochemia Medica 2013;23(3):237–41  http://dx.doi.org/10.11613/BM.2013.030  240Šupak-Smolčić V. Salami publication Answer : There are legitimate reasons for suspect - ing salami publication i.e.,Non-OADS,/arxiv_data1/oa_pdf/5a/15/biochem-23-3-237-2.PMC3900084.pdf
http://dx.doi.org/10.11613/BM.2013.030 Biochemia Medica 2013;23(3):237–41    241Šupak-Smolčić V. Salami publication give a detailed explanation to the journal’s •	 editor on all above mentioned points be - cause transparency is crucial .,Non-OADS,/arxiv_data1/oa_pdf/5a/15/biochem-23-3-237-2.PMC3900084.pdf
Biochem Med 2013;23:150-3. http://dx.doi.org/10.11613/BM.2013.019.,Non-OADS,/arxiv_data1/oa_pdf/5a/15/biochem-23-3-237-2.PMC3900084.pdf
Sci-ence 1981;211:1137-9. http://dx.doi.org/10.1126/scien- ce.7008199.,Non-OADS,/arxiv_data1/oa_pdf/5a/15/biochem-23-3-237-2.PMC3900084.pdf
J Am Med Assoc 2004;291:974-80. http://dx.doi.org/10.1001/jama.291.8.974.,Non-OADS,/arxiv_data1/oa_pdf/5a/15/biochem-23-3-237-2.PMC3900084.pdf
2008;45:1257-60. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5a/15/biochem-23-3-237-2.PMC3900084.pdf
Available at: http://www.fra-minghamheartstudy.org/about/index.html.,Non-OADS,/arxiv_data1/oa_pdf/5a/15/biochem-23-3-237-2.PMC3900084.pdf
Available at: http://www.cha-nning.harvard.edu/nhs/.,Non-OADS,/arxiv_data1/oa_pdf/5a/15/biochem-23-3-237-2.PMC3900084.pdf
Rev Esp Cardiol 2005;58:601-4.  http://dx.doi.org/10.1157/13074852.,Non-OADS,/arxiv_data1/oa_pdf/5a/15/biochem-23-3-237-2.PMC3900084.pdf
Available at: http://www.icmje.org/publishing_4overlap.html.,Non-OADS,/arxiv_data1/oa_pdf/5a/15/biochem-23-3-237-2.PMC3900084.pdf
Avai-lable at: http://publicationethics.org/files/u2/01A_Redun-dant_Submitted.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5a/15/biochem-23-3-237-2.PMC3900084.pdf
Available at: http://publicationethics.org/files/u2/01B_Redundant_Pu-blished.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5a/15/biochem-23-3-237-2.PMC3900084.pdf
"Biochemia Medica 2013;23(1):70–7  http://dx.doi.org/10.11613/BM.2013.009 70Abstract Introduction : Optimal storage of serum specimens in central laboratories for a long period for multicenter reference interval studies, or e pidemi- ologic studies remains to be determined.",Non-OADS,/arxiv_data1/oa_pdf/09/c3/biochem_med-23-1-70-8.PMC3900085.pdf
http://dx.doi.org/10.11613/BM.2013.009 Biochemia Medica 2013;23(1):70–7   71Cuhadar S. et al.,OADS,/arxiv_data1/oa_pdf/09/c3/biochem_med-23-1-70-8.PMC3900085.pdf
Biochemia Medica 2013;23(1):70–7  http://dx.doi.org/10.11613/BM.2013.009 72Cuhadar S. et al.,OADS,/arxiv_data1/oa_pdf/09/c3/biochem_med-23-1-70-8.PMC3900085.pdf
http://dx.doi.org/10.11613/BM.2013.009 Biochemia Medica 2013;23(1):70–7   73Cuhadar S. et al.,OADS,/arxiv_data1/oa_pdf/09/c3/biochem_med-23-1-70-8.PMC3900085.pdf
Biochemia Medica 2013;23(1):70–7  http://dx.doi.org/10.11613/BM.2013.009 74Cuhadar S. et al.,OADS,/arxiv_data1/oa_pdf/09/c3/biochem_med-23-1-70-8.PMC3900085.pdf
http://dx.doi.org/10.11613/BM.2013.009 Biochemia Medica 2013;23(1):70–7   75Cuhadar S. et al.,OADS,/arxiv_data1/oa_pdf/09/c3/biochem_med-23-1-70-8.PMC3900085.pdf
Biochemia Medica 2013;23(1):70–7  http://dx.doi.org/10.11613/BM.2013.009 76Cuhadar S. et al.,OADS,/arxiv_data1/oa_pdf/09/c3/biochem_med-23-1-70-8.PMC3900085.pdf
http://dx.doi.org/10.11613/BM.2013.009 Biochemia Medica 2013;23(1):70–7   77Cuhadar S. et al.,OADS,/arxiv_data1/oa_pdf/09/c3/biochem_med-23-1-70-8.PMC3900085.pdf
Clin Chem 2007;53:1986-7. http://dx.doi.org/10.1373/clinchem.2007.091371.,Non-OADS,/arxiv_data1/oa_pdf/09/c3/biochem_med-23-1-70-8.PMC3900085.pdf
Scand J Clin Lab Invest 2007;67:741-7. http://dx.doi.org/10.1080/00365510701297480.,Non-OADS,/arxiv_data1/oa_pdf/09/c3/biochem_med-23-1-70-8.PMC3900085.pdf
Metabolomi-cs 2009;5:507-16. http://dx.doi.org/10.1007/s11306-009-0174-2.,OADS,/arxiv_data1/oa_pdf/09/c3/biochem_med-23-1-70-8.PMC3900085.pdf
Available at: http://www.westgard.com/biodatabase1htm#11.,OADS,/arxiv_data1/oa_pdf/09/c3/biochem_med-23-1-70-8.PMC3900085.pdf
Int J Epidemiol 2008;37:116-22. http://dx.doi.org/10.1093/ije/dym280.,OADS,/arxiv_data1/oa_pdf/09/c3/biochem_med-23-1-70-8.PMC3900085.pdf
Annals of Epidemiol 2002;12:528. http://dx.doi.org/10.1016/S1047-2797(02)00391-5.,Non-OADS,/arxiv_data1/oa_pdf/09/c3/biochem_med-23-1-70-8.PMC3900085.pdf
Biotechnol and Bioeng 2003;82:685-90. http://dx.doi.org/10.1002/bit.10612.,OADS,/arxiv_data1/oa_pdf/09/c3/biochem_med-23-1-70-8.PMC3900085.pdf
Cell Preserv Technol 2008;6:223-30. http://dx.doi.org/10.1089/cpt.2008.0012.,OADS,/arxiv_data1/oa_pdf/09/c3/biochem_med-23-1-70-8.PMC3900085.pdf
Lipids Health Dis 2012;11:53. http://dx.doi.org/10.1186/1476-511X-11-53.,Non-OADS,/arxiv_data1/oa_pdf/09/c3/biochem_med-23-1-70-8.PMC3900085.pdf
Clin Biochem 2012;45:816-26. http://dx.doi.org/10.1016/j.clinbiochem.2012.03.029.,OADS,/arxiv_data1/oa_pdf/09/c3/biochem_med-23-1-70-8.PMC3900085.pdf
Clin Chim Acta 2008;396:56-7. http://dx.doi.org/10.1016/j.cca.2008.06.023.,OADS,/arxiv_data1/oa_pdf/09/c3/biochem_med-23-1-70-8.PMC3900085.pdf
Biochemia Medica 2013;23(1):12–5  http://dx.doi.org/10.11613/BM.2013.003 12Abstract By writing scientifi  c articles we communicate science among collea gues and peers.,Non-OADS,/arxiv_data1/oa_pdf/91/1b/biochem_med-23-1-12-3.PMC3900086.pdf
http://dx.doi.org/10.11613/BM.2013.003 Biochemia Medica 2013;23(1):12–5   13Simundic AM.,Non-OADS,/arxiv_data1/oa_pdf/91/1b/biochem_med-23-1-12-3.PMC3900086.pdf
Biochemia Medica 2013;23(1):12–5  http://dx.doi.org/10.11613/BM.2013.003 14Simundic AM.,Non-OADS,/arxiv_data1/oa_pdf/91/1b/biochem_med-23-1-12-3.PMC3900086.pdf
http://dx.doi.org/10.11613/BM.2013.003 Biochemia Medica 2013;23(1):12–5   15Simundic AM.,Non-OADS,/arxiv_data1/oa_pdf/91/1b/biochem_med-23-1-12-3.PMC3900086.pdf
Account Res 2002;9:65-74. http://dx.doi.org/10.1080/08989620212968.,Non-OADS,/arxiv_data1/oa_pdf/91/1b/biochem_med-23-1-12-3.PMC3900086.pdf
http://dx.doi.org/10.11613/BM.2013.002 Biochemia Medica 2013;23(1):7–11   7Abstract An increasing prevalence of gestational diabetes has become a ve ry challenging task in prenatal care worldwide.,Non-OADS,/arxiv_data1/oa_pdf/17/83/biochem_med-23-1-7-2.PMC3900087.pdf
Biochemia Medica 2013;23(1):7–11  http://dx.doi.org/10.11613/BM.2013.002 8Vucic Lovrencic M. et al.,OADS,/arxiv_data1/oa_pdf/17/83/biochem_med-23-1-7-2.PMC3900087.pdf
http://dx.doi.org/10.11613/BM.2013.002 Biochemia Medica 2013;23(1):7–11   9Vucic Lovrencic M. et al.,OADS,/arxiv_data1/oa_pdf/17/83/biochem_med-23-1-7-2.PMC3900087.pdf
Biochemia Medica 2013;23(1):7–11  http://dx.doi.org/10.11613/BM.2013.002 10Vucic Lovrencic M. et al.,OADS,/arxiv_data1/oa_pdf/17/83/biochem_med-23-1-7-2.PMC3900087.pdf
http://dx.doi.org/10.11613/BM.2013.002 Biochemia Medica 2013;23(1):7–11   11Vucic Lovrencic M. et al.,OADS,/arxiv_data1/oa_pdf/17/83/biochem_med-23-1-7-2.PMC3900087.pdf
Arch Gynecol Obstet 2007;276:237-43. http://dx.doi.org/10.1007/s00404-007-0334-4.,Non-OADS,/arxiv_data1/oa_pdf/17/83/biochem_med-23-1-7-2.PMC3900087.pdf
http://dx.doi.org/10.2337/dc07-s225.,Non-OADS,/arxiv_data1/oa_pdf/17/83/biochem_med-23-1-7-2.PMC3900087.pdf
N Engl J Med 2008;358 :1991-2002. http://dx.doi.org/10.1056/NEJ- Moa0707943.,Non-OADS,/arxiv_data1/oa_pdf/17/83/biochem_med-23-1-7-2.PMC3900087.pdf
Diabetes Care 2010;33:676-82. http://dx.doi.org/10.2337/dc10-0719.,Non-OADS,/arxiv_data1/oa_pdf/17/83/biochem_med-23-1-7-2.PMC3900087.pdf
http://dx.doi.org/10.2337/ dc12-s011.,Non-OADS,/arxiv_data1/oa_pdf/17/83/biochem_med-23-1-7-2.PMC3900087.pdf
http://dx.doi.org/10.1373/clinchem.2010.161596.,Non-OADS,/arxiv_data1/oa_pdf/17/83/biochem_med-23-1-7-2.PMC3900087.pdf
http://dx.doi.org/10.11613/BM.2013.013 Biochemia Medica 2013;23(1):107–11   107Abstract Introduction : Zonulin is a eukaryotic protein structurally similar to Vibrio cholerae’s  zonula occludens toxin.,Non-OADS,/arxiv_data1/oa_pdf/0a/9b/biochem_med-23-1-107-12.PMC3900088.pdf
Biochemia Medica 2013;23(1):107–11  http://dx.doi.org/10.11613/BM.2013.013 108Klaus DA.,OADS,/arxiv_data1/oa_pdf/0a/9b/biochem_med-23-1-107-12.PMC3900088.pdf
http://dx.doi.org/10.11613/BM.2013.013 Biochemia Medica 2013;23(1):107–11   109Klaus DA.,OADS,/arxiv_data1/oa_pdf/0a/9b/biochem_med-23-1-107-12.PMC3900088.pdf
Biochemia Medica 2013;23(1):107–11  http://dx.doi.org/10.11613/BM.2013.013 110Klaus DA.,OADS,/arxiv_data1/oa_pdf/0a/9b/biochem_med-23-1-107-12.PMC3900088.pdf
http://dx.doi.org/10.11613/BM.2013.013 Biochemia Medica 2013;23(1):107–11   111Klaus DA.,OADS,/arxiv_data1/oa_pdf/0a/9b/biochem_med-23-1-107-12.PMC3900088.pdf
Crit Care Med 2012;40:2016-21. http://dx.doi.org/10.1097/CCM.0b013e318250aa72.,Non-OADS,/arxiv_data1/oa_pdf/0a/9b/biochem_med-23-1-107-12.PMC3900088.pdf
Surgery 2007; 141: 563-9. http://dx.doi.org/10.1016/j.surg.2007.01.021.,OADS,/arxiv_data1/oa_pdf/0a/9b/biochem_med-23-1-107-12.PMC3900088.pdf
Curr Opin Crit Care 2003;9:143-51. http://dx.doi.org/10.1097/00075198-200304000-00011.,Non-OADS,/arxiv_data1/oa_pdf/0a/9b/biochem_med-23-1-107-12.PMC3900088.pdf
Shock 2007;28:384-93. http://dx.doi.org/10.1097/shk.0b013e31805569df.,Non-OADS,/arxiv_data1/oa_pdf/0a/9b/biochem_med-23-1-107-12.PMC3900088.pdf
Ann N Y Acad Sci 2012;1258: 9-18. http://dx.doi.org/10.1111/j.1749-6632.2012.06613.x.,OADS,/arxiv_data1/oa_pdf/0a/9b/biochem_med-23-1-107-12.PMC3900088.pdf
Ann N Y Acad Sci 2000;915:129-35. http://dx.doi.org/10.1111/j.1749-6632.2000.tb05235.x.,OADS,/arxiv_data1/oa_pdf/0a/9b/biochem_med-23-1-107-12.PMC3900088.pdf
Lancet 2000;355:1518-9. http://dx.doi.org/10.1016/S0140-6736-(00)02169-3.,OADS,/arxiv_data1/oa_pdf/0a/9b/biochem_med-23-1-107-12.PMC3900088.pdf
Diabetes 2006;55:1443-9. http://dx.doi.org/10.2337/db05-1593.,Non-OADS,/arxiv_data1/oa_pdf/0a/9b/biochem_med-23-1-107-12.PMC3900088.pdf
http://dx.doi.org/10.1371/journal.pone.0037160.,Non-OADS,/arxiv_data1/oa_pdf/0a/9b/biochem_med-23-1-107-12.PMC3900088.pdf
Ann N Y Acad Sci 2012;1258:25-33. http://dx.doi.org/10.1111/j.1749-6632.2012.06538.x.,Non-OADS,/arxiv_data1/oa_pdf/0a/9b/biochem_med-23-1-107-12.PMC3900088.pdf
Clin Gastroenterol Hepa-tol 2005;3:335-41. http://dx.doi.org/10.1016/S1542-3565-(04)00778-5.13.,Non-OADS,/arxiv_data1/oa_pdf/0a/9b/biochem_med-23-1-107-12.PMC3900088.pdf
Chest 1992;101:1481-3. http://dx.doi.org/10.1378/chest.101.6.1481.,Non-OADS,/arxiv_data1/oa_pdf/0a/9b/biochem_med-23-1-107-12.PMC3900088.pdf
J Trauma 1998;44:1031-5; discussion 5-6. http://dx.doi.org/10.1097/00005373-199806000-00016.,Non-OADS,/arxiv_data1/oa_pdf/0a/9b/biochem_med-23-1-107-12.PMC3900088.pdf
Crit Care Med 2005;33:1125-35. http://dx.doi.org/10.1097/01.CCM.0000162680.52397.97.,Non-OADS,/arxiv_data1/oa_pdf/0a/9b/biochem_med-23-1-107-12.PMC3900088.pdf
J Clin Invest 1995;96:710-20. http://dx.doi.org/10.1172/JCI118114.,Non-OADS,/arxiv_data1/oa_pdf/0a/9b/biochem_med-23-1-107-12.PMC3900088.pdf
http://dx.doi.org/10.1152/ajpgi.00024.2006.,OADS,/arxiv_data1/oa_pdf/0a/9b/biochem_med-23-1-107-12.PMC3900088.pdf
Gastroenterology 2002;123:1607-15. http://dx.doi.org/10.1053/gast.2002.36578.,Non-OADS,/arxiv_data1/oa_pdf/0a/9b/biochem_med-23-1-107-12.PMC3900088.pdf
J Gastrointest Surg 2011;15:853-9. http://dx.doi.org/10.1007/s11605-011-1431-z.,Non-OADS,/arxiv_data1/oa_pdf/0a/9b/biochem_med-23-1-107-12.PMC3900088.pdf
Shock 2006;25:147-54. http://dx.doi.org/10.1097/01.shk.0000189843.78729.e2.,Non-OADS,/arxiv_data1/oa_pdf/0a/9b/biochem_med-23-1-107-12.PMC3900088.pdf
http://dx.doi.org/10.11613/BM.2013.007 Biochemia Medica 2013;23(1):43–63   43Abstract Bone and immune system are functionally interconnected.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Biochemia Medica 2013;23(1):43–63  http://dx.doi.org/10.11613/BM.2013.007 44Zupan J. et al.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
http://dx.doi.org/10.11613/BM.2013.007 Biochemia Medica 2013;23(1):43–63   45Zupan J. et al.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Biochemia Medica 2013;23(1):43–63  http://dx.doi.org/10.11613/BM.2013.007 46Zupan J. et al.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
http://dx.doi.org/10.11613/BM.2013.007 Biochemia Medica 2013;23(1):43–63   47Zupan J. et al.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Biochemia Medica 2013;23(1):43–63  http://dx.doi.org/10.11613/BM.2013.007 48Zupan J. et al.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
http://dx.doi.org/10.11613/BM.2013.007 Biochemia Medica 2013;23(1):43–63   49Zupan J. et al.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Biochemia Medica 2013;23(1):43–63  http://dx.doi.org/10.11613/BM.2013.007 50Zupan J. et al.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
http://dx.doi.org/10.11613/BM.2013.007 Biochemia Medica 2013;23(1):43–63   51Zupan J. et al.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Biochemia Medica 2013;23(1):43–63  http://dx.doi.org/10.11613/BM.2013.007 52Zupan J. et al.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
http://dx.doi.org/10.11613/BM.2013.007 Biochemia Medica 2013;23(1):43–63   53Zupan J. et al.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Biochemia Medica 2013;23(1):43–63  http://dx.doi.org/10.11613/BM.2013.007 54Zupan J. et al.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
http://dx.doi.org/10.11613/BM.2013.007 Biochemia Medica 2013;23(1):43–63   55Zupan J. et al.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Nat Med 2003;9:1151-7. http://dx.doi.org/10.1038/nm914.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Immunity 2005;22:259-70. http://dx.doi.org/10.1016/j.immuni.2005.01.008.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
http://dx.doi.org/10.1301/nr.2007.dec.S147-S151.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Nature  2000;408:535-6. http://dx.doi.org/10.1038/35046196.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Science 1972;177:793-5. http://dx.doi.org/10.1126/science.177.4051.793.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Nature 1997;390:175-9. http://dx.doi.org/10.1038/36593.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Exp Med 1997;186:2075-80. http://dx.doi.org/10.1084/jem.186.12.2075.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Cell 1998;93:165- 76. http://dx.doi.org/10.1016/S0092-8674(00)81569-X.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Na-ture 2000;408:600-5. http://dx.doi.org/10.1038/35046102.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Clin Invest 2008;118:3537-45. http://dx.doi.org/10.1172/JCI36389.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Arthritis Rheum 2010;62:647-57. http://dx.doi.org/10.1002/art.27290.15.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Med Hypotheses 2011;76:317-21. http://dx.doi.org/10.1016/j.mehy.2010.09.023.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Immunol Rev 2005;208:181-93. http://dx.doi.org/10.1111/j.0105-2896.2005.00337.x.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Nature 2004;428:758-63. http://dx.doi.org/10.1038/nature02444.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Cell Sci 2010;123:2955-63. http://dx.doi.org/10.1242/jcs.069872.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Clin Invest 2011;121:3505-16. http://dx.doi.org/10.1172/JCI45913.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Eur J Immunol 2007;37:747-57. http://dx.doi.org/10.1002/eji.200636534.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Pathol 2007;211:10-7. http://dx.doi.org/10.1002/pa-th.2078.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Clin Invest  2006;116:1195-201. http://dx.doi.org/10.1172/JCI28568.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Biochemia Medica 2013;23(1):43–63  http://dx.doi.org/10.11613/BM.2013.007 56Zupan J. et al.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Blood 2007;110:82-90. http://dx.doi.org/10.1182/blood-2006-05-021352.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Stem Cells 2007;25:1814-22. http://dx.doi.org/10.1634/stemcells.2007-0002.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Annu Rev Immu-nol 2002;20:795-823. http://dx.doi.org/10.1146/annurev.immunol.20.100301.064753.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Genes Dev 1999;13:2412-24. http://dx.doi.org/10.1101/gad.13.18.2412.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Nat Med 2011;17:1231-4. http://dx.doi.org/10.1038/nm.2452.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Ann N Y Acad Sci 2008;1143:123-50. http://dx.doi.org/10.1196/annals.1443.016.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Nat Genet 2000;24:45-8. http://dx.doi.org/10.1038/71667.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Joint  Bone Spine 2010;77:222-8. http://dx.doi.org/10.1016/j.jbspin.2010.02.004.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Nature 2003;423:337-42. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Biochem Biophys Res Co-mmun 1999;265:144-50. http://dx.doi.org/10.1006/bbrc.1999.1623.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Nature 1999;402:304-9. http://dx.doi.org/10.1038/46303.42.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Arthritis Rheum 2001;44:1003-12. http://dx.doi.org/10.1002/1529-0131(200105)44:5<1003::AID-ANR179>3.0.CO;2-#.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Clin Invest 2007;117:122-32. http://dx.doi.org/10.1172/JCI30074.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Biochem Biophys Res Commun 2000;275:768-75. http://dx.doi.org/10.1006/ bbrc.2000.3379.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
http://dx.doi.org/10.1186/ar581.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Arthritis Rheum 2009;60:3158-63. http://dx.doi.org/10.1002/art.24886.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Endocr Rev 2005;26:743-74. http://dx.doi.org/10.1210/er.2004-0001.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Biol Chem 2008;283:11535-40. http://dx.doi.org/10.1074/jbc.M607999200.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Bone 2000;26:249-53. http://dx.doi.org/10.1016/S8756-3282(99)00275-6.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Calcif Tissue Int 2003;73:584-93. http://dx.doi.org/10.1007/s00223-003-0059-8.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Endocrinology 2005;146:1991-8. http://dx.doi.org/10.1210/en.2004-1167.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
http://dx.doi.org/10.11613/BM.2013.007 Biochemia Medica 2013;23(1):43–63   57Zupan J. et al.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Bone 2002;30:901-8. http://dx.doi.org/10.1016/S8756-3282-(02)00722-6.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Arthritis Rheum 2001;44:275-85. http://dx.doi.org/10.1002/1529-0131(200102)44:2<275::AID-ANR44>3.0.CO;2-B.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Bone Miner Res 1989;4:113-8. http://dx.doi.org/10.1002/jbmr.5650040116.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Science  2000;289:1504-8. http://dx.doi.org/10.1126/science.289.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Bone Miner Res 1996;11:1736-44. http://dx.doi.org/10.1002/jbmr.5650111117.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Biol Chem 2000;275:4858-64. http://dx.doi.org/10.1074/jbc.275.7.4858.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Clin Invest 2005;115:3418-27. http://dx.doi.org/10.1172/JCI26132.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Autoimmun Rev 2009;8:538-42. http://dx.doi.org/10.1016/j.autrev.2009.01.012.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Arthritis Rheum 2009;60:2747-56. http://dx.doi.org/10.1002/art.24781.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
En-docrinology 1998;139:1564-72. http://dx.doi.org/10.1210/en.139.4.1564.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Clin Invest 1994;93:1516-24. http://dx.doi.org/10.1172/JCI117130.69.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Bone Miner Res 2005;20:1093-102. http://dx.doi.org/10.1359/JBMR.050209.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Exp Med 2006;203:2673-82. http://dx.doi.org/10.1084/jem.20061775.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Arthritis Rheum 2003;48:594-601. http://dx.doi.org/10.1002/art.10816.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Am J Pathol 2005;167:141-9. http://dx.doi.org/10.1016/S0002-9440(10)62961-6.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Bi-ochimie 2010;92:398-404. http://dx.doi.org/10.1016/j.biochi.2009.12.011.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Blood 2001;97:14-32. http://dx.doi.org/10.1182/blood.V97.1.14.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Arthritis Rheum 2006;54:1151-64. http://dx.doi.org/10.1002/art.21731.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Arthritis Rheum 2010;62:3300-10. http://dx.doi.org/10.1002/art.27645.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Bone 2003;33:28-37. http://dx.doi.org/10.1016/S8756-3282(03)00086-3.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Immuni-ty 2005;22:131-42. http://dx.doi.org/10.1016/S1074-7613-(04)00380-2.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Biochemia Medica 2013;23(1):43–63  http://dx.doi.org/10.11613/BM.2013.007 58Zupan J. et al.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Endocrinology 1994;135:1077-83. http://dx.doi.org/10.1210/en.135.3.1077.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
N Engl J Med 1995;332:1594-9. http://dx.doi.org/10.1056/NEJM199506153322402.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Nature 2002;416:744-9. http://dx.doi.org/10.1038/416744a.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Biol Chem 2002;277:27880-6. http://dx.doi.org/10.1074/jbc.M203836200.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Bone Miner Metab 2009;27:643-52. http://dx.doi.org/10.1007/s00774-009-0084-4.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
http://dx.doi.org/10.1186/ar1165.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Bone 1999;25:459-63. http://dx.doi.org/10.1016/S8756-3282(99)00182-9.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Ar-thritis Rheum 2010;62:1127-37. http://dx.doi.org/10.1002/art.27312.92.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
BMC Gastroenterol 2005;5:30. http://dx.doi.org/10.1186/1471-230X-5-30.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Cytokine 1995;7:78-82. http://dx.doi.org/10.1006/cyto.1995.1010.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Bone 1998;22:361-5. http://dx.doi.org/10.1016/S8756-3282(97)00296-2.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Bone Miner Res 1994;9:1533-9. http://dx.doi.org/10.1002/jbmr.5650091005.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Cell Biochem 1991;47:272-7. http://dx.doi.org/10.1002/jcb.240470313.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Immunol Lett 2003;88:193-8. http://dx.doi.org/10.1016/S0165-2478-(03)00082-8.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
http://dx.doi.org/10.1186/ar3736.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
BMC Cell Biol 2007;8:4. http://dx.doi.org/10.1186/1471-2121-8-4.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Bone 2007;41:592-602. http://dx.doi.org/10.1016/j.bone.2007.05.016.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Immunol 2009;183:2444-55. http://dx.doi.org/10.4049/jimmunol.0804165.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
http://dx.doi.org/10.11613/BM.2013.007 Biochemia Medica 2013;23(1):43–63   59Zupan J. et al.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Cell Biochem 1996;60:469-83. http://dx.doi.org/10.1002/(SICI)1097-4644(19960315)60:4<469::AID-JCB4>3.0.CO;2-Q.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Eur J Oral Sci 2006;114:42-9. http://dx.doi.org/10.1111/j.1600-0722.2006.00283.x.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Clin Invest 1998;101:595-603. http://dx.doi.org/10.1172/JCI1333.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Calcif Tissue Int 2011;89:65-73. http://dx.doi.org/10.1007/s00223-011-9494-0.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Biochem Biophys Res Commun 2001;281:361-6. http://dx.doi.org/10.1006/bbrc.2001.4380.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Calcif Tissue Int 2010;86:242-8. http://dx.doi.org/10.1007/s00223-010-9335-6.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Bone Miner Res 2003;18:975-83. http://dx.doi.org/10.1359/jbmr.2003.18.6.975.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Bi-ochem Biophys Res Commun 2012;417:217-22. http://dx.doi.org/10.1016/j.bbrc.2011.11.088.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Bone Miner Res 2011;26:704-17. http://dx.doi.org/10.1002/jbmr.269.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Bone Miner Metab 2007;25:19-27. http://dx.doi.org/10.1007/s00774-006-0723-y.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Bone Miner Res 2006;21:695-702. http://dx.doi.org/10.1359/jbmr.060117.116.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Endocrinology 2003;144:3524-31. http://dx.doi.org/10.1210/en.2002-221057.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Bone Miner Res 2012. http://dx.doi.org/10.1002/jbmr.1553.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Bone 2006;39:658-65. http://dx.doi.org/10.1016/j.bone.2006.03.009.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Pathol 2007;212:47-55. http://dx.doi.org/10.1002/path.2153.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Ann N Y Acad Sci 2007;1117:377- 84. http://dx.doi.org/10.1196/annals.1402.002.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Ann Rheum Dis 2003;62:113-9. http://dx.doi.org/10.1136/ard.62.2.113.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Sci-ence 1993;260:547-9. http://dx.doi.org/10.1126/scien-ce.8097338.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Nat Rev Immunol 2007;7:292-304. http://dx.doi.org/10.1038/nri2062.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Bone 2003;33:721-32. http://dx.doi.org/10.1016/S8756-3282-(03)00213-8.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Immunol 2011;187:951-9. http://dx.doi.org/10.4049/jim-munol.1003986.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
http://dx.doi.org/10.1186/ar2297.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Biochemia Medica 2013;23(1):43–63  http://dx.doi.org/10.11613/BM.2013.007 60Zupan J. et al.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Nat Med 2009;15:757-65. http://dx.doi.org/10.1038/nm.1979.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Cell  Immunol 2008;252:68-80. http://dx.doi.org/10.1016/j.cellimm.2007.06.008.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Scien-ce 1992;257:88-91. http://dx.doi.org/10.1126/scien-ce.1621100.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Wien Med  Wochenschr 2010;160:438-45. http://dx.doi.org/10.1007/s10354-010-0809-y.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Clin Invest 2000;106:1229-37. http://dx.doi.org/10.1172/JCI11066.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Endocri-nology 1998;139:3022-5. http://dx.doi.org/10.1210/en.139.6.3022.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Clin Invest 1997;99:1699-703. http://dx.doi.org/10.1172/JCI119333.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Bone Miner Res 2006;21:1704-12. http://dx.doi.org/10.1359/jbmr.060726.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Blood 2007;109:3839-48. http://dx.doi.org/10.1182/blood-2006-07-037994.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Bone 2008;43:92-100. http://dx.doi.org/10.1016/j.bone.2008.02.017.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Endocr Rev 2002;23:90-119. http://dx.doi.org/10.1210/er.23.1.90.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Ann N Y Acad Sci 2006;1068:256-74. http://dx.doi.org/10.1196/annals.1346.030.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Bone Miner Res 2010;25:492-8. http://dx.doi.org/10.1359/jbmr.090802.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Osteoporos Int 2011;22:2869-77. http://dx.doi.org/10.1007/s00198-010-1496-7.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Clin Endocrinol Metab 2001;86:2032-42. http://dx.doi.org/10.1210/jc.86.5.2032.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Biomed Sci 2012;19:28. http://dx.doi.org/10.1186/1423-0127-19-28.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Clin Chem Lab Med 2012;50:1379-85. http://dx.doi.org/10.1515/cclm-2011-0589.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Bone Mi-ner Res 1990;5:983-8. http://dx.doi.org/10.1002/jb-mr.5650050912.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Bone Miner Res 2007;22:724-9. http://dx.doi.org/10.1359/jbmr.070207.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Osteoporos Int 2006;17:1410-9. http://dx.doi.org/10.1007/s00198-006-0142-x.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Maturitas 1997;26:63-71. http://dx.doi.org/10.1016/S0378-5122(96)01080-8.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
http://dx.doi.org/10.11613/BM.2013.007 Biochemia Medica 2013;23(1):43–63   61Zupan J. et al.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Bone Miner Res 1995;10:971-7. http://dx.doi.org/10.1002/jb-mr.5650100619.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Bone 2001;29:216-22. http://dx.doi.org/10.1016/S8756-3282(01)00501-4.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Arthritis Res 2000;2:33-7. http://dx.doi.org/10.1186/ar67.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Arthritis Rheum 2001;44:1237-47. http://dx.doi.org/10.1002/1529-0131-(200106)44:6<1237::AID-ART214>3.0.CO;2-F. 160.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
London: Springer; 2007. http://dx.doi.org/10.1007/978-1-84628-701-5.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Curr Drug Targets 2007;8:283-92. http://dx.doi.org/10.2174/138945007779940179.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Orthop Res 2004;22:742-50. http://dx.doi.org/10.1016/j.orthres.2003.12.007.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Biol Chem 2000;275:40307-15. http://dx.doi.org/10.1074/jbc.M002721200.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Curr Drug Targets 2007;8:367-76. http://dx.doi.org/10.2174/138945007779940061.166.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Arthritis Rheum 2003;48:3452-63. http://dx.doi.org/10.1002/art.11355.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Osteoarthritis Cartilage 2004;12:627-35. http://dx.doi.org/10.1016/j.joca.2004.03.003.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Osteoarthritis Car-tilage 2007;15:597-604. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Arthritis Rheum 2003;48:3442-51. http://dx.doi.org/10.1002/art.11328 170.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Arthritis Rheum 1997;40:62-8. http://dx.doi.org/10.1002/art.1780400110.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Bone 1999;25:255-9. http://dx.doi.org/10.1016/S8756-3282-(99)00162-3.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Bone Miner Res 2000;15:1459-66. http://dx.doi.org/10.1359/jbmr.2000.15.8.1459.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Exp Cell Res 1999;247:84-93. http://dx.doi.org/10.1006/excr.1998.4320.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Endo-crinology 1998;139:3157-64. http://dx.doi.org/10.1210/en.139.7.3157.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Clin Invest 2000;106:1481-8. http://dx.doi.org/10.1172/JCI11176.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Biochemia Medica 2013;23(1):43–63  http://dx.doi.org/10.11613/BM.2013.007 62Zupan J. et al.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Exp Med 2000;191:275-86. http://dx.doi.org/10.1084/jem.191.2.275.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Exp Med 2005;202:589-95. http://dx.doi.org/10.1084/jem.20050978.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Pathol 2002;198:220-7. http://dx.doi.org/10.1002/path.1190.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Bone 2003;32:1-7. http://dx.doi.org/10.1016/S8756-3282(02)00915-8.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Bone Miner Res 1998;13:393-9. http://dx.doi.org/10.1359/jbmr.1998.13.3.393.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Exp Cell Res 2004;294:149-58. http://dx.doi.org/10.1016/j.yexcr.2003.11.009.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Ann N Y Acad Sci 2006;1068:225-33. http://dx.doi.org/10.1196/annals.1346.047.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Cancer Res 2005;65:11001-9. http://dx.doi.org/10.1158/0008-5472.CAN-05-2630.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Endocrinology 1998;139:4743-6. http://dx.doi.org/10.1210/en.139.11.4743.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Endocrinology 2001;142:3850-6. http://dx.doi.org/10.1210/en.142.9.3850.188.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Clin Invest 1999;103:1345-52. http://dx.doi.org/10.1172/JCI5703.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Cell Biochem 2009;108:947-55. http://dx.doi.org/10.1002/jcb.22326.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
http://dx.doi.org/10.1371/journal.po-ne.0004173.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Dent Res 2001;80:351-5. http://dx.doi.org/10.1177/00220345010800011001.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Im-munol Lett 2011;137:53-61. http://dx.doi.org/10.1016/j.imlet.2011.02.017.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Biochem Biophys Res Commun 2000;276:868-72. http://dx.doi.org/10.1006/bbrc.2000.3577.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Biol Chem 2006;281:15809-20. http://dx.doi.org/10.1074/jbc.M513225200.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Cell Biochem 2011;112:3385-92. http://dx.doi.org/10.1002/jcb.23269.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Bi-ochem Biophys Res Commun 2005;329:839-45. http://dx.doi.org/10.1016/j.bbrc.2005.02.049.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
http://dx.doi.org/10.11613/BM.2013.007 Biochemia Medica 2013;23(1):43–63   63Zupan J. et al.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Biol Chem 2006;281:2414-29. http://dx.doi.org/10.1074/jbc.M510160200 200.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Immunology 2007;120:573-9. http://dx.doi.org/10.1111/j.1365-2567.2006.02538.x.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Bone Miner Res 2008;23:750-8. http://dx.doi.org/10.1359/jbmr.080203.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Bone Mi-ner Res 2003;18:984-93. http://dx.doi.org/10.1359/jbmr.2003.18.6.984.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Biol Chem 2002;277:6622-30. http://dx.doi.org/10.1074/jbc.M104957200.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Ann Rheum Dis 2004;63:1379-86.  http://dx.doi.org/10.1136/ard.2003.018481.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
http://dx.doi.org/10.1136/ard.2006.058479.206.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Cell Physiol 2006;207:244-50. http://dx.doi.org/10.1002/jcp.20563.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Bone 2009;45:1010-6. http://dx.doi.org/10.1016/j.bone.2009.07.079.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Nature 2006;441:235-8. http://dx.doi.org/10.1038/natu-re04753.,OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
Ann Med 2011;43:503-11. http://dx.doi.org/10.3109/07853890.2011.577093.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
J Bone Miner Metab 2007;25:277-85. http://dx.doi.org/10.1007/s00774-007-0766-8.,Non-OADS,/arxiv_data1/oa_pdf/63/c4/biochem_med-23-1-46-6.PMC3900089.pdf
http://dx.doi.org/10.11613/BM.2013.011 Biochemia Medica 2013;23(1):83–95   83Abstract Introduction : Technological innovation requires the laboratories to ensure th at modifi  cations or incorporations of new techniques do not al ter the  quality of their results.,Non-OADS,/arxiv_data1/oa_pdf/47/65/biochem_med-23-1-83-10.PMC3900090.pdf
Biochemia Medica 2013;23(1):83–95  http://dx.doi.org/10.11613/BM.2013.011 84Fernandez-Calle P .,Non-OADS,/arxiv_data1/oa_pdf/47/65/biochem_med-23-1-83-10.PMC3900090.pdf
http://dx.doi.org/10.11613/BM.2013.011 Biochemia Medica 2013;23(1):83–95   85Fernandez-Calle P .,Non-OADS,/arxiv_data1/oa_pdf/47/65/biochem_med-23-1-83-10.PMC3900090.pdf
Biochemia Medica 2013;23(1):83–95  http://dx.doi.org/10.11613/BM.2013.011 86Fernandez-Calle P .,Non-OADS,/arxiv_data1/oa_pdf/47/65/biochem_med-23-1-83-10.PMC3900090.pdf
http://dx.doi.org/10.11613/BM.2013.011 Biochemia Medica 2013;23(1):83–95   87Fernandez-Calle P .,Non-OADS,/arxiv_data1/oa_pdf/47/65/biochem_med-23-1-83-10.PMC3900090.pdf
Biochemia Medica 2013;23(1):83–95  http://dx.doi.org/10.11613/BM.2013.011 88Fernandez-Calle P .,Non-OADS,/arxiv_data1/oa_pdf/47/65/biochem_med-23-1-83-10.PMC3900090.pdf
http://dx.doi.org/10.11613/BM.2013.011 Biochemia Medica 2013;23(1):83–95   89Fernandez-Calle P .,Non-OADS,/arxiv_data1/oa_pdf/47/65/biochem_med-23-1-83-10.PMC3900090.pdf
Biochemia Medica 2013;23(1):83–95  http://dx.doi.org/10.11613/BM.2013.011 90Fernandez-Calle P .,Non-OADS,/arxiv_data1/oa_pdf/47/65/biochem_med-23-1-83-10.PMC3900090.pdf
http://dx.doi.org/10.11613/BM.2013.011 Biochemia Medica 2013;23(1):83–95   91Fernandez-Calle P .,Non-OADS,/arxiv_data1/oa_pdf/47/65/biochem_med-23-1-83-10.PMC3900090.pdf
Biochemia Medica 2013;23(1):83–95  http://dx.doi.org/10.11613/BM.2013.011 92Fernandez-Calle P .,Non-OADS,/arxiv_data1/oa_pdf/47/65/biochem_med-23-1-83-10.PMC3900090.pdf
http://dx.doi.org/10.11613/BM.2013.011 Biochemia Medica 2013;23(1):83–95   93Fernandez-Calle P .,Non-OADS,/arxiv_data1/oa_pdf/47/65/biochem_med-23-1-83-10.PMC3900090.pdf
Biochemia Medica 2013;23(1):83–95  http://dx.doi.org/10.11613/BM.2013.011 94Fernandez-Calle P .,Non-OADS,/arxiv_data1/oa_pdf/47/65/biochem_med-23-1-83-10.PMC3900090.pdf
Available at: http://www.westgard.,Non-OADS,/arxiv_data1/oa_pdf/47/65/biochem_med-23-1-83-10.PMC3900090.pdf
Available at: http://www.westgard.com/biodatabase-2012-update.htm).,OADS,/arxiv_data1/oa_pdf/47/65/biochem_med-23-1-83-10.PMC3900090.pdf
http://dx.doi.org/10.11613/BM.2013.011 Biochemia Medica 2013;23(1):83–95   95Fernandez-Calle P .,Non-OADS,/arxiv_data1/oa_pdf/47/65/biochem_med-23-1-83-10.PMC3900090.pdf
Available at: http://www.westgard.com/lesson23.htm.,Non-OADS,/arxiv_data1/oa_pdf/47/65/biochem_med-23-1-83-10.PMC3900090.pdf
Available at: http://www.westgard.com/hitchhike-mu.htm.,Non-OADS,/arxiv_data1/oa_pdf/47/65/biochem_med-23-1-83-10.PMC3900090.pdf
Clin Chem Lab Med 2008;46:1319-25. http://dx.doi.org/10.1515/CCLM.2008.256.,OADS,/arxiv_data1/oa_pdf/47/65/biochem_med-23-1-83-10.PMC3900090.pdf
http://dx.doi.org/10.1016/j.clinbiochem.2011.06.009.,OADS,/arxiv_data1/oa_pdf/47/65/biochem_med-23-1-83-10.PMC3900090.pdf
http://dx.doi.org/10.1016/j.cca.2006.07.018.,OADS,/arxiv_data1/oa_pdf/47/65/biochem_med-23-1-83-10.PMC3900090.pdf
Clin Chem Lab Med 2008;46:1489-500. http://dx.doi.org/10.1515/CCLM.2008.292.,OADS,/arxiv_data1/oa_pdf/47/65/biochem_med-23-1-83-10.PMC3900090.pdf
http://dx.doi.org/10.1016/j.cca.2005.12.033.25.,OADS,/arxiv_data1/oa_pdf/47/65/biochem_med-23-1-83-10.PMC3900090.pdf
http://dx.doi.org/10.1515/CCLM.2008.159.,Non-OADS,/arxiv_data1/oa_pdf/47/65/biochem_med-23-1-83-10.PMC3900090.pdf
Clin Chem Lab Med 2012;50:963-4. http://dx.doi.org/10.1515/cclm.2011.826.,OADS,/arxiv_data1/oa_pdf/47/65/biochem_med-23-1-83-10.PMC3900090.pdf
Available at: http://www.westgard.com/clia.htm.,Non-OADS,/arxiv_data1/oa_pdf/47/65/biochem_med-23-1-83-10.PMC3900090.pdf
Available at: http://www.westgard.com/rcpa-australasian-quality-requirements.htm.,Non-OADS,/arxiv_data1/oa_pdf/47/65/biochem_med-23-1-83-10.PMC3900090.pdf
http://dx.doi.org/10.1016/j.clinbiochem.2010.04.073.,OADS,/arxiv_data1/oa_pdf/47/65/biochem_med-23-1-83-10.PMC3900090.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/47/65/biochem_med-23-1-83-10.PMC3900090.pdf
http://dx.doi.org/10.1373/clinchem.2006.084715.,Non-OADS,/arxiv_data1/oa_pdf/47/65/biochem_med-23-1-83-10.PMC3900090.pdf
Biochemia Medica 2013;23(1):78–82  http://dx.doi.org/10.11613/BM.2013.010 78Abstract Background : Early diagnosis is crucial for management of patients with susp ected acute myocardial infarction (AMI).,Non-OADS,/arxiv_data1/oa_pdf/06/e9/biochem_med-23-1-78-9.PMC3900091.pdf
http://dx.doi.org/10.11613/BM.2013.010 Biochemia Medica 2013;23(1):78–82   79Lippi G. et al.,OADS,/arxiv_data1/oa_pdf/06/e9/biochem_med-23-1-78-9.PMC3900091.pdf
Biochemia Medica 2013;23(1):78–82  http://dx.doi.org/10.11613/BM.2013.010 80Lippi G. et al.,OADS,/arxiv_data1/oa_pdf/06/e9/biochem_med-23-1-78-9.PMC3900091.pdf
http://dx.doi.org/10.11613/BM.2013.010 Biochemia Medica 2013;23(1):78–82   81Lippi G. et al.,OADS,/arxiv_data1/oa_pdf/06/e9/biochem_med-23-1-78-9.PMC3900091.pdf
Biochemia Medica 2013;23(1):78–82  http://dx.doi.org/10.11613/BM.2013.010 82Lippi G. et al.,Non-OADS,/arxiv_data1/oa_pdf/06/e9/biochem_med-23-1-78-9.PMC3900091.pdf
Cir-culation 2012;125:188-97. http://dx.doi.org/10.1161/CIR.0b013e3182456d46.,OADS,/arxiv_data1/oa_pdf/06/e9/biochem_med-23-1-78-9.PMC3900091.pdf
Am J  Emerg Med 2008;26:373-4. http://dx.doi.org/10.1016/j.ajem.2007.11.001.,OADS,/arxiv_data1/oa_pdf/06/e9/biochem_med-23-1-78-9.PMC3900091.pdf
Clin Chim Acta 1998;272:79-86. http://dx.doi.org/10.1016/S0009-8981-(97)00254-4.,OADS,/arxiv_data1/oa_pdf/06/e9/biochem_med-23-1-78-9.PMC3900091.pdf
Lancet 1993;341:1032-3. http://dx.doi.org/10.1016/0140-6736(93)91129-A.,OADS,/arxiv_data1/oa_pdf/06/e9/biochem_med-23-1-78-9.PMC3900091.pdf
BMC Med Res Methodol 2003;3:25. http://dx.doi.org/10.1186/1471-2288-3-25.,Non-OADS,/arxiv_data1/oa_pdf/06/e9/biochem_med-23-1-78-9.PMC3900091.pdf
Clin Chem Lab Med 2005;43:1351-8. http://dx.doi.org/10.1515/CCLM.2005.231.,OADS,/arxiv_data1/oa_pdf/06/e9/biochem_med-23-1-78-9.PMC3900091.pdf
Clin Biochem 2007;40:1245-51. http://dx.doi.org/10.1016/j.clinbiochem.2007.07.018.,OADS,/arxiv_data1/oa_pdf/06/e9/biochem_med-23-1-78-9.PMC3900091.pdf
Bio-med Pap Med Fac Univ Palacky Olomouc Czech Repub 2007;151:247-9. http://dx.doi.org/10.5507/bp.2007.041.,Non-OADS,/arxiv_data1/oa_pdf/06/e9/biochem_med-23-1-78-9.PMC3900091.pdf
Novel biomarkers in early diagnosis of acu-te myocardial infarction compared with cardiac troponin T. Eur Heart J 2008;29:2843-50. http://dx.doi.org/10.1093/eu-rheartj/ehn363.,Non-OADS,/arxiv_data1/oa_pdf/06/e9/biochem_med-23-1-78-9.PMC3900091.pdf
Cardiol J 2011;18:496-502. http://dx.doi.org/10.5603/CJ.2011.0004.,Non-OADS,/arxiv_data1/oa_pdf/06/e9/biochem_med-23-1-78-9.PMC3900091.pdf
Clin Bi-ochem 2011;44:1343-5. http://dx.doi.org/10.1016/j.clinbiochem.2011.07.008.,OADS,/arxiv_data1/oa_pdf/06/e9/biochem_med-23-1-78-9.PMC3900091.pdf
N Engl J Med 2009;361:858-67. http://dx.doi.org/10.1056/NEJ-Moa0900428.,Non-OADS,/arxiv_data1/oa_pdf/06/e9/biochem_med-23-1-78-9.PMC3900091.pdf
Clin Chem Lab Med 2008;46:1313-8. http://dx.doi.org/10.1515/CCLM.2008.250.,OADS,/arxiv_data1/oa_pdf/06/e9/biochem_med-23-1-78-9.PMC3900091.pdf
Special issue: Responsible writing in science http://dx.doi.org/10.11613/BM.2013.001  Biochemia Medica 2013;23(1):5–6   5Editorial Abstract From the issue 23(1) we have implemented several major changes in  the editorial policies and proc edures.,Non-OADS,/arxiv_data1/oa_pdf/5a/2f/biochem_med-23-1-5-1.PMC3900092.pdf
Biochemia Medica 2013;23(1):5–6  http://dx.doi.org/10.11613/BM.2013.001 6Simundic AM.,Non-OADS,/arxiv_data1/oa_pdf/5a/2f/biochem_med-23-1-5-1.PMC3900092.pdf
Biochem Med 2013;23:16-8. http://dx.doi.org/10.11613/BM.2013.004.,OADS,/arxiv_data1/oa_pdf/5a/2f/biochem_med-23-1-5-1.PMC3900092.pdf
http://dx.doi.org/10.1371/journal.po-ne.0051928.,Non-OADS,/arxiv_data1/oa_pdf/5a/2f/biochem_med-23-1-5-1.PMC3900092.pdf
"Biochemia Medica 2013;23(1):64–9  http://dx.doi.org/10.11613/BM.2013.008 64Abstract Background:  In vitro hemolysis can be induced by several biological and tech nical sources, and may be worsened by forced aspiration of blo od in  vacuum tubes.",Non-OADS,/arxiv_data1/oa_pdf/25/b6/biochem_med-23-1-64-7.PMC3900093.pdf
http://dx.doi.org/10.11613/BM.2013.008 Biochemia Medica 2013;23(1):64–9   65Lippi G. et al.,OADS,/arxiv_data1/oa_pdf/25/b6/biochem_med-23-1-64-7.PMC3900093.pdf
Biochemia Medica 2013;23(1):64–9  http://dx.doi.org/10.11613/BM.2013.008 66Lippi G. et al.,OADS,/arxiv_data1/oa_pdf/25/b6/biochem_med-23-1-64-7.PMC3900093.pdf
http://dx.doi.org/10.11613/BM.2013.008 Biochemia Medica 2013;23(1):64–9   67Lippi G. et al.,OADS,/arxiv_data1/oa_pdf/25/b6/biochem_med-23-1-64-7.PMC3900093.pdf
Biochemia Medica 2013;23(1):64–9  http://dx.doi.org/10.11613/BM.2013.008 68Lippi G. et al.,OADS,/arxiv_data1/oa_pdf/25/b6/biochem_med-23-1-64-7.PMC3900093.pdf
Clin Chem Lab Med 2006;44:358-65. http://dx.doi.org/10.1515/CCLM.2006.073.,OADS,/arxiv_data1/oa_pdf/25/b6/biochem_med-23-1-64-7.PMC3900093.pdf
Clin Chem Lab Med 2011;49:1113-26. http://dx.doi.org/10.1515/cclm.2011.600.,OADS,/arxiv_data1/oa_pdf/25/b6/biochem_med-23-1-64-7.PMC3900093.pdf
Semin Thromb Hemost 2012;38:565-75. http://dx.doi.org/10.1055/s-0032-1315961.,Non-OADS,/arxiv_data1/oa_pdf/25/b6/biochem_med-23-1-64-7.PMC3900093.pdf
http://dx.doi.org/10.11613/BM.2013.008 Biochemia Medica 2013;23(1):64–9   69Lippi G. et al.,OADS,/arxiv_data1/oa_pdf/25/b6/biochem_med-23-1-64-7.PMC3900093.pdf
J Clin Lab Anal 2012;26:246-7. http://dx.doi.org/10.1002/jcla.21512.,OADS,/arxiv_data1/oa_pdf/25/b6/biochem_med-23-1-64-7.PMC3900093.pdf
Clin Chem Lab Med 2012;50:599-600. http://dx.doi.org/10.1515/cclm-2012-0120.,OADS,/arxiv_data1/oa_pdf/25/b6/biochem_med-23-1-64-7.PMC3900093.pdf
Crit Rev Clin Lab Sci 2011;48:143-53. http://dx.doi.org/10.3109/10408363.2011.600228.,Non-OADS,/arxiv_data1/oa_pdf/25/b6/biochem_med-23-1-64-7.PMC3900093.pdf
Clin Chem Lab Med 2008;46:764-72. http://dx.doi.org/10.1515/CCLM.2008.170.16.,OADS,/arxiv_data1/oa_pdf/25/b6/biochem_med-23-1-64-7.PMC3900093.pdf
Clin Chem Lab Med 2009;47:934-9. http://dx.doi.org/10.1515/CCLM.2009.218.,OADS,/arxiv_data1/oa_pdf/25/b6/biochem_med-23-1-64-7.PMC3900093.pdf
Scand J Clin Lab Invest 1999;59:491-500. http://dx.doi.org/10.1080/00365519950185229.,Non-OADS,/arxiv_data1/oa_pdf/25/b6/biochem_med-23-1-64-7.PMC3900093.pdf
Transfusion 1981;21:750-1. http://dx.doi.org/10.1046/j.1537-2995.1981.21682085769.x.,Non-OADS,/arxiv_data1/oa_pdf/25/b6/biochem_med-23-1-64-7.PMC3900093.pdf
Clin Chem Lab Med 2005;43:319-25. http://dx.doi.org/10.1515/CCLM.2005.055.,OADS,/arxiv_data1/oa_pdf/25/b6/biochem_med-23-1-64-7.PMC3900093.pdf
Clin Chem Lab Med 2006;44:657-61. http://dx.doi.org/10.1515/CCLM.2006.109.,OADS,/arxiv_data1/oa_pdf/25/b6/biochem_med-23-1-64-7.PMC3900093.pdf
Am J Crit Care 2009;18:474-8. http://dx.doi.org/10.4037/ajcc2009686.,Non-OADS,/arxiv_data1/oa_pdf/25/b6/biochem_med-23-1-64-7.PMC3900093.pdf
Transfusion 1981;21:750-1. http://dx.doi.org/10.1046/j.1537-2995.1981.21682085769.x.,Non-OADS,/arxiv_data1/oa_pdf/25/b6/biochem_med-23-1-64-7.PMC3900093.pdf
Biochemia Medica 2013;23(1):96–106  http://dx.doi.org/10.11613/BM.2013.012 96Abstract Introduction : We examined the cost-eff  ectiveness of the three diff  erent D-di mer measurements in the screening of DVT in models with and wit ho- ut calculation of pre-test probability (PTP) score.,Non-OADS,/arxiv_data1/oa_pdf/11/c1/biochem_med-23-1-96-11.PMC3900094.pdf
http://dx.doi.org/10.11613/BM.2013.012 Biochemia Medica 2013;23(1):96–106   97Bogavac-Stanojević N. et al.,OADS,/arxiv_data1/oa_pdf/11/c1/biochem_med-23-1-96-11.PMC3900094.pdf
Biochemia Medica 2013;23(1):96–106  http://dx.doi.org/10.11613/BM.2013.012 98Bogavac-Stanojević N. et al.,OADS,/arxiv_data1/oa_pdf/11/c1/biochem_med-23-1-96-11.PMC3900094.pdf
http://dx.doi.org/10.11613/BM.2013.012 Biochemia Medica 2013;23(1):96–106   99Bogavac-Stanojević N. et al.,OADS,/arxiv_data1/oa_pdf/11/c1/biochem_med-23-1-96-11.PMC3900094.pdf
Biochemia Medica 2013;23(1):96–106  http://dx.doi.org/10.11613/BM.2013.012 100Bogavac-Stanojević N. et al.,OADS,/arxiv_data1/oa_pdf/11/c1/biochem_med-23-1-96-11.PMC3900094.pdf
http://dx.doi.org/10.11613/BM.2013.012 Biochemia Medica 2013;23(1):96–106   101Bogavac-Stanojević N. et al.,OADS,/arxiv_data1/oa_pdf/11/c1/biochem_med-23-1-96-11.PMC3900094.pdf
Biochemia Medica 2013;23(1):96–106  http://dx.doi.org/10.11613/BM.2013.012 102Bogavac-Stanojević N. et al.,OADS,/arxiv_data1/oa_pdf/11/c1/biochem_med-23-1-96-11.PMC3900094.pdf
http://dx.doi.org/10.11613/BM.2013.012 Biochemia Medica 2013;23(1):96–106   103Bogavac-Stanojević N. et al.,OADS,/arxiv_data1/oa_pdf/11/c1/biochem_med-23-1-96-11.PMC3900094.pdf
Biochemia Medica 2013;23(1):96–106  http://dx.doi.org/10.11613/BM.2013.012 104Bogavac-Stanojević N. et al.,OADS,/arxiv_data1/oa_pdf/11/c1/biochem_med-23-1-96-11.PMC3900094.pdf
http://dx.doi.org/10.11613/BM.2013.012 Biochemia Medica 2013;23(1):96–106   105Bogavac-Stanojević N. et al.,OADS,/arxiv_data1/oa_pdf/11/c1/biochem_med-23-1-96-11.PMC3900094.pdf
http://dx.doi.org/10.1001/archinte.158.6.585.,Non-OADS,/arxiv_data1/oa_pdf/11/c1/biochem_med-23-1-96-11.PMC3900094.pdf
Pathophysiol Haemost Thromb 2006;35:128-32. http://dx.doi.org/10.1159/000093554.,Non-OADS,/arxiv_data1/oa_pdf/11/c1/biochem_med-23-1-96-11.PMC3900094.pdf
http://dx.doi.org/10.1016/j.amepre.2009.12.017.,OADS,/arxiv_data1/oa_pdf/11/c1/biochem_med-23-1-96-11.PMC3900094.pdf
N Engl J Med 2004;351:268-77. http://dx.doi.org/10.1056/NEJMcp031676.,OADS,/arxiv_data1/oa_pdf/11/c1/biochem_med-23-1-96-11.PMC3900094.pdf
http://dx.doi.org/10.1001/archinte.1991.00400050081016.,Non-OADS,/arxiv_data1/oa_pdf/11/c1/biochem_med-23-1-96-11.PMC3900094.pdf
http://dx.doi.org/10.1001/jama.279.14.1094.,Non-OADS,/arxiv_data1/oa_pdf/11/c1/biochem_med-23-1-96-11.PMC3900094.pdf
J Thromb Haemost 2007;5(Suppl 1):41-50. http://dx.doi.org/10.1111/j.1538-7836.2007.02493.x.,Non-OADS,/arxiv_data1/oa_pdf/11/c1/biochem_med-23-1-96-11.PMC3900094.pdf
http://dx.doi.org/10.1373/clinchem.2004.031765.,Non-OADS,/arxiv_data1/oa_pdf/11/c1/biochem_med-23-1-96-11.PMC3900094.pdf
J Thromb Haemost 2004;2:1256-60. http://dx.doi.org/10.1111/j.1538-7836.2004.00824.x.,Non-OADS,/arxiv_data1/oa_pdf/11/c1/biochem_med-23-1-96-11.PMC3900094.pdf
J Thromb Haemost 2005;3:2465-70. http://dx.doi.org/10.1111/j.1538-7836.2005.01556.x.,OADS,/arxiv_data1/oa_pdf/11/c1/biochem_med-23-1-96-11.PMC3900094.pdf
JAMA 2008;300:1653-9. http://dx.doi.org/10.1001/jama.300.14.1653.,Non-OADS,/arxiv_data1/oa_pdf/11/c1/biochem_med-23-1-96-11.PMC3900094.pdf
http://dx.doi.org/10.1097/MBC.0b013 e32832e0605.,Non-OADS,/arxiv_data1/oa_pdf/11/c1/biochem_med-23-1-96-11.PMC3900094.pdf
Biochemia Medica 2013;23(1):96–106  http://dx.doi.org/10.11613/BM.2013.012 106Bogavac-Stanojević N. et al.,OADS,/arxiv_data1/oa_pdf/11/c1/biochem_med-23-1-96-11.PMC3900094.pdf
Available at: http://www.cebm.net/.,Non-OADS,/arxiv_data1/oa_pdf/11/c1/biochem_med-23-1-96-11.PMC3900094.pdf
"Accessed: Fe-bruary 18, 2012. http://dx.doi.org/10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I.",OADS,/arxiv_data1/oa_pdf/11/c1/biochem_med-23-1-96-11.PMC3900094.pdf
Clin Chem 2010;56811:1758-66. http://dx.doi.org/10.1373/clinchem.2010.147892.,OADS,/arxiv_data1/oa_pdf/11/c1/biochem_med-23-1-96-11.PMC3900094.pdf
http://dx.doi.org/10.1111/j.1538-7836.2009.03627.x.,Non-OADS,/arxiv_data1/oa_pdf/11/c1/biochem_med-23-1-96-11.PMC3900094.pdf
http://dx.doi.org/10.1016/j.thromres.2008.04.007.,OADS,/arxiv_data1/oa_pdf/11/c1/biochem_med-23-1-96-11.PMC3900094.pdf
http://dx.doi.org/10.1016/S0002-9343(00)00598-2.,OADS,/arxiv_data1/oa_pdf/11/c1/biochem_med-23-1-96-11.PMC3900094.pdf
http://dx.doi.org/10.1001/jama.295.2.172.,Non-OADS,/arxiv_data1/oa_pdf/11/c1/biochem_med-23-1-96-11.PMC3900094.pdf
http://dx.doi.org/10.1111/j.1538- 7836.2012.04895.x.,Non-OADS,/arxiv_data1/oa_pdf/11/c1/biochem_med-23-1-96-11.PMC3900094.pdf
Thromb Hae-most 2011;106:405-15. http://dx.doi.org/10.1160/TH11-02-0132.,OADS,/arxiv_data1/oa_pdf/11/c1/biochem_med-23-1-96-11.PMC3900094.pdf
"http://dx.doi.org/10.11613/BM.2013.015 Biochemia Medica 2013;23(1):A1–A55   A1 Basic course in scientific methodology and biostatistics Rovinj, Croatia  Preliminary Programme available on www.milan2013.satellitemeetings.org & www.milan2013.orgin cooperation with the Croatian Society of Medical Biochemistry and Laboratory Medicine 2nd EFLM-BD European Conference on Preanalytical Phase Preanalytical quality improvem ent – in quality we trust Hotel Westin, Zagreb, Croatia March 1-2, 2013 Organizers: European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) in collaboration with: BD Diagnostics, Preanalytical Systems Organizing Committee: Ana-Maria Simundic (chair), Croatia Silvia Cattaneo, Italy Marijana Miler, Croatia Lora Dukic, Croatia Sanja Dobrijevic, Croatia Scientifi  c Committee: Ana-Maria Simundic (chair), Croatia Michael Cornes, United Kingdom Kjell Grankvist, Sweden Giuseppe Lippi, Italy Mads Nybo, Denmark Svjetlana Kovalevskaya, Russia Ludek Sprongl, Czech Zorica Sumarac, Serbia Stephen Church, United Kingdom",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
"Biochemia Medica 2013;23(1):A1–A55  http://dx.doi.org/10.11613/BM.2013.015 A22nd EFLM-BD European Conference on Preanalytical Phase P1 Experimental study of blood tubes  underfi  lling for routine coagulation  testing Lippi G *1, Salvagno GL2, Lima-Oliveira G2, Funk-Adcock DM3,  Guidi GC2, Favaloro EJ4 1Laboratory of Clinical Chemistry and Hematology, Department  of Pathology and Laboratory Medicine, Academic Hospital of Parma, Italy 2Section of Clinical Biochemistry, Department of Life and  Reproductive Sciences, University of Verona, Italy 3Esoterix, Inc., Englewood Colorado, USA 4Department of Haematology, Institute of Clinical Pathology  and Medical Research (ICPMR), Westmead Hospital, NSW, Australia Background:  The preanalytical phase represents  the major source of variability in laboratory diag-nostics.",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
"http://dx.doi.org/10.11613/BM.2013.015 Biochemia Medica 2013;23(1):A1–A55   A32nd EFLM-BD European Conference on Preanalytical Phase using modifi  ed Clauss method by two measuring  principles: 1) opto-mechanical measurement, ac-curate for lipemic samples on Siemens BFT™II Ana-lyzer using Siemens Multifi  bren* U reagent in na- tive lipemic plasma samples; and 2) optical meas-urement on Siemens Sysmex CA-560 System using Dade Thrombin Reagent in plasma aliquots cleared of lipemia by high-speed centrifugation (10500 x g, 15 minutes).",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
Biochemia Medica 2013;23(1):A1–A55  http://dx.doi.org/10.11613/BM.2013.015 A42nd EFLM-BD European Conference on Preanalytical Phase P5 Free beta human chorionic gonadotropin  and pregnancy-associated plasma protein A in the fi  rst trimester screening.,Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
http://dx.doi.org/10.11613/BM.2013.015 Biochemia Medica 2013;23(1):A1–A55   A52nd EFLM-BD European Conference on Preanalytical Phase system (BD) was established to monitor time and  temperature during samples transport in each route.,Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
"Biochemia Medica 2013;23(1):A1–A55  http://dx.doi.org/10.11613/BM.2013.015 A62nd EFLM-BD European Conference on Preanalytical Phase P8 Serbian survey study on extra-analytical  phase of laboratory diagnostics Šumarac Z*1, Beletić A1, Ignjatović S1,2, Lalić N1, Milinković N1,  Majkić-Singh N1,2 1Institute for Medical Biochemistry, Clinical Centre of Serbia,  Belgrade, Serbia 2Pharmaceutical Faculty, University of Belgrade, Belgrade,  Serbia Background : Pre-analytical and post-analytical  ph a se s h a v e bec o me t h e m a j o r s o u r c e o f l a bo r a-tory errors.",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
"http://dx.doi.org/10.11613/BM.2013.015 Biochemia Medica 2013;23(1):A1–A55   A72nd EFLM-BD European Conference on Preanalytical Phase key) using photometer (Sinnova, BS-3000P , China).",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
"Biochemia Medica 2013;23(1):A1–A55  http://dx.doi.org/10.11613/BM.2013.015 A82nd EFLM-BD European Conference on Preanalytical Phase P11 Cardiovascular diseases predicted  by fasting and nonfasting lipids and apolipoproteins Kolpepaj R*1, Buzo S2, Harxhi A3, Kallco M4 1University of Tirana, Faculty of Nursing, Tirana, Albania 2Laboratory Department, University Hospital Centre “Mother  Teresa” , Tirana, Albania 3University Hospital Centre “Mother Teresa” , Tirana, Albania 4Hospital Regional, Durres, Albania Background : Most humans are in the nonfasting  or postprandial state in the majority of a 24 hour cycle; however, lipids, lipoproteins, and apolipo-proteins are usually measured in the fasting state.",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
"http://dx.doi.org/10.11613/BM.2013.015 Biochemia Medica 2013;23(1):A1–A55   A92nd EFLM-BD European Conference on Preanalytical Phase nm (for icteric, hemolytic or lipemic samples) and  w e r e  r e p o r t e d  i n  s e c o n d s  a n d  I N R .",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
"Biochemia Medica 2013;23(1):A1–A55  http://dx.doi.org/10.11613/BM.2013.015 A102nd EFLM-BD European Conference on Preanalytical Phase P14 The incidence of macroprolactinemia in  patients with hyperprolactinemia Dragašević I*1, Jovičić S1, Kangrga R1, Žugić B1, Dajak M1,  Ignjatović S2 1Medical Biochemistry Center, Clinical Center of Serbia,  Belgrade 2Medical Biochemistry Center, Clinical Center of Serbia and the  University of Belgrade, Faculty of Pharmacy Background:  The presence of macroprolactin in  serum is very often cause of wrong diagnosis, putting the patient on unnecessary and expensive tests and applying the wrong therapy.",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
http://dx.doi.org/10.11613/BM.2013.015 Biochemia Medica 2013;23(1):A1–A55   A112nd EFLM-BD European Conference on Preanalytical Phase ful operations with the risk to the patients can be  identifi  ed and the error sources can be improved.,Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
Biochemia Medica 2013;23(1):A1–A55  http://dx.doi.org/10.11613/BM.2013.015 A122nd EFLM-BD European Conference on Preanalytical Phase the other was centrifuged with a centrifuge with- out temperature control (Group 2).,Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
http://dx.doi.org/10.11613/BM.2013.015 Biochemia Medica 2013;23(1):A1–A55   A132nd EFLM-BD European Conference on Preanalytical Phase fore be taken when it suits the baby and not nec- essarily when it suits the phlebotomist.,Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
"Biochemia Medica 2013;23(1):A1–A55  http://dx.doi.org/10.11613/BM.2013.015 A142nd EFLM-BD European Conference on Preanalytical Phase P21 Infl uence of metamizole on serum  creatinine measurements (case report) Fliser E* , Modrič E, Klavž J, Jevšnikar B, Gorenjak M Department for Laboratory Diagnostics, University Clinical  Center Maribor, Maribor, Slovenia Background: Metamizole is the active substance  of an analgesic drug, known as Analgin, Novalgin or Dipyrone.",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
http://dx.doi.org/10.11613/BM.2013.015 Biochemia Medica 2013;23(1):A1–A55   A152nd EFLM-BD European Conference on Preanalytical Phase the 4 °C show R2 = 0.9719.,Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
"Biochemia Medica 2013;23(1):A1–A55  http://dx.doi.org/10.11613/BM.2013.015 A162nd EFLM-BD European Conference on Preanalytical Phase P24 Assessment of the preanalytical phase  for molecular biology testing through participation in EU SPIDIA project Kardum Paro MM *, Šiftar Z, Flegar- Meštrić Z Department of Medical Biochemistry and Laboratory Medicine,  „Merkur“ University Hospital, Zagreb, Croatia Background : In molecular biology testing defi  nite  gene changes are identifi  ed or ruled out directly  or indirectly on nucleic acids level.",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
http://dx.doi.org/10.11613/BM.2013.015 Biochemia Medica 2013;23(1):A1–A55   A172nd EFLM-BD European Conference on Preanalytical Phase all lipemic sera.,Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
"Biochemia Medica 2013;23(1):A1–A55  http://dx.doi.org/10.11613/BM.2013.015 A182nd EFLM-BD European Conference on Preanalytical Phase P27 Comparison between 6-hour and 24-hour  cupriuria in monitoring of therapy with D-penicillamine in patients with Wilson disease Ivanova I*1, Krastev Z1, Petkova T1, Dragneva S2 1Department of Clinical Laboratory, University Hospital St.",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
http://dx.doi.org/10.11613/BM.2013.015 Biochemia Medica 2013;23(1):A1–A55   A192nd EFLM-BD European Conference on Preanalytical Phase tainer® tubes: the use of this device prevents the  change of the number of WBC and BACT as well.,Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
Biochemia Medica 2013;23(1):A1–A55  http://dx.doi.org/10.11613/BM.2013.015 A202nd EFLM-BD European Conference on Preanalytical Phase institution staff  .,Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
http://dx.doi.org/10.11613/BM.2013.015 Biochemia Medica 2013;23(1):A1–A55   A212nd EFLM-BD European Conference on Preanalytical Phase coagulation tubes fi  l l e d  t o  l e s s  t h a n  9 0 %  o f  t u b e   volume 7%; gloves not worn 37%; incorrect activa-tion of needle safety device 19%.,Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
Biochemia Medica 2013;23(1):A1–A55  http://dx.doi.org/10.11613/BM.2013.015 A222nd EFLM-BD European Conference on Preanalytical Phase error grids.,Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
http://dx.doi.org/10.11613/BM.2013.015 Biochemia Medica 2013;23(1):A1–A55   A232nd EFLM-BD European Conference on Preanalytical Phase That is due to systemic education of blood donors  on the favorable pre-donation dietery habits which has been performed for many years in our Institute.,Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
Biochemia Medica 2013;23(1):A1–A55  http://dx.doi.org/10.11613/BM.2013.015 A242nd EFLM-BD European Conference on Preanalytical Phase to design a high quality and controlled phleboto- my process.,Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
http://dx.doi.org/10.11613/BM.2013.015 Biochemia Medica 2013;23(1):A1–A55   A252nd EFLM-BD European Conference on Preanalytical Phase samples.,Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
Biochemia Medica 2013;23(1):A1–A55  http://dx.doi.org/10.11613/BM.2013.015 A262nd EFLM-BD European Conference on Preanalytical Phase Results : The total proportion of clotted samples  decreased from 0.04% in 2009 to 0.03% in 2010 (P = 0.004); and this reduction was maintained in 201 1.,Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
"http://dx.doi.org/10.11613/BM.2013.015 Biochemia Medica 2013;23(1):A1–A55   A272nd EFLM-BD European Conference on Preanalytical Phase P41 The preanalytical phase starts before  blood collection Attard R *, Farrugia R, Bezzina Wettinger S Department of Applied Biomedical Science, Faculty of Health  Sciences, University of Malta Msida, Malta Background : Large biological collections are be- ing set up for biobanking, epidemiological studies and in the search of biomarkers.",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
Biochemia Medica 2013;23(1):A1–A55  http://dx.doi.org/10.11613/BM.2013.015 A282nd EFLM-BD European Conference on Preanalytical Phase de-identifi  ed and then evaluated using general  statistical methods.,Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
"http://dx.doi.org/10.11613/BM.2013.015 Biochemia Medica 2013;23(1):A1–A55   A292nd EFLM-BD European Conference on Preanalytical Phase P44 National guideline for phlebotomy in the  Netherlands Eppens E1, Roelofs-Thijssen M2, de Jonge N3, van Dongen-Lases E*4 1Department of Clinical Chemistry, Gelderse Vallei Hospital,  Ede, the Netherlands 2Department of Clinical Chemistry, Rijnstate Hospital, Arnhem,  the Netherlands 3Department of Clinical Chemistry, Leiden University Medical  Center, Leiden, the Netherlands 4Department of Clinical Chemistry, Academic Medical Center,  Amsterdam, the Netherlands Background : The Working Group Preanalytical  Phase of the Netherlands Society for Clinical Chem-istry and Laboratory Medicine addresses all ele-ments of the preanalytical phase of clinical chem-istry laboratory testing in the Netherlands.",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
Biochemia Medica 2013;23(1):A1–A55  http://dx.doi.org/10.11613/BM.2013.015 A302nd EFLM-BD European Conference on Preanalytical Phase Materials and methods : Plasma samples were  obtained from umbilical vein from 50 healthy full t e r m  n e o n a t e s  b o r n  i n  U n i v e r s i ty  M e d i c a l  C e n t r e  Ljubljana.,Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
"http://dx.doi.org/10.11613/BM.2013.015 Biochemia Medica 2013;23(1):A1–A55   A312nd EFLM-BD European Conference on Preanalytical Phase P47 Transportation of blood samples  through adjacent phlebotomist cabins to the laboratory by a simple conveyer belt reduces turn around time for the samples and waiting time for the patients and may make recommended hand inversions of samples with additives superfl  uous Stender S *, Mandir IA Department of Clinical Biochemistry, Copenhagen University  Hospital, Gentofte, Denmark Background : In our out-patient clinic blood sam- ples are drawn by phlebotomists in 5 separate but adjacent cabins placed as an elongation of the lab-oratory.",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
Biochemia Medica 2013;23(1):A1–A55  http://dx.doi.org/10.11613/BM.2013.015 A322nd EFLM-BD European Conference on Preanalytical Phase ous clinical departments.,Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
"http://dx.doi.org/10.11613/BM.2013.015 Biochemia Medica 2013;23(1):A1–A55   A332nd EFLM-BD European Conference on Preanalytical Phase P50 Implementing safe sharps practices in  Europe, what do I need to do?",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
"Biochemia Medica 2013;23(1):A1–A55  http://dx.doi.org/10.11613/BM.2013.015 A342nd EFLM-BD European Conference on Preanalytical Phase Results:  In the examined range of both lipemia in- dex and triglyceride concentration there was no signifi  cant diff  erence between the sodium levels,  measured by the above mentioned methods.",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
"http://dx.doi.org/10.11613/BM.2013.015 Biochemia Medica 2013;23(1):A1–A55   A352nd EFLM-BD European Conference on Preanalytical Phase P53 Appropriate time of thrombophilia  testing related to oral anticoagulant therapy: are recommended guidelines followed Margetić S* , Getaldić B, Ćelap I, Vrkić N Clinical Institute of Chemistry, Medical School Clinical Hospital  Center Sestre Milosrdnice, Zagreb, Croatia Background : The appropriate time of testing re- lated to oral anticoagulant therapy (OAT) is one of the crucial preanalytical variables for throm-bophilia investigation since many of these tests are aff  ected by this therapy.",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
Biochemia Medica 2013;23(1):A1–A55  http://dx.doi.org/10.11613/BM.2013.015 A362nd EFLM-BD European Conference on Preanalytical Phase tem (HIS) or LIS.,Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
"http://dx.doi.org/10.11613/BM.2013.015 Biochemia Medica 2013;23(1):A1–A55   A372nd EFLM-BD European Conference on Preanalytical Phase P56 Metabolomics technology validated  quality markers for biobank plasma samples Kamlage B*1, Schmitz O1, Schatz P2 1Metanomics GmbH, Berlin, Germany 2Metanomics Health GmbH, Berlin, Germany Background : Research in the healthcare area like  identifi  cation and validation of new diagnostic bi- omarkers, drug target discovery and treatment monitoring approaches often starts with the anal-ysis of existing biobank samples.",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
Biochemia Medica 2013;23(1):A1–A55  http://dx.doi.org/10.11613/BM.2013.015 A382nd EFLM-BD European Conference on Preanalytical Phase Conclusions : The C18 MEPS bin was found to be  eff ective for sample preparation of drugs of abuse  before forensic toxicological analysis.,Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
"http://dx.doi.org/10.11613/BM.2013.015 Biochemia Medica 2013;23(1):A1–A55   A392nd EFLM-BD European Conference on Preanalytical Phase Materials and methods : Verifi  cation of the  claimed LoD was performed on Cobas e 41 1 ana-lyzer (Roche Diagnostics GmbH, Mannheim, Ger-many).",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
"Biochemia Medica 2013;23(1):A1–A55  http://dx.doi.org/10.11613/BM.2013.015 A402nd EFLM-BD European Conference on Preanalytical Phase P61 Evaluation of the thrombin tubes and  processing by Statspin express for the need of urgent laboratory assays and impact on TAT Meško Brguljan P University Clinic for Respiratory Diseases and Allergy Golnik,  Clinical Chemistry Department, Golnik, Slovenia Background : The laboratory, in consultation with  the users, shall establish turnaround times (TAT) for each of the examinations that refl  ect clinical needs.",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
"http://dx.doi.org/10.11613/BM.2013.015 Biochemia Medica 2013;23(1):A1–A55   A412nd EFLM-BD European Conference on Preanalytical Phase munster, Austria) and Tube II: 3 mL Venosafe® 5.9  mg K2EDTA (Terumo, Europe, Leuven, Belgium).",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
"Biochemia Medica 2013;23(1):A1–A55  http://dx.doi.org/10.11613/BM.2013.015 A422nd EFLM-BD European Conference on Preanalytical Phase P64 Performance characteristics of a  commercially available reagent and dietil-eter for removing lipoproteins Marevic S *, Laskaj R, Sokolic B University Hospital for Infectious Diseases ‘’Dr.",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
http://dx.doi.org/10.11613/BM.2013.015 Biochemia Medica 2013;23(1):A1–A55   A432nd EFLM-BD European Conference on Preanalytical Phase penia due to antibiotic treatment of erysipelas.,Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
Biochemia Medica 2013;23(1):A1–A55  http://dx.doi.org/10.11613/BM.2013.015 A442nd EFLM-BD European Conference on Preanalytical Phase patient’s results.,Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
"http://dx.doi.org/10.11613/BM.2013.015 Biochemia Medica 2013;23(1):A1–A55   A452nd EFLM-BD European Conference on Preanalytical Phase P69 Pre-analytical factors of routine  coagulation assays in Norwegian hospital laboratories Kristoff  ersen AH*1, Stavelin A2, Vannes S1, Kristensen GB3 1Laboratory of Clinical Biochemistry, Haukeland University  Hospital, Bergen, Norway 2Norwegian Quality Improvement of Primary Care Laboratories  (NOKLUS), Department of Public Health and Primary Health Care, University of Bergen, Bergen, Norway 3Norwegian Clinical Chemistry EQA Programme (NKK), Bergen,  Norway Background : External quality assessment schemes  mainly consider the quality in the analytical phase, but studies have shown that up to 70% of the er-rors occur in the pre-analytical phase.",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
Biochemia Medica 2013;23(1):A1–A55  http://dx.doi.org/10.11613/BM.2013.015 A462nd EFLM-BD European Conference on Preanalytical Phase Results : 57 of 69 (83%) laboratories responded.,Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
"http://dx.doi.org/10.11613/BM.2013.015 Biochemia Medica 2013;23(1):A1–A55   A472nd EFLM-BD European Conference on Preanalytical Phase P72 Unsuitable specimens in clinical practice:  before and after an educational lecture Čeprnja M* , Serdar T, Hodak N, Živković M, Marijančević D,  Romić Ž Clinical Department for Laboratory Diagnostic, University  Hospital Dubrava, Zagreb, Croatia Background : Analyzing inadequate samples or  incorrectly identifi  ed samples can lead to fatal  consequences, so it is extremely important not to accept them for laboratory testing.",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
Biochemia Medica 2013;23(1):A1–A55  http://dx.doi.org/10.11613/BM.2013.015 A482nd EFLM-BD European Conference on Preanalytical Phase focus their attention on the incidents with the  greatest overall risk in their laboratory.,Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
"http://dx.doi.org/10.11613/BM.2013.015 Biochemia Medica 2013;23(1):A1–A55   A492nd EFLM-BD European Conference on Preanalytical Phase P75 Verifi  cation of lipemia interference for  routine clinical chemistry Nikolac N* , Miksa M, Saracevic A, Simundic AM University Department of Chemistry, Medical School University  Hospital Sestre Milosrdnice, Zagreb, Croatia Background : Lipemia interferes with large  number of laboratory tests.",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
Biochemia Medica 2013;23(1):A1–A55  http://dx.doi.org/10.11613/BM.2013.015 A502nd EFLM-BD European Conference on Preanalytical Phase patient group.,Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
"http://dx.doi.org/10.11613/BM.2013.015 Biochemia Medica 2013;23(1):A1–A55   A512nd EFLM-BD European Conference on Preanalytical Phase P78 Teaching preanalytics in biomedical  laboratory science Penttinen U Biomedical Laboratory Science, Novia University of Applied  Sciences, Vaasa, Finland In Finland education in biomedical laboratory sci- ence (BLS) is given by Universities of Applied Sci-ences (UAS) in Helsinki (Helsinki Metropolia UAS), Turku (Turku UAS), Kuopio (Savonia UAS), Tampere (Tampere UAS), Oulu (Oulu UAS), and Vaasa (Novia U A S ) .",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
Biochemia Medica 2013;23(1):A1–A55  http://dx.doi.org/10.11613/BM.2013.015 A522nd EFLM-BD European Conference on Preanalytical Phase necessary to fi  nd another way of storage.,Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
http://dx.doi.org/10.11613/BM.2013.015 Biochemia Medica 2013;23(1):A1–A55   A532nd EFLM-BD European Conference on Preanalytical Phase Material and methods: One tube from each of at  least 10 healthy volunteers was used for each test-ed condition.,Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
"Biochemia Medica 2013;23(1):A1–A55  http://dx.doi.org/10.11613/BM.2013.015 A542nd EFLM-BD European Conference on Preanalytical Phase not interfere up to 700 μmol/L (Jaff  e) and 300  μmol/L (enzymatic; manufacturer’s recommenda-tion: 171 and 342, respectively).",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
http://dx.doi.org/10.11613/BM.2013.015 Biochemia Medica 2013;23(1):A1–A55   A552nd EFLM-BD European Conference on Preanalytical Phase the Roche instrumentation for each specimen was  also recorded.,OADS,/arxiv_data1/oa_pdf/dd/b9/biochem_med-23-1-a1-14.PMC3900095.pdf
"http://dx.doi.org/10.11613/BM.2013.005 Biochemia Medica 2013;23(1):19–27   19Abstract Blood gas testing is a commonly ordered test in hospital setting s, where the results almost always have the potential to dictat e an immediate or  urgent response.",Non-OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
Biochemia Medica 2013;23(1):19–27  http://dx.doi.org/10.11613/BM.2013.005 20Baird G. Preanalytical considerations in blood gas analysis guards can be implemented.,Non-OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
http://dx.doi.org/10.11613/BM.2013.005 Biochemia Medica 2013;23(1):19–27   21Baird G. Preanalytical considerations in blood gas analysis Common indications for arterial blood gas testing  have been reviewed elsewhere (14).,Non-OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
Biochemia Medica 2013;23(1):19–27  http://dx.doi.org/10.11613/BM.2013.005 22Baird G. Preanalytical considerations in blood gas analysis should be at least 30 minutes) (29).,Non-OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
"http://dx.doi.org/10.11613/BM.2013.005 Biochemia Medica 2013;23(1):19–27   23Baird G. Preanalytical considerations in blood gas analysis esized to be a low temperature induced contrac- tion of the polymer molecules in plastic tubes, leading to a widening in the atomic-scales pores in the material; these pores would need to be large enough to allow oxygen to escape, but too small for the larger carbon dioxide molecules to transit, since pCO 2 does not change signifi  cantly in sam- ples in chilled plastic tubes.",Non-OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
Biochemia Medica 2013;23(1):19–27  http://dx.doi.org/10.11613/BM.2013.005 24Baird G. Preanalytical considerations in blood gas analysis dosis.,Non-OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
http://dx.doi.org/10.11613/BM.2013.005 Biochemia Medica 2013;23(1):19–27   25Baird G. Preanalytical considerations in blood gas analysis TABLE  2.,Non-OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
Biochemia Medica 2013;23(1):19–27  http://dx.doi.org/10.11613/BM.2013.005 26Baird G. Preanalytical considerations in blood gas analysis Summary Control of preanalytical variables in blood gas test- ing is critical for ensuring an accurate and prompt response to what is often an urgent test.,Non-OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
JAMA 1981;245:1762-3. http://dx.doi.org/10.1001/jama.1981.03310420052033.,Non-OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
Am J Clin Pathol 2011;136:829-33. http://dx.doi.org/10.1309/AJCPR28HWHSSDNON.,Non-OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
Ann Lab Med 2012;32:5-16. http://dx.doi.org/10.3343/alm.2012.32.1.5.,OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
Clin Bio- chem 2004;37:1043-51. http://dx.doi.org/10.1016/j.clinbio-chem.2004.,OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
Clin Biochem 2004;37:1052-62. http://dx.doi.org/10.1016/j.clinbiochem.2004.08.009.,OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
Clin Bio- chem 2004;37:1063-71. http://dx.doi.org/10.1016/j.clinbio- chem.,OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
Am J Clin Pathol 2003;120:18-26. http://dx.doi.org/10.1309/8U5D0MA6MFH2FG19.,Non-OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
Ann Clin Biochem 2010;47:101-10. http://dx.doi.org/10.1258/acb.2009.009222.,Non-OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
Clin Chem Lab Med 2008;46:3-8. http://dx.doi.org/10.1515/CCLM.2008.004.,OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
Clin Chem Lab Med 2008;46:271-9. http://dx.doi.org/10.1515/C CLM.2 008.043.13.,OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
Int J Qual Health Care 2005;17:243-8. http://dx.doi.org/10.1093/intqhc/mzi025.,OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
Clin Chim Acta 1995;233:1-17. http://dx.doi.org/10.1016/0009-8981-(94)05964-T. 20.,OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
Arch In-tern Med 2002;162:1885-90. http://dx.doi.org/10.1001/archinte.162.16.1885.,Non-OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
Clin Chem 2006;52:784-5. http://dx.doi.org/10.1373/clinchem.2005.064139.,OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
Nurs Crit Care 2008;13:132-7. http://dx.doi.org/10.1111/j.1478-5153.2008.00275.x.,Non-OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
http://dx.doi.org/10.11613/BM.2013.005 Biochemia Medica 2013;23(1):19–27   27Baird G. Preanalytical considerations in blood gas analysis 25.,Non-OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
Am J Surg  1986;151:362-3. http://dx.doi.org/10.1016/0002-9610(86)90468-X.,OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
": Available from: http://www.goldcopd.org/, 2011.",Non-OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
Respir Care 2011;56:503-9. http://dx.doi.org/10.4187/respcare.01175.,Non-OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
J Intensive Care Med 2010;25:104-10. http://dx.doi.org/10.1177/0885066609356164.,Non-OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
Crit Care Med 2008;36:296-327. http://dx.doi.org/10.1097/01.CCM.0000298158.12101.41.,Non-OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
"N Engl J Med 2001;345:1368-77. http://dx.doi.org/10.1056/NEJMoa010307, 34.",OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
Clin Biochem 1999;32:101-7. http://dx.doi.org/10.1016/S0009-9120(98)00098-8.,OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
Clin Chim Acta 2011;412:696-701.  http://dx.doi.org/10.1016/j.cca.2011.01.004.,OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
Clin Biochem 2012;45:372-3. http://dx.doi.org/10.1016/j.clinbiochem.2011.12.005.42.,OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
Crit Rev Clin Lab Sci 2011;48:143-53. http://dx.doi.org/10.3109/10408363.2011.600228.,Non-OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
Scand J Clin Lab Invest 2009;69:585-91. http://dx.doi.org/10.1080/00365510902878716.,Non-OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
Clin Biochem 2010;43:4-25. http://dx.doi.org/10.1016/j.clinbiochem.2009.10.001.,OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
Clin Chem Lab Med 2011;49:1303-9. http://dx.doi.org/10.1515/cclm.2011.611.,OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
Clin Chem 2011;57:1390-7. http://dx.doi.org/10.1373/clinchem.2011.167932.,OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
J Clin Pathol 2002;55:105-7. http://dx.doi.org/10.1136/jcp.55.2.105.,Non-OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
Eur Respir J 2008;31:469-72. http://dx.doi.org/10.1183/0 9031936.00039607.,Non-OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
Crit  Care Med 2005;33:1854-6. http://dx.doi.org/10.1097/01.CCM.0000171838.41529.22.,Non-OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
Am J He-matol 2010;85:882-5. http://dx.doi.org/10.1002/ajh.21810.,Non-OADS,/arxiv_data1/oa_pdf/0b/33/biochem_med-23-1-19-5.PMC3900096.pdf
Special issue: Responsible writing in science Biochemia Medica 2013;23(1):112–6  http://dx.doi.org/10.11613/BM.2013.014 112Abstract Introduction : Respiratory syncytial virus (RSV) infection is the most common  cause of hospitalization in infants and small children.,Non-OADS,/arxiv_data1/oa_pdf/e5/b7/biochem_med-23-1-112-13.PMC3900097.pdf
http://dx.doi.org/10.11613/BM.2013.014 Biochemia Medica 2013;23(1):112–6   113Kristić Kirin B. et al.,OADS,/arxiv_data1/oa_pdf/e5/b7/biochem_med-23-1-112-13.PMC3900097.pdf
Biochemia Medica 2013;23(1):112–6  http://dx.doi.org/10.11613/BM.2013.014 114Kristić Kirin B. et al.,OADS,/arxiv_data1/oa_pdf/e5/b7/biochem_med-23-1-112-13.PMC3900097.pdf
http://dx.doi.org/10.11613/BM.2013.014 Biochemia Medica 2013;23(1):112–6   115Kristić Kirin B. et al.,OADS,/arxiv_data1/oa_pdf/e5/b7/biochem_med-23-1-112-13.PMC3900097.pdf
Biochemia Medica 2013;23(1):112–6  http://dx.doi.org/10.11613/BM.2013.014 116Kristić Kirin B. et al.,OADS,/arxiv_data1/oa_pdf/e5/b7/biochem_med-23-1-112-13.PMC3900097.pdf
